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Abstract. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
Aims: 
To explore the lived experience of patients with chronic venous leg ulceration and to establish 
whether themes that impact on quality of life are addressed during wound care consultations. To 
develop a consultation template based on these themes and to evaluate the feasibility of a future 
randomised controlled trial to evaluate template utility. 
 
Methods: 
Three phases were undertaken. The first comprised qualitative interviews with 9 patients to identify 
how themes impacted on the daily lives of those with chronic venous leg ulceration.  The second 
phase used non-participant observation for 5 of the 9 patients to establish whether these themes 
were disclosed and addressed during consultations. A nominal group meeting of experts was 
undertaken to construct a new consultation template, which was verified by patient participants. The 
template was piloted with 9 new patient participants during the final phase to ascertain if a future 
randomised controlled trial to evaluate efficacy would be feasible.  
 
Results: 
Phase 1 established a range of themes and subthemes that served to diminish the quality of life of 
participants. Phases 2 revealed that many of these themes were either not disclosed by patient 
participants or, when raised, were often not fully addressed by the nurse during wound care 
consultations.  The new consensus consultation template was developed and piloted during phase 3.  
 
 
 
 
 
 
iii 
Conclusion: 
Chronic venous leg ulceration impacts on every area of the patient’s life but often such concerns 
were not disclosed or effectively addressed during wound care consultations. Although the pilot of 
the consultation template demonstrated that a future randomised controlled trial would not be 
feasible, valuable information was provided to inform potential future study design. 
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Glossary of terms: 
 
Ankle brachial pressure index (ABPI) 
An ABPI measurement provides a ratio of the systolic blood pressure in the arm, as an estimate of central 
systolic pressure, and the highest systolic pressure of three named vessels (the anterior and posterior tibial 
arteries and the doraslis pedis artery), in the lower leg for each limb. An ankle brachial pressure index (ABPI) 
of 0.8 is seen as the lowest reading to apply high compression bandaging (Vowden & Vowden, 2001). 
 
Chronic venous insufficiency (CVI) 
Is a long standing medical condition in which the veins have problems returning blood back to the heart. 
Valves may be incompetent, the veins may be partly blocked, blood may be leaking from the vessels and 
there may be deep vein thrombosis or phlebitis as a precursor to this condition. Skin reactions include 
varicose eczema, discoloration, thickening and an increased risk of ulceration. 
  
Chronic venous leg ulceration (CVLU) 
Chronic venous leg ulcer is defined as an open lesion between the knee and the ankle joint that remains 
unhealed for at least four weeks and occurs in the presence of venous disease (SIGN, 2010). 
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Department of Health (DH) 
The Department of Health (DH) lead across health and care by creating national policies and legislation, 
providing the long-term vision and ambition to meet current and future challenges, putting health and care at 
the heart of government, and being a global leader in health and care policy. 
 
District Nurse (DN) 
The DN is a key member of the primary health care team and plays a crucial role, visiting people in their own 
homes or in residential care homes, providing care for patients and supporting family members. 
 
Evidence based practice (EBP) 
EBP is an interdisciplinary approach to clinical practice based on the principle of the importance of research to 
support clinical decisions.  
 
General Practitioner (GP) 
A medical practitioner, who treats both acute and chronic disease, provides preventative care and health 
promotion most often in a primary care environment. 
 
Health care professional (HCP) 
In the context of this thesis, HCP refers to all health care professionals who have face-to-face patient contact, 
including doctors, nurses, physiotherapists and occupational therapists. 
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Health related quality of life (HRQoL) 
HRQoL is a multi-dimensional concept that includes physical, psychological and social functioning and 
focuses on the impact conditions and illnesses on quality of life.  
 
Nursing and Midwifery Council (NMC) 
The NMC is the regulator for nursing and midwifery in England, Wales, Scotland, Northern Ireland and the 
Islands. They safeguard public health and wellbeing of the public; they set the standards for education, 
training, conduct and performance so that nurses and midwives; they ensure that skills, knowledge and 
professional standards are upheld.  
 
Patient centred care (PCC) 
PCC supports the active engagement of the patient and their family in their care and decision making.   
 
Patient reported outcome measures (PROMs) 
PROMs provide an assessment of the quality of care delivered to NHS patients from the patient perspective.  
 
Primary care 
Primary care is healthcare provided outside acute hospitals, it is often the first point of contact and is most 
often general practice focused.   
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Quality of life (QoL) 
QoL refers to the general well-being of individuals and society and is often used interchangeably with HRQoL. 
 
Shared decision making (SDM) 
SDM refers to a patient being actively involved in decisions relating to their care, as opposed to decisions 
being made for them by their HCP. 
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Key to transcripts in Chapter 4.3: 
 
 
 [     ]  Background information to make the context, meaning or dialect clear. 
 
 ……  Pause 
 
 (…..)  Words or phrases have been edited out. 
 
      *  Comment from field notes (not interview transcript).    
 
 
Transcript conventions have been adapted from the ethnographic text by P. E. Willis (1977, page 
viiii). 
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Chapter 1: Introduction. 
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Chapter 1:  Introduction. 
 
Chapter 1 provides an introduction to the thesis and includes an overview of the area of study, 
accompanied by the personal and professional motivation for the exploration of this topic area. In 
addition, the construction of the specific research questions, the background to study design and an 
outline of the structure of the thesis is provided (figure 2, page 22). 
 
1.1  Introduction. 
Chronic venous leg ulceration (CVLU) is a long term condition that affects many thousands of people 
worldwide, most often as a result of chronic venous insufficiency (CVI) (Posnett & Franks, 2007). 
The annual costs for the care and management of the condition are high and, with a global ageing 
population, are expected to continue to rise since prevalence increases with age (Moffatt et al, 2004; 
Persoon et al, 2004; Posnett & Franks, 2007). The majority of care for these patients is delivered in 
the community, at a clinic location or at home, principally by teams of district nurses (DN) (Nelzen et 
al, 1997; McGuckin et al, 2000). Research suggests that this care often has an exclusive wound 
management focus and is of varying quality, with little attention paid to the impact that the ulceration 
poses for the individual (Callam et al, 1985; McGuckin et al, 2000; Persoon et al, 2004). The 
personal cost to the patient and their carers as a result of the CVLU is significant and is often either 
underestimated or simply overlooked by their health care professional (HCP) (Franks & Moffatt, 
2007). 
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1.2   Rationale for the study. 
The delivery of nursing care within the community has, over recent years, undergone considerable 
‘modernisation’ which has expanded the remit of DN teams to include responsibility for more acute 
patients and an increasingly busy schedule (QNI, 2009; DH, 2013, RCN, 2013). In addition to these 
increasing ‘acute’ demands, each DN continues to have day-to-day responsibility for the care of 
many patients who suffer from debilitating long term and palliative conditions. Balancing these 
competing demands, often accompanied by diminishing staff numbers, presents every DN team with 
daily challenges (QNI, 2013). As a result, DNs are increasingly having to take a reactive approach to 
their expanding workload, ‘juggling’ the challenge of new, dependent patients with their regular 
patients, in order to ensure that risks are managed and care is optimised (QNI, 2009). These 
changes, according to the Queen’s Nursing Institute (QNI, 2009; 2013), often result in delayed visits, 
hurried consultations and potentially compromised care.  
 
Patients with CVLU are generally, but not exclusively, elderly and often present with long periods of 
ulceration and, when healing does occur, frequently there is recurrence as a result of their underlying 
CVI (Lindsay, 2000; Ebbeskog & Ekman, 2001a; Yarwood-Ross & Haigh, 2013). Regular DN visits 
of considerable length are required for such patients, which places significant pressure on an already 
strained service and its limited resources (Ouien et al, 2000). Such increasing pressure on the 
service may be a factor that contributes to the reported wound management focus of consultations 
and the variability of the quality of the care provided (Callam et al, 1985; McGuckin et al, 2000; 
Persoon et al, 2004).  
 
Many DN teams, as a way of managing these increasing demands, have adopted the approach of 
providing wound care consultations at central clinic bases. Such clinics often employ a variety of 
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innovative models such as the Leg Club Model (Lindsay, 1999), which aims to provide holistic care 
in non-clinical surroundings, and out of hours clinics that improve access to services (Lindsay, 2000; 
DH, 2013). These steps go some way to managing increasing demands; however, it is often the 
CVLU patients specifically who are unable to attend such clinics due to the effects of co-morbidities 
and the impact of their increasing age (Lindsay, 2000; SIGN, 2010). Effective service redesign is 
essential and is high on the Government agenda, but in the meantime it appears that the needs of 
CVLU patients are often not being met during their current wound care consultations (DH, 2013; 
QNI, 2013). 
 
1.2.1  Personal motivation for the study. 
Having been a DN Caseload Manager for eight years, I had seen at first hand the increasing 
pressure on the service; including reductions in staffing levels, earlier discharges of very dependent 
patients from hospital into the community and an expansion of the caseload. The challenge of 
allocating and managing this daily workload was mounting and my ability to deliver high quality care 
was gradually being challenged; consultation times were subsequently reduced and the allocation of 
time was being closely monitored by managers.  
 
Following a move into nurse education in 2003, I maintained my links with local DN teams by 
accompanying students on their placements in clinical practice. It was on one of these accompanied 
student visits that this research was inspired. During one such visit, I met Nellie who was 82 years of 
age and had a long history of CVLU. On this visit the student nurse had been asked to renew Nellie’s 
bilateral leg bandages and it was during this visit that I had an opportunity to discuss with Nellie the 
impact that leg ulceration had made on her life.  
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I asked Nellie to tell me about her leg ulcers, to which she sighed and recounted her experience of 
60 years of ulceration. On her wedding photograph on the wall she had bilateral bandages on her 
legs and on this day, 60 years later, we were in attendance, again replacing her bilateral bandages. I 
was astounded; despite knowing of the longevity of CVLU, this was certainly the longest I had ever 
known anyone suffer from CVLU. Nellie reported having experienced some periods of healing but 
her ulcers had inevitably returned: sometimes after months, occasionally after a year but most often 
after only a few weeks following healing. 
 
Throughout this 60 year period Nellie spoke of being a wife and a mother; she had worked at a local 
pottery company; she had seen her children marry and have children of their own and she had been 
widowed 10 years earlier. Throughout all of these episodes of her life she had suffered from CVLU; 
and now at the age of 82 years, she was dependent on carers, immobile and still required bilateral 
bandages to her lower legs. Nurses were currently visiting three times weekly for up to 45 minutes 
per visit to redress her ulcers.  
 
Nellie’s life had been completely defined by her ulceration. This made me consider the care she had 
received over this prolonged period and whether, on the many occasions she had contact with the 
HCPs to care for her leg ulcers over these 60 years, had we, as HCPs, ever really explored what 
Nellie’s life was like on a day-to-day basis. Had we ever considered whether anything could be put in 
place to improve her symptoms and ease the impact of her CVLU, however simple? Healing without 
recurrence may never have been an achievable goal in Nellie’s case, but easing of her symptoms 
and attempting to reduce the impact on her daily functioning may well have been a more appropriate 
priority for her care. 
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Nellie’s visit certainly made an impact on me and profoundly influenced my choice of study topic for 
future research. I came away from the visit knowing that the current priority of care for CVLU 
patients, which so often was focussed on the achievement of healing in an almost blinkered fashion, 
even when, for many, this was not an achievable goal was not always the most appropriate priority 
(Heit et al, 2001). I wanted to explore whether a shift in the focus of the consultation away from an 
exclusive healing focus towards a more patient centred approach (PCC), where the daily needs of 
the patient were central, would enhance quality of life (QoL) and satisfaction with care provision for 
this patient group.  
 
1.3  Background to the study area. 
This thesis presents a mixed methods study that explores a patient centred approach to care for 
people with chronic venous leg ulceration. The study question was formulated using the PICO 
approach to ensure that it was relevant and sufficiently focussed (Richardson et al, 1995; Huang et 
al, 2006). The overall study question is: 
 
Does a patient focus to consultations in the care of patients with chronic venous leg 
ulceration improve patient satisfaction and quality of life? 
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PICO (Richardson et al, 1995) is an acronym which stands for the population or patient problem (P); 
the intervention (I); the comparator (C) and the outcome (O). The following sections (1.3.1 – 1.3.4.2) 
provide explanations of the key PICO elements which have informed the development of both the 
overall and the individual research questions for this study:  
 the population (P): adult patients in the community setting with CVLU; 
  the intervention (I): PCC;  
 the comparison (C): usual care (applied during phase 3 of the study) (chapter 8;page 
247) and  
 the outcomes (O): patient satisfaction and quality of life.   
 
1.3.1 Population (P) – adults with chronic venous leg ulceration in the community 
setting. 
A leg ulcer is defined as a wound below the knee which fails to heal within six weeks (Nelzen et al, 
1997; SIGN, 2010). Prevalence of ulcers internationally is high and up to 80% of cases have a 
venous component and, as a result of the underlying CVI; such ulcers are difficult to heal and have a 
high tendency to recur (Callam et al, 1985; Moffat et al, 1992; Nelzen et al, 1997; Posnett & Franks, 
2007).  Leg ulcers are classified as venous, mixed or of arterial aetiology following a thorough clinical 
assessment and the recording of an ankle-brachial pressure index (ABPI) ratio using a Doppler 
ultrasound (Vowden & Vowden, 2001). The clinical assessment is the key feature of assessment, 
with the ABPI ratio an adjunct to diagnostic process (Ruff, 2003). The ABPI reading is the ratio of the 
systolic blood pressure at the ankle divided by the brachial systolic blood pressure and, along with 
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the clinical assessment, informs the optimal management of the range of leg ulcer classifications 
(Vowden & Vowden, 2001; Ruff, 2003; SIGN, 2010). 
 
Table 1: Ankle brachial pressure index classification and interpretation (Vowden & Vowden, 2001). 
 
ABPI value Interpretation. 
> 1.2 Vessels abnormally hardened due to peripheral vascular disease: routine specialist 
referral. 
0.8 - 1.2 Normal range. Classified as venous aetiology. 
0.5 - 0.8 Moderate arterial disease: specialist referral. Classified as mixed aetiology. 
< 0.5 Severe arterial disease: urgent specialist referral. Classified as arterial aetiology. 
 
 
Table 1 (above) provides detail of potential ABPI ratio results and subsequent ulcer classification. 
Ulcers are deemed to be of venous aetiology following a clinical assessment and an ABPI ratio of 
between 0.8-1.2. Such a ratio indicates that high compression bandaging; a method of venous ulcer 
management evidenced to improve healing rates, may be safely applied (Moffat, 1998; 2004; SIGN, 
2010). Arterial ulcers, in contrast to venous, differ in their cause, location and presentation, and 
account for 13 - 15% of all leg ulcers (Callam et al, 1985; Kippel & Dieppe, 1998). An arterial ulcer 
presents with an ABPI ratio of below 0.5 (Vowden & Vowden, 2001). Healing for such patients is 
dependent on the surgical restoration of circulation and oxygenation and an urgent specialist referral 
is required; the use of any compression bandaging is contraindicated as it would compromise an 
already limited blood supply (Vowden & Vowden, 2001). In between these two aetiologies, 10 - 15% 
of ulcers have an element of arterial impairment (Callam et al, 1985) and are classified as being of 
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‘mixed aetiology’, presenting with an ABPI ratio of between 0.5 and 0.8. Such patients require a 
routine specialist referral, but following further assessment, are often managed in a similar way to 
their venous counterpart, albeit with reduced compression (Vowden & Vowden, 2001). Patients with 
either venous and mixed aetiology ulcer classifications were included within this study, as their 
presentation, symptoms and management are similar. Patients with arterial ulceration differ 
considerably in both their presentation, symptoms and management and often have a multitude of 
other co-morbidities to deal with; in view of this, patients with arterial ulceration were excluded from 
the study. 
 
CVLUs are the most commonly occurring wound with the most recent estimates of up to one in 500 
of the UK population experiencing an ulcer (Yarwood-Ross & Haigh, 2013). Heit et al (2001) 
demonstrated an annual recurrence rate of between 33-42%, a statistic that has not improved over 
the last 20 years. The condition is expensive, with annual costs for care and management 
conservatively estimated in 2007 to be in the region of £200 million (Posnett & Franks, 2007); a sum 
mostly directed to primary care where the majority of the care for such patients is delivered (Posnett 
& Franks, 2007; SIGN, 2010).  Indeed studies estimate that DNs provide care for 82-87% of patients 
with CVLU (Callam et al, 1985; Nelzen et al, 1990; SIGN, 2010). CVLUs impact on all areas of the 
life of the patient and their carers (Hyde et al, 1999; Rich & McLachlan, 2003); with lives complicated 
by issues such as intractable pain, restricted mobility, odour, depression, anxiety and social isolation 
(Jones & Nelson, 2005). QoL is diminished both as a result of the debilitating symptoms of the 
ulceration but also due to the recalcitrant nature of the condition (Persoon et al, 2004; Briggs & 
Flemming, 2007).  
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1.3.2  Intervention (I) - patient centred care (PCC).   
The concept of PCC underpins this study and is explored more fully in chapter 2 (page 23) but also 
describes the intervention for the study. PCC depicts a move from seeing the patient in terms of their 
disease or pathology to thinking in terms of the person and their problems (Henbest & Stewart, 1989; 
McCormack & McCance, 2006). A PCC approach embraces the development of an environment 
where healthcare decisions are made jointly between the practitioner and the patient (Légaré et al, 
2009); indeed Stewart (2001) described this as an attempt to make  
“...the implicit in patient care explicit.” (Stewart, 2001; p. 444)  
The clinical consultation is considered to be the central focus of HCP-patient communication, with 
the development of a therapeutic relationship between the professional and the patient considered 
an essential component to PCC (Dieppe et al, 2002; Entwistle & Watt, 2006: Lewin et al, 2009). The 
relationship between the HCP and the patient, it is said, should be based on,  
“…mutual trust, understanding and shared knowledge being paramount.” (McCormack & 
McCance, 2006; p.472) 
 
A number of studies report that PCC is valued by patients and demonstrate that it results in 
improved communication, optimised patient participation, enhanced concordance and improved 
adherence to treatment plans, better health outcomes, enhanced satisfaction with care and 
improvements in QoL (Stewart et al, 2000; Stewart, 2001; Dieppe et al, 2002; Michie et al, 2002; 
Swenson et al, 2004; Irwin & Richards, 2006; Poochikian-Sarkissian et al, 2010). There also appear 
to be significant advantages for the health care professional, with research asserting that the delivery 
of PCC improves job satisfaction and enhances feelings of empowerment (Thorne, 2005; Brown et 
al, 2006). 
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1.3.3  The comparator (C) –usual care. 
Usual care is frequently adopted as the care delivered to a control group during a randomised 
controlled trial and provides a baseline with which to compare results (Hicks, 2004). It is said that 
usual care  
“...depends heavily on the knowledge, skills and resources of the health care professionals 
delivering it” (Hotopf, 2002; p. 329) 
For the purpose of the final phase of the study, a pilot study, the intervention (I) to enhance PCC was 
compared (C) to usual care for the same group of patients.  
 
1.3.4  The outcomes (O) – patient satisfaction and quality of life. 
Following a review of the literature, two outcomes were considered to be appropriate for the final 
phase of the study. Patient satisfaction is an important and widely used outcome measure often 
applied to evaluate the effectiveness of interventions that manipulate care provision (Kinmonth et al, 
1998; Pill et al, 1998). Such studies are explored in more detail in chapter 6 (page 194). QoL, as an 
outcome measure, has also been used extensively not only to explore the effectiveness of care 
interventions but also to capture the impact of a variety of conditions on the patient’s life (Jull et al, 
2004; Franks et al, 2006; Faria et al, 2011). QoL studies in relation to CVLU are explored in the 
literature review in chapter 3 (page 50). 
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1.3.4.1  Patient satisfaction. 
Patient satisfaction is defined as, 
“...the extent of an individual’s experience compared with his or her expectations.” (Asadi-
Lari et al, 2004; p. 33) 
Assessing and monitoring such satisfaction within health care has become increasingly important 
and constitutes a significant focus within the NHS, especially with the recent emphasis on patient-
reported outcome measures (PROMs) which aim to reflect what a patient sees as significant from 
their care (McDonald & Langford, 2000; DH, 2006; Marshall et al, 2006). Such patient satisfaction is 
seen as an important outcome of care; indeed patients who are satisfied are increasingly likely to be 
concordant with their treatment plan and to perceive their care to be of good quality (Donadedian, 
1988; Baker, 1990; Asadi-Lari et al, 2004; Moffatt, 2004). The evaluation of patient satisfaction is 
seen as an essential feature to improving service provision (Gill & White, 2009); however many 
satisfaction studies have tended to focus on the development and validation of measurement tools, 
which, to date, are said to be of varying quality (Hawthorne, 2006).  
 
Few studies have explored and evaluated patient satisfaction in relation to the care provided in the 
community setting generally or, more specifically, patient satisfaction with their DN consultations 
(Poulton, 1996; Gilleard & Reed, 1998; McDonald & Langford, 2000; Tornvist et al, 2000). Tornvist et 
al (2000), however, undertook one such study in Sweden and demonstrated that, overall, patients 
reported that they were extremely satisfied with the care from their DN, although deficits were 
demonstrated in the areas of patient involvement in SDM, pain management and continuity of care. 
Even fewer studies have sought to review satisfaction with care specifically for patients with CVLUs; 
indeed Tornvall and Wilhelmsson’s (2010) study was thought to be the first study to specifically 
evaluate the perspective of patients with CVLU with the quality of their DN care provision. This study 
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similarly concluded that there was a high degree of satisfaction with DN care (Tornvist et al, 2000) 
but patients expressed a need for improved patient centredness in their consultations, enhanced 
pain management and enriched continuity of care delivery. Again this study was undertaken in 
Sweden and, as such, may reflect the design of Swedish community services which are markedly 
different than our United Kingdom (UK) service design. To date, no UK studies have aimed to 
evaluate care delivery for this client group and, since CVLU is a longstanding condition that 
demands a lengthy and intense relationship with the nurse, there is an urgent need for more 
research to evaluate care delivery for this client group (Chase et al, 1997; Douglas, 2001; Tornvall & 
Wilhelmsson, 2010). 
 
1.3.4.2  Quality of life (QoL). 
The World Health Organisation (WHO) (1997) defines quality of life (QoL) as an 
“...individual’s perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns. It is a broad ranging concept affected by the person’s physical state of health, 
psychological state, level of independence, social relationships, personal beliefs and their 
relationship to salient features of the environment”  (WHO, 1997; p. 1). 
The concept when related to health and health care is often termed health related quality of life 
(HRQoL) and refers to the self reported appraisal of health - in physical, psychological and social 
domains – by an individual, over time (Bowling, 2005). Such an assessment is helpful when 
assessing the effects of chronic illness and in developing an understanding of how illness affects a 
person's day-to-day life (Walters et al, 1999; Fayers & Machin, 2000; Franks & Moffatt, 2001; 
Charles, 2004; van Korlaar et al, 2003).  
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Over the last 20 years there has been a growing interest in exploring and attempting to quantify the 
QoL of people across the whole range of healthcare delivery (Bowling, 2005). This interest has been 
attributed to a number of factors including the development of professional roles, a growing reliance 
on the evidence base for practice (EBP) and a need to foster patient empowerment; especially in the 
management of long term conditions (DH, 2005; O’Boyle, 2008; Moore & Cowman, 2009). These 
factors have served to heighten an awareness of the need to explore the impact of a variety of 
chronic illnesses on the QoL of the patient, both to understand the impact of the illness and also to 
investigate the effects of various treatment modalities on the life of the sufferer (Bowling, 2005).  
 
QoL evaluation is frequently applied as an outcome measure in research that evaluates the impact 
of treatment or care delivery (DH, 2013). In the area of CVLU care, research unequivocally 
demonstrates a decline in the QoL of the patient, with significant effects demonstrated across 
physical, psychological and social dimensions (Chase et al, 1997; Franks & Moffatt, 2001; Persoon 
et al, 2004; Briggs & Flemming, 2007). Studies that explore QoL for this client group apply a range of 
research methods. Qualitative studies serve to develop our understanding of how life is for the leg 
ulcer patient, in their words (Persoon et al, 2004; Briggs & Flemming, 2007); the rich data produced 
provides a clear insight into the opinions and feelings behind the participants’ responses, which are 
supported by the use of powerful quotations. In contrast, the quantitative studies focus on 
enumerating characteristics, using instruments to assess QoL which are generic in their design, 
devised to assess the population in general or disease-specific, devised to focus on a particular 
disease and to be sensitive to precise aspects of that condition (Bowling, 2005). The generic QoL 
measures are broad ranging and well established, often having been used extensively with many 
conditions (Bowling, 2005) and include the Medical Outcome Study Short Form-36 (SF-36) (Ware & 
Sherbourne, 1992), the Nottingham Health Profile (NHP) (Hunt et al, 1986) and the EuroQol (EQ) 
(EuroQol Group, 1990). The disease-specific QoL questionnaires are designed specifically to focus 
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on characteristics of a particular condition and aspire to be responsive to even minor changes in the 
health of the sufferer (Bowling, 2005). In order for these disease-specific tools to be effective, the 
validity and reliability of the instrument has to be tested and established along with their practicality, 
sensitivity and specificity (Hareendran et al, 2005; Palfreyman, 2007a). A number of the studies 
utilise both disease-specific QoL tool and generic tools (Smith et al, 2000; Price and Harding, 2004; 
Iglesias et al, 2005; Palfreyman, 2008) and, as a result, aim to provide a wide range of information 
and often a more complete picture of the patient experience. 
 
1.4  The study hypotheses. 
The care of the patient with CVLU tends to overlook the impact of the condition on day-to-day 
functioning, with the nurse appearing to favour a wound care focus for the consultation (Persoon et 
al, 2004). Such a focus may preclude the consulting nurse from effectively evaluating the impact of 
ulceration beyond the provision of wound care and thus may limit their ability to address the needs of 
the patient effectively. Since this study involves a number of qualitative phases and a pilot study, 
hypothesis testing is not appropriate (Leon et al, 2011), however, a number of hypotheses would 
underpin a future randomised controlled study (RCT), if such a study were deemed to be feasible. 
Such hypotheses, for a full RCT, are described as being experimental (H1) and null (H0). The 
experimental hypothesis (H1) 
“predicts a relationship between two or more variables.” (Hicks, 2004; p. 66) 
while the null hypothesis (H0) describes a situation when the relationship described by the 
experimental hypothesis does not exist, with any change being attributed to chance or other 
unrelated factors. In any ensuing study, the researcher’s aim is to reject the null hypothesis and thus 
evidence sufficient support for the experimental hypothesis (Hicks, 2004; Denscombe, 2007). As 
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said, hypothesis testing would not be undertaken within this study since the final phase is designed 
as a pilot study, however the following hypotheses would be appropriate for a future full RCT:  
 
H1 Patients with chronic venous leg ulceration will demonstrate improvements in satisfaction 
with their care as a result of a patient centred consultation when compared to their usual 
consultation. 
H0 Patients with chronic venous leg ulceration will not demonstrate improvements in 
satisfaction with their care as a result of a patient centred consultation when compared to 
their usual consultation. 
H1 Patients with chronic venous leg ulceration will demonstrate improvements in their quality of 
life as a result of a patient centred consultation when compared to their usual consultation. 
H0 Patients with chronic venous leg ulceration will not demonstrate improvements in their 
quality of life as a result of a patient centred consultation when compared to their usual 
consultation. 
 
1.5  The research questions. 
In response to the above hypotheses, a three phased mixed method study was proposed in order to 
answer the following four research questions:     
1. What are the significant factors that impact on the day-to-day lives of people with 
chronic venous leg ulceration (Phase 1)? 
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2. To what extent are these factors elicited and addressed during the patients’ 
consultations (Phase 2)?  
 
3. Can expert and patient consensus create a model consultation template for patients with 
chronic venous leg ulceration (Nominal group)? 
 
4. Is a future full randomised controlled trial (RCT) of the new model consultation template 
feasible (Phase 3)?  
 
A mixed methods approach has been adopted in order to effectively answer these research 
questions. Qualitative methods have been applied during the initial phases (phase 1 and 2 and the 
nominal group) in order to provide a preliminary base; qualitative methods are often used in this way, 
most often when there is a scarcity of relevant prior knowledge (Hicks, 2004).  For the final phase, 
quantitative methods were employed to pilot the newly developed consultation template (Pope & 
Mays, 1995). Such a mixed methods approach ensures the accuracy of study findings, allows for the 
triangulation of results and provides a pragmatic approach to the research problem (Meadows, 2003; 
Denscombe, 2007).  
 
Following a review of the literature available in this area (chapter 3, page 50), this study design was 
felt to represent an original approach to the development of a patient focus to the care and 
management of patients who suffer from CVLU. This project builds on previous research and 
generates new knowledge in relation to factors that impact on the day-to-day life of patients with 
CVLU. This study develops a patient centred approach to care for patients with CVLU and pilots this 
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in terms of patient satisfaction and QoL outcomes, using a number of previously validated 
measurement tools. The overall study design is illustrated in figure 1 overleaf. 
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Figure 1: Whole study flow chart 
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1.6  Structure and content of the thesis. 
As discussed (page 4), the questions that formed the basis for this study were embedded in the 
clinical context in which they were formulated. This study has not only been a research journey for 
myself, as a clinical practitioner and novice researcher, but also for the nurse and patient participants 
who formed part of my study, to whom grateful thanks are extended. This thesis documents this 
journey and conveys the learning and development which occurred along the way. Figure 2 (page 
22) provides an illustration of the overall layout of the thesis. Each of the distinct phases has been 
reported within a single chapter to include a combined methodology and methods section, a results 
section and discussion relating to the findings for that study phase. It was felt that such an approach 
would provide structure and clarity for the reader. 
 
Chapter 1 has provided an introduction to the study and has described the clinical context of the 
condition under scrutiny and its associated care delivery. It has provided an outline of the 
professional and personal impetus to develop and undertake the study, often during very difficult 
times in a rapidly changing National Health Service (NHS) (QNI, 2009; DH, 2013). It has also 
provided explanations of key terms related to CVLU and introduced the research questions. Chapter 
2 provides an introduction to the theoretical underpinnings and explores both the central and 
interrelated theories that support the methods, design and development of the study. The third 
chapter presents a review of the literature to date that has explored the impact of CVLU on QoL and 
includes detail of the systematic literature search and the narrative synthesis process that was 
undertaken.  
 
Chapters 4 and 5 focus on phase 1 and 2 of the study respectively and are each presented to 
include the methodology and methods, results and discussion. The sixth chapter presents a succinct 
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review of the literature relating to consultation-based nurse interventions designed to improve the 
patient centredness of clinical encounters. Chapter 7 provides an exploration of the nominal group 
technique and reports the development of the new consultation template. Chapter 8 is again 
presented to include the methodology and methods, results and discussion for phase 3, the final 
phase of the study. Finally, chapter 9 presents an overall synthesis and discussion of the findings of 
the study as a whole, its inherent strengths and weaknesses of the study and the conclusions drawn. 
This chapter also provides recommendations for improvements in patient care, developments to 
clinical practice and ideas for further research. References and appendices complete the thesis. 
 
1.7  Conclusion. 
This chapter has provided the background to the study area and has detailed explanations of some 
of the key terms. It has explored the motives that underpin the study and described the construction 
of the research questions. An explanation of the layout of the thesis chapters has also been 
provided. The next chapter presents an exploration of the theoretical underpinnings of the thesis. 
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Figure 2: Overall PhD structure. 
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Chapter 2: An introduction to the theoretical underpinnings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24 
Chapter 2:  An introduction to the theoretical underpinnings. 
 
 
This chapter provides the background to patient centred care (PCC), the main underpinning theory 
for the study. In addition a number of interrelated theories and concepts that have also underpinned 
and strengthened the design, analysis and interpretation of this study are explored. Links are made, 
where appropriate, throughout the thesis to these theories and concepts.  
 
2.1   Introduction. 
As presented in chapter 1 (page 1 - 21), the basis of this study originated within clinical care and was 
based on the premise that putting the patient at the centre of the consultation would improve their 
experience, their satisfaction and, potentially, their QoL. The centrality of the patient within their care 
provision is fundamental to a number of theories and is often described as either patient or person 
centred care (PCC) (Henbest & Stewart, 1989; McCormack & McCance, 2006); terms that have 
been applied interchangeably within this thesis. PCC is important in both the UK and international 
healthcare agenda and has recently been acknowledged as a key measure of the quality of health 
care provision (DH 2000, 2001a, 2004; Dieppe et al, 2002; Entwistle et al, 2004; WHO, 2005; de 
Haes, 2006; McCormack & McCance, 2006; Robinson et al, 2008; Timmins & Astin, 2009).  
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2.2   Patient centred care. 
The concepts embedded in PCC were initially described in the 1950s by a Hungarian psychoanalyst, 
Michael Balint. Balint (1957) outlined a biopsychosocial approach, specifically related to medical 
care, which he labelled ‘patient-centred medicine’. This, at the time, was in direct contrast to the 
firmly established biomedical model which was dominated by a disease focus and was historically 
paternalistic in its approach (Henbest & Stewart, 1989; Teutsch, 2003). In the 1950s, practice was 
completely provider-focussed and patients received care with little or no consideration for their 
preferences (Robinson et al, 2008).  
 
The development of PCC was also influenced by the work of the psychologist Carl Rogers, a 
renowned humanistic psychologist who proposed a ‘person centred approach’ in order to facilitate 
the psychological progression of his clients (Rogers & Stevens, 1967). Rogers (1967) emphasised 
that clients should be fully involved in their care, with a genuine, empathetic relationship between the 
client and their HCP at the centre; a relationship Rogers (1967) described as ‘the helping 
relationship’. This principle is a central characteristic of many models of PCC today (Salvage, 1990) 
and at the core of a number of nursing models and theories across specialities (Orem, 1971; Roy, 
1976; Benner, 1984; Watson, 1985). The work of an American, George Engel (1977), also a 
psychologist, also influenced the development of PCC with proposals for a new medical model 
based on the bio-psychosocial rather than the widely held biomedical model in medicine.  
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More recently, Stewart et al (2000), a general practitioner (GP) renowned for her research exploring 
the nature of consultations in primary care, defined PCC as a relationship between the HCP and the 
patient that has as its focus the well-being of the patient, with their psychological and social situation 
and their experience of illness central to the interaction. Stewart et al (2000) claimed that such a 
PCC relationship could be achieved by ensuring patient involvement in all treatment decisions and 
with improved communication. The Cochrane Collaboration (Lewin et al, 2009) provides a more 
recent definition of PCC stating that it is based on two main features: the sharing of decisions 
regarding health problems with the patient and the provision of care that focuses on the patient as a 
person not just a disease.  
 
Conceptual developments surrounding PCC have stalled, partly because of a lack of consensus on a 
clear definition of PCC and little evidence of benefit (Mead & Bower, 2000; de Haes, 2006; Lewin et 
al, 2009). There are distinct similarities with other ‘theories’ that surround the HCP-patient 
relationship, which, de Haes (2006) has suggested, may also have limited distinct PCC theory 
development and may have led to it being seen as a “...‘fuzzy’ or elusive concept” (de Haes, 2006; p. 
292).  This view, de Haes (2006) claims, has resulted in a temptation to group all that is ‘good’ about 
care and communication as being PCC, a feature that has not been helpful in establishing the 
effectiveness of a PCC approach. 
 
Despite the centrality of the consultation within PCC and the availability of some evidence to support 
that a patient centred clinical encounter has benefits including improvements in functional status, 
enhanced self-care and enriched patient satisfaction (Mead & Bowers, 2000; Lewin et al, 2009; 
Poochikian-Sarkissian et al, 2010); practitioners continue to fail to elicit patients’ concerns or to 
negotiate their treatment options consistently during consultations (Ley et al, 1976; Griffin et al, 
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2004; de Haes, 2006). Research also demonstrates that patients are frequently reluctant to disclose 
their concerns (Bugge et al, 2006). This lack of effective two-way communication during the 
consultation has been the feature of a number of research studies. In 1979, Stewart, McWhinney 
and Buck undertook a study of GP consultations and demonstrated that 54% of patient problems 
and 45% of patient concerns were either not elicited by the physician or disclosed by the patient 
during the consultation. Tuckett et al (1985) reported that during only 6% of observed consultations 
the doctor made an active effort to elicit patient views about the significance of their diagnosis and in 
1995, Stewart observed that the physician and patient failed to agree on the presenting problem 
during 50% of consultations. More recently, in 2002, an MRCGP study that utilised video to evaluate 
consultations found that established criteria to demonstrate patient-centredness were rarely 
achieved (Campion et al, 2002; McLean & Armstrong, 2004).  
 
Thorne (2005) highlighted that communication between the HCP and the patient presents a pivotal 
opportunity within the consultation, which could have either negative or positive effects. Historically, 
HCP communication has been seen as a ‘soft science’, an ‘extra’ that may be bestowed upon a 
fortunate patient by their HCP but not an essential feature of the delivery of effective healthcare 
(Stewart, 2001; Thorne, 2005). More recent research into chronic illness however, has presented 
HCP-patient communication as having great potential to facilitate coping, self-care and to optimise 
the patient’s QoL (DH, 2005; Thorne, 2005). The partnership approach required for PCC is seen to 
have the potential to empower and enhance independence, enabling clients to be involved in 
managing their life and health (Mead & Bowers, 2000; Stewart, 2001). Such factors are especially 
important within the home care environment where the aim of healthcare is to optimise autonomy, 
maintain independence and to avoid hospitalisation (DH, 2005). PCC is said to represent true 
collaborative working, where health care professionals share their knowledge and, as a result, their 
decision making power with their patient (Stewart, 2004). However, patients continue to report 
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feeling marginalised within the illness discourse and powerless to make their own decisions about 
care (Henderson, 2003; Helman, 2007). Beck (1997) claimed that it was not possible for the nurse 
and the patient to have equal power in the practice setting; the patient is sick and vulnerable and, 
unless the nurse actively seeks to promote patient empowerment, the patient is unlikely to make 
decisions about their care.  
 
Failure to provide PCC is not confined to doctors; McCabe in 2004 reported that nurses frequently 
failed to communicate effectively and tended to only approach their patients to deal with either 
administrative tasks or functional activities. Patients reported that on occasions they felt intimidated 
by their HCP and, as a result, were reluctant to express their needs (Henderson, 2003; Helman, 
2007); a problem compounded by poor clinical communication (McCabe, 2004; Wong & van der 
Horst, 2010). Historically, a nurses’ approach to care provision was been one of ‘doing for’ the 
patient, which tends to reinforce an unequal power base since the nurse has more power than the 
patient (Brickman et al, 1982; Godfrey, 2001; McWilliam et al, 2001). This power imbalance base 
has traditionally shaped the nurse-patient relationship and is often grounded in an expectation of 
client compliance (Godfrey, 2001).  
 
An ‘effective’ PCC consultation, aims to promote SDM but is also reliant on the patient disclosing 
their concerns, which research demonstrates, is not always an approach that is activated by the 
nurse or appreciated by the patient (Swenson et al, 2004). Indeed, Henderson (2003) found that 
despite nurses knowing that optimal patient involvement required them to give information and share 
their decision-making powers, many remained reluctant. Most of the nurses in her study reflected 
that they wanted to make decisions rather than assist their patients to do this which created a power 
imbalance within the HCP-patient interaction and allowed the patient only minimal input in their care 
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beyond their activities of daily living. Henderson (2003) found that the nurses in her study felt that 
they often knew best and identified three types of communication. 
 
1. Nurses giving information. 
Most often undertaken using a closed question approach which simply required the patient 
to provide a yes or no answer (Gibb & O’Brien, 1990). Henderson (2003) concluded that this 
was a strategy employed by the nurse in order to increase patient compliance by limiting the 
depth of any ensuing conversations and ensuring that the nurse retained their control of the 
interaction (Lanceley, 1985).  
 
2. Nurses controlling the amount and type of interactions with their patient.  
Here communication focused entirely on physical care needs and again employed a 
predominance of closed questions. Care was characterised by a conscious avoidance of 
any lengthy conversations with the patient that may lead to a lack of control (Henderson, 
2003).  
 
3. Nurses using power with their patients. 
These encounters left patients concerned that a failure to comply with any requests made by 
the nurses may preclude them from receiving good care or could result in them being 
labelled ‘difficult’ patients.  In their earlier research, Prodasky and Sexton (1988) had 
similarly described the reaction of nurses to patients who they perceived as being ‘difficult’, 
claiming that this could lead to a further restriction in communication with information 
withheld and the provision of only minimal care. Findings supported by Stockwell (1972) and 
Moscrop (2010). 
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Henderson (2003) highlighted a need for nurses to proactively share information and thus encourage 
a positive relationship with their patients; achieved by joking, being friendly, actively listening and 
encouraging patient input; not features that were often observed in her study (Henderson, 2003). 
Smith (2004), a nurse consultant, found often that despite some blurring of boundaries within the 
consultation, effective social interaction between the patient and the health care professional 
remained a major predictor of the success of the consultation, judged in terms of patient satisfaction 
and the achievement of clinical outcomes. 
 
A number of initiatives have aimed to equalise the balance of power within the HCP-patient 
relationship, to encourage the adoption of a partnership approach and to enhance the sharing of 
decisions about care (DH, 1991; DH, 2001c). One of the first such documents was published in 1991 
by the Department of Health (DH) and was entitled ‘The Patient’s Charter’ (DH, 1991). This 
document (DH, 1991) outlined the rights of National Health Service (NHS) patients, highlighting a 
need for patients to exercise these rights and encouraging them to become involved in decisions 
about their care, with important caveats that patients were well enough and wanted to be involved.  
 
Ridsdale et al (1992) found that a ‘willingness’ to become involved within the consultation was often 
reliant on both the state of health of the patient and the complexity of the decisions that needed to be 
made. Not all patients wanted to be ‘fully’ involved in decisions about their care; indeed, Ridsdale et 
al (1992) found that many patients wanted information about their condition and treatment, but may 
not, necessarily, want to fully participate in making complex treatment choices. Elwyn et al (2000) 
similarly found that optimal SDM behaviour was most likely to occur where there was a situation of 
equipoise regarding decisions and that the treatment choices required having albeit different, but 
equally acceptable outcomes; a situation that is often not the case in clinical practice. 
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With similar intentions to enhance SDM, and against a backdrop of the increasing prevalence of 
long-term health conditions (LTC), in 2001, the DH published ‘The Expert Patient’ (DH, 2001c). This 
document set out an objective to encourage patients, especially those with a LTC, to become more 
actively involved in their treatment decisions in order to improve compliance and, thus, enhance their 
QoL. At the time, it was acknowledged that this venture very much depended on the extent to which 
the patient could be seen as an expert and, often more importantly, whether the patient wanted and 
the HCP would allow the patient a more equitable and positive role within the consultation (DoH, 
2001c). Despite the commendable goals of expert patient programmes (DoH, 2001c), many patients 
with a LTC continued to report a lack of PCC with impolite, demeaning and often upsetting episodes 
of communication with their health care professionals. Thorne (2005) condemned such incidents as 
wholly unacceptable and claimed that they are damaging and create scepticism about the healthcare 
system. The majority of complaints from patients involving their HCP relate to communication and 
include a failure to listen, to provide the information that was required and even a lack of respect for 
the patient. Such communication issues result in patients leaving the consultation without asking the 
important questions which had been troubling them and had prompted the request for the 
consultation or without having received a satisfactory response (Pendleton et al, 2003). Such reports 
come from a variety of settings and across a range of conditions, and thus demonstrate the 
widespread attitudinal and structural barriers to PCC which presents a potential cause of 
dissatisfaction and, often, non-compliance (Ley, 1988; Pendleton et al, 2003; Thorne, 2005).  
 
Shared decision making presumes a two-way flow of information, from the HCP to the patient and 
from the patient to the HCP and should include both medical and personal information. Research 
surrounding PCC and patient involvement often highlights the need for SDM within the consultation. 
Bugge et al (2006) undertook a study in which they recorded HCP-patient consultations, followed by 
interviews with both the patient and the HCP. Analysis revealed incidences when either the patient 
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or the HCP failed to disclose relevant information and the reasons offered for this non-disclosure. 
Bugge et al (2006) identified 34 episodes of non-disclosure relating to patient problems, with 52 
relating to either treatment or management. They found that some of the observed incidents had an 
impact on the quality of subsequent decision making or negatively impacted on the patient’s 
healthcare. Bugge et al (2006) concluded that patients often did not provide their HCP with sufficient 
information regarding their history or concerns and similarly that the HCP often did not provide 
important information required to enable the patient to be fully involved in the interaction; findings 
evidenced in other studies (Langewitz et al, 2002; Henderson, 2003; Pendleton et al, 2003). 
Reasons for patient non-disclosure included an environment that was not conducive to sharing 
information; that the HCP displayed off-putting behaviour, appearing hurried or actually blocked or 
interrupted any the patient attempts to share information; they felt the information was not necessary 
or they consciously withheld the information in order to increase their chance of achieving the goals 
that they desired (Bugge et al, 2006). HCP reasons for their non-disclosure also included a non-
conducive environment; a lack of sufficient knowledge; a feeling that the required decision should be 
based on their knowledge and skills or they felt that the information was inappropriate at the time of 
the consultation. Bugge et al (2006) concluded that if either the patient or the HCP refrained from 
fully disclosing relevant information, shared understanding would not be achieved.  
 
Entwistle and Watt (2006) stressed the need for the HCP to agree about the value of patient 
involvement in decision making, proposing that there was a lack of consensus about what optimal 
patient involvement actually constituted and how this varied across different health care situations. 
They felt that there was agreement that patient involvement was essential to the achievement of 
good healthcare outcomes and found that increasing use of decision aids were being used as a 
method of supporting patients to make informed health decisions (McCaffery et al, 2007).  Decision 
aids serve to increase knowledge and facilitate patients to disclose their preferences in order that 
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their values are incorporated into the subsequent consultation and any treatment decisions. It has 
been demonstrated that decision aids increase patient involvement in the decision making process 
and are viewed, by many, as superior to normal care (Entwistle & Watt, 2006). The use of decision 
aids fits well with the model of SDM, providing that the patient wishes to be involved in the decision 
making process. Entwistle and Watt (2006) however, warn that healthcare decisions are often 
extremely complex and, on the whole, are new to the patient. Such decisions are emotional and 
require that the patient predict how they will feel in a future unknown health situation; as a result, 
they are not simple and may be something that the patient wishes to avoid (Swenson et al, 2004). 
 
Every person experiences his or her illness uniquely, reacting in a distinctive way and they confront 
their disease-related stressors in relation to their life context (Thorne, 2005). Effective 
communication in such situations represents the HCP’s recognition of the limits of what they can 
offer in terms of science in trying to solve the everyday problems that the patient is experiencing. At 
this point the HCP is recognising the patients’ authority in understanding what their life is like with 
their condition (McCaffery et al, 2007). It is said that at this point, the HCP surprisingly becomes 
more useful to their patient as advisors within a shared care context (McCaffery et al, 2007). 
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2.3  Measures to enhance PCC. 
In 1957 Balint first described what we know as PCC and, despite the purported benefits for the 
patient (Stewart et al, 2000; Irwin & Richards, 2006) and the HCP (Thorne, 2005; Brown et al, 2006), 
over the ensuing 55 years improvement has been slow, with patient complaints relatively 
commonplace (Pendleton et al, 2003). There continues to be a need for measures and interventions 
to enhance PCC and to evaluate their efficacy so that improvements can be made at every 
consultation, for every patient or, to coin a Department of Health phrase, to ensure we ”...make every 
contact count” (DH, 2012; page 12). 
 
McCormack (2003) provided a conceptual framework to support PCC with the principle of, what he 
termed, “….being in relation.” (McCormack, 2003; p. 205). He proposed that such a HCP-patient 
relationship would be based on informed flexibility, mutuality, transparency and negotiation. To date, 
recommendations to enhance PCC have focussed on two separate approaches or a combination of 
the two: interventions that aim to change practitioner behaviour, such as enhancing consultation 
style (EPOC, 2008) or patient mediated interventions, which aim to activate the patient such as 
decision aids (Kinnersley et al, 2007; McCaffery et al, 2007; O’Connor, 2009) (figure 3).  
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Figure 3: Interventions to enhance patient centred care. 
 
 
A number of studies have demonstrated that training HCPs can enhance PCC, especially with 
interventions that focus on their consultation style, encouraging empathy, listening skills and 
improved identification and handling of emotional problems (Lewin et al, 2009; Fischer & Ereaut, 
2011). Such HCP-patient communication has been the focus of research with barriers to effective 
communication being attributed to a number of factors: ‘the asymmetry of the physician-patient 
relationship’ (Jordan, 1997; page 32); poor communication (Jarrett & Payne, 1995); organisational 
constraints (Pritchard, 1992); delays in answering patient’s questions (Roberts, 2000); a focus on 
functional activities (Heit et al, 2001; Henderson, 2003). Work, to date, has mainly focused on the 
practitioner with, de Haes (2006) claims, insufficient attention as to why patients may not express 
their concerns. 
 
A number of studies have considered the factors that constitute PCC from patients’ perspectives. 
Factors that were consistently identified in such studies were: knowing about the patient’s progress, 
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being responsive to needs, encouraging patient participation in planning care, providing information 
on condition and treatment plan and treating the patient with respect (Poochikian-Sarkissian et al, 
2010). Further studies have provided evidence to support the benefits of PCC and its impact on 
levels of patient satisfaction and the quality of care received; despite a wide range of studies 
reported, there is minimal evidence that PCC consistently leads to better patient outcomes (Henbest 
& Stewart, 1989; McLean & Armstrong, 2004).  
 
In view of these findings, investigators have increasingly adopted the concept of PCC as an indicator 
of good quality consulting; with patient satisfaction with care the most frequently assessed and 
thought to be the most reliable measure of PCC (Mead et al, 2002; Robinson et al, 2008). Few 
researchers have attempted to evaluate approaches to enhance PCC in nursing and its associated 
outcomes, either for the HCP or the patient (McCormack & McCance, 2006). McCormack and 
McCance (2006) postulated that such a study would require a shift in thinking about the role of the 
patient within healthcare,  
“Being patient centred requires the formation of a therapeutic narrative between professional 
and patient that is built on mutual trust, understanding and a sharing of collective 
knowledge.” (McCormack & McCance, 2006; p. 473)  
McCormack et al (2010) demonstrated a need for more research to evaluate specific nursing 
outcomes as a result of PCC interventions. Descriptive accounts do reveal a positive impact on the 
patient’s experience of care but there is further need to reach convincing conclusions. 
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2.4  PCC and this study. 
This study, with its aim to evaluate whether a patient centred focus to consultations for CVLU 
patients improves their satisfaction and QoL, has its foundations in the concepts of PCC.  The study 
is based on Langewitz et al’s (1998) definition of the patient at the centre of the consultation with, 
“….communication that invites and encourages the patient to participate and negotiate in 
decision-making regarding their own care.” (Langewitz et al, 1998; p.268)  
Throughout the thesis, PCC and other interrelated theories will be applied to the design, analysis 
and interpretation of results. 
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2.5  Theories and concepts that are interrelated to the study design. 
Although PCC is the central tenet of this study, a number of theories and concepts relate to the 
conceptual developments that underpin PCC and also this study. These theories serve to enhance 
our understanding of the HCP-patient relationship and, at times, go some way to explain the actions 
and reactions of each party within this complex relationship. These theories are discussed briefly 
here, and potential links to both PCC and this study are highlighted here and throughout the thesis 
(figure 4).  
 
Figure 4: Interrelated theories and concepts that underpin the study. 
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2.5.1   Medicalisation and holism. 
The term medicalisation is used to describe a ‘reductionist’ philosophy that some authors claim has 
been adopted by medicine in its quest to describe and define disease processes (Ahn et al, 2006; 
Beresford, 2010). Although the aim of medicalisation is to develop our understanding and 
management of disease, it is frequently criticised for its tendency to focus on the minutiae which 
results in research that is extremely focused and lacks subsequent insight into the ‘bigger’ picture of 
the impact of the condition on the patient (Ahn et al, 2006). Consequently the risk, in such situations, 
is that the actual phenomenon being studied becomes disassociated from the patient (Beresford, 
2010). This problem is said to be intensified by the increasing reliance on evidence based practice 
(EBP), which emphasises the need to reduce clinical problems to a level that permits the 
investigation of efficacy, using such methods as randomised controlled trials (RCT) rather than their 
effectiveness within a real life context (Beresford, 2010). Beresford (2010) warns that the resultant 
advice from such ‘reductionist’ research may be so specific that any subsequent individual 
application to real patients could lead to potential harm.  
 
Such medicalised reductionism can be seen as a feature of the care of patients with CVLU, where 
research is increasingly focused on the nature of the wound itself, the science, the cell biology of the 
healing process and the chemical components of the dressings used, often to the exclusion of the 
patient’s experiences and preferences (Lansdown & Williams, 2005; Davydov, 2011). This ‘wound’ 
focus to HCP-patient interactions, alluded to in chapter 1, can be interpreted as medicalisation of 
CVLU. 
 
In contrast, holism represents the opposite approach to medicalisation, with an emphasis on the 
centrality of the patient within the disease process and the need for the whole person to be 
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accounted for within research and the delivery of care. Beresford (2010) effectively sums up holism 
as 
“…. looking at the patient and disease as a whole rather than focusing on interactions at 
cellular level.” (Beresford, 2010; p. 721) 
The first holistic practitioner in nursing was said to be Florence Nightingale herself, who emphasised 
a need to focus care on the whole patient and to have an awareness of the influence of 
environmental factors on their health and recovery (Dossey, 2005). Contemporary issues in 
healthcare raise questions about whether our current approach to nursing is indeed holistic 
especially since care is increasingly delivered within specialisms, which emphasise a single disease 
focus, despite the growing prevalence of multimorbidity (Smith et al, 2011). The themes stressed 
within holism include the centrality of the patient as a whole, positioned at the centre of the care 
dialogue and are at the heart of PCC and underpin the research questions at the centre of this study.    
 
2.5.2   Unpopular patient. 
In 1972, Stockwell published her seminal text, ‘The Unpopular Patient’, which aimed to describe and 
explore the interpersonal relationship between the nurse and their patient within hospital wards. The 
focus of Stockwell’s (1972) section of a larger study was the interaction between the patient’s 
personality and nurse’s personality and it aimed to investigate the meaning behind why some 
patients were classified as “difficult’ by their nursing staff. Stockwell (1972) described these 
‘unpopular’ patients as 
“…patients whom the nursing team enjoys caring for less than others.” (Stockwell, 1972; p. 
11) 
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The impact of this classification on patient care in the study was surprising, with results identifying a 
middle group of patients who were categorised as being neither popular nor unpopular patients, who 
were subsequently deprived of attention (Stockwell, 1972). Stockwell’s (1972) research, at the time, 
was extremely contentious and challenged the widely held view that nurses were non-judgmental in 
their care. 
 
More recently, the description of patients as ‘heartsink’ was coined within general practice (O’Dowd, 
1988) in reference to patients who caused their HCP, generally the GP in the studies described, to 
feel ‘heartsink’ when they consulted with them (Moscrop, 2010). Ellis (1986) had previously 
described such patients and this feeling as ‘dysphoria’, which he described as: 
“….the feelings felt in the pit of your stomach when their (the patients’) names are seen on 
the morning's appointment list”.  (Ellis, 1986; p. 318) 
O’Dowd (1988) described such patients as being dissatisfied, manipulative, demanding and frequent 
complainers but, on closer inspection, they actually represented a disparate group of often quite 
complex patients; views O’Dowd is said to have amended during ensuing years (Moscrop, 2010). 
This ‘heartsink’ description displayed many similarities to Stockwell’s (1972) ‘unpopular patients’ and 
her revelations about nurse attitudes. ‘Heartsink’ patients, studies demonstrate, may experience 
ineffectual management of their condition as a result of their impact on the HCP concerned, who 
may be frustrated and act in an unprofessional manner during clinical contact (O’Dowd, 1988; 
Moscrop, 2010).  
 
Such research suggests that patients may fall into the category of being unpopular, difficult or a 
heartsink patient, without actually being aware of such marginalisation and the impact that this may 
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have on their subsequent care (Stockwell, 1972; O’Dowd, 1988). As discussed in the introduction 
(page 9), patients with CVLU are longstanding and present a considerable and on-going demand on 
the DN and the caseload, which may predispose to their classification as ‘heartsink’ or unpopular 
patients, which may directly impede the likelihood of care that is patient centred.  
 
2.5.3  Body image. 
Everyone has a personal perception of his or her body. This refers to the picture of our body held in 
our mind which ultimately defines how we see ourselves (Schilder, 1935). Changes to our physical 
appearance due to illness or disease have an impact on our personal identity and may displace this 
view (Price, 1999; 2000). Price (1999) claims that initial steps to correct this distorted view early in 
an illness trajectory may be successful but, as the course of the illness or disease progresses, the 
effectiveness of interventions diminish. As a result, the illness actually stigmatised the person due to 
their changed appearance and a general loss of bodily control (McIntyre, 1995; Price, 1999).  
 
Price (1995) describes altered body image as, 
“….a state of personal distress, defined by the patient, which indicates that the body no 
longer supports self-esteem and which is dysfunctional to individuals, limiting their social 
engagement with others.”  (Price, 1995; page 180) 
Such altered body image is extremely common in, although not limited to, palliative cancer care. It 
may result from a person’s diminished ability to manage the impact of their illness or as a result of 
the reactions of others to their condition (Cook, 1999), but it is generally associated with a loss of 
control (Price, 1998). CVLU impacts extensively on the patients’ self image with complications such 
as bandaged legs, copious exudate and unwanted odour and as a result may limit social 
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engagement, self-esteem and daily functioning (Hyde et al, 1999; Rich & McLachlan, 2003). The 
impact on the patient’s body image is considerable and will be revisited. 
 
2.5.4  Power in the health care professional-patient relationship. 
As has been suggested (page 30), the HCP-patient relationship is not necessarily one of equals 
(Beck, 1997; Henderson, 2003); a factor which may subsequently have an impact on the 
effectiveness of any ensuing dialogue. Power in the nurse-patient relationship was explored using by 
Hewison (1995) by analysing and exploring the language used during nurse-patient interactions. He 
(Hewison, 1995) concluded that nurses used language to exert power over their patients, a 
behaviour that was generally accepted as normal, which in itself presented a barrier to the 
development of a collaborative nurse-patient relationship and prevented open and meaningful 
communication. Hewison’s (1995) study also confirmed that the majority of nurse-patient interactions 
were trivial, routine and related to tasks and is in line with other studies discussed such as 
Henderson (2003) and McCabe (2004).  The impact of power in HCP-patient dialogue serves to limit 
disclosure and thus the application of appropriate interventions.  
 
2.5.5  Stress and coping. 
Theories of stress, coping and health are often derived from Lazarus’ (1993) original Transactional 
Model, which was developed in response to an increasing interest in the area of stress in the 1960s 
and 1970s. Responses to stress, Lazarus (1993) believed, depend on the meaning that the 
individual attributes to a stressful stimulus and ultimately, has an effect on both health behaviour and 
coping. Lazarus (1993) proposed that coping efforts were dependent on primary and secondary 
appraisals of an impending stressor. Primary are said to refer to an assessment of the threat of a 
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situation, and secondary, a review of the resources available to cope with the stressor. These 
responses, Lazarus (1993) believed, are problem-focused strategies, such as information seeking or 
emotionally focused strategies such as changing personal thinking about a situation, avoidance and 
denial. Lazarus’ (1993) Transactional Model supports the positive benefits of social support in 
respect of both well-being and health, which links with the theories of both saltogenesis (Antonovsky, 
1979; page 46) and locus of control (Seligman, 1975; page 44).  
 
2.5.6   Locus of control. 
Many studies explore personal characteristics in order to establish why patients act in a certain way; 
one such psychological theory, known as locus of control, was expounded by Rotter (1954) in order 
to describe the degree that a person believes that they can control the events that impact on their 
life. A person’s locus, or place, is described as being either internal or external. When a person has 
an internal locus of control they believe that they are in control of their life. In contrast, a person with 
an external locus of control feels that they and their decisions are controlled by factors that are 
beyond their control (Rotter, 1954). The significance of the theory of locus of control is the potential 
impact that an external locus poses to a person’s ability to self-care and their belief about whether 
they can make effective changes in order to improve their health outcomes.  
 
The concept of locus of control (Rotter, 1954) has been investigated in relation to CVLU (Charles, 
1995) who found that those who had an internal locus assumed a more active approach to their ulcer 
management, believing that they had control over events whereas, in contrast, those with an 
external locus believed that they were under the control of others.  
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2.5.7  Learned helplessness. 
Another personal characteristic that is relevant to PCC and the effectiveness of consultations is 
learned helplessness, a trait used by Seligman (1975) to describe why some people, when faced 
with a negative situation, have a tendency to behave helplessly and remain passive, despite having 
an opportunity to correct the situation.  
 
Seligman (1975) conducted experiments on dogs and humans and adopted the phrase learned 
helplessness to describe the expectation that events were out of the individual’s control. In addition 
to the negative expectations held by those with learned helplessness, such feelings were often 
accompanied by feelings of low self-esteem and persistent failure. As with locus of control (Rotter, 
1954), the theory of learned helplessness is significant in relation to the consulting characteristics of 
patients with a number of long term conditions including CVLU. 
 
2.5.8  Self-management theories. 
The theory of self-management is embedded in much current policy and practice (DH, 1991; 2001a) 
and is defined as care that is directed and led by the patient themselves (Morden et al, 2012). The 
term self-management is often used interchangeably with self-care, it is key to a patient centred 
health care system and a fundamental element in the management of LTC (DH, 2005). The theory of 
self-management is underpinned by patient’s motivation to engage in their care and is linked to the 
theories of locus of control (Rotter, 1954; page 44) and learned helplessness (Seligman, 1975; page 
45).  
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Elements that are key to the adoption of self-management are encapsulated in the theory of self-
determination, initially developed by Deci and Ryan (2000), which focuses on two types of motivation 
for health: controlled and autonomous. People who demonstrate controlled motivation tend to 
undertake interventions for extrinsic reasons, for example for a specific reward or to make people 
happy. In contrast, those with autonomous motivation act for intrinsic reasons and undertake things 
for the benefit of themselves. Autonomous motivation, as with the similar internal locus of control 
(Rotter, 1954; page 44), is seen to be predictor of positive changes for health benefit and key in self-
management, weight loss and other positive health interventions (Deci & Ryan, 2000). Social 
learning theory, or self efficacy as it is also known (Bandura, 1977), is also implicated in a patient’s 
motivation to engage in self-management and focuses on an individual perceiving that they are able 
to undertake the behaviours necessary in order to improve their health and is said to be predictive of 
self-management behaviour (Bandura, 1977; Skinner et al, 2003). 
 
When faced with the longevity of a chronic condition such as CVLU, patient engagement, self 
efficacy (Bandura, 1977) and concordance with an agreed treatment plan are crucial. The personal 
belief in one’s own ability to improve health outcomes is often predictive of the success of treatment 
interventions and impacts on compliance with such regimes (Deci & Ryan, 2000). These issues are 
considered in the light of the research findings for patients with CVLU throughout the thesis. 
 
2.5.9  Salutogenesis. 
Antonovsky (1979; 1987), as Balint (1957) had done before (page 25), also contested the widely 
held biomedical model of health of the time and proposed a new ‘continuum model’ of health where 
each person was positioned, at any point in time, along a health (salutogenesis) / disease 
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(pathogenesis) continuum. Antonovsky (1987) distinguished factors that he felt maintained an 
individual’s health and their ability to adapt to disease, stressing the importance of their sense of 
coherence, a unique attribute held by each individual. Sense of coherence describes an orientation 
towards the world which perceives it as a continuum and as ‘comprehensible, manageable and 
meaningful’ (Johnson, 2004; page 420); a factor that Antonovsky (1987) felt was of significance in 
facilitating an individual’s movement toward the health end of the continuum when faced with a 
particular stressor. Those with a strong sense of coherence would understand the challenge, be 
motivated to cope and would apply the resources necessary (Antonovsky, 1987).  
 
Antonovsky (1979) also expounded the importance of generalised resistance resources, properties 
necessary to enable a person to cope and to view the world as making sense - cognitively, 
instrumentally and emotionally - thus facilitating movement towards the health pole of the continuum. 
Generalised resistance resources were described by Antonovsky (1979; 1987) as biological, material 
and psychological factors which make it easier for people to see their lives as consistent, structured 
and understandable and include money, knowledge, experience, self-esteem, being loved, healthy 
behaviour, commitment, social support, cultural capital, intelligence, traditions and view of life 
(Antonovsky, 1979). Antonovsky (1979; 1987) proposed that if a person has some or all of these 
factors at their disposal they would have a better chance of them coping with the challenges of life 
(Antonovsky, 1979; 1987; Lindstrom & Eriksson, 2005; 2006). Research demonstrates that in all age 
groups, socioeconomic backgrounds and across cultures, those who demonstrate a strong sense of 
coherence experience better perceived health, improved mental well-being, healthier ageing and 
enhanced quality of life and conversely, those with a weak sense of coherence have poorer 
perceived health and low mood (Antonovsky, 1987; Lindstrom & Eriksson, 2006). Clear links can 
also be seen with locus of control (Rotter, 1954; page 44), learned helplessness (Seligman, 1975; 
page 45) and self-management theories (Morden et al, 2012; page 45). 
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2.5.10  Nursing models: Roy (1976) and Orem (1971). 
The foundations of PCC are said to transcend many nursing theories including Roy’s Adaptation 
Model (1976) and Orem’s Self-Care Model (1971). Orem’s Self-Care Model of nursing (1971) is a 
model often used in primary care and rehabilitation areas. Orem (1971) proposed that all people 
needed to be self-reliant, responsible for their own care and that of their family. The model focuses 
on the patient’s perspective of their illness; with the aim of nursing care being to assist them to meet 
their own self-care needs, whilst encouraging independence. If the patient is unable to meet their 
self-care needs, Orem’s model (1971) purports that it is the role of the Registered Nurse (RN) to 
define their deficits and to provide sufficient support, until self-care is achieved. 
 
Roy (1976), in her adaptation model, described individuals as biopsychosocial beings who were 
constantly interacting with various environmental challenges. In order to cope, Roy (1976) 
suggested, individuals use both innate and acquired mechanisms and adapt to the challenges in four 
modes: physiological, self-concept, role function and interdependence. The goal for nursing in Roy’s 
model (1976) is to assist the person to adapt to the challenges that they face, thus improving their 
health and QoL. 
 
Both nursing models have their basis in patient adaptation to disease, the encouragement of 
independence and adaption to the challenges of disease with the aim of achieving self-care (Orem, 
1971; Roy, 1976). Care for patients with CVLU has been criticised as often having a wound care 
focus to the exclusion of patient concerns, hence the importance of considering these models in 
relation to care for patients with CVLU (Callam et al, 1985; McGuckin et al, 2000; Persoon et al, 
2004; page 2). 
 49 
2.6  Conclusion. 
All of the related theories and concepts presented within this section have the potential to diminish 
PCC and to limit communication between the HCP and the patient during their consultation. They 
lead to potentially mismatched goals and limit patient expectations of improved self-management. 
Throughout the thesis these theories, along with PCC, will be linked to study design and the 
interpretation of results. 
 
This chapter has provided an overview of theories relating to PCC. Key research publications have 
been included along with an exploration of the advantages of this approach both for the patient and 
the HCP. As mentioned, there is a paucity of literature that evaluates explicit PCC interventions in 
nursing care and their outcomes and this is an area highlighted for further research (McCormack & 
McCance, 2006). Other related theories and concepts that enhance our knowledge of PCC and the 
role of both the patient and the HCP in this dialogue have also been summarised.  The next chapter, 
chapter 3, provides a review of the literature surrounding CVLU and HRQoL. This review 
synthesises the body of literature in this area and establishes those areas where CVLU impacts on 
the life of the patient.  
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Chapter 3:  Does chronic venous leg ulceration impact on the quality 
of life of the patient? A systematic review. 
 
This chapter provides a review of the literature that explores the factors that impact on QoL for a 
patient with CVLU. The introductory chapter clearly demonstrated the prevalence of CVLU and the 
wide-ranging limitations that this condition imposes on the patient’s functioning. This chapter 
provides a review of the literature in this area and positions this study within the scope of what is 
already understood. 
 
3.1  Introduction. 
In the area of CVLU research demonstrates that QoL is limited (Chase et al, 1997; Briggs & 
Flemming, 2007); often a factor that is intensified by a ‘wound’ focus to DN consultations in the 
community (Callam et al, 1985; McGuckin et al, 2000). The chronicity of ulceration impacts on all 
areas of life for the patient and, often, their carers (Hyde et al, 1999; Rich & McLachlan, 2003). 
Qualitative studies in this area provide the patient’s perspective of living with a CVLU (Persoon et al, 
2004; Briggs & Flemming, 2007); with the rich data providing a clear insight the feelings behind 
participants’ responses, which are supported by the use of powerful quotations. In contrast, the 
quantitative studies enumerate these characteristics, using instruments to assess QoL. Findings 
have been presented separately (section 3.8; page 70 & 3.9; page 77) and then have been 
synthesised (section 3.10; page 89) to provide a more complete picture of the patient experience. 
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3.2   Aim. 
The aim of this rapid review was to explore the impact of CVLU on the patients’ QoL. Systematic 
methods have been adopted including a search strategy that aimed to identify,  
“...the findings of all relevant individual studies” (CRD, 2009; p. v)  
and in so doing, provide a review that it replicable, robust, comprehensive and scientific (CRD, 
2009). In order to synthesise the sourced studies, a narrative synthesis was undertaken as is 
standard in systematic reviews and, where the level of heterogeneity has allowed, a meta-analysis 
has been included (Popay et al, 2005; Lucas et al, 2007; Rodgers et al, 2009; Booth et al, 2012).  
 
3.3  Review question. 
The PICO approach (Richardson et al, 1995; Booth, 2006), introduced in chapter 1 (page 7), was 
used to devise the study question. For the purpose of this literature review, the adapted acronym 
PECOs (National Collaboration Centre for Methods & Tools (NCCMT), 2012) was applied to assist in 
the development of the review title: population (P), exposure (E), comparator (C), outcome (O) and 
study type (s). PECOs (NCCMT, 2011) is the acronym of choice where there is no specific 
intervention under investigation (Booth et al, 2012) and, for this review, PECOs (NCCMT, 2012) 
stands for: 
 P – adult patients based in the community. 
 E – chronic venous leg ulceration. 
 C – no chronic venous leg ulceration. 
 O – quality of life. 
 s – any study type. 
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As a result, the question developed and addressed by this review is: 
Does chronic venous leg ulceration impact on the quality of life of the patient? 
 
3.4  Methods. 
A systematic search of articles was undertaken using the Health Databases Advanced Search 
(HDAS) engine, an interface of ‘NHS Evidence’ (www.evidence.nhs.uk/) that provides access to a 
range of bibliographic databases across a range of disciplines including medicine, nursing and 
psychology. Each database was searched individually, applying search terms line by line (detailed 
on page 57), with inclusion and exclusion criteria applied to the articles sourced (page 55). A fellow 
reviewer agreed the final selection of articles and a range of data was extracted (page 63) and 
summarised (page 67 onwards). A meta-analysis of quantitative data has been undertaken where 
heterogeneity has allowed (page 79) (Franks & Moffatt, 1998; Franks & Moffatt, 2001; Franks et al, 
2006; Furtado et al, 2008). 
 
3.4.1  Literature databases. 
A range of database resources were searched for the purpose of this review, with each providing 
access to various collections of material. The databases were:  
 MEDLINE (Medical Literature Analysis and Retrieval System Online), a life science 
database from the United States (US) National Library of Medicine, which provides access 
to an extensive range of journals. To ensure comprehensive searching MEDLINE also 
utilises Medical Subject Headings (MeSH®), a controlled vocabulary thesaurus that 
facilitates searching using terminology at various levels of specificity. 
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 CINAHL (Cumulative Index to Nursing and Allied Health Literature) is a comprehensive 
nursing and allied health professional database and has been available since 1985. Similar 
to MeSH®, CINAHL headings are available to ensure that the most inclusive search is 
achieved.  
 The British Nursing Index (BNI) is a United Kingdom (UK) nursing and midwifery database 
and has been available since 1992.  
 EMBASE (Excerpta Medica Database) is a large pharmacological and biomedical database, 
which commenced in 1980.  
 PsycINFO (Psychological Information Database) provides wide-ranging access to mental 
health and behavioural science material.  
 AMED (Allied and Complementary Medicine) provides access to literature from three subject 
areas: professions allied to medicine, complementary medicine and palliative care.  
 Health Business Elite is a database of health care administration and non-clinical aspects of 
healthcare management. 
 HMIC (Health Management Information Consortium), which provides access to King’s Fund 
and DH records.  
It was felt that by accessing the eight databases above all relevant material would be retrieved and 
reviewed. In addition the Cochrane Collaboration database was searched in order to access any 
relevant systematic reviews and Google Scholar was searched using key terms in order to check all 
relevant material had been sourced. Once the search was complete, hand searching, reference and 
citation tracking was undertaken.   
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3.4.2  Article inclusion criteria. 
In order for an article to be selected for inclusion within the review, a range of criteria in relation to 
PECOs (NCCMT, 2012) was applied (table 2 below). Only study participants over the age of 18 
years were included, since CVLU almost exclusively affects adults, most often of increasing age 
(Posnett & Franks, 2007; page 2). Since care for those with CVLU is predominantly delivered by a 
DN, it was felt that study participants would be located in a community environment (Callam et al, 
1985; page 9), rather than within secondary care. In view of this, secondary care was excluded from 
the search. 
 
Table 2: Criteria for inclusion in the review. 
 
 
 
Inclusion criteria  Description 
 
Age (P)    Adult patients over 18 years. 
Study type (s) Qualitative, quantitative and mixed methods studies.   
Populations (P)    Primary care / Community based. 
Disease (E)   Venous leg ulcers or mixed aetiology. 
Outcome measure (O)  QoL exploration or evaluation. 
 
An accepted ‘leg ulcer’ definition was applied to aid study selection requiring selected participants to 
have suffered from active ulceration for in excess of six weeks (Nelzen et al, 1997; SIGN, 2010), 
ideally defined by an ankle brachial pressure index (ABPI) of more than 0.5 (Vowden & Vowden, 
2001; page 8). Where this level of detail was not available within study information, if the sample was 
referred to as having venous or mixed aetiology ulcers they were included for further review. Arterial 
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ulcers (with an ABPI of less than 0.5), pressure ulcers and neuropathic ulcers were excluded from 
the study since their presentation, symptoms and impact on the patient differ considerably.  
 
Only articles available in English were sourced since there was no funding available for translation; it 
was, however, noted that this might have limited the completeness of the review. Finally the review 
was restricted to research published since 1990; studies completed prior to this would be of doubtful 
relevance in view of advances in research and improvements in the management of patients with 
CVLU since this time. Studies were included irrespective of methodology or design. 
 
3.4.3  Article exclusion criteria. 
Studies were excluded from the review if the participants were 17 years of age or under, as leg 
ulceration is rare in this age group (Persoon et al, 2004). Studies were also excluded if they 
focussed purely on a single domain, such as pain (Krasner, 1998; Guarnera et al, 2007), as it was 
felt that such studies would fail to fully explore the range of factors that impact on the daily lives of 
patients with CVLU. Where the study focussed on a specific therapy, such as ultrasound for wound 
healing and its impact on QoL (Watson et al, 2011), again the study was excluded as the patients’ 
QoL was only evaluated in response to the therapy under review. Where studies investigated a 
product, such as a new dressing (Bjellerup et al, 1993; Kirby, 2008) or an intervention, such as a 
novel approach to the delivery of community services (Collins et al, 1998; Edwards et al, 2005); 
these were excluded as the focus of the study was an aspect rather than the full realm of effects on 
QoL and often such studies were funded by industry. Finally, where a study was designed to 
evaluate or compare QoL instruments (Hyland & Thomson, 1994; Price & Harding, 1996; Walters et 
al, 1999; Price & Harding, 2004; Hareendran et al, 2005 & 2007; Iglesias et al, 2005; Palfreyman, 
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2007a & 2008; Jull et al, 2010), these studies were excluded. Such studies focus on measurement 
tool validation or item generation rather than a specific patient focus and were felt not to be relevant. 
This is not an exclusion criterion that has necessarily been applied across other reviews (Persoon et 
al, 2004; Herber et al, 2007a) but such exclusion has enhanced the patient focus of this review. 
 
3.4.4  Search strategies. 
As already outlined, this systematic search accessed eight databases, the Cochrane Collaboration 
database and Google Scholar, with each bibliographic database searched individually, line by line 
and replicated in every source (full detail is included in appendix 1). A series of comprehensive 
search terms, developed using the PECOs approach (NCCMT, 2012), were systematically applied 
along with Boolean operators (AND / OR) (Hicks, 2004). The search terms are detailed in table 3 
below.  
Table 3:  Search terms. 
 
1 venous ulcer* 
2 chronic venous insufficiency 
3 varicose ulcer* 
4 stasis ulcer* 
5 leg ulcer* 
6 chronic wound* 
7 MeSH leg ulcer 
8 OR all of the above 
9 quality of life 
10 “quality of life” 
11 health related quality of life 
12 “health related quality of life” 
13 MeSH quality of life 
14 OR 9 – 13 
15 combine 9 AND 14 
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In order to ensure a focus on venous or mixed aetiology ulcers, a number of alternate search terms 
were combined including MeSH® terms: “varicose ulcer” and synonyms: “stasis ulcer”, “leg ulcer” 
and “chronic wound”. In addition the term “chronic venous insufficiency” was added, since this is 
most often the underlying cause of the ulceration and could potentially lead to the identification of 
other relevant studies. The outcome measure of interest was the QoL of patients with CVLU. QoL is 
a term that is often interchangeably used with HRQoL, so the terms “quality of life” and “health 
related quality of life” were searched separately. In addition MeSH® terms for “leg ulcer” and “quality 
of life” were applied ensuring that articles sharing these common themes were retrieved at the 
appropriate point of the search.  
 
3.4.5  Screening, selection and quality assessment of articles. 
This stage of the search process involved the screening of titles, abstracts and, finally, full texts 
against the eligibility criteria by the researcher, with duplicates and unsuitable articles removed at 
this point. An educational supervisor independently assessed a proportion of those rejected in order 
to verify the decisions made. Following this process of selection, a proportion of the studies deemed 
to meet the inclusion criteria were independently reviewed by both the researcher and an 
educational supervisor. Good inter-rater reliability was demonstrated (Hicks, 2004) and once 
consensus was reached, final inclusion was agreed. 
 
3.5  Search results. 
The search initially resulted in a total of 13560 articles. Following removal of duplicates and a review 
of the relevancy of the study titles, 4453 were retained for more detailed review. Of these 453, 
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following review of the abstract, 114 were retained and reviewed by two reviewers. A review of the 
full articles resulted in the exclusion of 89 articles and the retention of 25 for final synthesis. The 
selected 25 articles covered 24 studies in total and were the subject for the full review (figure 5).  
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Figure 5: Stages of article selection – PRISMA flow chart (Moher et al, 2009; CRD, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
POTENTIALLY RELEVANT ARTICLES 
IDENTIFIED BY SEARCH AND 
SCREEN 
N = 13560. 
MEDLINE 741 
CINAHL 7689 
BNI 112 
EMBASE 1713 
PSYCinfo 1347 
AMED 29 
Health Business 
Elite 
1890 
HMIC 17 
Google SCHOLAR 22 
 
 
 
 
ARTICLES RETAINED FOR 
DETAILED EVALUATION 
N = 453 
ARTICLES EXCLUDED AT ELECTRONIC 
SCREENING STAGE 
N = 13107 
Duplicate, not available in English, pre-
1990, complete text not available. 
Numbers of articles excluded at electronic 
screening stage: 
MEDLINE 636 
CINAHL 7546 
BNI 62 
EMBASE 1605 
PSYCinfo 1333 
AMED 20 
Health Business 
Elite 
1887 
HMIC 7 
Google SCHOLAR 11 
 
ARTICLES RETRIEVED FOR FULL 
PAPER REVIEW 
N = 114 
ARTICLES EXCLUDED FOLLOWING 
FULL PAPER REVIEW 
N = 89 
Reasons for exclusion at full paper review:  
Review 11 
Other aetiology 6 
QoL instrument 
validation 
14 
Single domain 23 
Dressing evaluation 22 
Discussion paper 12 
Poor quality 1 
 
ARTICLES INCLUDED IN THE 
REVIEW 
N = 25 papers covering 
24 studies.  
ARTICLES EXCLUDED AT ABSTRACT 
SCREENING STAGE 
N = 339 
Case study, review, paediatric focus, wound 
focus other than venous leg ulcers, 
measurement tool validation and 
commercial dressing product evaluation. 
Numbers of articles excluded at abstract 
screening stage: 
MEDLINE 99 
CINAHL 108 
BNI 13 
EMBASE 87 
PSYCinfo 14 
AMED 3 
Health Business 
Elite 
3 
HMIC 10 
Google SCHOLAR 2 
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3.5.1  Data extraction. 
For each study, data was extracted and summarised on data extraction sheets, produced separately 
for the qualitative and quantitative studies (table 5; page 64). This process was undertaken by the 
researcher and again checked for accuracy. The data extracted was the author, year of publication 
and the location of the study. The design of the study was summarised, including the duration of the 
study and the frequency of data collection. Participant information of interest included sample size, 
participant age (range where available) and participant gender. The outcome measures of interest 
for each study were recorded and a brief summary of the results recorded. In order to provide a clear 
overview, thorough analysis and complete review of the selected studies, the Critical Appraisal Skills 
Programme (CASP, 2010) to the critical analysis of literature was applied to ensure the quality, 
validity and relevance of the information sourced. Finally any study limitations and ethical approval 
status were recorded along with the quality score (QS) discussed earlier (Hawker et al, 2002). 
 
3.5.2  Quality assessment. 
Appraisal of the quality of quantitative studies, generally RCTs, within systematic reviews is well 
established; indeed Moher et al (1995) identified 34 such tools in 1995, a total which is ever 
increasing and includes tools recommended by CRD (2009), CASP (2010) and a domain-based 
evaluation currently recommended by Cochrane (Higgins and Green, 2011). In terms of the quality 
appraisal of qualitative studies there remains much debate of the value of such appraisal, although 
such an approach is, on the whole, encouraged (Goldsmith et al, 2007; Mays et al, 2005; CRD, 
2009; Higgins & Green, 2011). Where a review involves ‘disparate data’ from differing research 
methods (Hawker et al, 2002; page 1291), quality appraisal potentially becomes much more 
complicated. In response to this, Hawker et al (2002) developed a framework to assess the quality of 
incongruent studies, whilst acknowledging that some would question whether qualitative and 
 62 
quantitative studies could be reviewed against the same criteria. The subsequent scoring system 
(Hawker et al, 2002) was based around similar scoring systems, such as an earlier CASP tool (1998) 
(CASP, 2010) and sets out to provide an explicit indication of the strengths and weaknesses of each 
of the studies included in a review. In view of its simplicity, the Hawker et al (2002) was selected as 
the tool of choice to assess the quality of both the qualitative and quantitative studies included in this 
review, thus providing an overall impression of study quality irrespective of method. Since the 
application of such a generic approach is potentially contentious (Dixon-Woods et al, 2004), no 
studies were excluded as a result of their score but such scores were taken into account during the 
data synthesis. 
 
The Hawker et al (2002) system provides a summed score for nine aspects of study reporting 
including study methodology, each rated from 10 (very poor), 20 (poor), 30 (fair) and 40 (good). 
Scores are summed and evaluated in terms of Hawker et al (2002) guidelines: with scores of less 
than 90 deemed to indicate the study was of very poor quality; scores of 90-180 deemed to indicate 
poor quality; scores of 180-270 deemed of fair quality and 270-360 indicated good quality (Hawker et 
al, 2002).  
 
The elements of reporting assessed for each publication were the abstract and title, introduction and 
aims, method and data, sampling, data analysis, ethics and bias, findings/results, 
transferability/generalisability and implications and usefulness. Full details of the assessment and 
scores for each of the elements are provided in appendix 2; however, the studies included in the 
review ranged from none of very poor quality, four of poor quality, six of fair quality and 14 of good 
quality with scores displayed in table 4 overleaf. 
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Table 4: Quality appraisal scores (chronological order). 
 
Author & year  Total Score  
(Range: 90-360) 
Lindholm et al (1993)  240 (F) 
Charles, H. (1995)  170 (P) 
Walshe, C. (1995)  330 (G) 
Bland, M. (1996) 130 (P) 
Chase et al (1997)  240 (F) 
Franks, P.J. & Moffatt, C. (1998) 310 (G) 
Hyde et al (1999)  280 (G) 
Chase et al (2000) 230 (F) 
Douglas, V. (2001) 270 (G) 
Ebbeskog, B. & Ekman, S. (2001)  320 (G) 
Franks, P.J. & Moffatt, C. (2001) 330 (G) 
Wissing et al (2002)  230 (F) 
Franks, P. J. et al (2003) 310 (G) 
Rich, A. & McLachlan, L. (2003)  340 (G) 
Charles, H. (2004)  230 (F) 
Hopkins, A. (2004)  270 (G) 
Jull et al (2004)  330 (G) 
Brown, A. (2005 a, b)  290 (G) 
Yamada, B. & Santos, V. (2005)  180 (P) 
Franks et al (2006)  350 (G) 
Heinan et al (2006)  340 (G) 
Furtado et al (2008)  320 (G) 
Byrne, O. & Kelly, M. (2010)  160 (P) 
Faria, E. et al (2011)  250 (F) 
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Table 5: Detail of included qualitative studies (11): 
Author, 
year & 
location 
Design of study Participant 
characteristics 
Outcome measure Results Limitations & ethical 
approval 
Bland, M. 
(1996) New 
Zealand 
 
Heideggerian phenomenology 
Single interview 
 
n=9  
Gender: 5 male 
Age: 56-81 years 
Aetiology not defined 
Loosely structured interviews to 
explore the personal 
experience of condition. 
Themes included: 1) impact on life; 2) pain, odour, infection & 
exudate were constant issues; 3) rest; 4) compliance issues 
mentioned. 
Lacks study detail. 
Ulcer aetiology stated. 
Ethical approval not 
documented. QS: 130 
Brown, A. 
(2005 a, b) 
UK 
Phenomenology 
Single interview 
n=8  
Gender not defined 
Age: Over 65 
All of venous 
aetiology 
To explore the social impact of 
living with a leg ulcer. 
Three themes: 1) pain; 2) social disconnectedness; 3) coping. Age range not defined. 
Gender is not stated. 
Ethical approval is 
documented. QS: 290 
Byrne, O. & 
Kelly, M. 
(2010) ROI 
 
Heideggerian, hermeneutic 
phenomenology 
Single interview 
n=12  
Gender not defined 
Age: Older people 
All of venous 
aetiology 
To explore the lived experience 
of venous leg ulceration. 
Four themes: 1) physical; 2) psychological; 3) social experience; 4) 
the experience of the therapeutic relationship. 
Age range not defined. 
Gender not stated. 
Ethical approval not 
stated. QS: 160 
Charles, H. 
(1995) UK 
 
Phenomenology 
Single interview 
n=4  
Gender: 3 male 
Age: 43-62 years 
All of venous 
aetiology 
To explore the effects of 
ulceration on the patient’s life.  
Three themes: 1) physical; 2) psychological; 3) social areas all 
suffered negative effects. 
Ethical approval stated. 
QS: 170 
Chase et al 
(1997) USA 
 
Phenomenology 
Single interview with 12 month 
review  
 
n=7  
Gender not defined 
Age: no detail 
All of venous 
aetiology 
 
To explore the experience of 
leg ulceration. 
Four themes: 1) a forever healing process; 2) limits & 
accommodations; 3) powerlessness; 4) who cares?  
Focus on mobile, clinic 
attenders. 
No age or gender detail. 
Ethical approval not 
stated. QS: 240 
Douglas, V. 
(2001) UK 
 
Qualitative grounded theory 
Single interview 
 
n=8  
Gender: 2 male 
Age: 65-94 years 
All of venous 
aetiology 
 
To explore the patients’ 
experiences of leg ulceration. 
Five categories: 1) HCP & patient relationship; 2) physical 
experience; 3) loss of control; 4) vision of the future; 5) carers’ 
perspective 
Change of interview 
criteria – working or lived 
with carer. 
Ethical approval not 
stated. QS: 270 
 
 
Ebbeskog, 
B. & 
Ekman, S. 
(2001) 
Sweden 
Phenomenological-
hermeneutical approach 
Single interview 
n=15  
Gender: 3 men 
Age: 74-89 years 
All of venous 
aetiology 
To explore the meaning of the 
lived experience of leg 
ulceration. 
Four themes: 1) emotional consequences of altered body image; 2) 
living a restricted life; 3) achievement of well-being with a painful 
wound & bandages & 4) struggle between hope & despair with 
regard length of healing process. 
 
Female dominance 
Consent stated but not 
ethical approval. QS: 320 
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Hopkins, A. 
(2004) UK 
Hermeneutic phenomenology 
Single interview & diary 
completion over 2 weeks 
n= 5  
Gender: 4 male 
Age: 47-78 years 
All of venous 
aetiology 
To explore what it is like to live 
with a non-healing ulcer. 
Four themes: 1) biographical disruption, 2) ways of coping, 3) social 
implications; 4) therapeutic relationships. 
Participants known to 
researcher. 
Ethics approval stated. 
QS: 270 
Hyde et al 
(1999) Aus 
Qualitative descriptive study 
1 hour interview & 30 min 
follow up to verify themes 
n=12 
Gender: all female 
Age range: 70-93 
years 
Aetiology not defined 
To gain an insight into the lives 
of older women living with leg 
ulcers. 
Two themes: 1) gaining and maintaining control over vulnerable 
limbs: 2) lifestyle consequences of ulcers & mobility. 
Female focus. 
Ethical approval not 
stated. QS: 280 
Rich, A. & 
McLachlan, 
L. (2003) 
UK 
Phenomenology. 
Single interview 
n=8  
Gender: 3 male 
Age: 55-89 years 
All of venous 
aetiology 
To explore patients’ 
experiences of living with a leg 
ulcer. 
Four themes: 1) symptoms; 2) treatment; 3) perceptions, emotions & 
coping strategies; 4) restrictions. 
Researcher known to 
patients. 
Ethics approval stated. 
QS: 340 
Walshe, C. 
(1995) UK 
Phenomenology 
One occasion 
n=13 
Gender: 1 male 
Age: elderly 
All of venous 
aetiology 
To describe the experience of 
living with a leg ulcer. 
Four themes: 1) symptoms; 2) description of treatment; 3) restrictions 
caused by ulceration; 4) perceptions of & coping with ulceration. 
Age range not defined. 
Ethics approval stated. 
QS: 330 
 
 
 
Detail of include quantitative studies (13): 
 
Author, 
year & 
country 
Design of study Participant 
characteristics 
Outcome measures Results Limitations & ethical 
approval 
Charles, H. 
(2004) UK 
 
 
Prospective quantitative 
review 12 weeks duration with 
data collected at start & end 
n=65  
Gender: 43% male 
Age: Median 72 years 
Aetiology not defined 
SF-36 used to compare health 
domains with AEN at start & 12 
weeks whether healed or not. 
 
SF-36 & compared to AEN (where available) gave lower scores in 
CVLU patients. Significant improvement in all SF36 domains for all 
patients over 12 weeks. Where healed showed statistically significant 
improvement in the vitality domain. Where healing did not occur also 
showed some improvement. 
 
Not all AEN available.  
Age range detail not 
available. 
Consent stated but not 
ethics. QS: 230 
Chase et al 
(2000) USA 
 
Quantitative descriptive study  
SF-36 on single occasion 
n=21  
Gender: 3 men 
Age: 39-73 years 
All of venous 
aetiology 
 
 
SF-36 to compare functional 
health status to US AEN 
Preliminary assessment of knowledge & functional status of CVLU 
patients demonstrated that limitations in physical function & vitality 
were moderate to severe. 
Small sample  
Consent stated but not 
ethics. QS: 230 
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Faria, E. et 
al (2011) 
Brazil 
 
 
Quantitative study Single 
completion of SF36  
n=160 
Gender: 30% male 
Age: 46-85 years 
All of venous 
aetiology 
 
 
SF-36, self-esteem & Stanford 
questionnaire on one occasion 
to assess HRQoL, self-esteem 
& functional status of CVLU 
patients 
All SF-36 domains received low scores for CVLU patients. Self-
esteem scores were the same as control. Stanford questionnaire 
(HAQ-20) revealed negative impact of CVLU on functional status. 
Single occasion.  
Clinic patients.  
Ethics approval stated. 
QS:250 
Franks, P.J. 
& Moffatt, 
C.J. (2006) 
UK 
Cross sectional quantitative 
study   Single completion of 
NHP questionnaire 
n=758 
Gender: 272 male 
Age: 74.6 
Venous: 66% 
Nottingham health profile (NHP) 
to cross section compared to 
AEN. (2006 – secondary 
analysis). 
Scores indicated poorer health for CVLU patients, esp. mobility, pain 
& energy. Less pain & better sleep quality for those seen at DN 
clinic. Greater impairment was revealed for male & younger age 
groups respondents. Large & long duration ulceration leads to poorer 
HRQoL. Nurse led clinic patients had better HRQoL. 
 
Single completion.  
Ethics approval not 
stated. QS: 310 
Franks., 
P.J. & 
Moffatt, C.  
(2001) UK 
Quantitative study 12 week 
study, data collected at start & 
end with NHP 
N=383 
Gender: 37% male 
Age: median 74 years 
All of venous 
aetiology 
 
To evaluate the responsiveness 
of NHP (and compare to 
Walters et al (1999) results with 
the SF-36) 
 
Improvements in all dimensions for NHP. Study authors argue that 
the NHP may be better tool for use with this group of patients. 
Complex comparison. 
Self-completion. 
Ethics approval not 
stated. QS: 330 
Franks, 
P.J., 
McCullagh, 
L. & Moffatt, 
C.J. (2003) 
UK 
Prospective quantitative study 
SF36 start & 12 weeks. 
n=118  
Gender: 27% male 
Age: mean 78 years 
Aetiology not defined 
Interview and SF-36 recorded 
at baseline & 12 weeks to 
assess QoL in LU patients 
HRQoL worse LU patients compared AEN. Improvement in results 
when ulcer healed, especially bodily pain. Statistical difference 
between those with healed and non-healed ulcers for bodily pain and 
mental health. 
Short duration.  
Ethics approval not 
stated. QS: 310 
Franks et al 
(2006) UK 
Cross sectional quantitative 
study NHP start, 24 and 48 
weeks 
n=95  
Gender: 35 male 
Age: median age 76 
years 
Venous, mixed, 
diabetic & 
multifactorial 
aetiology. 
 
 
NHP to review longer term 
improvement in symptoms. 
Improvements overall but esp. in pain, energy over 24 weeks. QoL 
improvement not maintained at 48 weeks. Pain & mobility 
improvement reduced compared baseline & 24 weeks. Positive 
effects of treatment on HRQoL may not be sustained over time.  
 
Ethics approval stated. 
QS: 350 
Furtado et 
al (2008) 
Portugal 
 
Cross sectional quantitative 
study NHP, EQ & VAS at 
baseline & 12 weeks 
98 at baseline / 68 FU 
at 12 weeks (37% 
male) 
Age: Mean age 71.9 
(SD 10.6) 
Aetiology: ND 
 
 
Examine impact of CVLU on 
HRQoL in Portugal. 
Higher NHP scores for all compared AEN. Improved over 12 weeks 
both NHP & EQ. Treatment improves pain but not in other areas. 
Energy & social isolation improved in patients who healed. 
 
 
Ethics approval not 
stated. 
QS: 320 
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Heinan et al 
(2006) 
Netherlands 
Descriptive, cross-sectional 
quantitative study with 
interview & questionnaire. 
n=141 
Gender: 37% male 
Age: 29-92 years 
Venous 50% 
 
 
To describe leg ulcer issues for 
patients. 
Main issues identified were pain, outdoor mobility, footwear. No 
difference VLU & mixed aetiology. 
Venous & mixed 
aetiology.  
Outpatient sample.  
Ethics approval stated. 
QS: 340 
Jull et al 
(2004) NZ 
Case control study on one 
occasion comparing SF-36 
scores to AEN 
n=465 
Gender: 41% male 
Age: mean age 75 
years 
Aetiology not defined 
 
 
To quantify the effect of leg 
ulceration on HRQoL. 
Leg ulcers reduce QoL comparably to other long term conditions in 
all 8 domains of SF36 
NZ AEN used.  
Modest response rate. 
Ethics approval stated. 
QS: 330 
Lindholm et 
al (1993) 
Sweden 
Postal survey questionnaire 
using the NHP on one 
occasion 
n=125  
Gender: 51 male 
Age: range 36-93 
years 
All aetiologies 
 
 
To explore the impact of CVLU 
on QoL 
Higher score demonstrating increased impact for men. Also shop 
workers & longer duration of ulceration. 
No comparison to AEN. 
Gender comparisons 
made.  
Consent detailed but not 
ethical approval. QS: 240 
Wissing et 
al (2002) 
Sweden 
Quantitative study 
Philadelphia Geriatric Center 
Multilevel Assessment 
Instrument PGCMAI on one 
occasion 
n=144 
Gender: 44  
Age: mean 79 years 
Aetiology not defined  
To compare life situation of 
ulcer patients to those without. 
CVLU patients had lower mean value in all domains of physical 
health, ADL, cognition, time use & social behaviour, personal 
adjustment & environmental quality than those without. 
Questionable relevance 
due to location of study.  
New questionnaire.  
Ethics approval stated. 
QS: 230 
Yamada, B. 
& de 
Gouveia 
Santos, V. 
(2005) 
Brazil 
Correlational descriptive, 
exploratory, cross-sectional 
study Interviews using the 
generic version of Ferrans & 
Powers QoL Index (QLI) 
adapted for Brazilians on one 
occasion 
n=89 
Gender: 28 male 
Age: 25-84 years 
Venous: 100% 
Analyse QoL of individuals with 
CVLU in Brazil. 
Applied the QLI instrument. Patients with VLUs showed good levels 
of QoL mainly in family & psychological/spiritual subscales – 
contradicts other studies demonstrated scores indicative of good & 
very good QoL in VLU. 
Transferability of results. 
Contradictory findings. 
Ethics approval not 
stated. QS: 170 
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3.6  Overview of articles in the final review. 
Due to the different approaches adopted and the diversity of reporting approaches in the included 
studies, these have been split in respect of their methodology. This approach is common to ensure 
the clarity of synthesis (Booth et al, 2012). 
 
3.6.1  Characteristics of qualitative studies. 
Eleven qualitative studies, published between 1995 and 2010, were selected for inclusion within the 
review. One study was reported in two papers (Brown, 2005 a&b). These studies represented the 
views of 106 participants. Where gender was specified (8 studies containing 74 of the total study 
participants; Charles, 1995; Walshe, 1995; Bland, 1996; Hyde et al, 1999; Douglas, 2001; Ebbeskog 
& Ekman, 2001a; Rich & Lachlan, 2003; Hopkins, 2004), 53 of these (68%) were female. Study 
participants were aged between 43 - 94 years and were located across three continents; Europe, 
North America and Australia. Study sample sizes ranged from 4 – 15, with the median number of 
participants being eight. Quality scores for study reporting ranged from three studies rated as poor 
(Charles, 1995; Bland, 1996; Byrne & Kelly, 2010), one study rated as fair (Chase et al, 1997) and 
seven rated as of good quality (Walshe, 1995; Hyde at al, 1999; Douglas, 2001; Ebbeskog & Ekman, 
2001a; Rich & McLachlan, 2003; Hopkins, 2004; Brown, 2005a & b) (Hawker et al, 2002).   
 
3.6.2  Characteristics from quantitative studies. 
Thirteen quantitative studies, published between 1993 and 2012, were retained for inclusion in the 
review. These represented the views of 2634 participants, of which approximately 1563 (59%) were 
female. Study participants were between 25 - 92 years of age and were located across four 
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continents: North America, South America, Europe and Australia. Study sample sizes ranged from 
21 – 758, with the median number of participants being 141. Quality scores for study reporting 
ranged from one study rated as poor (Yamada & Gouveia Santos, 2005), five rated as fair (Lindholm 
et al, 1993; Chase et al, 2000; Wissing et al, 2002; Charles, 2004; Faria et a, 2011) and seven rated 
as of good quality (Franks & Moffatt, 1998 & 2001; Jull et al, 2004; Franks et al, 2003; Franks et al, 
2006; Heinan et al, 2007; Furtado et al, 2008). 
 
3.7 Methods of Synthesis. 
The value of any review, according to Booth et al (2012), lies not only in the search and selection of 
studies but in the synthesis of the evidence that is extracted, leading to new explanations or to 
strengthen our understanding. For the purpose of this review, the qualitative and quantitative studies 
were synthesised separately in order to ensure clarity; a process that commenced with data 
extraction and the completion of the summary table (table 4; page 63 - 67) (Booth et al, 2012).  
 
The synthesis of the qualitative studies involved a process of thematic synthesis (Thomas et al, 
2004) whereby the findings of multiple studies were coded, integrated and then grouped into themes. 
As a result, consistency of review technique was maintained across the studies and themes that 
enhance our understanding of the quality of life and leg ulceration were identified and thoroughly 
explored (Briggs, 2009; Booth et al, 2012). 
 
The synthesis of the quantitative studies has similarly involved a narrative thematic synthesis and a 
meta-analysis where heterogeneity allowed (page 81) (Booth et al, 2012). For clarity, studies have 
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been grouped according to the main QoL instrument that was applied (SF36, NHP, etc), thus 
enabling comparisons of the reported themes to be more clearly reported. 
 
3.8 Results of qualitative studies. 
The eleven qualitative studies reviewed combined their findings into a total of 41 subthemes. For the 
purpose of this narrative synthesis these 41 themes have been incorporated into the four 
overarching themes as a preliminary stage of the analysis using a process of thematic analysis 
(CRD, 2009).  The four themes were: 
1) The physical implications of CVLU;  
2) The psychological implications of CVLU;  
3) The social implications of CVLU;  
4) The nurse-patient relationship. 
 
Each of the themes also contained a number of related subthemes, which have been displayed in 
diagrammatic form in figure 6 below. 
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Figure 6:  Thematic map of qualitative themes. 
 
 
3.8.1  Physical Implications. 
3.8.1.1  Pain. 
Pain was the dominant theme reported consistently across all eleven of the qualitative studies. Pain 
was described as significant (Bland, 1996; Rich & McLachlan, 2003; Brown, 2005b); indeed, it was 
referred to as the worst symptom and the cause of enormous suffering. In Byrne and Kelly’s (2010) 
study, one respondent commented on the severity of their pain, stating: 
“Oh severe ache of a pain, as if you were jamming it with a knife all the time….” (Byrne & 
Kelly, 2010; p. 48) 
Patient with 
CVLU – 
qualitative 
findings. 
Physical implications:  
symptoms, pain, odour, exudate, 
rest, limits & accommodations, a 
restricted life, gaining control over 
vulnerable limbs, mobility and 
restrictions. 
 
Psychological 
implications: 
compliance, coping,  
powerlessness, who 
cares?, loss of control, 
vision for the future, 
emotional consequences, 
hope & despair, 
biographical disruption, 
perceptions.  
 
Social implications:  
social disconnectedness, 
social isolation and lifestyle 
consequences.   
Nurse-patient 
relationship:  
therapeutic nurse-
patient relationship, 
relationships and 
treatment issues.  
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Pain was overwhelming, continuous and unrelenting; it had profound effects, impacting on sleep, 
mobility and almost every other area of day-to-day functioning and was exacerbated by dressings 
and treatment regimens (Charles, 1995; Walshe, 1995; Hyde et al, 1999; Douglas, 2001). Pain, for 
some participants, was their ‘constant companion’, persistently reminding them of the unremitting 
nature of their ulceration (Walshe, 1995; Hopkins, 2004). Pain was central to the life of participants, it 
controlled their existence and made them sad, angry and ‘to cry in despair’ (Ebbeskog & Ekman, 
2001; page 239).  
 
The control of pain was also problematic and highlighted specifically in four of the studies (Walshe, 
1995; Bland, 1996; Douglas, 2001; Byrne & Kelly, 2010); respondents disclosed that they often 
under-reported their pain and were reluctant to take analgesia which was often deemed to be 
ineffective against ulcer related pain. Pain management was felt to be an area of care that was 
frequently inadequately managed (Rich & McLachlan, 2003).  
 
3.8.1.2  Exudate and Odour. 
Eight of the eleven studies referred to issues with leakage from the wound and malodour (Walshe, 
1995; Bland, 1996; Hyde et al, 1999; Douglas, 2001; Ebbeskog & Ekman, 2001a; Rich & McLachlan, 
2003; Hopkins, 2004; Byrne & Kelly, 2010). Participants reported profuse exudate, which was 
unbearable and devastating (Rich & McLachlan, 2003). Dressings leaked regularly which caused 
distress and shame; exacerbated by the unpredictable nature of such episodes (Byrne & Kelly, 
2010). There were reports of wet shoes, wet bedding and concerns of what people might think 
(Douglas, 2001). Where leakage was associated with malodour, the impact was even greater and 
the symptoms were often inadequately managed. These symptoms were of particular concern and 
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had an even greater impact when the patient was working (Hyde et al, 1999). Participants felt that 
mechanisms to manage exudate and odour were consistently inadequate, with the odour being 
described as the worst thing associated with ulceration (Walshe, 1995; Bland, 1996; Hopkins, 2004). 
For one study participant, 
“It was an embarrassment. No matter where I went, people – you could see them moving 
away – because of the smell.” (Bland, 1996, p.13) 
The leakage and odour resulted in limitations to social contacts, self-consciousness and a feeling 
that matters that should remain private had somehow become public with efforts to improve 
symptoms most often proving to be inadequate (Walshe, 1995; Chase et al, 1997).  
 
3.8.1.3  Mobility and daily living. 
Six of the studies referred to mobility issues (Walshe, 1995; Chase et al, 1997; Douglas, 2001; 
Ebbeskog & Ekman, 2001a; Brown, 2005b; Byrne & Kelly, 2010). For many respondents mobility 
was constrained, most often as a result of ulcer related pain, wound leakage and bandages (Walshe, 
1995; Chase et al, 1997; Hyde et al, 1999; Douglas, 2001; Ebbeskog & Ekman, 2001a). Many were 
virtually housebound (Walshe, 1995), unable to work and to socialise; issues that were further limited 
by fears of falling and sustaining additional injuries (Brown, 2005b). These limitations were viewed 
with a sense of loss and resignation (Byrne & Kelly, 2010). 
 
3.8.1.4  Sleep. 
Sleep disturbances were a prevailing feature in six of the studies reviewed and was most often 
attributed to ulcer-related pain, which negatively impacted on well-being (Charles, 1995; Walshe, 
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1995; Douglas, 2001; Ebbeskog & Ekman, 2001a; Rich & McLachlan, 2003; Byrne & Kelly, 2010). 
Participants reported that it was rare to experience a full night of sleep, leading to daytime tiredness 
and a lack of strength and energy (Ebbeskog & Ekman, 2001b).  
 
A number of other areas of physical functioning were restricted due to ulceration. There were 
difficulties in maintaining personal hygiene, raised in five of the studies, which further impacted on 
perceptions of well-being and contributed to social isolation (Walshe, 1995; Bland, 1996; Douglas, 
2001; Ebbeskog & Ekman, 2001a; Rich & McLachlan, 2003). Respondents also reported not having 
their feet washed for long periods (Walshe, 1995; Bland, 1996; Chase et al, 1997; Ebbeskog & 
Ekman, 2001a), resulting in worries about odour that further exacerbated their social isolation.   
 
Five of the studies explored issues relating to sourcing adequate, comfortable footwear and suitable 
clothing which would effectively conceal the dressings (Chase et al, 1997; Hyde et al, 1999; 
Ebbeskog & Ekman, 2001a; Rich & McLachlan, 2003; Hopkins, 2004). Hyde et al (1999), in their 
study of female participants, found respondents had to modify clothing to conceal their ulceration 
and referred to the limitations of choices of clothing as yet another restriction to their personal style 
and erosion to their femininity.  
 
3.8.2  Social Implications. 
All eleven studies made reference to the major impact CVLU has on social life, often as a result of 
wound leakage and any associated odour (Hyde et al, 1999; Ebbeskog & Ekman, 2001a; Hopkins, 
2004). Some participants reflected on a desire not to subject those close to them to the effects of the 
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exudate and voluntarily excluded themselves from engaging in social activity due to their fear of how 
people might react to them (Ebbeskog and Ekman, 2001a; Hopkins, 2004). Private things had been 
moved into the public domain was the response of participants (Hopkins, 2004) and, as a result of 
these concerns, sufferers reported that they would voluntarily exclude themselves from society, in an 
attempt to avoid the associated embarrassment (Rich & McLachlan, 2003).  
 
Hyde et al (1999) reported a self-inflicted social isolation as an attempt to limit further damage to 
legs and to prevent ulcer recurrence. Patients spoke of looking forward to an end of ulceration so 
that they could initiate social interaction again; the time with ulcers was referred to as ‘wasted days’ 
(Walshe, 1994; Chase et al, 1997; Ebbeskog & Ekman, 2001a). Brown (2005b) referred to this social 
disconnectedness as being  
“…on the inside, looking out” (Brown, 2005b; p. 986), 
of being separate from everyday society, almost an introverted and closed life of social isolation 
(Hyde et al, 1999; Byrne & Kelly, 2010).  
 
For some, their ulcers limited their ability to work (Charles, 1995; Bland, 1996); one gentleman 
reported having to finish working due to his ulcer, a situation he was resigned to, but felt that the 
ulcer had cost him his freedom and his livelihood (Chase et al, 1997). A gentleman in Bland’s study 
(1996) reflected on concerns regarding job security due to extended and recurrent periods of sick 
time due to his ulceration.  
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3.8.3  Psychological Implications. 
All eleven studies commented on the psychological implications of living with CVLU. Hopkins (2004) 
explains a concept of ‘biographical disruption’, whereby a clear distinction was perceived 
distinguishing life before and after ulceration, with a marked effect on their physical and social 
activity. Participants had feelings of loss but, despite this, many studies revealed that there was also 
hope for the future (Bland, 1996; Ebbeskog & Ekman, 2001a; Hopkins, 2004). This disparity between 
hope and expectations was seen as an important part of coping with the condition (Ebbeskog & 
Ekman, 2001a; Rich & McLachlan, 2003). Hyde et al (1999) reported an inner strength held by 
participants, a determination to cope, stoicism, resilience and hope for the future and healing.   
 
Participants were preoccupied with their ulcers and constantly thought about them (Walshe, 1995). 
For some, in order to cope, there was an intentional normalisation of the ulcer, an attempt to bracket 
it off in an effort to live a normal life (Hopkins, 2004). Some had difficulties with self-image, feelings 
of disgust towards themselves and pessimism in relation to the likelihood of healing were reported 
(Walshe, 1995). Chase et al (1997) described the lengthy healing process as a ‘forever healing’, with 
the chronic nature of the wounds impacting on the sufferers daily living and making them want to 
hide their bodies. For many a role reversal had occurred, between the ulcer sufferer and their family, 
with those who had previously been the head of the family now being dependent on other members 
for help and support (Douglas, 2001).  
  
 77 
3.8.4  Nurse-patient relationship. 
Nine of the studies reported that the role of the DN was significant to the patient (Charles, 1995; 
Walshe, 1995; Bland, 1996; Chase et al, 1997; Douglas, 2001; Rich & McLachlan, 2003; Hopkins, 
2004; Brown, 2005b; Byrne & Kelly, 2010) reflected on as one of the only positive aspects of CVLU, 
with reports of nurses going beyond the necessity of their visits and enjoying a ‘laugh and a joke’ 
(Walshe, 1995; Chase et al, 1997; Hopkins, 2004). Participants were confident in their nurses’ ability. 
Some studies reported inconsistencies in and dissatisfaction with the care provided by nurses, 
especially temporary or agency nurses – the continuity of the nurse was paramount; some even 
complained of time wasted whilst they waited for nurse visits (Charles, 1995; Chase et al, 1997; 
Brown, 2005b; Byrne & Kelly, 2010). In spite of this, participants remained grateful and trusted in 
their nursing staff (Hyde et al, 1999; Douglas, 2001; Rich & McLachlan, 2003). Studies, however, 
revealed an overall lack of understanding of the underlying causes and treatment of ulceration, 
which served to exacerbate feelings of powerlessness and may have resulted in some compliance 
issues (Chase et al, 1997; Douglas, 2001).  In spite of these factors, patients were grateful for the 
care provided, especially for the personal characteristics of the nurses.  
 
3.9  Results of quantitative studies. 
The thirteen quantitative studies reviewed combined a number of established generic HRQoL 
instruments. Five studies applied the Short Form 36 (Ware & Sherbourne, 1992) and five applied the 
Nottingham Health Profile (NHP) (Hunt et al, 1986), occasionally in combination with other 
instruments. The remaining three studies utilised a combination of other instruments including; the 
Sickness Impact Profile (de Bruin, 1996), Cantril’s ladder of life (Cantril, 1965), the Barthel index 
(Mahoney & Barthell, 1965) and the subjective sleep quality scale (Cox, 1992; Heinen et al, 2007); 
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the Philadelphia geriatric center multilevel assessment (Wissing et al, 2002); Ferrans and Powers 
QoL index (1985) (Yamada & de Gouveia Santos, 2005) and Freiburg life quality assessment for 
wounds (Herberger et al, 2011).  Meta-analysis has been undertaken where the heterogeneity of 
studies have allowed (page 85); otherwise synthesis has been purely narrative. 
 
3.9.1  Studies using the SF-36 
The Short Form – 36 is a generic health survey that provides QoL information and is designed for 
self-completion (Ware & Sherbourne, 1992). It is possibly the most widely evaluated tool and has 
proven validity and reliability (Garratt et al, 2002). Completion produces a range of scores across 
eight domains with lower scores indicating more limited functioning in that area; in contrast to the 
scoring range of the NHP.  Five of the selected studies used the SF-36 in order to evaluate the QoL 
of their participants with CVLU (Charles, 1995; Chase et al, 2000; Franks et al, 2003; Jull et al, 2004; 
Faria et al, 2011). The studies range over a period of 16 years (1995 – 2011) and include a total 
sample size of 829 participants. Two studies (Franks et al, 2003; Jull et al, 2004) utilised a control 
group in order to demonstrate comparisons, whereas the remaining three studies used Age 
Equivalent Norms (AEN) of various origins (other studies, gender or country specific). A meta-
analysis of three studies has been possible (Charles, 1995; Franks et al, 2003; Jull et al, 2004). 
 
Scores are recorded in table 6 overleaf. The range of control and AEN scores show considerable 
variation but still serve to demonstrate the consistently lower scores, and hence compromised QoL, 
across all domains for the participants with CVLU. In some of the more recent studies composite 
scores were calculated to indicate overall physical and mental component scoring (PCS and MCS), 
however since these were not available for four of the selected studies they have not been utilised. 
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Two of the studies (Charles, 1995; Franks et al, 2003) recoded SF-36 scores at entry to the study 
and after 12 weeks in order to observe for improvements over time and with healing. The remaining 
three studies applied the SF-36 on a single occasion.  
 
Table 6: SF-36 Mean domain scores. 
 
 Charles (1995) Chase et al 
(2000) 
Franks et al (2003) Jull et al (2004) Faria et al (2011) 
SF-36 Domains Entry Exit AEN Study AEN Entry Exit Control Study Control Study Control 
Physical 
function 
44.3 45.1 59.0 56.2 84.2 29.1 31.1 50.7 49.5 75.7 48.68 80.06 
Role-physical 35.4 38.5 54.0 67.9 81.0 41.8 40.3 63.0 43.2 72.7 22.5 75.31 
Bodily pain 45.0 61.8 60.0 75.5 75.2 53.9 56.0 65.5 55.3 72.9 57.81 72.29 
General Health 61.9 61.4 58.0 72.7 72.0 55.3 54.4 58.2 59.2 73.5 66.18 73.13 
Vitality 44.8 49.4 60.0 50.0 69.9 45.9 45.9 48.7 53.2 67.6 59.37 70.75 
Social 
functioning 
49.7 59.8 76.0 83.9 83.3 57.3 55.6 78.6 69.9 87.6 56.25 81.60 
Role-emotional 44.6 52.3 73.0 81.0 81.3 58.1 59.5 84.9 68.9 85.3 41.61 80.34 
Mental health 62.5 68.1 68.0 80.0 74.1 69.1 67.5 73.2 76.2 82.2 64.9 71.94 
 
Physical functioning explored limitations to performing physical activities such as washing and 
dressing and was limited across all five of the included studies, with mean scores being consistently 
below their comparators; this was also the case where scoring had been repeated at 12 weeks and 
even in the event of healing (Charles, 1995; Franks et al, 2003). The role-physical domain refers to 
problems working or with other daily activities due to physical health and was diminished across all 
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studies. Bodily pain refers to extremely debilitating pain and was significant for all participants across 
four of the five studies, with the exception of Chase et al (2000).  
 
Where the study was conducted over 12 weeks, improvements in bodily pain were demonstrated 
irrespective of healing. General health was the least compromised of the eight health domains; 
indeed Charles (1995) and Chase et al (2000) demonstrated improved scores for their participants 
when compared with the AENs selected. General health was most compromised for the participants 
of Jull et al’s (2004) study, which demonstrated a mean 14 points below their selected AEN. The 
vitality score represents energy levels for the respondents. Vitality was compromised for participants 
in all studies, to varying degrees, which reflects consistently reduced energy reserves for this client 
group.  
 
Social functioning reflects health interfering with the participant’s ability to socialise as they would 
like and was reduced for the participants of four of the studies. Chase et al (2000) was the only study 
that demonstrated higher scores for their respondents in the social functioning domain than their 
AEN. Role-emotional scores explore limitations to daily physical functioning due to the emotional 
effects of their illness and were compromised for all; again with Chase et al (2000) demonstrating the 
least compromised compared to their AEN. The final domain, mental health, explores feelings of 
nervousness and depression and in four of the five studies was compromised, with Chase et al 
(2000) again being the exception. Charles (1995) demonstrated an improvement in mental health 
over the 12 weeks of her study with the final score being above her AEN. In contrast, Franks et al 
(2003) demonstrated a reduction in the mental health score indicating deteriorating function over the 
12 weeks of their study. 
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Overall, all five studies demonstrate reduced functioning across all eight domains and thus 
compromised QoL for those patients with CVLU. Improved care delivery and even healing did not 
consistently improve functioning that reflects the recurring and debilitating nature of this condition. 
Jull et al (2004) proposed that CVLU compromised health states in all areas by approximately 10%, 
effectively reflecting their compromised health state with this condition (Faria et al, 2011).  
 
3.9.1.1  Meta-analysis of SF-36 scores for physical functioning and mental health. 
A meta-analysis refers to a statistical ‘pooling’ of data to allow for scores from a number of studies to 
be compared and contrasted in order to ascertain similarities or differences (Booth et al, 2012). In 
order for a meta-analysis to be undertaken, the studies need to be homogenous in terms of 
population, exposure, comparator and outcome (PECO) (NCCMT, 2012). For the quantitative 
studies reviewed here, only three demonstrated sufficient similarity in the reporting of data to be 
included in a meta-analysis (Charles, 1995; Franks et al, 2003; Jull et al, 2004). Review Manager 
5.2, a computer package developed by the Cochrane Collaboration was utilised to undertake the 
meta-analysis (RevMan, 2012), with the output demonstrated in figure 7 overleaf. 
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Figure 7:  Forest plot for SF36 Physical Functioning and Mental Health scores. 
 
 
 
3.9.1.2  SF-36 QoL – Physical Functioning. 
There were three studies in this analysis. The pooled mean difference for QoL physical functioning 
was -21.59 (95% CI: -27.96 to -15.22; p <0.00001). Therefore, QoL physical functioning was 21.59 
lower in people with CVLU than those without and this effect was statistically significant at the 
p<0.05 level. There was moderate heterogeneity between the studies (I2 = 46%; p 0.16). All three 
studies had a lower mean QoL physical functioning in the CVLU patients than in those without 
ulcers, but the magnitude of this effect varied between studies. 
 
3.9.1.3  SF-36 QoL – Mental Health. 
There were three studies in this analysis. The pooled mean difference for QoL mental health was      
-5.42 (95% CI: -8.26 to -2.57; p 0.0002). Therefore, QoL mental health was 5.42 lower in people with 
CVLU than those without and this effect was statistically significant at the p<0.05 level. There was 
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low heterogeneity between the studies (I2 = 0%; p 0.85). All three studies had a lower mean QoL 
mental health in the CVLU patients than in those without ulcers, but the magnitude of this effect 
varied between studies. 
 
3.9.1.4  Meta-analysis results overall. 
Taking two outcomes for these three studies, demonstrated that the pooled mean difference for QoL 
in these areas was -12.72 (95% CI: -20.34 to -5.09; p 0.001). Therefore, both QoL physical 
functioning and mental health was 12.72 lower in people with CVLU than those without and this 
effect was statistically significant at the p<0.05 level. Overall, when these two outcomes were 
combined, there was high heterogeneity between the studies (I2 = 88%; p <0.000001), however all 
three studies had lower mean QoL physical functioning and mental health scores in the CVLU 
patients than in those without ulcers, but the magnitude of this effect varied between studies.  
 
This meta-analysis demonstrates a consistently lower mean score, and thus diminished QoL, for 
patients with CVLU when compared to those without ulceration on review of SF36 completion (Ware 
& Sherbourne, 1992) across these three studies (Charles, 1995; Franks et al, 2003; Jull et al, 2004). 
Such meta-analysis strengthens individual study results and represents the combined responses of 
779 participants.  
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3.9.2  Studies using the Nottingham Health Profile. 
The NHP (Hunt et al, 1986) is a generic quality of life survey that is used to evaluate subjective 
physical, emotional and social aspects of health of the respondent. It is designed for self-completion 
with higher scores over the six domains reflecting poorer levels of health and has proven levels 
reliability and validity (McDowell & Newell, 1996). Five of the fourteen quantitative studies used the 
NHP to determine the QoL of their participants with CVLU (Lindholm et al, 1993; Franks & Moffatt, 
1998, 2001; Franks et al, 2006; Furtado et al, 2008). The studies range over a period of 15 years 
(1993 – 2008) and include a total sample size of 1459 participants. Two studies (Franks & Moffatt, 
1998; Furtado et al, 2008) utilised AENs of various origins (age, gender or location specific) which 
provide a norm-referenced approach to facilitate the comparison of one individual with another 
(Hicks, 2004). Two recorded NHP scores at intervals throughout the study (Franks & Moffatt, 2001; 
Franks et al, 2006) and one of the earlier studies was only reported narratively (Lindholm et al, 
1993), without the inclusion of scoring detail and thus scored only a fair quality score (240) (Hawker 
et al, 2002). This lack of consistency of reporting reflects considerable heterogeneity and has made 
comparisons difficult to draw, thus meta-analysis has not been possible and the studies have been 
reported narratively.  
 
Lindholm et al (1993) concluded that CVLU presented a marked impact on subjectively assessed 
perceived health but failed to present the data on which this assumption was founded. Their analysis 
of NHP scores recorded on a single occasion was compared with age / sex adjusted norms and 
distinctions were made related to occupational / class status, although data was not included as 
evidence in the article. The narrative summary reported higher scores for men in the energy domain 
compared with the female respondents with CVLU and the general population. Higher pain scores 
were reported in both male and females participants. Emotion scores were similar for female 
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respondents compared to the general population but were higher for men. Sleep presented slightly 
higher scores for women but consistently higher for men. Social isolation was unchanged for the 
female respondents but the males demonstrated elevated scores. In the area of mobility, female 
respondents had slightly elevated scores whereas their male counterparts were significantly higher. 
 
Franks and Moffatt (1998; 2001) and Franks et al (2006) conducted a number of studies exploring 
the QoL of patients with CVLU using the NHP. Only in the 1998 study (Franks & Moffatt, 1998) were 
scores compared to the general population according to gender, although data was collected on a 
single occasion. Both the 2001 and 2006 studies (Franks & Moffatt, 2001; Franks et al, 2006) were 
conducted over an extended period of 12 weeks and 48 weeks respectively. In addition Furtado et al 
(2008) applied the NHP (table 7 below). 
 
Table 7: NHP Mean domain scores. 
 
 Franks & Moffatt (1998) Franks  & 
Moffatt (2001) 
Franks et al (2006) Furtado et al (2008) 
NHP Domains Male Male 
AEN 
Female Female 
AEN 
Entry Week 
12 
Entry Week 
24 
Week 
48 
Entry Week 
12 
AEN 
Energy 26.2 21.1 38.1 36.9 29.1 21.9 43.1 36.75 51.84 51.9 56.6 26.1 
Bodily pain 28.5 9.5 32.5 21.6 30.8 18.0 31.3 21.7 25.32 61.3 50.8 27.7 
Emotion 14.6 11.3 19.8 15.0 14.6 10.6 21.3 19.6 20.27 45.6 41.2 22.7 
Sleep 23.8 17.9 31.3 35.2 29.6 20.8 34.3 32.56 28.44 47.3 43.0 33.7 
Social 
isolation 
12.0 7.2 14.6 10.6 11.7 8.9 18.9 19.23 19.02 35.4 29.9 21.2 
Mobility 28.5 12.6 40.9 27.2 30.7 26.2 41.7 40.77 47.11 50.2 48.2 25.3 
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Three of the studies (Franks & Moffatt, 1998, 2001; Franks et al, 2006) revealed compromised QoL 
across all six domains at baseline of the study, with highest scores recorded for mobility, pain and 
energy. Franks and Moffatt (1998) demonstrated that participants scored considerably higher scores 
than the age/sex-matched scores available, which indicate poorer perceived health. Scores for 
women, when analysed, were higher than their male counterparts for energy, emotion, sleep and 
mobility. Scores were also higher in the younger patients, compared to their older equivalents in all 
domains.  
 
Franks and Moffatt’s (2001) study recorded NHP scores at baseline and after 12 weeks, allowing for 
analysis where a wound had healed. This analysis demonstrated that where ulcers healed, bodily 
pain and sleep improved most dramatically. Their later study in 2006 (Franks et al, 2006) recorded 
NHP scores at baseline, 24 weeks and 48 weeks providing greater scope for comparisons to be 
drawn. At 24 weeks, pain and energy had improved, irrespective of whether healing had occurred or 
not but social isolation had increased for all. However, such improvements were not sustained at 48 
weeks (Franks et al, 2006) and in some domains scores returned to below those recorded at 
baseline in the latter stages of the study. Improvements in pain were reduced, energy levels and 
mobility declined below those recorded at baseline. These three studies (Franks & Moffatt, 1998, 
2001; Franks et al, 2006) conclude that CVLU impacts on all areas of QoL when compared to the 
general population. There is some discrepancy in relation to age and gender effects but domains 
were limited for all, which implies reduced QoL and poorer functioning. 
 
Furtado et al (2008) applied the NHP along with EuroQoL (EuroQoL Group, 1990) and Visual 
Analogue Scale (VAS) (Melzack, 1987) at entry to the study and after 12 weeks. The study was 
based in Portugal and scores were compared these to the Portuguese AEN. Higher scores were 
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seen for the study participants across all domains compared to the AEN at baseline and 12 weeks, 
although bodily pain was the only statistically significant result. Improvements were demonstrated 
over the 12 weeks of the study (Furtado et al, 2008). Where ulcer healing had occurred, 
improvements were seen in social isolation, sleep and energy when compared with their non-healed 
counterparts. 
 
Overall, all five studies (Lindholm et al, 1993; Franks & Moffatt, 1998, 2001; Franks et al, 2006; 
Furtado et al, 2008) that applied the NHP demonstrate reduced functioning across the six domains 
and thus compromised QoL for those patients with CVLU. There is some variation in reporting in 
relation to age and gender but all studies conclude limitations attributable to CVLU and, significantly, 
Franks et al (2006) demonstrate that improvements recorded in the short term (12 week) were not 
sustained at 48 weeks. 
 
3.9.3  Studies using other instruments.  
The remaining three studies used a number of other generic instruments (Wissing et al, 2002; 
Yamada & de Gouveia Santos, 2005; Heinen et al, 2007) with two of the three similarly concluded 
that CVLU negatively impacts on QoL (Wissing et al, 2002; Heinen et al, 2007).  
 
Wissing et al (2002) undertook a case control study in Sweden which compared 70 patients with leg 
ulceration with 74 elderly patients without leg ulceration, although recruitment was not randomised. 
The questionnaire used was the Philadelphia Geriatric Center Multilevel Assessment Instrument 
(PGCMAI) which assesses well-being and behavioural competence with low scores indicating 
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compromised functioning. Participants with CVLU demonstrated lower scores through all domains 
when compared to the control group. This revealed compromised functioning in physical health, 
activities of daily living, cognition, time management, social interaction, psychological well-being and 
environmental quality (Wissing et al, 2002). 
 
Heinen et al (2007) undertook their study across seven hospitals in the Netherlands (n=141) with 
data collected using interviews, questionnaires and wound assessment. Sampling was not 
randomised but included all with an open venous or mixed aetiology ulcer who were able to 
understand the Dutch language. The questionnaires applied included the Sickness Impact Profile (de 
Bruin, 1996), Cantril’s ladder of life (Cantril, 1965), the Barthel index (Mahoney & Barthell, 1965) and 
the subjective sleep quality scale (Cox, 1992). These were accompanied with interviews and wound 
observations. Results demonstrated a negative effect of ulcer related problems with pain, mobility 
and difficulties getting adequate footwear impacting significantly on QoL. Problems with sleep, 
wound care, daily activities and negative emotions were present as a result of CVLU (Heinen et al, 
2007). 
 
Yamada and de Gouveia Santos (2005) undertook their Brazilian study using the generic Ferrans 
and Powers Quality of Life Index (QLI) (1985) that had been specially translated and adapted for this 
client group. The study is described as a ‘descriptive, exploratory and cross-sectional study’ 
(Yamada & de Gouveia Santos, 2005; page 178) and accessed 89 patients across three public 
hospitals, although sampling was not randomised. This study was the first report of the application of 
the QLI to this population and provided results in four subscales; health/functioning, social/economic, 
psychological/spiritual and family. In complete opposition to other published studies, Yamada & de 
Gouveia Santos (2005) reported scores above 20 indicating positive QoL for those with CVLUs. 
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These results are hard to validate since the QLI has not been used either for this group of patients or 
translated for a Brazilian population prior to this study. This study achieved the only poor rating in 
terms of the quality score (180) (Hawker et al, 2002) and as such these results must be treated with 
caution. 
 
3.10  Synthesis of study findings. 
All but one of the studies included in this review (Yamada & de Gouveia Santos, 2005), whether 
qualitative or quantitative in their methodology, demonstrated a reduction in QoL caused by CVLU 
and the quality of the opposing study was poor. Each of the approaches adopted had inherent 
limitations but it is when the findings are synthesised that we can accurately assess the severe and 
wide ranging effects of the condition on the life of the sufferer.  
 
Leg ulceration is a debilitating condition, characterised by long periods of ulceration, and where 
healing is achieved, a high incidence of recurrence exists (Heit et al, 2001). Significant, QoL limiting 
symptoms are the common theme across the research presented and the negative impact that the 
ulceration has on the psychological well-being of the sufferer is also an important feature; with 
feelings of low self-esteem, frustration and inadequacy being frequently reported. Self-imposed 
social isolation either to protect from further damage or to limit the exposure of others to the 
debilitating symptoms of ulceration was widespread and served to reduce the QoL of the 
participants. 
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3.11  Discussion. 
3.11.1  Overall findings 
For the purpose of this review, twenty five studies were identified, with a combined sample size of 
2740 participants aged between 25 and 94 years. Qualitative studies provided rich data that 
revealed the very personal impact of CVLU on day-to-day functioning for the participant. The studies 
demonstrated that every area of life for the patient was restricted, with pain dominating the 
functioning of many (Bland, 1996; Rich & McLachlan, 2003; Brown, 2005b). Exudate and odour 
embarrassed participants which resulted in an often self-imposed social isolation, low mood and 
depression and poor self-esteem (Ebbeskog & Ekman, 2001a; Rich & McLachlan, 2003; Byrne & 
Kelly, 210). The ability of participants to maintain adequate standards of personal hygiene was 
restricted (Walshe, 1995; Bland, 1996; Rich & McLachlan, 2003) and choices in the selection of 
clothes and shoes were limited (Chase et al, 1997; Hopkins, 2004), factors which served to further 
limit self-esteem (Ebbeskog & Ekman, 2001a). Sleep was restricted due to pain and other symptoms 
and was a problem for many study participants (Douglas, 2001; Byrne & Kelly, 2010).  
 
Quantitative studies similarly revealed poor QoL, demonstrating limitations across every area of 
functioning, whether physical, social or psychological (Franks & Moffatt, 1998; 2001; Jull et al, 2004). 
Scores were lower when compared to the AEN across the majority of studies and improvements as 
a result of healing were generally not sustained over studies of longer duration (Franks et al, 2006). 
All of the data presented supports the notion of CVLU as a long term condition, with sustained 
healing not likely to occur and widespread limitations in functioning for the sufferer – findings in line 
with similar reviews of literature (Persoon et al, 2004; Briggs & Flemming, 2007; Herber et al, 2007a; 
Gonzalez-Consuegra & Verdu, 2011). 
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3.12  Strengths and limitations of the review. 
3.12.1  Strengths. 
The strengths of this review are the application of robust and replicable systematic search strategy 
and the thorough peer reviewed process adopted for study selection. The application of a valid 
quality scoring tool (Hawker et al, 2002) to assess the quality of a range of areas of the reporting of 
each of the studies, in addition to the use of the CASP (CASP, 2010) approach to the critical 
appraisal of each article have also strengthened the review. A meta-analysis was undertaken on 
selected SF-36 data which reiterated the impact of CVLU on the lives of patients across the studies 
(Charles, 1995; Franks et al, 2003; Jull et al, 2004). This review was also subject to a double blind 
peer review prior to two publications in a popular nursing journal, although the search was updated 
for the final thesis; a factor which supports the rigour of the approach adopted (Green & Jester, 
2009; 2010). 
 
3.12.2  Limitations. 
Studies not available in English were excluded from the study, as funding for translation services 
was not available which may have limited coverage. Studies that aimed to construct, validate or 
evaluate a QoL instrument were excluded, as mentioned previously, since their aim was instrument 
specific. The review was time limited as it formed part of an overall PhD study and was undertaken 
with only limited funding. Meta-analysis was not possible on all of the quantitative studies due to 
marked heterogeneity, especially in relation to the studies that applied the NHP (Lindholm et al, 
1993; Franks & Moffatt, 1998, 2001; Franks et al, 2006; Furtado et al, 2008). 
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3.13  Conclusion and research implications. 
This chapter has presented a review that has explored studies that have evaluated the impact of 
CVLU on the QoL of the patient. It supports the findings of earlier reviews (Persoon et al, 2004; 
Herber et al, 2007a) in demonstrating the wide-ranging nature of the effects of ulceration across 
every area of functioning. The consistently negative implications of CVLU reported in these studies 
that span over 16 years, clearly demonstrates a need to move away from studies that simply 
reiterate these negative effects, to more innovative research that explores potential solutions to 
these issues. The studies demonstrate a need to develop and evaluate interventions that may go 
some way to improving QoL for these patients and reiterate the research aims that form the basis for 
this study. 
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Chapter 4:  Phase 1. 
 
 
Chapter 4 provides detail of the underlying methodological decisions made and the methods 
adopted during the first phase of the study, including an outline of the measures taken to ensure 
veracity and rigour (4.1). Subsequent results (4.2) are followed by a discussion of the significance of 
the findings in the light of the research presented in chapter 3 (page 50) (4.3). 
 
4.1  Phase 1. 
Phase 1 of this mixed methods study has been designed to answer the following research question: 
 
What are the significant factors which impact on the day-to-day lives of people with 
chronic venous leg ulceration? 
 
4.1.1  Phase 1 design and methodology. 
A qualitative approach was adopted for phase 1, specifically phenomenology, in order to accurately 
establish the lived experience of patients with CVLU. The generic term qualitative research 
encompasses a range of methods of data collection and analysis characterised by the ‘emic’ 
perspective or ‘insider’s view’ (Pike, 1954; Salmon, 2012); all aspire to uncover the participant’s 
understanding of their world and experiences (Bowling & Ebrahim, 2005; Holloway & Wheeler, 2010; 
Smith et al, 2012). Qualitative research is inductive, providing opportunities to clarify the subjective 
interpretations which people place on their actions and encompasses a range of innovative 
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approaches which include ethnography, grounded theory and phenomenology (Atkinson et al, 2001; 
Meadows, 2003; Astin & Long, 2009). Phenomenological approaches aim to establish the meaning 
of a given phenomenon and to explore how an individual experiences it, often using first person 
narrative. Phenomenology endeavours to discover the uniqueness of human behaviour and to unveil 
and understand the everyday experiences of others without aiming to ‘solve’ the problem posed by 
the research question (Cresswell, 2007; Pratt, 2012; Salmon, 2012). Phenomenology is valuable, 
especially within nursing research, as it enlightens our understanding of the life experience and QoL 
of study participants (Pratt, 2012) and, as such, was seen as the ideal approach for phase 1 of this 
study which forms a preliminary basis for the subsequent phases.  
 
A variety of research methods can be applied from a phenomenological perspective. Each of the 
potential methods have a similar focus on the 
 “…lived experience” (Husserl, 1970; p.240),  
of the individual and include participant observation, focus groups, interviews and action research 
(Lester, 1999). Following consideration of a range of alternative methods, such as a patient focus 
group or a period of observation of patients with CVLU, interviews were selected as the most 
appropriate approach in order to effectively capture first person narrative from the study participants 
(Denscombe, 2007). Interviews are a versatile method, providing the researcher with ample 
opportunity to understand, explore and clarify the behaviour of participants by allowing their 
perceptions and views to be explored in their own words (Chung & Munroe, 2003; Kvale, 2004; 
Bowling & Ebrahim, 2005).  
 
Interviews provide a structured encounter, with that level of ‘structure’ used to categorise them into 
three distinct types: structured, semi-structured and unstructured interviews (figure 8 below) (Green 
& Thorogood, 2004; Holloway and Wheeler, 2010). Structured interviews are likened to a 
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questionnaire that is administered face-to-face and are predominantly applied in quantitative 
research with pre-set questions and answers that are generally ‘closed’ in nature (Denscombe, 
2007). Unstructured interviews are at the opposite extreme; entirely participant led allowing them to 
speak freely, with minimal intervention from the researcher (DiCicco-Bloom & Crabtree, 2006). 
Finally, semi-structured interviews fall somewhere between these two extremes, with the researcher 
able to set the agenda but the participant able to dictate the data produced (Hicks, 2004; Bowling & 
Ebrahim, 2005).  In reality, semi-structured and unstructured interviews sit along a continuum and, 
within each interview, there is a seamless movement between these two ‘approaches’; such 
flexibility ensures that the most comprehensive data is sourced (Grbich, 1999; Denscombe, 2007).  
 
Figure 8: Interview continuum. 
 
 
Since the aim of phase 1 was to gain a candid insight into the daily life of participants, an 
unstructured approach was felt to be most appropriate, whilst accepting that, on occasion, this 
approach might move along the interview continuum to a more semi-structured style (Denscombe, 
2007).  An unstructured approach is a powerful technique for gathering rich data and provides the 
participant with a ‘voice’, allowing them to tell their story with little direction or guidance from the 
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researcher (Meadows, 2003; DiCicco-Bloom & Crabtree, 2006). Each interview commenced with the 
researcher simply introducing the topic and asking the participant to  
“….tell me about your leg ulceration?” 
thus encouraging the participant to speak in a relaxed manner, free to develop their ideas and 
thoughts as they wished. In addition, a topic guide of potential questions and themes drawn from the 
literature review (chapter 3; page 50-92) was developed and available for use, if necessary, during 
the interviews (appendix 3). The availability of such a guide for such unstructured interviews is not 
uncommon (Ryan et al, 2009), simply providing a backup to ensure that important themes are not 
overlooked (Grbich, 1999). During this study, the topic guide was felt to be of particular importance 
since participants were generally older and the researcher was new to the process. Despite the 
preparation of the topic guide, it was not actually required during the phase 1 interviews and 
participants appeared comfortable to speak without prompting.  
 
Interviewing is a skilled process that requires a rapport be built promptly between researcher and 
participant, thus encouraging the participant to speak openly about their thoughts and feelings within 
the ‘safety’ of the interview (Green & Thorogood, 2004). Interviewing is a skill, with the role of the 
researcher of central importance to the quality of the data produced; any lack of rapport and 
understanding would potentially constrain the quality of the data produced (Grbich, 1999; Meadows, 
2003). Indeed, the interview process is founded on the premise that the events and feelings to be 
explored are of significance to both the researcher and the participant (Grbich, 1999).  An important 
consideration for the phase 1 interviews was how the researcher should introduce themselves and 
their role to the participant, in order to optimise rapport and mutual understanding. The ‘role’ of the 
researcher is not without consequence; it assists the interviewer to gain access to the participant, but 
it also potentially affects the views and actions of both parties during the forthcoming interview 
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situation (O’Reilly, 2005). Following consideration, it was decided to make participants aware of the 
researcher’s background as a DN since it was felt that participants may feel at ease when discussing 
their leg ulcer symptoms, confident in the knowledge that their condition would be fully understood. 
Such an approach is not without risk, since the perceived status difference between the interviewer 
and interviewee can give rise to ‘expected’ responses due to ‘social desirability bias’, with 
respondents responding in a manner that they feel is expected (Paulhus & Reid, 1991).  
 
Despite the DN background, it was essential that each interview be approached from a position of 
equipoise, thus limiting the impact of the researcher on the data collected (Bowling & Ebrahim, 
2005). To achieve this, the researcher was reflexive - actively reflecting on the process as a whole – 
in order to ensure the veracity and trustworthiness of the data produced (Kvale, 2004; Bowling & 
Ebrahim, 2005, Clarke, 2006). Such data is bound to the context from which it was drawn; thus it 
was essential that the researcher became immersed as an equal in order to truly establish, describe, 
analyse and understand the meanings and behaviour of the participant (Holloway & Wheeler, 2010). 
 
Since the majority of care for patients with CVLU is delivered by DNs in the patient’s own home 
(Callam et al, 1985; Nelzen et al, 1990; SIGN, 2010) and many such patients are elderly and 
physically limited (Ebbeskog & Ekman, 2001a), interviews were arranged at a time convenient to the 
participant at their own home, if the participant was agreeable to this. Interviewing the patient in his 
or her own environment, it was felt, might encourage them to feel comfortable and hasten the 
development of rapport between interviewer and interviewee (Green & Thorogood, 2004). If any 
patient had been uncomfortable being seen at their home and requested an alternate location, a 
clinic base was available; the location of interview, however, did not prove to be a problem. 
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4.1.2  Phase 1 sampling framework. 
As outlined in chapter 1, following the completion of the phase 1 interviews, a period of non-
participant observation of the nurse and patient participants was planned. As a result of this 
continued involvement of participants it was essential that both the nurse and patient participants 
were consistent across both phases, thus consent was gained for both phases at the start of the 
study. A purposive rather than a random approach to sampling was chosen for these phases since 
the selection of participants who were best able to provide quality information was deemed to be 
essential. Much qualitative research adopts such non-probability methods of sampling to ensure a 
‘good’ informant (Patton, 1990; Coyne, 1997; Grbich, 1999; Bowling & Ebrahim, 2005; Saks & 
Allsop, 2007). This involves the intentional selection of the respondent, the study setting or both to 
ensure that specific characteristics of interest are captured in the research process and data quality 
is maximised (Greenhalgh, 1997; Bowling & Ebrahim, 2005).  
 
For such qualitative studies such as this there is no universal agreement or calculation to indicate an 
optimal sample size. In view of this, interviews continued until data saturation was achieved, 
described as: 
“…the point at which no new information or themes are observed in the data.”                    
(Guest et al, 2006; p. 74) 
Guest et al (2006) cite a requirement of between four and 25 interviews for such ‘theoretical 
saturation’ to be attained, depending on the nature of the study, with the lower requirements 
ascribed to studies with greater participant homogeneity which is often the case when purposive 
sampling techniques are applied (Kuzel, 1992; Morse, 1994; Creswell, 1998; Guest et al, 2006). 
Since data during phase 1 was analysed simultaneously, as the interviews were undertaken, data 
saturation was achieved when no new themes emerged during the concurrent thematic analysis.  
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4.1.2.1  Inclusion and exclusion criteria. 
In order to ensure data quality, meticulous consideration was given to the criteria for the sampling of 
both the nurse and the patient participants and the following inclusion / exclusion criteria were 
applied to sample selection (Hicks, 2004). These criteria were intended to be as inclusive as 
possible but it was acknowledged that hard to reach groups of patient participants, such as 
homeless clients, would be unlikely to be sampled since access to such groups are limited within 
mainstream district nursing.  
 
Nurse participants: 
Inclusion criteria for nurse participants: 
 The nurse was registered with the Nursing and Midwifery Council. 
 The nurse was a permanent team member rather than a temporary or bank member of staff. 
 The nurse was willing to take part in the study. 
 The nurse provided care for leg ulcer patients regularly. 
 
Exclusion criteria for nurse participants: 
 Unqualified staff. 
 Agency / bank staff. 
 Those who withheld consent. 
 
Patient participants: 
Inclusion criteria for patient participants: 
 101 
 The patient suffers from leg ulceration of either venous or mixed aetiology (as diagnosed by 
Doppler Ankle Brachial Pressure Index (ABPI) ratio of between 0.5 - 1.2 and detailed history 
taking) (Vowden & Vowden, 2001). 
 Ulceration had been present for in excess of six weeks. 
 The patient was able to understand English. 
 Visiting posed no risk to the patient or researcher. 
 The patient was willing to take part in the study. 
 
Exclusion criteria for patient participants: 
 The patient does not fit all of the above inclusion criteria. 
 The patient’s leg ulceration, outlined under the first point of the inclusion criteria, is of arterial 
aetiology (as diagnosed by Doppler ABPI ratio of below 0.5 and detailed history taking) 
(Vowden & Vowden, 2001). 
 
4.1.3  Phase 1 study procedure.  
The study was undertaken across two, North Staffordshire Primary Care Trusts (PCT), one inner city 
and one rural in nature. A team was consented from each of the PCTs but, due to low patient 
participant recruitment levels, it was necessary to recruit a third team. The process of data collection 
for phase 1 is outlined in the following flow chart (figure 9, overleaf).  
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Figure 9: Phase 1 flow chart. 
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Managers nominated DN teams suitable for the study who were then contacted by the researcher to 
ascertain their interest in taking part. Study packs, including a letter of introduction, study information 
and a consent form, were distributed to staff (appendix 6). On receipt of their completed consent 
forms, a visit to each team was undertaken to provide study details and to explain the inclusion / 
exclusion criteria for the potential patient participants (detailed on page 98). Following this meeting 
and once the nurses felt comfortable, the distribution of the patient ‘study packs’ to those patients on 
their caseload who were deemed suitable to take part in the study commenced. Potential patient 
participants were encouraged to discuss study requirements with their relatives, carers and friends in 
order to support them in their decision to take part. Additional contact details were also provided if 
potential participants required any further information. Over the next three to four weeks the 
researcher received completed patient consent forms, these participants were then contacted and a 
convenient interview time and location arranged. 
 
4.1.4  Phase 1 data collection. 
With participant consent, interviews were digitally recorded to facilitate accurate transcription 
(Grbich, 1999). This ensured that the researcher could concentrate on what was said during the 
interview without needing to simultaneously take notes; which may have distracted the interviewee 
(Denscombe, 2007). Such recording is not without issue since many participants had a very strong 
local dialect; access to such a recording, however, allowed multiple attempts at transcription in order 
to ensure accuracy. Following transcription, each participant was offered an opportunity to review 
their interview transcripts prior to analysis, as is good practice, but, on this occasion, all refused 
(Ryan et al, 2009).  
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In order to ensure the veracity of the data collected, contextual notes and reflections on the 
interview, environment and post interview comments were recorded soon after completion of the 
interview and were reflected upon during the transcription process. Where notes were felt to provide 
important background information to the transcribed data, comments were added to the quotations in 
brackets, following the protocol outlined at the start of the thesis (page xxiv). In addition to these 
measures, an educational supervisor verified the accuracy of a sample of transcription from the 
original digital recordings. Both of these factors were designed to enhance the rigour of the data 
collection process (Seidman, 2005).  
 
4.1.5  Phase 1 data analysis. 
Analysis of the data from such interviews varies however, following consideration of alternatives 
(Colaizzi, 1978; Giorgi, 1985), a process of thematic analysis outlined by Braun and Clarke (2006) 
was adopted. This process provided a simple, structured step-by-step approach with an auditable 
decision trail which is ideal for a novice researcher (Braun & Clarke, 2006). Unclear reporting of 
thematic analysis has been criticised in the past (Colaizzi, 1978), with an emphasis on a need for 
clarity including clear reflection on the researcher’s role in the analysis process, to minimise bias 
(Attride-Stirling, 2001). These features were all present in the Braun and Clarke framework (2006) 
displayed in table 8 below. 
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Table 8: The six phases of thematic analysis (Braun & Clarke, 2006). 
 
 
Phase Description of process 
1. Familiarisation with the 
data. 
Transcription of the data. Reading and re-reading with initial themes noted. 
2. Generating initial codes. Interesting features of the data are coded systematically across the entire data set. 
Data relevant to each code is collated.  
3. Searching for themes. Codes are collated into potential themes and all data relevant to each potential theme 
is collated. 
4. Reviewing themes. Checking if the themes work in relation to the coded extracts and the entire data set. 
Generating a thematic ‘map’ of the analysis. 
5. Defining and naming 
themes. 
On-going analysis to refine each theme and the overall story told by the data, 
generating clear definitions and names for each theme. 
6. Producing the report. The final analysis. Selecting compelling extracts and examples, relating the analysis 
back to the research question and producing a scholarly report of the analysis. 
 
 
Thematic analysis commences with a close inspection of the key issues under investigation, which 
are gradually refined to provide a conceptual description of the phenomenon under review (Braun & 
Clarke, 2006). Holloway and Todres (2003) described this process as ‘thematising’, a skill they 
describe as generic in qualitative analysis which provides a rich and detailed account of the data by 
identifying, analysing and reporting themes (Braun & Clarke, 2006). The thematic analysis process 
initially provides a superficial reflection of the data but as the stages progress, the information 
beneath the surface of the data is unravelled and the focus is shifted from what was said and 
observed, to an investigation of what underlies this (Rapley, 2011). Miles and Huberman (1994) 
emphasise researcher engagement in this process of data reduction; the selecting, focussing, 
simplifying and transforming transcript data in order to draw out and verify conclusions. Immersion in 
the data is essential during this analysis process, especially when the researcher undertakes the 
analysis (Miles & Huberman, 1994).  
 
Following verbatim transcription of each interview these were analysed using this six stage 
framework (Braun & Clarke, 2006). Initial immersion in the data was accompanied by ‘repeated’ 
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active reading to uncover meanings and patterns, a process aided by the coding of the early ideas. 
Once complete, more formal coding was undertaken and the data collated with themes formed. 
Themes were refined and the entire data revisited to ascertain whether these themes ‘worked’ in 
relation to the whole data set. A thematic map of the data was created to provide a description of the 
scope and content of the themes (appendix 7). Final analysis and formulation of a report to tell the 
complicated story completed the process (Braun & Clarke, 2006). To confirm the accuracy and to 
optimise rigour, an educational supervisor undertook an independent thematic analysis and 
consensus was achieved using a reflexive approach (Grbich, 1999; Todres, 2007).  
 
 
4.1.6  Ethical considerations in phase 1. 
Research ethics are fundamental to the research process, irrespective of design, and are 
underpinned by three central principles: respect for persons, beneficence and justice (Dimond, 
2005). Participants have the right to an equitable recruitment process, informed consent and to be 
protected throughout the research process (Bowling, 2009). The UK process for ethical approval 
within health research is extremely robust in order to ensure that the rights, safety, dignity and well-
being of all research participants – both staff and patients – is vigorously protected (RCN, 2011). The 
guide to consent provided by the DH (2001b) emphasises that all study participants are competent to 
provide consent and are provided with sufficient information to make an informed decision to take 
part. The guide to consent (DH, 2001b), along with the guidance relating to mental capacity (DH, 
2007), were important considerations in view of the predominantly elderly nature of the patient 
participants for this study (Ebbeskog & Ekman, 2001a) and were considerations that were reflected 
in the inclusion / exclusion criteria for the study (page 100).  
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Specific considerations for patient participants were the location of interviews, undertaken in 
patients’ own home by a lone researcher and a risk that participants may have unresolved questions 
or may become upset following completion of the interview. In order to address these considerations, 
the facility to undertake the interviews in a clinic location was an option if the patient participant so 
desired. The University ‘lone working’ policy was adopted to ensure the safety of the researcher and 
the information leaflet for patients included details of who to contact for support, should this have 
been necessary. For nurse participants, the challenges of their involvement included the provision of 
access to their caseload and the observation of their practice by the researcher in phase 2 which 
may have made them feel vulnerable. The nurse participants were made aware that if there were 
any issues about specific practice issues, these would be dealt with as recommended by the NMC 
(2008).  
 
In February 2010 the Local Research Ethics Committee (LREC) granted their approval for phase 1 
and 2 of the study to proceed (Ref: 10/H1203/13; appendix 4) and the local National Health Service 
(NHS) Research and Development Department (R&D) committee subsequently approved access to 
staff and patients in March 2010 (appendix 5). The process included stringent review and approval of 
potential nurse and patient participant information including letters of introduction, detailed consent 
forms and comprehensive written information to outline the study (appendix 6). The information 
included the requirements of respective study participants, arrangements for assuring the anonymity 
of participants, the maintenance of the confidentiality and information surrounding the withdrawal of 
consent in line with recommendations from the Research Ethics Service.  
 
For the nurse participants, consent evidenced agreement to distribute research information to 
suitable patients on their caseload in preparation for the phase 1 interviews and also their agreement 
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for their wound care consultations to be observed during phase 2. The facility to withhold consent for 
the phase 2 observations was included in the consent form. If this were the case, arrangements 
would be made for that specific observation to be undertaken with another consenting member of 
staff. For patient participants, consent evidenced their agreement to be interviewed and to have their 
subsequent wound care consultations observed by the researcher. Consent forms also included the 
option for the digital recording of the interview and the inclusion of anonymous direct quotations in 
the final thesis. Consent from both nurse and patient participants was reaffirmed at every 
opportunity, at the start of each interview and prior to each of the observations, thus providing an 
additional opportunity for consent to be withdrawn if a participant so desired. 
  
 109 
4.2  Phase 1 results. 
Following the distribution of study packs, a total of 13 nurses across three teams consented to take 
part in the study. The nurses had worked within primary care for a median of five years (range 6 
months – 20 years). Interviews were undertaken and continued, as discussed (page 99), until 
saturation, which provided a total of nine patient interviews all undertaken by the one researcher to 
ensure rigour (Guest et al, 2006). Table 9 (below) provides an outline of the demographic details of 
each of the patient participants and details the pseudonym assigned to each, to protect their 
confidentiality (NMC, 2010). The letter and number codes next to the name refer to the location of 
the patient (L1, L2 or L3) and number of the participant (P1 – P6). Four were male with a median 
age of 76 years (range 39–99 years).  
 
Table 9: Patient participant demographics. 
 
 
Participant 
pseudonym.  Age. Gender. 
Marital 
status. Residential status. 
Total 
duration 
of 
ulceration. 
Number of 
episodes. 
Tom (L1,P1) 76 Male Married With wife, own adapted bungalow. 10 years 2-3 
Mary (L1, P2) 72 Female Married With husband, own adapted bungalow. 30 years >5 
Evan (L1, P3) 76 Male Single Private Residential Home. 35 years >5 
May (L1, P4) 99 Female Widow Private Residential Home. 3 years 1 
Pam (L1, P5) 78 Female Married With husband, own house. 30 years 3 
Ellen (L1, P6) 80 Female Widow Private Residential Home. 2 years 1 
Steve (L2, P1) 39 Male Single Alone, upstairs local authority flat. 14 years 1 
Marg (L3, P1) 72 Female Widow With dog, upstairs local authority flat. 20 years >5 
Sam (L3, P2) 86 Male  Married With wife, own house. 40 years >5 
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4.2.1  Themes and subthemes. 
The thematic analysis process identified four themes: the ulcer, symptoms, wound management and 
the effects on daily life and a number of subthemes significant in the lives of the patient participants. 
These are represented in the figure 10 below (Green et al, 2013a).  
 
 
Figure 10: Themes and subthemes from the interviews (Green et al, 2013a). 
 
 
 
 
 
Each theme and respective subthemes were summarised and illustrated with verbatim quotations, to 
add depth and enhance understanding and are presented under theme headings. Verbatim 
quotations that include the participant’s local dialect are included but, to avoid any confusion, a 
 
 
 
• Restrictions to daily life 
• Mobility 
• Hygiene 
• Clothes and shoes 
• Sleep 
• Relationships 
 
 
 
• The nurse. 
• The treatment 
applied and 
understanding. 
• Concordance. 
• Pain 
• Exudate and odour 
• Emotional effects of 
ulceration. 
• Family history 
• Comorbidities 
• Cause, location, 
duration & 
description of 
ulcers. 
The Ulcer Symptoms 
Effects on 
daily life 
Wound 
Management 
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Standard English alternative is provided in brackets. At the end of each quotation, the pseudonym 
assigned to the participant (page 109) is provided. 
 
4.2.2  Theme 1: The Ulcer.  
Without exception, all study participants were keen to describe the ‘journey’ of their ulceration with 
the researcher. This generally included any associated family history, details of their co-morbidities 
and the cause, location and duration of their leg ulceration. 
 
4.2.2.1  Family History. 
Three participants reflected on the history of leg ulceration in their first order relatives. A family 
predisposition, for these participants, was significant and had led to them feeling susceptible to the 
development of leg ulcers throughout their life. When ulcers had subsequently developed they 
seemed to refer to them with almost resignation. Mary reflected:  
 
‘All my mother’s sisters had it and me [my] mother...runs in my family it does with us.’       
Mary        
 
 
Marg similarly reflected on her family history and spoke of her mother’s long-standing ulceration and 
them managing the ulcers at home for periods of time: 
 
‘My Mum had them and they’ve told me as [that] they can be hereditary.....have you heard 
that? She worked with hers (......) the treatments that I‘ve seen, they used to soak hers in 
this purple stuff, but they did seem to clear....you know, and she’d get another one (.....) 
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sometimes we’ve doctored them on our own because she’d seen how they’d done it them 
many times.’   Marg 
 
 
For the remaining participants (6), ulceration did not reflect a family predisposition.  
 
4.2.2.2  Co-morbidities. 
Co-morbidities were common. Three participants reported no co-morbidities, three had one and the 
remaining three had two or more. The co-morbidities were rheumatoid arthritis (RA) (2), 
osteoarthritis (OA) (3), cardiovascular disease (CVD) (1) and sight problems (2).  
 
Where participants suffered from co-morbidities, their underlying conditions had a tendency to 
exacerbate their ulceration but despite this, having other conditions also appeared to make the 
participant more tolerant of the ulcer symptoms. Tom (76 years), who was extremely debilitated by 
his RA and had extremely severe bilateral ulceration, reflected on his ulcers as simply being a 
nuisance. In contrast, Marg, who other than her leg ulcer was in good health, was devastated by the 
impact of her leg ulcer symptoms on her daily life. 
  
4.2.2.3  Cause, location, duration and description of ulcers. 
All participants described the development of their ulcers; five were able to describe the actual 
incident which had caused the initial wound, which then progressed to become ulcerated. Ellen (80 
years) reflected on two incidents which initiated an ulcer developing:  
 
‘I had a shower and I was getting out and I knocked my ankle (.....) I was going past this 
chair and there was something sticking out and I gashed all up me shin.’  Ellen 
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For Steve (39 years), many years of intravenous (IV) drug abuse had culminated with him injecting 
heroin directly into his lower legs, as this was the only place he could gain access to his badly 
damaged venous system. This had resulted in him developing severe bilateral leg ulcers.  
 
‘When I was injecting under the skin, in little veins and I was going in capillaries as well 
(......) just underneath the skin......it’s like acid just burning underneath my skin, that’s how it 
all burned and fell into the big, deep holes.’  Steve 
 
The participants who were unable to describe the specific cause which led to their ulcer developing 
(4), reflected on their uncertainty about why they had started and a fear that they would recur as 
unexpectedly when they healed.  
 
‘Oh no, it must of [have] just come (....) I’ve got bad veins, I suppose that started it.’         
Sam 
 
Of the nine participants, six had a history of bilateral ulcers. Two reported ulcer recurrence in exactly 
the same location at each recurrence, whereas the remaining (7) reported ulceration recurring in a 
variety of different locations on their lower legs. 
 
‘It’s always like this and always in the same place.’  Marg 
 
The patient participants disclosed a range of duration for their ulcers; most (7) had experienced at 
least one healed episode, although not all. For some, the healing was extremely slow and a very 
frustrating process. All participants reflected that long periods of their lives had been ‘taken over’ or 
defined by their ulceration.  
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Some participants reflected on periods when they were able to self-manage their ulcers, often when 
they initially occurred, before eventually having to accept that professional intervention was required 
as a result of the wound deteriorating or an infection developing. Steve spoke of periods when he 
completely avoided the required clinic visits, reflecting that he was ‘non-compliant’ when the situation 
just became too much for him: 
 
‘You just go through mad stages [....] I’d phone and say ‘Sister, I don’t need to come today 
me [my] bandages haven’t leaked through’...’are you sure cause we can change them or 
come to you?’.... I’d say ‘no, you’re alright, they haven’t leaked through or nothing’ but I’d 
done it myself, it was just a stage I went through with them, just trying not to have to go [...] 
three times a week, I mean, come on, it’s tedious isn’t it. They put them on on a Monday, 
you go up Monday afternoon, you’ve got Tuesday all day and I’m back there on Wednesday, 
so it’s only a day and a half they’re staying on and then they’re being changed.’     Steve 
 
Most of the other participants had experienced some healed episodes (7). Steve, however, had 
never experienced healing and reflected on the time it was taking for the healing to take place:  
 
‘God, they’ve been doing it, this Christmas it’ll be just over about 14 years. It’s just been               
millimetres, millimetres all the time just going in, very, very slow. Cause I’ve not been 
anywhere, not done nothing for 12, 13, 14 years. All me [my] life’s been is Doctors and 
hospitals and nurses and surgeons…. you know. It does get to you, you know, but I haven’t 
let it get me down and I’ve stuck with it and, …... yes, I’m doing alright now like, I’m getting 
there, it’s getting there.’  Steve  
 
Lack of healing or the slow nature of healing presented significant challenges for participants, with 
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their ulceration simply taking over their lives.  
 
Recurrence of an ulcer following an episode of healing was seen as both frustrating and 
disheartening. 
 
‘Off and on, I must have had them at least a dozen times.’   Sam  
 
‘I think I’ve had about three or four, but the last two have been horrendous.’   Marg 
 
The interviews revealed the very personal ‘story’ of leg ulceration. Comments were consistent and 
unprompted by the participants and provided a rich insight into the person behind the ulceration, the 
extent of the impact of CVLU on their daily life and provided the background to their personal 
journey.  
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4.2.3  Theme 2: Symptoms. 
All participants reported a range of debilitating symptoms due to their ulceration which included pain, 
exudate and odour and the emotional impact of their ulcers.  
 
4.2.3.1  Pain. 
Pain dominated the lives of the participants and was at the heart of every interview. Descriptions of 
nature of the pain had many similarities, including its unceasing nature, severity and the timing of the 
pain. A number of subthemes emerged related to pain including the type of pain, the timing and 
duration, the cause and the use and effectiveness of pain relief. 
 
All respondents described their pain as being significant and extremely debilitating. Steve’s 
description was particularly disturbing: 
 
‘It was getting more painful, it was like one time it was like burning pain, then it was more 
like a stabbing pain, then (.....) now it’s like real sore, like someone is just rubbing, rubbing, 
rubbing, all the time. Oh, the pain......it’s just unbearable.’  Steve 
 
 
Vivid descriptions of the pain associated with ulceration included its constant and persistent nature; 
which were often further complicated by intermittent episodes of a much more severe pain. 
Descriptions included: 
 
‘Sometimes you feel as though you’re being cut’   Ellen 
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Participants described the timing and duration of the pain, with a number of similarities in relation to 
its continuous nature and increasing severity, especially when legs were elevated, participants were 
in bed and throughout the night. Pain appeared to intensify during the night for many of the 
participants, leading to disturbed sleep and daytime tiredness. 
 
 ‘When you just lie down in bed, it’s worse than any time ...... all through the night and you 
just can’t get any rest’    Mary 
 
 
Steve provided a comprehensive description of the unrelenting nature of the pain he experienced: 
 
‘It’s just the same pain, 24/7, (…) I just have to put up with it; it’s either that or kill myself or 
somat [something]. It’s like the pain, I know I’ll have pain but this pain and soreness, all the 
time’     Steve 
 
Steve’s emotions as a result of his pain were quite extreme, but all participants reflected on the very 
depressing nature of their unrelenting discomfort. 
 
Pain was attributed either to the actual ulcer or was exacerbated by the dressing procedure. Tom 
stated that when: 
 
 ‘It’s been dressed...for a few hours it can be hell’   Tom 
 
Likewise Mary reflected on increased pain following her dressing change, a factor which was made 
worse as she attended her local wound care clinic a few miles away from her home:   
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‘Sometimes I have a job to come home when it’s just been dressed.’     Mary 
 
Many respondents reflected on the specific discomfort which they felt was caused by their 
compression bandages, a dressing technique undertaken as part of their wound management plan. 
Ellen stated:  
 
‘Ooohh, they hurt. They get you all across your instep, it gets that tight.... you know and then 
I’d say oh, I could just do with cutting this off’    Ellen 
 
Steve spoke of the severe pain he experienced when his dressings were changed and reflected that 
on one occasion he had to remove the outer bandages in an attempt to relieve the discomfort. He 
said: 
 
‘Last night I took the fourth layer off, cause it was that tight. They always tell me if you get 
anything like pain or that just whip off the fourth layer.’   Steve 
 
For Marg the severity of her pain did not appear to reflect the size of the wound. She reflected that 
her pain was very intense and was much greater than she had expected in view of the size of her 
wound:  
 
 ‘There’s nothing to it, there’s nothing to it now really; other than the pain.’  Marg  
 
Many of the participants (7) reflected on their reluctance to take any analgesia, either due to it not 
being effective or concerns that they might become dependent on it. Sam explained: 
  
 ‘I don’t take them unless I have to, I’d rather not take painkillers.’   Sam 
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Even when analgesia was taken, for many this did not relieve their pain and the analgesia was 
deemed to be ineffective. One respondent reflected: 
 
 ‘They don’t really take the pain off though’    Ellen 
 
For those who reported co-morbidities (6), pain relief was often taken for their ‘other’ conditions. This 
was evident in a number of comments:  
 
 ‘With all that I take for my arthritis, I figured it was covered. No, I’m taking that damn 
 many.’    Tom 
 
Even though participants had been encouraged to take additional analgesia, they appeared reluctant 
to increase or add to their current regime; even when this regime was ineffective.  
 
Pain was the central issue and dominated every interview. It was vividly described in terms of its 
severity and its incapacitating nature by all of the patient participants. 
 
 
4.2.3.2  Exudate and odour. 
The impact of exudate and odour was also powerfully portrayed by all of the participants. These 
descriptions included reflections on the challenges that both exudate and odour posed in their daily 
lives. They also reflected on the absolutely devastating nature of these symptoms, which triggered 
embarrassment, shame and stress. A number of participants described the problems they 
experienced due to excessive exudate: 
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‘When this started, more rubbish came out of it and it even came through three layers plus 
me socks.’  Sam 
 
‘It varies, sometimes.... I can always tell because it comes through [looks at dressing].’ Pam 
 
Pam’s solution to her excessive exudate had been to redress and clean her wound in between her 
scheduled dressing changes; an intervention which had made her relationship with her DN team 
particularly problematic. She stated: 
 
‘They’re great with me on the whole [the nurses], but then they started getting cross that I 
washed me feet at night. Apart from showering I do wash me feet at night before bed 
anyway and they got a bit cross. I did leave it on, didn’t I [to husband] for quite a long time, 
for a week or more in the past...but we had a bit of a set to last week [with the nurses]...they 
said ‘You don’t do what we say, you keep taking it off’ and I said ‘I don’t keep taking it off’. 
But I said I do have a shower three times a week and if it’s been weeping a lot then I do 
wash it as well, if it does come through and it looks like it’s a mess then I take it off...cause I 
don’t feel like I want to keep it on...seeping, it’s seeping out. I’d say it was doing it a lot at 
one time (…..) you just have to take it off, I don’t see there is anything to be gained by 
leaving it on......’  Pam 
 
Pam strongly defended these actions saying: 
 
‘They get a bit cross [the nurses at clinic] because I do wash my legs but to me, ‘cleanliness 
is next to Godliness’’  Pam 
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Odour was often linked to an increase in exudate and was present, either occasionally or 
continuously, for most of the participants. All participants reflected that odour was both embarrassing 
and stressful. For some participants, the odour led them to restrict their contact with others which 
resulted in an almost self-imposed social isolation. 
 
‘Oh, and when you first have them, I wondered what the smell was.... oh, it’s terrible the 
smell, it all comes out, a lot of rubbish........when you went anywhere, you didn’t get too 
close to people because I can smell it terrible (.....) you know.’  Ellen 
 
‘They were really bad, once they’d been put on, the next day they were really stinky so.... so 
me, on the bus, paranoid, thinking people could smell it and everything.’  Steve 
 
For some participants, they interpreted their increased exudate and odour as an indication that their 
ulcer condition was deteriorating. This factor often resulted in a heightened monitoring of their 
exudate levels, in an attempt to assess whether healing was progressing satisfactorily or not. Steve 
explained: 
 
‘So when they were bad, they were bad, leaking and like I say, the smell and everything. If 
you were sitting here, what, eight years ago they’d be rank......really bad (….) you know and 
wet, the smell, horrible.’   Steve 
 
Exudate and its associated odour had devastating effects on the lives of the participants, resulting in 
limited contact with family and friends and a self-imposed isolation. This was seen as preferable to 
the embarrassment which these symptoms caused. 
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4.2.3.3  Emotional effects of ulceration.   
Participants reported a range of emotional effects due to their ulceration including depression, poor 
self-image and a fear of people’s reactions. The interviews revealed a range of coping strategies 
adopted by participants. Some described themselves as striving to maintain the level of ‘normal’ 
functioning which they had prior to their ulceration. Others explained how they suffered from severe 
anxiety and depression, with one respondent disclosing that he even had suicidal thoughts on 
occasions. Steve reflected on the disheartening nature of his condition and stated: 
 
‘It’s just depressing really, if you think about it, (….) I am on antidepressants; I just have to 
put up with it. It’s either that or kill myself.’  Steve 
 
But despite the obvious anguish that Steve expressed, he also spoke of his hope for healing:  
 
‘But I haven’t let it get me down and I’ve stuck with it and, yes, I’m doing alright now like, I’m 
getting there, it’s getting there...if it was like falling back and oh God, nothing’s working and 
they were on about me having one off (….) I’d be proper depressed you know. But luckily it 
is getting there, yes....’  Steve 
 
Steve was not alone in his feelings of depression. Marg reflected: 
 
 ‘It’s the lowness...very, very depressing. ‘  Marg 
 
‘Yes well, they’ve got me down, especially the pain..... the pain gets me down.’ Sam 
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Participants also disclosed their fears which included a fear of sustaining any further injury to their 
legs, which might exacerbate the condition of their ulcers. One participant reflected that she 
consciously protected the leg at all time and another felt her bandages gave her some protection: 
 
‘When I went up the hospital, I went and knocked it on there again and well (…..) it made it 
worse. You have got be very careful, I said, when they’re better and I’ve got these bandages 
off, I shall have to have a bell ‘Please mind my legs’.’   Ellen 
 
 ‘I’m frightened in the supermarket; I am frightened when I’m out. When I have been at the 
supermarket cause some people, they do push their trolleys everywhere, so it means that 
you’re on your guard all the time.’    Marg 
 
Participants reflected that they always needed to be on their guard, always conscious of any risks to 
their legs. Some even consciously avoided potentially ‘risky’ situations in order to escape any further 
injury. 
 
Other participants feared what people thought of them, a factor that was particularly problematic 
when ulcers were judged to be self-inflicted, such as in Steve’s case:  
 
‘And all this with me legs, would I tell people and I think probably no I wouldn’t. I’d say I was 
in a bad fire or something or make something up as some people just don’t take to saying 
you were on drugs and something like that’  Steve 
 
Finally, Steve spoke of his fears for the future:  
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‘It’s been hard, like I say, but it’s something I’ve had do or else, legs off you know what I 
mean? I didn’t want like lose my legs.’  Steve 
 
 
In contrast, despite the profound impact that Marg’s ulceration had on her daily life, she described 
how she endeavoured to continue with her activities as she had before her ulceration: 
 
‘I could cry (….) but I tell you, you have to shake yourself, shake your feathers and when 
you go out you have to put your outside face on, you just have to.’  Marg 
 
 
These symptoms that presented as three debilitating subthemes, were common to all interview 
participants and were vividly described. 
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4.2.4  Theme 3: Wound Management. 
Themes surrounding wound management were also raised in all of the interviews.  A number of 
subthemes were identified which include issues surrounding the role of nurse, the treatment applied, 
the participants’ understanding of their regime and their concordance.  
 
4.2.4.1  The nurse. 
Each nurse was highly valued by the participants; they were seen as very knowledgeable and 
experts in the management of leg ulcers. Tom reflected on a recent visit to his GP to review his 
wounds and being re-directed to the nurse for further advice and management:  
 
‘Doctors (….) say go to the nurses, they know more about ulcers than we ever know.’      
Tom 
 
 
Despite the nurses being deemed the ‘expert’ in their management of leg ulcers, some participants 
reflected on times when their dressing change resulted in increased discomfort, either due to some 
inconsistency in the dressing technique or the application of a dressing by a less experienced nurse. 
Some respondents reflected on such inconsistency despite still positively evaluated their relationship 
with the nurses. Tom stated: 
 
 ‘At times they can get it just wrong...’    Tom 
 
Another remarked: 
 
 ‘I think they’re tightened up too much....’    Marg 
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One participant remembered an occasion when he had to correct the nurse’s dressing technique 
during a consultation at the wound care clinic: 
 
‘I’ve seen loads of different nurses come and go (...) if they’re talking and putting something 
on and I’m talking to them and they’ve put something on wrong.... I’ll consciously just say 
‘that doesn’t go on there like that’ and after that they’ll say ‘Oh, I’m ever so sorry like’ ’    
Steve 
 
The consistency of the nurses, whether in clinic or at home, was seen as an extremely important 
factor to all of the participants:  
 
‘With the consistency of a team, much better. They did once send another from another 
surgery out of........it wasn’t the same, when you’re seeing someone only once, it isn’t the 
same. Nothing wrong with her...did the job just the same, fine, but I wasn’t used to her.’   
Tom 
 
Marg also commented: 
  
‘Last year when I had this other one, you’d go and there would be girls there and you’d 
perhaps see them twice and then you wouldn’t see them again. So, you’d get somebody 
else, so somebody else has a different way of doing it. So you didn’t know where you were 
(….) now the nurse I see, it seems to me that she’s like a bit in charge there, she’s there for 
three months.’   Marg 
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For most participants the relationship with their nurse was special and something they valued. The 
nurses were seen as friends with close bonds made over the course of many visits. and a number of 
participants revealed what their nurse meant to them: 
 
 ‘Some lovely nurses, they’ve been brilliant’   Mary 
 
 ‘I can have a joke with them, I torment them!’   Tom 
 
In contrast, Pam reflected on having a rather tense and difficult relationship with her nurses due, she 
felt, to her being perceived by them as non-compliant with her treatment regime. Pam felt the nurses 
had reprimanded her for removing her dressing in between clinic visits and reflected: 
 
 ‘As I say, they’re great with me on the whole [nurses], but then they started getting 
 cross that I washed me feet at night. Errr..... apart from showering I do wash me feet at 
 night before I go to bed anyway, and they got a bit cross [nurses].’ Pam 
 
For one participant waiting for the nurses to arrive to dress his wound had been an issue for him and 
at times had caused him to miss out on activities or trips at the residential home where he lived. 
Evan reflected:   
 
 ‘Sometimes when the nurses were late (….) I’d have to wait’  Evan 
 
Other participants (2) had made a conscious decision to attend the local wound care clinic rather 
than have dressings renewed at home. This enabled them to get out and also avoided the risk of 
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them being tied up waiting for the nurses to visit. Sam felt clinic attendance encouraged him to be 
active and, as a result, he felt it also had a therapeutic benefit.   
 
‘Well, they just asked me which would I prefer....you know, when I first went they said which 
would you prefer? Do you want to come here or do you want us to come to your house? 
(.....) I just said that I’d come up to Clinic. I just thought moving about a bit would be better 
(....) might do me better than just sitting about.’   Sam 
 
 
Some participants had needed a referral to the local hospital for a Tissue Viability Nurse (TVN) or 
Vascular Consultant review of their wound. When this happened, the participants reflected that such 
a specialist assessment provided them with new advice and was a welcome opportunity for some 
‘expert’ feedback about the progress of their wound. Such visits were often eagerly anticipated. 
Steve said: 
 
‘I went see me surgeon up the hospital (....) I saw him about three months ago (…) when he 
looked at it (…) he said carry on with this treatment. He tells the nurses what and then they 
write the letter for my District Nurses for [to] carry on, what to put on my legs and that And 
they measure them and that every time I go up.’    Steve 
 
Pam, who felt resented by her nurses as they felt she was ‘non-compliant’, had also been referred to 
a local specialist clinic for a review of her wound. In contrast, Pam felt that there was an ulterior 
motive for this referral: 
 
‘Next week I’m going to the general clinic cause they’re going to see whether they think I 
(…) I can accept the (...) compression bandages.’  Pam 
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She felt this clinic visit would be an opportunity for the nurses to impose their advice on her and 
encourage her to be more compliant with the dressing regime for leg ulcer. She did not feel that this 
was a battle which she would lose, reflecting that: 
 
 ‘Oh, they give up!!’  Pam 
 
 
4.2.4.2  The treatment applied and patient understanding. 
Participants spoke of the requirement for ‘tight’ compression bandages in order to bring about 
healing of their wounds. 
 
 ‘That’s how tight the bandages are and that’s how they’ve got to be because they’re 
 compression bandages.’   Steve 
 
 
May, a 99 year old lady in a local residential home, spoke of the bandages stating: 
 
 ‘It’s got to be tight...to send the fluid back up.’ May  
 
Of the participants interviewed, eight had experienced periods of requiring compression bandages 
applying. Some reflected that they were fully able to tolerate this technique: 
 
‘I can tolerate tight bandages (…) you know it doesn’t matter, I’ve had them on a lot (…) and 
it doesn’t bother me one bit (…) I feel comfortable in them because (…) it doesn’t hurt me 
with them on.‘   Mary 
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Whereas others felt that the dressings were uncomfortable and, at times, they were unable to 
tolerate them: 
 
‘I was in four layer and the nurse wrapped round the fourth layer, really tight. I got up for to 
walk and I couldn’t.... arrrgh, I was like a robot! I said are they supposed to be like this? She 
said ‘yes, they’ve got be tight’ (....) me [my] legs were really bad you know, holes in em 
[them] and that.... I was saying ‘they’re killing me’ and ’they’re hurting me (…).’ She said, 
‘Well yes, but that’s how it is.’   Steve 
 
Another reflected on the tightness, which often resulted in the nurses being re-called for 
unscheduled visits to reapply or readjust the bandages: 
 
‘That’s what does it (…) they hurt; they get all across your instep...it gets that tight, you 
know. And then I’d say ‘oh.... I could just do with this cutting off.’   Ellen 
 
All participants reflected on having had a variety of wound care products applied to their ulcers. They 
were knowledgeable about the products available and had a good understanding of how they 
worked. They spoke of their ‘partnership’ with the nurse, jointly trying to heal the ulcer. Steve stated:  
 
‘You name it, all the different patches with stuff in and creams. (…) The patches come out 
with the silver in and we went through every one of them. Errr...I’ve gone through loads of 
different stuff. They’ve put…. I’ve had trials of different stuffs put on and some have worked 
and some hasn’t.’  Steve 
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Many were able to name the various dressing products they had experienced over the course of 
many dressing changes.   
 
‘Yes, they tried all sorts you know. I think I’ve had iodine.... and different sorts of things.’ 
Ellen 
 
‘But I’ve had loads of different dressings on before that. I’ve had a lot of different things – 
silver, honey....’  Sam 
 
Patients’ experiences of the effectiveness of these products, however, varied. A number of 
participants spoke of having honey preparations applied to their wounds with varying responses. 
Sam reflected: 
 
‘Yes, I’ve never had honey on it before and even some of the girls there said they hadn’t 
heard of honey being used much (…) honey had definitely done this good, just a small 
piece, just enough to cover the ulcer itself, just cut accordingly.’  Sam 
 
Another participant had not been able to tolerate the honey at all and had found: 
 
‘They put honey on it. Oh dear, I wished it’d worked, cause people said to me honey is ever 
so good. But it drew and drew and, well that pain.... it felt as if it was knocking your hat off.’ 
Marg 
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4.2.4.3  Concordance. 
Participant concordance with the advice, treatment regimens and dressing procedures was also 
raised during the interviews. As has been confirmed, compliance with the dressing regime was 
problematic for Pam as a result of her regular removal of the dressing: 
 
‘You don’t do what we say, you keep taking it off’ (…) I said ‘I don’t keep taking it off’, but I 
said I do have a shower three times a week.... and if it’s been weeping a lot then I do wash it 
as well.’  Pam 
 
 
She attributed the need to remove the dressing solely to the hygiene issues she was experiencing, 
stating: 
 
‘If it looks like it’s a mess then I do, I take it off cause I don’t feel like I want to keep it on, 
seeping. It’s seeping out. I’d say it was doing it a lot at one time (…) and you just have to 
take it off. I don’t see there is anything to be gained by leaving it on.... and it stops it 
smelling.’   Pam 
 
 
Steve, who had endured many years of ulceration, also alluded to concordance issues. He felt that 
at times he electively avoided scheduled clinic attendance as a way of regaining some control over 
his life; a feature which was often short lived as his wounds deteriorated and he had to return to 
clinic. 
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4.2.5  Theme 4: Effects on daily life. 
All participants raised issues around the impact of their ulceration on daily life. These comments 
were grouped into the several subthemes including restrictions to daily life, limited mobility, issues 
when working, maintenance of personal hygiene, limited choices with clothes and shoes, sleep and 
the effect on relationships.  
 
4.2.5.1  Restrictions to daily life. 
For some participants the impact of their ulcers on day-to-day functioning was significant and 
something they were unable to limit:  
 
‘Well, they stop you from going anywhere...really, you know, you can’t get about, not the 
same.’   Ellen 
 
Steve forcefully summed up the effects on his life: 
 
‘I couldn’t get about (…) if I had to go somewhere I’d either get a lift off me [my]  Dad or go 
on the bus but it’d only be healthcare, either the Doctors, the hospital, or the dentist. It was 
all to do with health, you know what I mean. That’s all me life’s been since I’ve had the holes 
in me [my] legs.’   Steve 
 
But despite his despair, he still had hope and looked forward to a time when his ulcers had fully 
healed and he could plan for his future: 
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‘I’ll just go away (…) not to get in the sun like but just to get out of England (…..) cause I’ve 
not been anywhere.’  Steve 
 
Marg spoke of the limiting effects of her current ulcer, stating: 
‘It is this [points to leg]; it keeps me as a prisoner. On top of the pain (…) I’ve always been 
one who’s done me [my] housework, I can’t seem to get it done because I can stand for so 
long and then I think, I’ve got to sit down cause it starts to hurt.’ Marg 
 
Finally, Sam reflected that he usually acted as a carer for his wife who was partially sighted but 
found that he was struggling to fulfil this role due to his current episode of ulceration. 
 
‘When you find you can’t do the things you normally do, and when I’m in pain.... they soon 
starting aching now if I stand on them for long (…..) for any length of time. This time has 
been much worse, I haven’t been able to go round the supermarket, I just haven’t been able 
to manage it. I’d have to sit down and my wife would struggle round.’  Sam 
 
For others, their daily activities were not too constrained by their ulceration and they had managed to 
carry on just as they had before their ulcers.   
 
‘Yes, mine never stopped me doing anything. They’ve never, I can’t say that they’ve ever 
interfered with anything I’ve wanted to do.’  Mary 
 
‘I don’t let anything restrict my life.’ Pam 
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Ellen reflected that despite not feeling up to it at times, she felt it important to make an effort to get 
involved with people and clubs: 
 
‘You’ve not got to let that bother you. I go to the Blind Club once a month and I go to Old 
Age Pensioners.’  Ellen 
 
One participant reflected on needing to ask her neighbours to help her, to provide assistance with 
her shopping and lifts to clinic appointments: 
 
‘Yesterday the young man from along the way, he took me to the clinic. It’s a good job that 
he’s out of work else I don’t know what I’d have done, I don’t honestly. And he took me to 
the supermarket and I haven’t been since way before Christmas...he took me then. I mean 
you’re alright cause you’ve got the trolley, you can hold onto the trolley (…) he took me and 
then he came and dropped the shopping off and he came and fetched me (…) but I want 
things for myself, personal things but I can’t go. I just feel like... I know I’m getting older but I 
don’t feel old.... this has made me depressed [points to left leg].’  Marg 
 
Again, the youngest participant Steve summed up the extreme effects of his ulceration on his ability 
to engage with life: 
 
 ‘Social life? ‘Errrr, I haven’t got one [long pause] I just don’t bother cause I know I’ve gotta  
 [got to] get myself better.’  Steve 
 
Steve described times when he totally avoided any contact with others and spoke of the feelings of 
shame related to his ulceration. 
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Only one of the interview participants was of working age and he had been unable to work 
throughout the 15 year duration of his ulceration. He claimed sickness benefits for financial support; 
a factor which caused him considerable concern: 
 
‘When I come to renew it again, I get a bit worried (…) you think with your legs, have you got 
the nurses on board. I know I’ve got the Doctor on me [my] side but you don’t really need the 
nurses it’s just what the Doctor writes down, you know...but I have got a good Doctor’   
Steve 
 
Other participants remembered difficulties working during episodes of active ulceration and reflected 
on these: 
 
‘I carried on at work. I worked in a school kitchen...it never stopped me from working’      
Mary 
 
Marg remembered having problems with needing her dressing changes during work time but 
reflected that she had an understanding employer: 
 
‘For the last six years of my life I worked at a local factory (...) you were on your feet a lot. 
(…) the boss used to take me twice a week to the clinic’     Marg 
 
For others, ulceration started after they had retired so had not influenced their ability to work: 
‘I’ve been retired twenty five years (…) I don’t think I had ‘em [them] until I finished...but I’ve 
had them quite a lot since I’ve left work.’    Sam 
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4.2.5.2  Mobility.  
Mobility problems were common for participants, although for some the problems were also 
complicated by the impact of their co-morbidities. A number of respondents reported that pain was 
worse when walking, but revealed that they persevered despite this discomfort: 
 
‘Oh I can walk with my frame (…) no they’ve never stopped me doing things. I could walk 
better really before I had them. I’ve always walked alright with them until recently.’            
May 
 
One respondent actually felt that her mobility was limited, not as a result of the ulcers themselves, 
but as a result of their bandages: 
 
 ‘You can’t walk well cause I got these compression bandages on.’  Ellen 
 
Many of the participants were afraid of falling and sustaining further injury. Marg revealed her fears 
about falling stating: 
 
‘I’m scared of falling; I am so scared of falling. I mean last Christmas (…) I fell, and it had 
been snowing a little bit and that’s when I did this ulcer on this leg [indicates right leg]...it 
must have been when they tried for pick me up and scraped it (…) so I’m scared of falling.’ 
Marg 
 
Marg felt that the risk of falling was made worse by her ill-fitting prescription shoes which caused her 
to walk differently: 
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‘Cause you still throw your foot out (…) I put my foot out [indicates with left hand] (…) It’s 
because it isn’t a size as such, you know, it’s just a general size (…) you’d be in it if you took 
3’s, 4’s or 5’s.’  Marg 
 
Steve spoke of more severe and life-limiting effects on his mobility: 
 
‘ I felt as if I wasn’t walking right, wasn’t walking as far...before that I’d walk everywhere (…) 
you know I’d say to me [my] mate, ‘Wait for us, what’s up with you.... I can’t walk, I got to 
slow down’ (…) it was like me [my] veins and everything were tightening up back of me [my] 
carves and everything.’  Steve 
 
 
4.2.5.3   Hygiene. 
Some respondents raised the topic of difficulties maintaining effective hygiene levels, especially their 
ability to shower. Others referred to having their legs washed in between dressing changes. Steve, 
the youngest respondent, possibly had the most to say on this area: 
 
‘It’s bathing, things like that. I do whip them off and have, not a shower.... I could do with a 
shower. I whip them off and jump in the bath, wash them sometimes, about 15 minutes 
before I’m due up there [clinic] and then the compression isn’t really lost.’  Steve 
 
Pam, who removed her dressing regularly, spoke of her need to be clean. She said: 
 
‘But, every night I wash me [my] (…) leg and foot.... especially the foot to get all that white 
stuff off and put a fresh one [dressing] on.’    Pam 
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Ellen spoke of the dressing process undertaken by the nurses’ when they visited. She stated that 
they often did not wash her legs properly:  
 
‘No, they cut it all off (…) and then she just puts a bit of cream on.... and that’s it, another 
bandage on.’   Ellen 
 
One participant talked positively about a new aid which the nurses had prescribed for her. She 
explained that it was a waterproof boot; a ‘Seal Tight’ (Stang, 2010) and using it had enabled her to 
have a bath: 
 
‘You slide your foot to the point and then this at top seals around your leg like that 
[demonstrates]. Yes, it’s great, I wash my leg down to there [indicates right knee] before I 
get in the bath and then I sponge me [my] feet to there [indicates the start of the bandages].’ 
Sam 
 
For Pam showering had recently become problematic and, as a result, her husband had had to start 
to assist her. She reflected: 
 
‘He’s me [my] husband, fair enough, he’s seen more of me these last few months that he’s 
seen for years [laughs]. Well I said, I can put that leg in the shower and wash that leg up to 
about here [indicates knee] and that’s it. But then I’ve got to wash all the front of me. He’s 
got to wash all the back and do me [my] hair because I can’t do it on my own.’  Pam 
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4.2.5.4  Clothes and shoes. 
The selection of and the suitability of clothing and shoes was another frequently reported feature 
throughout the interviews. Steve said:  
 
‘I just have to undo the laces and untie them (…) so if I do go for a pair of trainers like, it’s 
hard, I have to get a pair a size bigger cause of all these bandages (…) I take a 9’s, these 
are 10’s and I went to buy a pair the other day and they were 11’s. They just looked like that 
[indicates length] and I thought I can’t wear them they look like boats.’  Steve 
 
Difficulties selecting footwear which would fit over the bandage was problematic for a number of 
participants. Ellen had to make her own adaptations to her shoes to enable them to fasten but they 
now appeared to be quite dangerous: 
 
 ‘I took the laces out because with these bandages I couldn’t get them on.’   Ellen 
 
In terms of clothing, Steve reflected: 
 
‘I’ve just lived in tracksuits, cause it’s the only thing I can get on (…) I can’t wear jeans or 
anything (…) at least I can get them up, unzip them so the nurses can get at the dressings. 
I’ve tried trousers, canvas trousers, jeans.... I just conna [can’t] get them on at all....’  Steve 
 
Similarly, the female respondents had made choices regarding their clothes, electing to wear items 
which would conceal their dressings but also allow easy access for the dressing procedures: 
 
 ‘I wear trousers all the time now.’  Mary 
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Marg was frustrated by her inability to wear the many attractive clothes which she owned: 
 
‘It’s horrible.... you can’t dress as you want to. I’ve got nice fine skirts (…) printed skirts for 
the summer, ever so nice.’   Marg 
 
 
4.2.5.5   Sleep.  
Sleep was an issue which was raised by most respondents and was often attributed to the presence 
of uncontrolled pain. Marg reflected that she would get up rather than be uncomfortable in bed: 
 
‘Some nights...last Thursday (…) I had no sleep with it all night (…) it was going like this 
[indicates clenching motion] every few minutes and you’re there trying to find somewhere to 
put your leg (…) it’s awful, so I’d get up and hobble in here [lounge] and get myself a drink 
and some Paracetamol.’  Marg 
 
Some participants attributed their night time discomfort to their compression bandages. For some 
analgesia relieved the problem and made it easier to sleep. Sam reflected: 
 
‘They’ve got me down, especially the pain...the pain gets me down (…..) when I went into 
bed, I tried to take the tablets, these co-codamols, I had to just so as I could get off to sleep.’ 
Sam 
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4.2.5.6  Relationships. 
Many of the participants spoke of the effects of ulceration on their relationships - whether with 
friends, family members or more intimate relationships. Pam reflected on the need for her husband 
to assist her in day-to-day activities. Sam similarly reflected on being unable to provide his wife with 
the support she needed.  
 
Steve differed slightly from the other participants, as he felt ashamed of his wounds feeling that he 
had inflicted them on himself. He found it difficult to reveal the true nature of his condition to his 
friends. He stated: 
 
‘I have got a few other people I can go and see them and talk to them (…) because they’re 
bad in their own ways you see (…..) I’ve got other mates as well who don’t know anything 
about [points to legs], they can’t see them and I just keep me [my] mouth shut.’  Steve. 
 
Steve also reflected on the effects of his ulcers on forming more intimate relationships. His ulcers 
had developed when he was 24 years old and reflected on the decision he had made to avoid such 
relationships, something he had almost put on hold until a time when his wounds had healed.  He 
reflected: 
 
‘But relationship wise.... errm, no chance...I couldn’t. Once these have healed then, 
obviously yes...but it’s just, you know, with these on me legs all the time you know. I can’t 
get in bed with me tracky [tracksuit] bottoms on can I [laughs] (…) there was one girl and I 
tried. She said ‘what’s all that on your legs?’ and I tried make out that I’d been in a fire and 
I’d burned myself but, with the smelling and that, it didn’t last and I’ve just sort of put it off.’ 
Steve 
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4.3   Phase 1 discussion.  
The findings of phase 1 of this study poignantly establish the persistent and profound impact of 
CVLUs on the daily lives of participants; indeed, the impact on physical, psychological, social 
functioning and, QoL overall, was devastating. Despite the overwhelming nature of their ulceration, 
participants demonstrated a range of responses. Some participants saw CVLUs as a challenge and, 
despite their associated difficulties, did all they could to maintain their usual functioning. In contrast, 
others withdrew from their normal activities, limiting their contact with others until a time when their 
condition would improve. This range of personal responses could be attributed to the theories 
discussed in chapter 2 (page 39 - 48) and is explored further on page 148-149.   
 
This study reinforces the findings of the other qualitative studies reviewed (Charles, 1995; Walshe, 
1995; Bland, 1996; Chase et al, 1997; Hyde et al, 1999; Douglas, 2001; Ebbeskog & Ekman, 2001; 
Rich & McLachlan, 2003; Hopkins, 2004; Brown, 2005 a & b; Byrne & Kelly, 2010; page 68 onwards) 
and also serves to extend our understanding of the impact of CVLUs with a number of findings 
contributing to new knowledge in this area (page 156).  
 
4.3.1  Sample demographics. 
A review of the demographic details of the patient participants for phases 1 and 2 (table 9; page 
109), when compared with known characteristics for those with CVLU, demonstrate that the sample 
participants were fairly typical. The study sample demonstrated a median age of 76 years and CVLU 
prevalence is known to increase in frequency with age in both genders (Nelzen et al, 1991; Beebe-
Dimmer et al, 2004). CVLUs are also known to be slightly more prevalent in women (1:1.4) (Nelzen 
et al, 1991), again reflected in a 4:5 male to female ratio for the study sample. Obesity (Moffatt, 
1998; Gattringer et al, 2010) and leg injuries (Moffatt, 1998) are also known to predispose to the 
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condition but in terms of the sample only one participant appeared to be significantly overweight 
however five had sustained leg injuries that had caused their initial ulceration (page 111). Other 
predictors highlighted in the research include deep vein thrombosis (DVT), pulmonary embolism 
(PE) (Scott et al, 1995; Bérard et al, 2002) and increased multiparity (Elder & Greer, 1995; Bérard et 
al, 2001) but these were not demonstrated in the sample.  
 
The one outlier in terms of this profile was Steve who, at 39 years of age, was by far the youngest 
study participant. Steve was an ex-IV drug abuser who revealed, during his interview, that he had 
frequently injected into the vessels in his lower legs which had resulted in his ulceration. IV drug 
abusers such as Steve represent a significant sub-group of CVLU patients who have the condition 
as a result of the irreversible damage caused by their drug addiction (Sudhindran, 1997; Finnie & 
Nicolson, 2002; Pieper & Hopper, 2005; Palfreyman, 2007b). Steve had suffered from severe 
ulceration for many years and provided a lengthy narrative about the impact of the condition on his 
life but, interestingly, the themes and subthemes were the same as those from the ‘traditional’ 
patients with CVLU but, at times, the impact was more profound (page 116). 
 
4.3.2  Theme discussion. 
4.3.2.1  The Ulcer. 
Each of the interview participants provided a narrative of their leg ulcer journey, without prompting 
from the researcher. The value of such patient stories is increasingly being recognised as significant 
in evaluating the effectiveness of healthcare delivery, especially in the care of patients with a range 
of LTC. Personal stories are also used to investigate the meanings people attribute to their health 
and illness and, as part of the consultation, are seen as an integral part of the therapeutic 
relationship between the patient and their HCP (Winterbottom et al, 2012). During the interviews, the 
 145 
participants took the opportunity to put their illness into context and to describe their journey to the 
interviewer; almost, as described in Antonovsky’s (1987) theory of salutogenesis, trying to develop a 
sense of coherence surrounding their illness (page 46).  
 
4.3.2.1.1  Family history. 
Three of the phase 1 participants reflected on what they described as a family predisposition to 
ulceration. Predictors for the development of CVLUs, to date, have mainly been extrapolated from 
data relating heredity and the development of varicose veins (Scott et al, 1995; Beebe-Dimmer et al, 
2004) however, evidence to support a link between heredity and subsequent CVLU development 
has been not only limited but also conflicting (Scott et al, 1995; Berard et al, 2002). One study 
demonstrated no association between heredity and either varicose veins or CVLU when estimates 
were adjusted for age, gender, obesity, previous thrombophlebitis and leg injury (Scott et al, 1995). 
In contrast, Bérard et al (2002) identified a number of new predictors for the development of CVLUs, 
which included a family history of maternal venous insufficiency. In relation to the study sample, the 
three participants who cited what they termed a ‘family predisposition’ were all evident on their 
maternal side.   
 
4.3.2.1.2  Co-morbidities. 
Six of the phase 1 participants suffered from co-morbidities which complicated their daily lives and 
also limited their QoL. Two participants suffered from extensive rheumatoid arthritis (RA), a condition 
known to predispose the sufferer to the development of CVLUs (Thurtle & Cawley, 1983); with a 
reported prevalence of between 9% (McRorie, 2000) and 38% (Nishikawa, 1983) compared to a 1% 
prevalence in the general adult population (McRorie et al, 2000). Three participants reported that 
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they suffered from quite extensive osteoarthritis (OA), present in up to 25% patients who present 
with a CVLU (Margolis et al, 2003). In both RA and OA, research demonstrates a link between the 
condition and calf pump dysfunction, which may result in the development of CVLU (Browse et al, 
1988; Margolis et al, 2003). Two of the participants reported sight problems, with one reporting that 
she was registered as blind; both attributed their ulcers to injuries they had sustained to their lower 
legs potentially as a result of their reduced vision.  
 
Of the six participants with co-morbidities, there was a preoccupation with these conditions during 
their interviews which appeared to almost diminish the impact of their CVLU, almost serving as a 
distraction (Tom, Ellen & Sam; page 110). In contrast, where ulceration occurred in isolation, 
symptoms seemed to overwhelm the participant and almost defined their existence (Marg; page 
121). This may well reflect the individual personal characteristics discussed in chapter 2 (page 39 - 
48) such as locus of control (Rotter, 1954; page 44), self efficacy (Bandura, 1977; page 45) and 
learned helplessness (Seligman, 1975; page 45) which identified that certain characteristics 
improved an individual’s ability to cope with the threats posed by illness.  
 
Indeed, Charles (1995) investigated whether her study participants with CVLU demonstrated either 
an internal or external locus of control and concluded that those with an internal locus assumed an 
active approach to their ulcer management and often appeared to cope better, believing that they 
had control over events. In contrast, those participants with demonstrated an external locus tended 
to believe that they are under the control of others and failed to cope as well with the impact of their 
CVLU (Rotter, 1954). Further research into the impact of the personal characteristics discussed in 
chapter 2 (page 39 - 48) and coping with LTCs including CVLU, would be useful and may enable 
nurses to motivate and empower their patients by tailoring their approaches to disease management 
in a more appropriate way for their patients.  
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4.3.2.1.3  Cause, location, duration and description of ulcers. 
All participants reflected on the cause, location, duration and recurrence of their venous ulceration 
but no overall pattern was demonstrated. Six participants identified an injury that caused their ulcer 
whereas three could identify no precursor and felt that their ulcers simply appeared ‘out of the blue’. 
Six participants suffered extensive bilateral ulcers, whereas three reported only unilateral ulceration. 
Two suffered recurrence at exactly the same site on each occasion, which they both, interestingly, 
attributed to an area where all of their shoes rubbed and they had both experienced periods of 
healing, despite wearing the same shoes. The duration of ulceration demonstrated by participants 
ranged between three and fourteen years.  
 
Recurrence of CVLU is known to be common, with ulcers generally proving to be difficult to heal and 
demonstrating a high tendency to recur (Callam et al, 1985; Moffat et al, 1992; Nelzen et al, 1997). 
This was alluded to earlier (page 9), with Heit et al (2001) reporting an estimated annual recurrence 
of such ulcers as between 33-42%, similar to the results of an earlier UK study by Franks et al 
(1995) which reported recurrence of 26% after one year and 31% after 18 months. A more recent 
study by Etufugh and Phillips in 2007 estimated CVLU recurrence rates to be at an alarmingly high 
level of between a 54 and 78%. Recurrence is demoralising for both the patient and the providers of 
care (Bérard et al, 2002; Barwell et al, 2004) however, most participants appeared to be resigned to 
this pattern of ulceration, healing and re-ulceration. 
 
The longevity of the healing process was a challenge to many of the participants who reflected on 
the time wasted either whilst waiting for healing to take place or waiting for the nurse to visit. This 
was a distressing feature and echoed the findings of Chase (1997) whose participants reflected on 
wasted days. Some participants had made a conscious decision to get out and about and to attend 
their local clinic for their wound care. This seemed to have had positive benefits in terms of their 
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outlook and coping strategies but may well have been influenced by their underlying personal 
characteristics, as discussed in chapter 2 (page 23 - 49). This may well prove to be a key feature of 
future research (Lindsay, 2000). 
 
4.3.2.2   Symptoms 
Table 10 below provides a summary of the themes and subthemes from the interviews related to the 
participants symptoms. 
 
Table 10: Symptoms – summary of themes and subthemes from phase 1 interviews.  
 
Subthemes:  Key findings – Symptoms. 
Pain:    The theme of pain dominated all of the interviews. 
 Descriptions of type 
of pain: 
 Background pain reported to always be present. 
 Intermittent episodes of more severe pain. 
 Timing & duration of 
pain: 
 Continuous nature of pain reported. 
 Pain worse at night resulting in disturbed sleep. 
 Causes of pain:  Described as constant pain, made worse by 
dressing procedure or the dressings applied. 
 Pain not directly related to wound size. 
 Use & effectiveness 
of pain relief: 
 Some were reluctant to take analgesia due to side 
effects, a stoical approach or too much medication 
taken already. 
 Effectiveness was poor when taken. 
Exudate and odour:   Management of excessive exudate was 
problematic which occasionally led to non-
compliance. 
 Odour was embarrassing, leading to self-imposed 
social isolation. 
Emotional impact 
of ulceration: 
  Where present along with multiple co-morbidities, 
accepted with stoicism. 
 Result in depression, even suicidal thoughts. 
 Some participants made a conscious effort to 
engage with daily activities despite ulceration. 
 Despite despair, all spoke of hope and optimism 
surrounding healing and were looking to the future.  
 Fears of further injury, of making a mess, of what 
other people think and of what the future holds. 
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4.3.2.2.1  Pain. 
Pain overwhelmingly dominated the lives of all participants and impacted on every aspect of the 
participant’s functioning. Pain interrupted sleep, limited their mobility, lowered mood and was often 
ineffectively managed. Pain was described as continuous, unbearable and was a constant reminder 
of their ulceration; findings similar to other studies reviewed (Walshe, 1995; Chase, 1997; Hyde, 
1999; Rich & McLachlan, 2003; Hopkins, 2004). Ebbeskog and Ekman (2001a) likewise reflected 
that pain was central to their participants’ lives, which made their participants ‘cry in despair’ 
(Ebbeskog & Ekman, 2001a; page 69), and analgesia was deemed to be ineffectual against their 
ulcer related pain.  
 
Tornvell and Wilhelmsson (2010) also reported inadequacies in pain management for patients with 
CVLU in their satisfaction study (page 12). The enduring nature of the pain experienced by patients 
with CVLU and the inadequacy of the analgesic options available to the study participants were 
themes which dominated the interviews and highlight the need for urgent research into the 
successful management of pain for this patient group (Douglas, 2001; Ebbeskog & Ekman, 2001b). 
 
4.3.2.2.2  Exudate and odour. 
Difficulties managing wound exudate and odour were again evident for all and had a distressing 
impact. The humiliation of the odour and its impact on self-image, the resultant self-imposed isolation 
in order to prevent others from being exposed to this embarrassing symptom, were key findings of 
this study. Odour and leakage have been acknowledged in other studies (Douglas, 2001; Ebbeskog 
& Ekman, 2001b; Persoon, 2004; Briggs & Fleming, 2007) but the daily effects of these symptoms 
on the social and psychological functioning of participants in this study provides an original insight 
and serves to highlight the need for more effective wound management strategies for these 
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distressing symptoms. The devastating impact of exudate and odour on the participant group is 
reminiscent of the work of Price (1995) on body image, albeit in a different condition, which similarly 
resulted in feelings of loss of control and a fear of the reaction of others to the effects of their 
condition. 
 
The combination of pain, exudate and odour severely limited social functioning and lowered the 
mood of study participants; even prompting thoughts of suicide for Steve. But despite the 
devastating limitations of these symptoms, the participants, on the whole, strived to maintain their 
functioning and some even attempted to engage as they had before their ulceration. The theme of 
hope, especially hope for healing, was evident for all participants and may again reflect their 
underlying personal characteristics (chapter 2; page 39 - 48) and is a theme that echoes the work of 
Walshe (1995).   
 
4.3.2.2.3  Emotional effects of ulceration 
The impact of CVLU on the psychological functioning of the study participants was also consistently 
reported and also reflected the findings of the studies reviewed (Rich & McLachlan, 2003; Byrne & 
Kelly, 2010). Feelings of depression, low mood and poor self image were common and impacted on 
the daily lives of participants. The psychological impact of the condition was evident in the fears 
disclosed by participants; fears about whether their ulcer would heal, of what people thought (Price, 
1999) and fears of further injury. The ability of participants to cope with these stressors may, again, 
be facilitated by their personal coping strategies (Antonovsky, 1987; Lazarus, 1993) and may be an 
area for future research. 
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Such psychological effects of ulceration were common to the research presented in chapter 3 (page 
50 - 92) and, when combined with the physical effects of ulceration, seem to intensify the impact on 
the participant’s functioning (Hopkins, 2004). But, again, despite such feelings of loss the 
participants also had hope for the future, which echoes the findings of Hyde et al (1999) whose 
participants had an inner strength, a determination to cope, stoicism, resilience and hope for the 
future. Again, outlooks that may be explained, in part, by the theories discussed in chapter 2 (page 
39 - 48) such as locus of control (Rotter, 1954; page 44), self efficacy (Bandura, 1977; page 45) and 
learned helplessness (Seligman, 1975; page 45).  
 
4.3.2.3   Wound Management 
Table 11 below summarises the wound management themes from the phase 1 interviews. 
 
Table 11: Wound management – summary of themes and subthemes from phase 1 interviews. 
 
Subthemes: Key findings – Wound Management: 
The Nurse:  An expert in the care of ulcers. 
 The nurse-patient relationship was valued. 
 Consistency of team was important. 
 Variations in dressing technique noted. 
 One reflected on a problematic nurse-patient relationship. 
 The location and timing of dressing was important, 
especially when chosen rather than imposed. 
 Specialist support was valued. 
Treatment applied and patient 
understanding: 
 Compression proved difficult for some and well tolerated by 
others. 
 The variety of dressing products was discussed; with some 
products tolerated better than others. 
 Patients demonstrated an excellent understanding of their 
care, the products applied and their management. 
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Most of the phase 1 participants (n=8) reflected positively about the expertise and support offered by 
their nurses with many commenting on their preference for the same nurses, claiming that this was a 
key factor in improving the personal nature and the effectiveness of the care they received. This is a 
finding echoed in a number of other studies (Chase et al, 1997; Tornvist et al, 2000; Hopkins, 2004; 
Tornvell & Wilhelmsson, 2010) and may have important implications in the organisation of future 
care delivery. As confirmed by earlier studies, consistent care (Chase et al, 1997; Hopkins, 2004), 
the competence of the nurse in dressing selection and application (Chase et al, 1997; Douglas, 
2001) and the provision of regular feedback on the progress of the wound to the patient (Charles, 
1995; Brown, 2005b) were considered key factors in the quality of the care delivered, elements that 
were important to the patient and are encapsulated by the theory of patient centred care (page 23 - 
37).  
 
For many, where the healing process was prolonged and their ulcer recurrence felt to be almost 
inevitable, the focus of care on healing as the sole outcome of care has to be questioned. Briggs and 
Flemming (2007) recommend the adoption of a new approach to leg ulcer management where care 
is delivered in line with other chronic, long term conditions. They suggested that the focus on healing 
may actually intensify the ‘hopelessness’ felt by the patient, almost fostering a ‘learned helplessness’ 
as described by Seligman (1975; page 45) by the patient (Briggs & Flemming, 2007). Briggs and 
Flemming (2007) recommend a renewed focus in wound care and propose that it may improve the 
patients coping strategies (page 43), enhance the patient focus of the consultations (page 24 - 37) 
and encourage the nurse to move away from a focus solely on the wound (page 2) (Persoon et al, 
2004). 
 
For just one participant in this study, Pam, the nurse–patient relationship had become problematic; a 
finding supported by other studies which highlighted potential negative nurse-patient relationships 
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(Chase et al, 1997; Hyde, 1999). Such problems were often attributed to a perceived non-
concordance to treatment recommendations by the nurse (Chase et al, 1997; Hyde, 1999) which 
may, in part, be due to issues relating to power in the HCP-patient relationship (Hewison, 1995; page 
43) and ineffective communication (Ley, 1988; page 24-37). The promotion of an open, concordant 
relationship between the patient and their HCP is essential to the fostering of the best quality of care 
and is key to a patient centred approach, where the patient is listened to and care delivered in 
accordance with their preferences (Stewart et al, 2004; page 10). 
 
Participants reflected that they had experienced a wide variety of wound care products over time and 
were knowledgeable about the wound management strategy adopted by their nursing team; often 
seeing themselves in partnership with their nurse against the ulceration. Other studies highlight 
similar positive effects of the nurse-patient relationship (Ebbeskog & Ekman, 2001a; Brown, 2005a & 
b).  
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4.3.2.4   Effects on daily life. 
Table 12 below summarises the effects on daily life subthemes for the phase 1 interviews. 
 
Table 12: Effects on daily life - summary of themes and subthemes from phase 1 interviews. 
 
Subthemes: Key findings – Effects on daily life. 
Restrictions to daily life:  Some reflected on being a ‘prisoner’. 
 Inability to provide care for loved ones.  
 Reflections on loss of independence. 
 Missed opportunities. 
 Some reflected on having little social life. 
 Optimism for the future. 
 Efforts to get out despite ulceration. 
Mobility:  Poor mobility due to the ulcer, the dressing or due to  
age. 
 Fear of falling. 
Hygiene:  Difficulties staying clean. 
 Led to non-compliance for one participant. 
 New aid was improving personal hygiene. 
Clothes & shoes:  Restricted choices of clothes & shoes. 
 Attempts were made to conceal dressings. 
Sleep:  Pain caused issues with sleep. 
 Many reflected on getting up in the night. 
Relationships:  Reliance on family for support. 
 The need to provide care was problematic. 
 Profound effects of severity of ulcers on family members. 
 Avoidance of intimate relationships. 
 Avoidance of telling friends about the ulceration. 
 
 
For many studies, as with this, the physical effects of CVLUs dictated the reflections of the 
participant. Daily living proved a challenge for all with getting out and about, limited mobility and 
difficulties maintaining personal hygiene due to the wound, the dressing or both; as were choices in 
what to wear. Sleep was regularly disturbed, most often by pain and relationships were altered, with 
carers becoming cared for and intimacy avoided; factors echoed in the findings of Bland (1996); 
Brown (2005b), Rich and McLachlan (2003) and Byrne and Kelly (2010). 
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Ulceration affected every area of functioning over long periods of time. Other studies have similarly 
presented a dominance of physical effects due to ulceration but have claimed, where this is the 
case, often the psychological and social issues are diluted (Brown, 2005 a & b); this did not appear 
to be the case during this study. Participants spoke at length about the impact on their psychological 
functioning, describing the effect on their mood, their motivation and their ability to engage in 
activities. When combined with the physical symptoms of ulceration, these two areas served to 
severely limit their social functioning. 
 
 
4.3.3   Strengths and weaknesses of phase 1. 
4.3.3.1   Strengths. 
The phase 1 interviews were conducted by a single researcher, which ensured that a consistent 
approach was maintained for each of the interviews. The researcher was a practicing DN, which may 
have enhanced disclosure by the participant who appeared happy to discuss the details of their 
condition, confident in the knowledge that these factors would be understood by the interviewer. This 
potentially served to enhance the flow of the interviews, as symptoms did not need to be explained 
or clarified.  
 
The researcher undertook the thematic analysis which ensured immersion in the data, 
recommended for the process of thematic analysis (Hicks, 2004). In addition, an educational 
supervisor undertook an independent analysis and achieved consensus with the researcher using a 
reflexive approach. Additionally, the findings from Phase 1 have undergone double blind peer review 
prior to publication (Green et al, 2013a), both factors that have confirmed the veracity and rigour of 
the process. 
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4.3.3.2   Weaknesses. 
On occasion, what appears to be a strength, could potentially become a weakness. The role of the 
researcher as a DN, which following deliberation with educational supervisors was disclosed to the 
patient participants (page 97), was felt to have facilitated a more open discussion but in reality, such 
knowledge may have led the participant to embellish factors relating to their ulceration due to the 
influence of social desirability bias discussed on page 98 (Paulhus & Reid, 1991). 
 
During every interview the researcher has an effect, the influence of which cannot be accounted for 
(Hicks, 2004). Approaching the interview in position of equipoise (Bowling & Ebrahim, 2005) and 
reflexivity throughout the process (Kvale, 2004) aims to limit this effect and were factors applied to 
the data collection, analysis and reporting of the study findings. 
 
4.3.4  Contribution to new knowledge. 
This phase of the study aimed to build on the body of knowledge presented by the reviewed studies 
(Charles, 1995; Walshe, 1995; Bland, 1996; Chase et al, 1997; Hyde et al, 1999; Douglas, 2001; 
Ebbeskog & Ekman, 2001; Rich & McLachlan, 2003; Hopkins, 2004; Brown, 2005 a & b; Byrne & 
Kelly, 2010; page 68). In addition, it is felt that there are a number of findings that have enhanced 
our understanding or are, indeed, new. These include: 
 The dominance and constancy of pain, reported as always being present for all participants, 
has not been reported as consistently by participants in other studies (page 116-119).  
 The presence of inadequate strategies to manage pain was a theme that was stressed by all 
participants, and again is alluded to by other studies but the prevalence in this study was 
greater (page116-119) 
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 The presence of hope for all participants, despite them all reflecting on their poor QoL, was 
again more consistently reported (page 122-124). 
 The patient’s preference for a consistent nursing team was reflected on by all participants 
and may be significant in the organisation of future care delivery (page 125-129). 
 Poor symptom management, especially in relation to exudate and odour, was revealed 
(page 119-121). 
 The impact of exudate and odour on both psychological and social functioning was identified 
(page 119-121). 
 
4.3.5   Further research. 
The evidence surrounding the impact of personal characteristics on the patients’ ability to cope with 
their long term conditions appears to be relevant to patients with CVLU (page 39-48). Further 
research that explores this relationship and encompasses this knowledge in the development and 
‘personalisation’ of the consultation may have the potential to effectively enhance PCC.   
 
Fostering of a therapeutic relationship between the patient and the nurse that is really patient 
centred; where the patient feels valued, supported and listened to and where the chronicity of their 
ulceration is understood, is vital and may result in improved healing rates and reduced ulcer 
recurrence (Briggs & Flemming, 2007). Further research is needed to determine whether this is so. 
 
In this current climate of modernisation of community care (DH, 2013) priorities need to focus on the 
importance of the patient in the consultation and the delivery of holistic care. The importance of the 
nurse-patient relationship and the need for consistent care provision highlighted by this study is an 
area that is of central importance.   
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Where patients had engaged and attended a clinic for their wound care, they reflected on a renewed 
positivity, an enhanced outlook and improved coping strategies, feeling in control of their care, rather 
than controlled by it (page 127-128). Research that builds on that of Lindsay (2000) in relation to 
wound care clinics and promotes patient choice in the location of care delivery would be beneficial. 
 
Reflection on personal narratives during the consultation may well serve to enhance patient 
understanding of their condition and enable them to develop effective coping strategies (Lazarus, 
1993) and a sense of coherence (Antonovsky, 1987). Consultation based research that facilitates a 
focus on such discussion may prove to be effective. 
 
4.3.6   Conclusion. 
This phase has effectively demonstrated that the QoL of patients with CVLUs is impaired in physical, 
social and psychological domains. The impact of ulceration was vividly described together with the 
life changing, debilitating symptoms which were often inadequately managed; combined these had 
an enervating effect on every aspects of daily living.  Understanding the ‘lived experience’, listening 
to the patient and providing effective symptom management for this chronic condition during wound 
care consultations is crucial to the improvement of QoL for this patient group. Subsequent phases of 
this study build on these findings.  
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Chapter 5: Phase 2. 
 
 
Chapter 5 provides detail of the underlying methodological decisions, the methods used, the 
research procedure undertaken during phase 2 (5.1), the subsequent results (5.2) followed by a 
discussion of the significance of the findings in the light of the research (5.3).  
 
 
5.1  Phase 2. 
Phase 2 of this mixed methods study was designed to answer the following research question: 
 
To what extent are the significant factors highlighted in the phase 1 interviews, elicited 
and addressed during the patients’ consultations?  
 
As with phase 1, qualitative methods of enquiry were applied during phase 2 of the study to 
determine the extent to which the themes and subthemes disclosed during the phase 1 interviews 
were addressed during the subsequent consultations for the same participants. Following 
consideration of other potential designs for phase 2, such as holding a focus group for nursing staff 
to discuss the nature of their consultations or the distribution of questionnaires to patients following 
their consultations, it was decided that to explore consultations as they happen, a period of non-
participant observation would be the optimal approach. Observation would facilitate the study of 
interactions between the nurse and the patient in real time and provide the researcher with an insight 
 161 
into what actually happens during the consultations and nurse-patient interactions as they take place 
in reality (Spradley, 1979; Hicks, 2004; Denscombe, 2007).  
 
5.1.1  Phase 2 design and methodology. 
As discussed (page 94), qualitative research encompasses a range of approaches and associated 
data collection methods to enable the researcher to gain a true-life perspective (Salmon, 2012). 
Observation itself is an important research technique which aims to provide a systematic description 
of people’s way of life and often affords a unique insight into the social context (Strauss and Corbin, 
1998; Barfield & Thomas, 2001). Observation provides an understanding of interactions and their 
context, whilst providing additional information regarding the physical environment; factors 
inextricably bound to the research process (Polgar & Thomas, 1991; Mulhall, 2003).  
 
Such research can be either overt in nature, with the purpose of the research known to participants, 
or covert; with participants unaware that the research is taking place. Each approach has inherent 
advantages and disadvantages in terms of the quality of the data produced and the ethical 
acceptability of the research (Denscombe, 2007). Phase 2 was designed to be overt which is often 
the case in healthcare research to comply with the stringent ethical processes with which it is 
governed. Thus, during phase 2, both the purpose and the process of the observations was fully 
explained to both nurse and patient participants, prior to their consent being gained but it was felt to 
be likely that the participants would ‘forget’ that they were the subjects of observation and, as a 
result, may act normally; a situation reported in other similar observational studies (O’Reilly, 2005). 
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The technique of observation is particularly important within the practice-based professions such as 
nursing, since it facilitates the study of participants’ behaviour and provides an opportunity to 
understand the actions and reactions of participants (Lofland & Lofland, 1971; Parahoo, 1997). In 
nursing the goal of ‘observation-type’ research is often to improve practice and it provides an 
excellent opportunity to describe and interpret behaviour, including interactions between patients and 
their HCPs (LeCompte & Preissle, 1993; Kennedy, 1999; Holloway & Wheeler, 2010; Fetterman, 
2010). Savage (2000) emphasises the importance of such research to understand the patients’ and 
clinicians’ worlds, from their own perspective and stresses that health researchers have a distinct 
advantage in such research situations as they are insiders and, as such, are able to ask questions 
and legitimately stay in the ‘field’; factors which may go some way to reducing any observer effect 
(Holloway & Wheeler, 2010). Despite this, the influence of the observer must always be taken into 
account, as all such data is influenced by the participation of the observer in the field (Borbasi et al, 
2005).  
 
Gold (1958) and Junker (1960) identified four types of observation and developed the typology 
displayed in figure 11. Observation approaches range on a continuum from the complete participant, 
where the true identity and purpose of the research is not known to those observed; participant-as-
observer, where both the researcher and the participants are aware that they have a field 
relationship; observer-as-participant with the observer participating simply by being in the location 
rather than actually working there and, finally, the complete observer, with the researcher completely 
removed from any social interaction with the informants and simply observes.  
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Figure 11: Typology of observation (Gold, 1958; Junker, 1960).
 
 
 
This typology (Gold, 1958; Junker, 1960) places the observer on a continuum of participation, 
moving between these levels of involvement; a principle upheld by many subsequent researchers 
(Pretzlik, 1994; Hammersley & Atkinson, 1995). Indeed Pretzlik (1994) suggests that in advance of 
the observation taking place, it is actually impossible to plan the intended ‘type’ of observation, as 
this alters along the continuum during the period of fieldwork (Gold, 1958; Wolcott, 1994; 
Hammersley & Atkinson, 1995; Pope & May, 1995). These shifts may well be beneficial since they 
may limit the influence of the observer on the data produced (Hammersley & Atkinson, 1995; 
Holloway & Wheeler, 2010).  
 
The intended approach to the observations in phase 2 was initially anticipated to be non-participant 
in nature, however, reflecting on the above typology (figure 11) and the need for a flexible response 
to the requirements of the participants and the environment, movement along the observation 
continuum was experienced (Gold, 1958; Junker, 1960). At times the researcher was a complete 
observer and at others a participant-as-observer; a role that was further complicated as the 
Observation 
typology 
Complete 
participant 
Participant 
as 
observer 
Complete 
observer 
Observer 
as 
participant 
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researcher was now known to the participants, having previously undertaken the phase 1 interviews. 
On occasion this did lead to comments from the participants and openings for conversation directed 
to the observer but these were minimised by the researcher responding politely but closing the 
questioning or diverting attention back to the nurse participant. 
 
The success of any observational research relies on gaining access to the environment to be studied 
which is often controlled by ‘gatekeepers’ who restrict access to protect either the environment, the 
potential participants or both (Hammersley & Atkinson, 1995; Pope & May, 1995). The gatekeepers 
for phase 2, as for phase 1, were the DNs but, having already assisted with access to the patient 
sample in phase 1, no problems were experienced gaining access to the sample during phase 2. 
Access issues often heighten the need for the researcher to consider their identity, as with 
interviewing (page 98), in order to assure gatekeepers that the research is non-threatening; a factor 
made easier when research is overt in nature such as this (Waddington, 1994; O’Reilly, 2005).  
 
Despite meticulous preparations prior to accessing the research environment, the presence of a 
researcher in the field invariably stimulates some sort of response from those ‘observed’ (Lincoln 
and Guba, 1985). The Hawthorne Effect (Roethlisberger & Dickson, 1939), where behaviour is 
altered as a direct result of the observation, cannot ever be completely eliminated and its effects can 
only be estimated (Alder & Alder, 1987), however, strategies can be employed to attempt to 
minimise this effect, including extending the duration or frequency of the observations. The phase 2 
observations were repeated on four occasions for each of the patient participants, a strategy 
intended to minimise both the Hawthorne Effect (Roethlisberger & Dickson, 1939) and any 
researcher effect (Denscombe, 2007). This approach appeared to be effective. 
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Field notes are said to be a vital element of observational research and depend on the quality of the 
observation skills of the researcher but also on their methods of recording the observations (Pope & 
Mays, 1995; Mulhall, 2003; Polit & Tatano Beck, 2004). Pretzlik (1994) advocates the use of a 
predetermined observation schedule completed during the observation to ensure an accurate 
recording of the detail and also to allow for quantitative data to be generated from the process 
(Denscombe, 1998; Bowling, 2009; Fetterman, 2010). For phase 2, an observation consultation 
checklist (appendix 9) was developed, in conjunction with an educational supervisor, based on the 
themes and subthemes extrapolated from the phase 1 interview data to facilitate accurate recording 
of observation detail and to minimise disruption during the observations (Denscombe, 1998; Bowling, 
2009; Fetterman, 2010).  The development of the observation checklist utilised the thematic map 
constructed during the phase 1 thematic analysis (appendix 7) to map potential checklist items to the 
themes (appendix 8), which resulted in 28 items, each independently selected by the researcher and 
an educational supervisor, thus ensuring rigour. As a result of the comprehensive development, the 
observation checklist successfully encompassed all of the phase 1 themes and subthemes 
(appendix 9). Table 13 below demonstrates the alignment of interview themes and subthemes with 
the checklist items. 
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Table 13: Phase 1 themes / subthemes with phase 2 checklist items. 
 
 
 
 
Phase 1 themes: Phase 1 subthemes. Phase 2 checklist items. 
The ulcer:   
 Family history.  
 Co-morbidities.  
 The cause, location and duration of ulcers.  
Symptoms:   
 Pain – description of the type of pain. Pain: 
            - timing and duration of pain. Presence of pain. 
            - causes of pain. Cause of pain. 
            - use and effectiveness of pain relief. Type of pain. 
  Timing and duration of pain. 
  Use & effectiveness of analgesia. 
  Advice regarding pain management. 
  Has the dressing been comfortable? 
  Discomfort during the procedure. 
  Advice regarding pain management. 
 Exudate and odour. Exudate 
  Odour 
 Emotional effects of ulceration. Depression 
  Fears and concerns 
  Self-image 
  Fear of people’s reactions 
  Fear of recurrence. 
Wound 
management: 
  
 The nurse. Nurse advice. 
 The treatment applied and patient 
understanding.  
Wound management: 
 Patient compliance. Has the dressing been comfortable? 
  Discomfort during the procedure. 
  Update on condition of the wound. 
  Objective measurement. 
  Knowledge and understanding of 
dressings. 
Effects on daily 
life: 
  
 Restrictions with everyday activities. Isolation. 
 Mobility. Restrictions to mobility. 
 Working. Opportunities for work and leisure. 
  Financial issues. 
 Maintenance of hygiene. Personal hygiene. 
 Clothes and shoes. Limitations to choice of clothes and 
shoes. 
 Sleep. Sleep problems. 
 Relationships. Relationships: carers, partners, etc. 
 Fears. Fears and concerns 
  Fear of people’s reactions 
  Fear of recurrence. 
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The checklist (appendix 9) included tick, comment and ‘scoring’ boxes for each of the items to 
ensure ease of completion and minimal distraction for the researcher, nurse and patient participants. 
The template also included the facility to indicate whether it was the patient participant or the nurse 
who raised a theme or subtheme, an important consideration since patient participants raised 
themes and subthemes without prompting during their interviews. A ‘scoring’ tool was also included, 
based on tools used in similar observational studies (Henbest & Stewart, 1989). The scoring tool 
facilitated the rapid assessment of the depth to which themes were explored during the consultation 
(table 14). 
 
Table 14: Scoring tool for checklist themes. 
 
 
0 Theme not raised by nurse or patient. 
1 Nurse did not identify cue. 
2 Nurse picked up cue only. 
3 Nurse identified patient cue and asked about the issue. 
4 Nurse picked up cue and partially dealt with it. 
5 Nurse picked up cue and dealt with it fully. 
 
 
 
5.1.2  Phase 2 sampling framework. 
The key to the success of phases 1 and 2 of the study was access to the same patient participants, 
a factor that would facilitate the tracking and linkage of the phase 1 data with the observation data. 
As a result, phase 2 utilised the same nurse and patient sample as phase 1 with the sampling 
framework, inclusion and exclusion criteria and sample size, as detailed for phase 1 of the study 
(pages 99 - 101). 
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5.1.3   Phase 2 study procedure. 
Once the consultation checklist had been developed on completion of phase 1; phase 2 commenced 
and is outlined in the following flow chart (figure 12). Nurse participants were accompanied during 
their routine wound care consultations with the phase 1 patient participants and the patients each 
had their consultations observed on four occasions, most often undertaken over four consecutive 
weeks. This ‘repetition’ designed to allow for a variety of staff members to be observed and also to 
minimise the Hawthorne Effect (Roethlisberger & Dickson, 1939) as discussed (page 164). Such 
repeated observations are said to provide the best opportunity to observe interactions as they take 
place in reality (Denscombe, 2007). In view of the time lapse between phases, prior to each 
observation opportunities were provided to reaffirm consent and to provide opportunity for consent to 
be withdrawn if any of the participants so desired. 
 
Each observation lasted for between 20 and 30 minutes, during which time the researcher, whilst 
remaining as unobtrusive as possible, completed the consultation checklist. Field notes were 
recorded promptly following each observation and referred to the context, interactions and relevant 
information about the environment. An example of such case notes is provided in appendix 10. Since 
only minimal time had elapsed since the interviews, and in view of the nature of CVLU, it was felt 
that the issues raised as significant during phase 1, would still be similarly problematic for the 
participants during phase 2.  
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Figure 12: Phase 2 flow chart. 
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5.1.4  Phase 2 data collection. 
The researcher completed the checklist during each observation, which provided a structured format 
for recording data and also serving to enhance the researchers’ objectivity during the observations 
(table 14, page 167). Reflexivity was enhanced by prompt completion of field notes following the 
observation adding to the veracity of the procedure (Miles & Huberman, 1994) (appendix 10). During 
each observation the researcher documented a score for each item on the checklist. A score of 0 
was allocated if either the patient or the nurse did not raise a theme, during the consultation. A score 
of 1 if the patient mentioned the theme, thus providing the nurse with a cue, but the nurse failed to 
acknowledge it, for whatever reason. A score of 2 was allocated if the patient gave a cue, the cue 
was acknowledged by the nurse but there was no further discussion relating to the theme. A score of 
3 allocated if there was some general discussion surrounding the theme. A score of 4 was attributed 
if the nurse offered a partial solution to the issues raised and, finally, a score of 5 was allocated if the 
nurse explored and fully dealt with the theme.  
 
5.1.5  Phase 2 data analysis. 
Data collection and analysis were simultaneous during phase 2, with analysis undertaken after each 
observation. The completed templates were analysed using descriptive statistics which provided 
ordinal data to illustrate both the frequency and depth to which the phase 1 themes and subthemes 
were raised and explored. Such quantitative analysis of qualitative data is not uncommon and serves 
to allow for the reporting of summary results in numeric terms to summarise the large quantity of 
qualitative data accumulated (Young, 1981; Abeyasekera & Lawson-McDowall, 2000).  
 
 171 
5.1.6  Ethical considerations. 
In order to facilitate the consistency of the participants, ethical approval was gained for both study 
phases at the start, thereby ensuring that the nurses and patients were consistent across the 
phases. Consideration of ethical issues relating to phases 1 and 2 were presented from page 99 
onwards. LREC NHS and R&D approval were applied for jointly for the two phases and were 
approved at the same time (REF: 10/H1203/13, appendix 4 & 5). The patient and nurse participant 
study packs and consent forms (appendix 6) included the details of both phases of the study and 
were completed at the start of phase 1. Nurse and patient participants were contacted at the start of 
phase 2 to confirm their consent and allow the researcher to make arrangements to accompany the 
nurses on their scheduled visits to participants whilst they delivered their usual wound care.  
 
It was acknowledged that phase 2 required a more extensive level of involvement from nurse 
participants since their consultations were now to be observed by a RN, which some may perceive 
as daunting. In view of this, the nurse participants were provided with the facility to withhold consent 
for the observation element of the study on their consent form. If this was case, arrangements were 
put in place for an alternate, consenting member of staff to conduct the consultation for the 
scheduled observation. Nurse participants were aware that if any issues surrounding their practice 
were of concern during the consultation, these would be dealt with as recommended by the NMC 
(2008). Specific issues in relation to phase 2 for the patient participant were the repeated nature and 
location of the observations, offered either at a clinic base or the patients’ own home.  
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5.2  Phase 2 results. 
5.2.1  Introduction. 
Of the nine patient participants recruited at the start of phase 1, five (three male) remained involved 
in phase 2 of the study.  Of those unable to take part, the ulcer of two had healed (Evan; Marg), one 
was in hospital following a fall (May) and one had been discharged (Pam). The patients involved in 
phase 2 had a median age of 76 years (range 39 - 86 years) (additional detail on page 109). As in 
phase 1, thirteen experienced nurses remained involved and were observed during phase 2. The 
nurses had a median of five years of experience in primary care (range 6 months – 20 years). 
 
5.2.2  Checklist items. 
During each of the observations, the checklist was completed for each participant. Results are 
displayed overall in summary table below (table 15 overleaf).  In the summary table, each of the 
boxes has a corresponding score based on the scoring tool (table 14; page 167). Where scoring 
boxes are also highlighted in yellow, this indicates that the theme or subtheme was specifically 
emphasised as being of particular importance to the participant during their phase 1 interview. This 
‘highlighting’ facilitated the tracking of known items across from the interview phase to the 
observation phase of the study and it is these statistics which constitute the reported results and was 
made possible by recruiting the same sample for both phases (page 99). In order to ensure the 
usefulness of the results, if a theme was not emphasised as being important to a participant, the 
score has been excluded. As discussed in the data analysis section (page 170), each theme and 
subtheme has been reported using descriptive statistics in the form of percentages.  
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Table 15: Summary table of checklist items. 
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 Name & visit 
number 
Tom: 01 5 5 5 5 3 3 3 3 5 0 3 3 0 0 3 0 4 0 5 5 3 4 3 3 5 0 3 
Tom: 02 3 3 3 3 1 0 5 5 0 0 3 0 0 0 0 0 3 0 0 0 3 0 0 0 3 3 3 
Tom: 03 5 5 0 0 0 0 0 4 0 0 0 0 0 0 0 0 5 0 5 3 3 0 0 0 5 1 3 
Tom: 04 5 0 4 0 3 3 3 0 5 0 0 0 0 0 0 0 3 0 3 5 0 0 3 0 3 3 3 
Mary: 01 0 0 0 0 0 0 4 0 4 0 0 0 0 0 0 3 5 0 5 0 0 0 0 0 0 0 0 
Mary: 02 0 0 0 5 0 5 0 0 3 0 0 0 0 0 0 0 0 0 5 0 0 0 0 3 3 3 0 
Mary: 03 3 5 0 0 0 0 5 0 5 0 0 0 0 0 0 0 5 0 5 0 0 0 0 0 3 3 0 
Mary: 04 0 0 0 3 3 5 3 0 5 0 0 0 0 0 0 0 5 3 3 0 0 0 0 3 3 3 0 
Ellen: 01 4 0 0 4 5 5 3 4 5 0 4 3 0 5 3 0 5 0 5 3 3 5 0 3 3 0 0 
Ellen: 02 3 3 3 3 5 5 3 0 3 0 3 0 0 0 0 0 3 0 5 0 4 5 0 3 3 3 0 
Ellen: 03 3 5 3 0 4 5 3 0 5 0 3 0 0 0 3 0 3 0 5 3 0 5 5 3 3 3 0 
Ellen: 04 3 3 0 0 3 0 5 3 5 0 0 3 0 0 0 0 4 5 3 3 0 0 0 3 3 3 0 
Steve: 01 4 4 3 0 0 0 5 3 5 0 5 0 0 3 0 0 5 3 4 4 0 4 3 5 4 0 0 
Steve: 02 3 0 3 0 0 0 5 0 0 1 3 3 0 2 0 0 4 3 5 5 0 1 0 3 0 0 3 
Steve: 03 0 0 0 0 0 0 3 0 5 2 0 1 0 0 1 1 4 0 3 5 0 0 0 0 0 0 0 
Steve: 04 1 0 0 0 1 0 0 0 5 5 0 3 0 0 0 0 0 0 4 0 0 2 0 0 0 0 5 
Sam: 01 3 0 0 3 0 0 3 3 5 0 0 0 0 0 0 3 5 0 3 3 0 5 0 3 3 3 3 
Sam: 02 1 3 2 0 1 0 5 5 3 0 1 0 1 0 0 3 3 0 4 3 0 3 0 1 1 1 3 
Sam: 03 3 5 3 3 0 0 3 3 5 0 3 5 0 0 0 1 5 0 5 3 0 5 0 1 3 3 1 
Sam: 04 3 1 1 1 1 1 0 1 3 3 1 3 0 0 0 0 3 0 3 2 0 3 0 1 3 1 3 
 
NON-PARTICIPANT OBSERVATION RATING SCALE. 
0 Theme not raised by nurse or patient. 
1 Nurse did not identify cue. 
2 Nurse picked up cue only. 
3 Nurse identified patient cue and asked about the issue. 
4 Nurse picked up cue and partially dealt with it. 
5 Nurse picked up cue and dealt with it fully. 
Symptoms   
Wound Management 
Effects on daily life 
Highlighted as important in phase 1 
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5.2.3  Themes and subthemes. 
This section is presented in theme order in line with the reporting of phase 1. Each theme is 
presented individually, with overall scores in table form for each theme and subtheme. Individual 
scoring, displayed in pie charts, for each of the important subthemes has been included as an 
appendix (appendix 11).  Overall results for the themes are summarised in the table below (table 16).  
 
Table 16: Summary scores for the main themes from the phase 2 analysis. 
 
Issue (total 
number of 
potential 
occurrences of 
each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Pain (132) 55 (42%) 9 (7%) 1 (1%) 36 (27%) 9 (7%) 22 (16%) 
Exudate & 
odour (28) 
9 (32%) 1 (4%) 1 (4%) 5 (18%) 1 (4%) 11 (38%) 
Emotional 
effects (28) 
16 (56%) 2 (7%) 1 (4%) 8 (29%) 0 (0%) 1 (4%) 
Wound 
management 
(32) 
3 (9%) 0 (0%) 1 (3%) 9 (28%) 4 (13%) 15 (47%) 
Effects on 
daily life (84) 
32 (38%) 8 (10%) 1 (1%) 33 (39%) 3 (4%) 7 (8%) 
Total (304) 115 (38%) 20 (7%) 5 (1%) 91 (30%) 17 (6%) 56 (18%) 
 
 
There was an opportunity to assess each of the 28 themes and subthemes within the checklist on 20 
occasions (four observations each for the five participants), which provided a total of 560 checklist 
items for assessment. As described, scores were only reported where the patient had stressed that 
the issue was important to them during their interviews, thus, of these 560 assessment opportunities, 
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304 of these items were highlighted as important to the patient participants and included in these 
results. 
 
Of these 304 themes of known importance, 189 (62%) were a feature of the consultation whereas 
115 (38%) items were not raised during the observed consultation. On 20 occasions (7%), the 
patient provided a cue about the theme but this was overlooked or not noticed by the nurse. On 5 
(1%) occasions the cue was acknowledged by the nurse but was not explored further. On 91 (30%) 
of occasions the nurse acknowledged the theme and proceeded to have a discussion with the 
patient about the issue. On 17 (6%) of occasions there was a partial solution offered and on 56 
(18%) occasions the issue was fully dealt with. 
 
5.2.3.1  Theme 1: The ulcer results. 
During each of the interviews, the ‘ulcer’ theme encompassed the patients’ story of their ulcer 
journey and was used by the patient to set the scene, often including their family history, co-
morbidities and wound history. During each of the observed consultations, discussion about the ulcer 
featured, providing the patient with an opportunity to put their ulceration into context. This theme did 
not require a specific response or intervention by the consulting nurse and, as a result, was not 
directly included within the consultation checklist. Where relevant, field notes recorded any 
significant disclosure which may have influenced the care delivered.  
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5.2.3.2  Theme 2: Symptoms results. 
5.2.3.2.1 Results for pain. 
Eight subthemes - the presence, cause, type, timing and duration of pain, the use and effectiveness 
of analgesia, advice regarding pain management, the comfort of the dressing and any discomfort 
during the procedure – encapsulated issues surrounding pain for participants. Each was assessed 
on 20 occasions (as discussed on page 174). Thus pain related items provided 160 opportunities in 
total to assess pain, but only 132 were stressed by participants as being significant during their 
phase 1 interview. 
 
Of these 132 occasions which were now ‘known’ to be significant, the items were not raised (score of 
0) on 55 occasions (42%); the cue was overlooked (score of 1) on 9 (7%) occasions and the theme 
was acknowledged but not explored further (score of 2) on 1 (1%) of the 132 occasions possible. 
The theme was discussed (score of 3) on 36 occasions (27%); partially dealt with (score of 4) on 9 
occasions (7%) and fully dealt with (score of 5) on 22 of the occasions (16%). These scores are 
displayed in table 17 below.  
 
Table 17:  Overall scores for pain. 
 
 
Issue (total 
number of 
potential 
occurrences 
of each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Pain (132) 55 (42%) 9 (7%) 1 (1%) 36 (27%) 9 (7%) 22 (16%) 
 
The subthemes related to pain - the presence, cause, type, timing and duration of pain, the use and 
effectiveness of analgesia, advice provided regarding pain management, the comfort of the dressing 
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and discomfort during the dressing procedure - were also analysed individually. Table 18 below 
shows the overall scores for each of the subthemes in the pain category. 
 
Table 18: Scores for pain subthemes. 
 
 
Issue (total number of 
potential occurrences 
of each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Presence of pain (20) 4 (20%) 2 (10%) 0 (0%) 9 (45%) 2 (10%) 3 (15%) 
Cause of pain (20). 9 (45%) 1 (5%) 0 (0%) 4 (20%) 1 (5%) 5 (25%) 
Type of pain (16). 8 (50%) 1 (6.25%) 1 (6.25%) 4 (25%) 1 (6.25%) 1 (6.25%) 
Timing & duration of 
pain (20). 
11 (55%) 1 (5%) 0 (0%) 5 (25%) 1 (5%) 2 (10%) 
Use & effectiveness of 
analgesia (20). 
9 (45%) 4 (20%) 0 (0%) 4 (20%) 1 (5%) 2 (10%) 
Advice regarding pain 
management (12). 
5 (42%) 0 (0%) 0 (0%) 2 (16%) 0 (0%) 5 (42%) 
Comfort of the 
dressing (12). 
2 (17%) 0 (0%) 0 (0%) 6 (50%) 1 (8%) 3 (25%) 
Discomfort: dressing 
procedure (12). 
7 (58%) 0 (0%) 0 (0%) 2 (17%) 2 (17%) 1 (8%) 
Total (132) 55 (42%) 9 (7%) 1 (1%) 36 (27%) 9 (7%) 22 (16%) 
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5.2.3.2.2  Exudate and odour. 
Two items within the checklist related to exudate and odour which provided 40 total opportunities for 
assessment of which 28 were highlighted as important to participants.  Of these 28 occasions to 
address known exudate and odour issues, the items were not raised (score of 0) on 9 occasions 
(32%); the cue was overlooked (score of 1) on 1 (4%) occasion and the theme was acknowledged 
but not explored further (score of 2) on 1 (4%) of the 28 occasions possible. The theme was 
discussed (score of 3) on 5 occasions (18%); partially dealt with (score of 4) on 1 occasion (4%) and 
fully dealt with (score of 5) on 11 occasions (38%). These scores are displayed in table 19 below.  
 
 
Table 19 – Overall scores for exudate and odour. 
 
 
Issue (total 
number of 
potential 
occurrences 
of each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Exudate & 
odour (28) 
9 (32%) 1 (4%) 1 (4%) 5 (18%) 1 (4%) 11 (38%) 
 
 
5.2.3.2.3  Emotional effects. 
A number of items within the checklist related to the emotional effects of ulceration and included 
depression, fears and concerns, self-image, fear of people’s reactions, isolation and the fear of ulcer 
recurrence. These six subthemes provided 120 opportunities to assess this subtheme which were 
highlighted to be significant to participants on 28 occasions. Of the 28 occasions to address known 
emotional effects, the items were not raised (score of 0) on 16 occasions (56%); the cue was 
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overlooked (score of 1) on 2 (7%) of occasions and the theme was acknowledged but not explored 
further (score of 2) on 1 (4%) of the 28 occasions possible. The theme was discussed (score of 3) on 
8 occasions (29%) and fully dealt with (score of 5) on 1 of the occasions possible (4%). These 
scores are displayed in table 20 below.  
 
Table 20 – Scores for emotional effects theme.
 
 
Issue (total 
number of 
potential 
occurrences 
of each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Emotional 
effects (28) 
16 (56%) 2 (7%) 1 (4%) 8 (29%) 0 (0%) 1 (4%) 
 
 
Each of the subthemes were also analysed individually and table 21 below shows the overall scores 
for each of the subthemes in the emotional effects category. 
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Table 21: Scores for emotional effects subthemes. 
 
 
Issue (total number 
of potential 
occurrences of 
each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Depression (8). 4 (50%) 0 (0%) 0 (0%) 3 (38%) 0 (0%) 1 (12%) 
Fears and 
concerns (4). 
2 (50%) 0 (0%) 0 (0%) 2 (50%) 0 (0%) 0 (0%) 
Self-image (4). 4 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Fear of people’s 
reactions (4) 
2 (50%) 0 (0%) 1 (25%) 1 (25%) 0 (0%) 0 (0%) 
Isolation (4) 3 (75%) 1 (25%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Fear of recurrence 
(4) 
1 (25%) 1 (25%) 0 (0%) 2 (50%) 0 (0%) 0 (0%) 
Total (28) 16 (56%) 2 (7%) 1 (4%) 8 (29%) 0 (0%) 1 (4%) 
 
5.2.3.3  Theme 2: Wound management results. 
A number of items within the checklist related to wound management included an update on the 
wound, nurse advice and patient knowledge and understanding of their dressings. These items 
provided a total of 80 opportunities overall of which 32 were deemed to be important by phase 1 
participants. Of these 32 occasions to address wound management issues, the items were not 
raised (score of 0) on 3 occasions (9%) and acknowledged but not explored further (score of 2) on 1 
(3%) of occasions. A score of 1 was not attributed to this theme. The theme was discussed (score of 
3) on 4 occasions (13%); partially dealt with (score of 4) on 4 occasions (13%) and fully dealt with 
(score of 5) on 15 occasions (47%). These scores are displayed in table 22 below. 
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Table 22 – Scores for wound management issues.  
 
 
Issue (total 
number of 
potential 
occurrences of 
each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Wound 
management 
(32) 
3 (9%) 0 (0%) 1 (3%) 9 (28%) 4 (13%) 15 (47%) 
 
The subthemes of the wound update, advice from the nurse and patient knowledge were also 
analysed individually and table 23 below shows the overall scores for each of the subthemes in the 
wound management category. 
 
 
Table 23: Scores for wound management subthemes. 
 
 
Issue (total number 
of potential 
occurrences of 
each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Wound update (4) 1 (25%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (75%) 
Advice from the 
nurse (20). 
1 (5%) 0 (0%) 0 (0%) 6 (30%) 3 (15%) 10 (50%) 
Patient knowledge 
(8).  
1 (12.5%) 0 (0%) 1 (12.5%) 3 (37.5%) 1 (12.5%) 2 (25%) 
Total (32) 3 (9%) 0 (0%) 1 (3%) 9 (28%) 4 (13%) 15 (47%) 
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5.2.3.4  Effects on daily life.  
Items related to the effect of ulceration on daily life included work and leisure; sleep; personal 
hygiene; mobility; choices of clothes and shoes; impact on work and the impact on relationships. 
These seven items provided a total of 140 opportunities to be evaluated of which 84 were deemed to 
be important by phase 1 participants. Of these 84 occasions to address known themes items were 
not raised (score of 0) on 32 occasions (38%); the cue was overlooked (score of 1) on 8 (10%) of 
occasions and the theme acknowledged but not explored further (score of 3) on 1 (1%) of the 
occasions possible. The theme was discussed (score of 3) on 33 occasions (39%); partially dealt 
with (score of 4) on 3 occasions (4%) and fully dealt with (score of 5) on 7 occasions (8%). These 
scores are displayed in table 24 below.  
 
Table 24 – Scores for effects on daily life.  
 
Issue (total 
number of 
potential 
occurrences of 
each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Effects on 
daily life (84) 
32 (38%) 8 (10%) 1 (1%) 33 (39%) 3 (4%) 7 (8%) 
 
 
The subthemes were also analysed individually and are displayed in table 25 below. 
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Table 25: Scores for effects on daily life subthemes. 
 
 
Issue (total 
number of 
potential 
occurrences of 
each issue) 
 
Not raised 
(score = 0) 
Cue not 
identified 
(score = 1) 
Cue 
blocked 
(score = 2) 
Discussed 
(score = 3) 
Partially 
dealt with 
(score = 4) 
Fully dealt 
with  
(score = 5) 
Work & leisure 
(8) 
1 (12.5%) 2 (25%) 0 (0%) 5 (62.5%) 0 (0%) 0 (0%) 
Mobility (12) 2 (17%) 3 (25%) 0 (0%) 6 (50%) 0 (0%) 1 (8%) 
Hygiene (12) 2 (17%) 1 (8%) 1 (8%) 2 (17%) 1 (8%) 5 (42%) 
Legs washed? 
(8) 
7 (87.5%) 0 (0%) 0 (0%) 1 (12.5%) 0 (0%) 0 (0%) 
Clothes & 
shoes (16). 
4 (25%) 1 (6.25%) 0 (0%) 10 (62.5%) 1 (6.25%) 0 (0%) 
Sleep (16) 14 (87.5%) 0 (0%) 0 (0%) 1 (6.25%) 1 (6.25%) 0 (0%) 
Relationships 
(12). 
2 (17%) 1 (8%) 0 (0%) 8 (67%) 0 (0%) 1 (8%) 
Total (84) 32 (38%) 8 (10%) 1 (1%) 33 (39%) 3 (4%) 7 (8%) 
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5.3   Phase 2 discussion 
Phase 1 clearly established the profound effect of CVLUs across all areas of the daily lives of the 
participants. Where these issues were emphasised as being important to participants during their 
interviews, they were highlighted and specifically observed in terms of the frequency and depth to 
which they were disclosed and addressed during the phase 2 observations.  
 
5.3.1  Discussion of results in theme category. 
5.3.1.1  Symptoms. 
Table 10 (page 148) provided a summary of the interview findings for the theme of symptoms. As 
demonstrated in the phase 1 analysis, patient symptoms dominated the interviews but were 
subsequently infrequently disclosed during the observed consultations (table 16; page 174).  
 
Despite pain dominating all of the interviews, patients seemed to be reluctant to raise this topic with 
the consulting nurse and, complete solutions with the provision of an effective pain management 
strategy were only achieved on 22 (16%) of occasions. The patient did not raise the issue during 
their consultation on 55 (42%) occasions, despite having highlighted its importance during their 
interview. On 10 (8%) occasions the nurse either overlooked or intentionally ‘blocked’ the topic, thus 
preventing any further exploration or the delivery of any advice to alleviate this symptom, which is a 
concern. These findings echo studies where pain has similarly been overlooked or ineffectually 
managed (Walshe, 1995; Rich & McLachlan, 2003). Indeed, Tornvall and Wilhelmson’s (2010) 
review of satisfaction with the care for CVLU patients specifically raised their overall dissatisfaction 
with the management of their pain (page 11).  
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Exudate and odour were managed more effectively than pain issues during observed consultations 
but this could have been attributed to the overt nature of this symptom which would have removed 
the need for the patient to raise the issue and the opportunity for the nurse to overlook it. These 
issues were not raised on 9 (32%) occasions however, a complete solution was offered on 11 (38%) 
of occasions. Generally in the literature, exudate and odour were not managed well with participants 
experiencing regular episodes of leakage and the reports of embarrassing odours (Walshe, 1995; 
Bland, 1996; Hopkins, 2004; Byrne & Kelly, 2010). Ineffectual management of exudate and odour 
may be as a result of a knowledge deficit on the part of the consulting nurse or may be due to a lack 
of effective products to manage this distressing symptom; both areas requiring further investment 
and research.   
 
Where patient concerns focussed on the emotional effects of ulceration, these were raised even less 
frequently on only 16 (56%) occasions and a complete solution was only offered on 1 (4%) occasion. 
This demonstrates a heightened reluctance by patients to raise issues relating to their psychological 
status with their nurses which may be due to the range of issues raised in Bugge et al’s (2006) study 
(page 32) and supported by other studies (Henderson, 2003). Further research would be useful to 
ascertain the reasons for such non-disclosure. 
 
5.3.1.2  Wound Management. 
Table 11 (page 151) provided a summary of the interview findings in the theme of wound 
management which was an area that patients raised more frequently than others. Only on 3 (9%) 
occasions did the patient fail to raise an issue which had been emphasised at interview; when it was 
raised, on 1 (3%) occasion the nurse blocked a cue, on 9 (28%) occasions there was some 
discussion, a partial solution was offered on 4 (13%) and a complete solution was offered on 15 
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(47%) occasions. These results demonstrate that the nurses provided wound care updates, advice 
and updated patient knowledge, at least at the level of discussion, on 28 (88%) of occasions; by far 
the best result of all of the themes and highlighting wound management as an area where both 
patients and nurses felt comfortable both disclosing and discussing issues. 
 
5.3.1.3  Effects on daily life. 
Table 12 (page 154) provided a summary of the interview findings in the theme of effects on daily 
life, however during the observations, the impact on daily life was only completely dealt with on 8% 
of occasions and patients failed to raise known issues on 32 (38%) occasions. When reviewed by 
subthemes, hygiene issues were most effectively addressed during the consultations being fully 
tackled on 5 (42%) occasions. Patients raised themes but most often a discussion of the issues 
ensued on 33 (39%) occasions with nurses failing to actually offer effective solutions. 
 
5.3.2 Discussion 
The findings of this phase overall demonstrate a reluctance by the patient participants to raise the 
issues during their wound care consultation that directly impacted on their daily lives, despite such 
issues being disclosed without prompting during their earlier interviews. Indeed, of the 304 
opportunities overall to disclose these known issues, they were not disclosed on 115 (38%) of 
occasions and when issues were raised, a complete solution was provided in only a minority of 
cases (18%), with discussion being the most common action of the consulting nurse on 91 (30%) of 
the possible 304 occasions. 
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A similar lack of patient disclosure was alluded to in Bugge et al’s (2006) study who postulated a 
number of reasons for this which included an unsuitable environment, a non-receptive HCP or the 
patient not feeling that the information was relevant. Other studies have also alluded to similar issues 
(Henderson, 2003; Pendleton, 2003; Swenson et al, 2004; Thorne, 2005). Such factors may have 
been apparent during the phase 2 observations but this cannot be quantified; further research where 
the patient was also interviewed following the observation would be useful to triangulate such results.  
 
Where known issues were raised across all themes and subthemes, a discussion most often ensued 
(30% of occasions) and only on a minority of occasions was a partial (6% of occasions) or complete 
solution offered (18% of occasions). This result is important and may indicate a reluctance of 
consulting nurses to move the consultation to a stage where they problem solve, preferring to simply 
engage in discussion; as such this is an area worthy of further research. Such a response may be 
due to organisational matters and time constraints but this lack of a patient focus to consultations 
requires further investigation (Henderson, 2003; Bugge et al, 2006). 
 
 
As discussed in chapter 2 (page 23 - 37), the clinical consultation is the central focus of PCC 
(Dieppe et al, 2002) with its effectiveness relying not only on the consulting skills of the HCP, 
although these are important (EPOC, 2008), but also on the willingness of the patient to disclose 
their concerns. Phase 2 has demonstrated an overall reluctance for disclosure on the part of the 
patient (38% of occasions). Stewart (2004), in her research into the clinical consultation, proposed a 
mechanism as to how the consultation could be utilised to improve health outcomes largely through 
its impact on patient behaviour (figure 13 overleaf).  
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Figure 13: The effects of patient centred care (Stewart, 2004). 
 
 
The combination of PCC and shared decision making (SDM), when applied, serve to facilitate a 
greater level of agreement between the patient and HCP and, as a result, the potential for increased 
concordance with an agreed management plan (page 10). Ideally, such increased concordance 
would result in enhanced behaviour change, improved health outcomes and an increased likelihood 
of improvements in patients’ functional status, self-care and satisfaction (Ekman et al, 2011).  
Although Stewart’s (2004) hypothesis appears to be relatively straightforward, evidence from a 
number of earlier studies outlined in chapter 2 (page 23 - 49) demonstrated that HCPs continue to 
fail to elicit patient concerns or share decision making within the consultation (Ley et al, 1976; Griffin 
et al, 2004; Wong & van der Worst, 2010). This reluctance may be due to inadequacies on the part 
of the HCP, but are also hampered by a lack of disclosure by the patient during their consultation 
(Bugge et al, 2006).  
 
Phase 2 has explored patient disclosure, which has been aided by utilising the same study 
participants across the two phases; an innovative design that has facilitated previously highlighted 
factors, known to be impacting on daily lives, to be monitored. Disclosure by the patient of their 
concerns is of similar importance to the abilities of the HCP in ensuring that the consultation is 
effective but if the patient, for whatever reason, does not share their concerns with the HCP, 
opportunities for PCC and SDM are thus severely limited (Bugge et al, 2006). As demonstrated, 
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during the phase 2 observations, the patient participants did not raise 38% of their concerns within 
the consultation and of the 62% that were raised, 8% were either missed or ignored by nurse 
participants, 30% were discussed but not managed leaving 24% that were at least partially managed 
(table 16; page 174).  
 
Wound management concerns were more likely to be acknowledged, with 60% being partially or 
completely managed, whilst emotional effects of the ulcer were the least likely to be acknowledged, 
with only 4% being managed effectively. On many occasions themes were discussed, most often 
without solutions being suggested (30% of occasions). Thus only 24% of patients’ concerns, overall, 
were addressed to some degree during the consultation. For every concern not picked up by the 
nurse (38% of occasions) the patient did not raise their concerns on a further 38% of occasions. 
 
If the results of phase 2 are developed into a figure based on Stewart’s (2004) earlier consultation 
hypothesis, where optimised PCC and SDM within the consultation could result in changed patient 
behaviour and improved patient health outcomes, the effects of this non-disclosure by the patient is 
demonstrated (figure 14 below). 
 
Figure14: Phase 2 results flow chart.  
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These results echo those of Stewart et al’s (1979) study of GP consultations where 54% of patient 
problems were not elicited or acted upon during the consultation, discussed on page 27, although 
Stewart et al’s (1979) study failed to identify the proportion of concerns that the patient failed to 
disclose. Phase 2 of this study has enabled this data to be unpicked to reveal that patients failed to 
raise 38% of their concerns during their consultations. Since the effectiveness of the consultation 
relies on the SDM behaviour of both the patient and the practitioner (LeBlanc et al, 2009), successful 
interventions require enhancement of patient disclosure as well as improved clinician training.  
 
Patient-practitioner communication has long been a subject of research (McKenzie, 2002) with 
barriers to effective communication being attributed to the mentioned ‘asymmetry of the physician-
patient relationship’ (p. 32) (Jordan, 1997). Work to date has tended to focus on practitioner 
developments (Langewitz et al, 1998; Légare et al, 2009; Lewin et al, 2009) with minimal attention 
paid as to why the patient may not express their concerns (Bugge et al, 2006). This second phase 
serves to quantify these facets that for every issue disclosed by a patient and not dealt with by a 
nurse (38%), another issue was not disclosed by the patient (38%). The focus of research into 
patient-practitioner communication in the future needs to be widened to include the patient and their 
role in the consultation. Unless patients are enabled to articulate their concerns, many will remain 
unacknowledged and, therefore unmanaged, thus urgent future work is needed to determine how 
HCPs can more effectively enable their patients to share their concerns, so that together they can be 
addressed and health outcomes subsequently improved. This provides the rationale for the 
remaining phases of the study. 
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5.3.2.1   Strengths and weaknesses of phase 2. 
5.3.2.1.1 Strengths. 
Each of the 20 observations in phase 2 was undertaken by the same researcher, a consistency 
which may have served to reduce the observer effect (page 164). With repeated observations and a 
single researcher, the participants had an opportunity to become accustomed to the same person 
observing on a number of occasions. Double blind peer review also confirmed the rigour of phase 2, 
prior to publication (Green et al, 2013b).  
 
The development and application of the consultation checklist during the observations enhanced the 
rigour and subsequent data collection, as this formed a pre-determined schedule (Pretzlik, 1994). 
The checklist proved to be simple, quick to apply and to provide the facility to provide summary 
numeric results from a large amount of data (Abeyasekera & Lason-McDowall, 2000; page 165). The 
scoring tool, adapted from earlier research by Henbest and Stewart (1989) again added to the 
robustness of the item assessment. 
 
The inclusion of the same sample for phase 1 and 2 was an innovative design, which facilitated the 
assessment of known issues in phase 2. Such a design would be useful in similar studies, especially 
with the addition of phases to triangulate the results. 
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5.3.2.1.2 Weaknesses. 
As with phase 1 (page 93 – 158), despite the repeated nature of the observations which enabled the 
patient and nurse participants to adjust to the presence of the observer, the observer still has an 
effect on the data collected, although the degree of this influence is unknown (Lincoln & Guba, 
1985). 
 
This phase demonstrated that patient participants failed to disclose known items of importance 
during their wound care consultations but the reasons for this were not ascertained during the study 
and highlight a future research need.  
 
5.3.2.2  Contribution to new knowledge.  
This novel phase of research has provided a number of elements of new knowledge. 
 When themes were reviewed overall, nurses had a discussion with their patient (30% of 
cases) more often than moving the consultation to offer a partial or complete problem 
solving approach (23%). 
 Despite pain being overwhelming for the patient participants, this was not disclosed to the 
consulting nurse on 42% of the possible occasions. 
 The data produced from phase 2 serves to define the data from Stewart et al’s (1979) study 
where 54% of patient problems were not elicited or acted upon. In phase 2, 38% were not 
disclosed, 8% were overlooked and a discussion ensued on 30% of opportunities (page 
174). 
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5.3.2.3  Further research. 
As a result of phase 2, there are a number of areas that would benefit from further research. 
Exploring the reasons that result in the lack of patient disclosure would be informative and may well 
enhance developments to improve the patient centredness of future consultations. Also, exploring 
why nurse participants demonstrated a reluctance to move to either partial or complete problem 
solving, preferring to simply discuss issues with the patient, may provide a basis to improve future 
training in relation to consultation skills. 
  
5.4  Summary 
The discussion of the phase 2 findings has established that many of the issues which were of known 
importance to participants were often not raised during the consultation and, when raised, were often 
inadequately addressed. In view of this and to support the development of an appropriate PCC 
based intervention a literature review of potential nurse-led interventions was undertaken, in order to 
assist in the development of the new consultation template. 
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Chapter 6: Literature review of patient centred interventions. 
 
 
This chapter provides a review of the literature that explores the effectiveness of nurse-led 
interventions to enhance the patient centredness of consultations. This review was undertaken to 
inform the design of the final phase of the research project which involved the development and pilot 
of a consultation template to enhance the patient focus of wound care consultations. 
 
6.1.  Introduction. 
As explored in chapter 2 (page 23 - 34), PCC represents a move from purely seeing patient care in 
terms of disease or pathology towards thinking of the patient and their problems and is recognised 
as a measure of the quality of health care (Ballint, 1955; Henbest & Stewart, 1989; WHO, 2005; 
Lewin et al, 2009; Timmins & Astin, 2009). This involves the patient, as a person, being central to the 
consultation and includes SDM between the patient and HCP regarding the patient’s health problems 
(Lewin, 2009). 
 
In chapter 2 the approaches to enhance PCC were discussed (page 23 - 34). A number of studies 
have explored either HCP training, interventions to enhance patient activation in order to improve 
PCC or a combination of these approaches (Lewin et al, 2009; Fischer & Ereaut, 2011) which have 
demonstrated an impact on patient satisfaction and the quality of care. However, there is minimal 
evidence of a consistent improvement in patient outcomes due to enhanced patient centredness 
(Henbest & Stewart, 1989; McLean, & Armstrong, 2004). 
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6.2  Aim. 
The aim of this review was to explore nurse-led interventions within primary care consultations that 
aimed to enhance patient centredness, with effectiveness evaluated in terms of an improvement in 
patient outcomes.  
 
6.3  Research question. 
In order to generate the question for this review, the PICOs approach (Richardson et al, 1995; 
detailed on page 6) was applied. In this case, in order to develop a question that could be answered 
by the review, the acronym stood for:  
 the population (P): adult patients within primary care; 
 the intervention (I): nurse led interventions to enhance PCC; 
 the comparison (C): defined by the study; 
 the outcome (O): patient outcomes, again defined by the study; 
 the study (s): any study design. 
 
As a result the following review question was developed: 
Does a nurse-led intervention to improve patient centredness within a primary care 
consultation improve patient outcomes? 
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6.4  Methods. 
A systematic search of articles was undertaken using the Health Databases Advanced Search 
(HDAS) engine to facilitate access to a range of bibliographic databases, which were each searched 
individually as specified in chapter 3 (page 53).  
 
6.4.1  Literature databases. 
A range of resources were accessed in order to undertake this review including MEDLINE, AMED, 
BNI, CINAHL, Health Business Elite, HMIC (NHS), PsycINFO, the Cochrane Collaboration database 
and EMBASE (1991-2012). Further detail of these databases was provided in chapter 3 (page 53). 
As with the initial review, additional studies were identified via Google Scholar, reference list, author 
and citation searching and the hand searching of relevant journals.  
 
 
6.4.2   Article inclusion criteria. 
In order for a study to be selected for review a range of criteria was applied (table 26 overleaf). Only 
study participants over the age of 18 years were included, since the care for those prior to 18 years 
often has a family focus, which may make the interventions of less relevance to an adult population. 
Only studies undertaken within primary care were selected, as face to face consultations between a 
patient and their HCP are most often undertaken within this environment. This review specifically has 
a nursing focus, thus only reviews where nursing participants were involved were suitable for 
inclusion; studies were still included if nurses were involved in addition to other HCPs. Face to face 
interventions between the patient and their HCP were included where the outcome was patient 
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rather than solely HCP focused. Again, only articles available in English were sourced due to funding 
constraints and no date restrictions imposed. 
 
Table 26: Criteria for inclusion in the review: 
 
 
Inclusion Criteria. 
 
Available in English 
Adult patients. 
Primary care. 
Nursing based intervention. 
Face to face interventions. 
Focus on improving patient outcomes. 
 
6.4.3  Article exclusion criteria. 
Studies were excluded (table 27 below) if the participants were 17 years of age or under, were based 
within secondary care, outpatient departments or within residential care; or if there was no nursing 
involvement in the study. Telephone and Internet interventions were also excluded as the study 
focus was on the actual face to face consultation rather than more ‘distant’ interventions.  
 
Table 27: Criteria for exclusion in the review: 
 
 
Exclusion Criteria. 
 
Paediatric patients. 
Secondary, Out Patient Dept. & Residential care. 
No nursing involvement.  
Telephone & internet interventions. 
No patient outcome evaluation. 
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6.4.4  Search strategy. 
This systematic search accessed eight databases individually, the Cochrane Collection and Google 
Scholar and are detailed in appendix 12. In order to focus on the area of choice a series of 
comprehensive search terms were systematically applied (table 28 below).  
 
Table 28: Search terms applied for this PCC review. 
1 consult* 
2 intervent* 
3 1 AND 2 
4 patient centre* 
5 3 AND 4 
6 nurs* 
7 5 AND 6. 
 
 
6.4.5  Screening, selection and quality assessment of articles. 
As with the first review of literature, title, abstract and full text were assessed against the eligibility 
criteria by the researcher, with duplicates and unsuitable articles being removed at this point. 
Independent assessment of the rejected articles was undertaken by an educational supervisor to 
verify the decisions made. The researcher and educational supervisor independently reviewed the 
remaining studies and consensus was reached for final inclusion. 
 
 
6.5   PCC search results. 
The search overall resulted in a total of 108 articles. Following removal of duplicates, 94 articles 
remained. Of these, on review of the title and abstract, 43 were deemed to be unsuitable which left 
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51 for full text review. The researcher and an educational supervisor independently reviewed the full 
text articles which resulted in the exclusion of 44 articles and the retention of four research studies 
within seven articles being retained for full synthesis. This process is demonstrated in a flow diagram 
(figure 15).  
 
 
Figure 15: Stages of article selection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 records identified through 
database searching. 
35 additional records identified 
through other sources. 
108 records identified. 
94 records remaining after duplicates removed. 
94 records screened on basis 
of title & abstract. 
43 records 
excluded  
as not relevant. 
51 full text articles assessed 
for eligibility. 
44 full text articles 
excluded: 
Review: 8 
Not in primary care: 10 
No nurse involvement:13 
Protocols: 4 
No intervention:  6 
No patient outcomes: 2 
Not face to face: 1 
 
 
 
4 studies included in review. 
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6.5.1   Data extraction. 
For each study, data was extracted and summarised on data extraction sheets (table 30 below) by 
the researcher and reviewed by an educational supervisor for accuracy. The information of interest 
included the author, year and location of the study; study design; participant characteristics; outcome 
measures and results. In addition a note was made of any limitations, whether the appropriate ethical 
approval was recorded and the quality score (QS) (Hawker et al, 2002). 
 
6.5.2  Quality assessment. 
Studies were again assessed for quality using the comprehensive tool applied in chapter 3 (page 70) 
(Hawker et al, 2002). Nine areas of each study were assessed with scoring range between 90 -360. 
Full details of the assessment are detailed in appendix 13 but the studies included in the review 
ranged, using the Hawker et al (2002) scale (detailed on page 61), from none of very poor or poor 
quality, three of fair quality and one of good quality and are displayed alphabetically in table 29 
below. 
 
Table 29: Quality appraisal scores for the PCC review. 
 
Author & year (alphabetical order) Total Score (Range: 90-360) 
Holmstrom et al (2004) 220 (F) 
Kinmonth et al (1998) 300 (G) 
Ogden & Hoppe (1997)  250 (F) 
Pill et al (1998) 250 (F) 
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Table 30: Data extraction chart for the PCC review (4 studies). 
 
Author, year & 
location 
Design of study Participant 
characteristics 
Outcome measures  Results Limitations & ethical 
approval. 
Holmstrom, 
Larsson, 
Lindberg & 
Rosenqvist 
(2004) Sweden 
Mixed method study to 
investigate whether an 
intervention focussed on HCP’s 
understanding of the diabetes-
patient encounter could improve 
PCC. Interviews, videos of 
consultations & patient 
comments. Videos of 18 
encounters reviewed by HCP & 
patients. 
Purposeful 4 HCPs (2 
GPs & 2 Diabetes 
Nurses). 18 patients. 
Type 2 diabetes. 
 
 
 
Verona-MICS/Dr analysis of video 
recordings. Categories dichotomised for 
PCC or doctor-centred. Assessed 
whether consultations were prescriptive 
(medical facts), reflective (patients’ 
experiences) or combined model. 
Patient comment 4 categories: 
1.satisfied & reached new 
understanding; 2. satisfied; 3. neutral & 
4. non-satisfied. 
Overall PCC of consultations did not 
improve (2 better/2 worse). Reflection for 
all 4 staff improved & use of patient-
involving transitions. New patient 
understanding occurred only in reflective 
encounters. Patients felt combined 
consultations were good enough but 
reflective model explores & influences 
patient understanding. Consultation skills 
of practitioner changed as early as the 2nd 
consultation. 
 
Small scale study. HCPs 
were a selected sample who 
wanted to develop way of 
encountering patients which 
may have caused bias. 
Ethical approval was gained. 
Consent of participants is 
mentioned. 
QS: 220 
Kinmonth, 
Woodcock, 
Griffin, Spiegal, 
Campbell 
(1998) UK 
A pragmatic parallel group study 
with randomisation between 
practice teams to assess the 
effect of additional training of PNs 
& GPs in PCC on lifestyle & 
physiological status with new 
Type 2 diabetes patients. 
Additional training for HCPs of 1.5 
days introducing evidence for & 
skills of PCC & patient held 
booklet encouraging questions. 
All new Type 2 
diabetic patients 
between 30-70 years 
over 12 months were 
recruited [250 
patients] in 41 
practices (21 
intervention / 20 
comparator). 
Self-report by patients on satisfaction & 
communication of practitioners. QoL, 
wellbeing, HbA1C, lipids, Bp, BMI. 
Analysis at 1 year. Baseline & 12 
months. 
Patients in intervention group reported 
better communication with HCPs, greater 
treatment satisfaction & well-being. BMI 
was slightly higher & lipids & knowledge 
scores were lower. Lifestyle & glycaemic 
scores unchanged. First study to show 
training in PCC can significantly improve 
communication, wellbeing & satisfaction 
amongst newly diagnosed diabetics. 
No improvement on 
hypothesised HCP and 
patient agreement on 
concerns, knowledge of 
diabetes & knowledge of 
care. Underpowered study. 
Ethical approval stated & 
consent. 
QS: 300 
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Author, year & 
location 
Design of study Participant 
characteristics 
Outcome measures  Results Limitations & ethical 
approval. 
Ogden & 
Hoppe (1997) 
UK. 
RCT to investigate impact of 2 
styles of educational package on 
PNs management of obesity. PNs  
allocated to 3 groups – learner 
centred (leaflet & seminar), expert 
(leaflet) & control. At 1 month, 
PNs gave 5 patients a 
questionnaire re. content & type 
of consultation. At 6 months, PN 
& patients sent questionnaire 
about consultation style & weight 
loss respectively. 
240 PNs in total – 80 
to each of 3 groups. 
179 patient 
questionnaires 
returned at 1 month; 
35 retuned after 6 
months.  
Leaflet to 2 groups 
and learner centred 
seminar for 1 of those 
group. 
Responders & non-responders 
compared over 6 months. Data 
collection from questionnaires at 
baseline, 1 month & 6 months. 
No change in PN beliefs about obesity. 
Learner group spent longer on the 
consultation & were more PC. Their 
patients rated themselves as more 
satisfied & were offered calorie controlled 
diets less often. PNs in the expert group 
reported giving weight loss advice more 
often & being less PCC. Their patients 
were more confident about weight loss 
but felt more likely to be offered 
traditional interventions. No effects on 
weight. 
Long questionnaire initially 
reduced FU questionnaire 
response rate. Attendance at 
seminar was poor. Ethical 
approval not mentioned. 
QS: 250 
Pill, Stott, 
Rollnick & Rees 
(1998) UK 
RCT with before & after design 
for measures of patient outcome 
to evaluate the effect of training in 
a PCC intervention for GPs & 
PNs on patient outcomes in 
Type2 diabetes. Experimental 
group: training at surgery to 
improve patient participation – at 
least 2 3hr sessions plus on-
going support. 
 
 
29 practices recruited 
[15 experimental [190 
[1] - 165 [2] patients 
with NIDDM over 6 
months.  
Glycosated haemoglobin, patient 
satisfaction, SF36 & professional ability. 
Start & 18 months. Audiotaped 
consultations at 9 months after training. 
Limited change in biochemical or 
functional improvements. More 
improvement in control group satisfaction 
than experimental. Control group 
improved in physical functioning. Failed 
to find significant clinical improvements in 
experimental group. Competence in 
intervention was minimal after 9 months.  
2 year study only 19% 
applying method at 2 years 
despite enthusiastic start. All 
practices self-selected & 
committed to improve diabetic 
care. Change was not 
sustained. Ethical approval 
included. 
QS: 250 
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6.6  Overview of PCC studies for final review. 
6.6.1  Characteristics of the studies. 
One mixed method study and three quantitative studies, published between 1997 and 2004 were 
retained for inclusion in this review. These studies accessed 809 patients in total and 230 primary 
care practices in the UK and Sweden. Three explored consultation based interventions within Type 2 
diabetes care and the other the care of patients requiring weight loss advice. Study sample sizes 
ranged from 4 - 240 HCPs and between 18 - 250 patients. Studies were heterogeneous and used 
complex, multifaceted interventions and a range of outcome measures.  
 
 
6.6.2  Results from the mixed method study. 
Holmstrom et al (2004) applied a mixed methods approach with 4 HCPS and 18 patient participants 
to investigate whether an intervention to enhance the HCPs management of consultations with 
diabetic patients would facilitate enhanced patient centredness in future encounters. Four HCPs, two 
GPs and two Practice Nurses (PNs), were purposefully recruited for the 12 month intervention. The 
study included interviews, videos of patient-practitioner encounters and patient comments relating to 
that encounter. Videos of consultations were analysed using the Verona Medical Interview 
Classification System (VR-MICS) using 22 mutually exclusive categories that were classified as 
patient-centred or doctor-centred.  
 
Assessment of the approach to the consultation was recorded, whether prescriptive, reflective or 
combined. A prescriptive consultation was based on medical facts; reflective on the patients’ life 
experiences and combined, the combination of both approaches was used. Patients’ comments 
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following the consultation were also reviewed in terms of whether they had received the help they 
required, whether they understood their illness and treatment with a range of responses from 
satisfied with new understanding; satisfied, neutral or non-satisfied. The results indicated a 
significant increase in two of the ‘patient-centred’ outcomes, facilitations and reassurance, over the 
study period but, whilst two HCPs changed their educational model, the approach of the remaining 
two HCPs was unchanged. Staff were reported to reflect on their practice and patient encounters, 
however the results were limited. Patients who had experienced the ‘reflective’ type of encounter 
with their HCP were the only participants to cite new understanding whereas difficulties in changing 
established consultation patterns for even willing HCPs were highlighted. The patient participants 
expressed high levels of satisfaction with the consultation but this seemed to reflect low expectations 
rather than the quality of the ‘improved’ consultation, although this was a small-scale study that 
involved a total of 18 patient participants. 
 
6.6.3  Results from the quantitative studies. 
Three studies, published between 1997 and 1998, adopted randomised approaches to evaluate 
changes in patient outcomes as a result of enhanced consultations. These studies were 
heterogeneous and applied a variety of interventions and a range of patient outcome measures. Two 
studies related to the care of patients with Type 2 diabetes in general practice (Kinmonth et al, 1998 
Pill et al, 1998) and one (Ogden & Hoppe, 1997), the management of the obese patient in relation to 
weight loss advice, again in general practice.  The diabetes studies involved interventions to both the 
GP and the PN consultation techniques whereas the obesity study solely manipulated the PN 
approach. 
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Kinmonth et al (1998) adopted a pragmatic parallel RCT with 41 practices of which 21 undertook the 
intervention, routine care with additional training on PCC including active listening, negotiation and 
eliciting behavioural change and 20 practices delivered routine care. Over the 12 month recruitment 
period, 250 people with newly diagnosed diabetes were recruited to the study with outcomes 
recorded at baseline and one year; to include a range of clinical and lifestyle data, patient rating of 
HCP communication, satisfaction with treatment and style of care, agreement with the HCP on their 
main concerns over the last 12 months and an evaluation of patient knowledge. For the intervention 
group, the study demonstrated improved communication between patient and HCP, greater 
satisfaction with treatment and improved well-being but also raised body mass index (BMI), raised 
triglycerides and lower knowledge scores. Other outcomes were not deemed to be significant. The 
study concluded that the intervention had resulted in greater attention to the consultation by the HCP 
but, as a result, preventative care no longer received the same level of attention, which may have 
resulted in the reported changes to BMI, and knowledge of their condition. This PCC intervention 
appeared to have positive outcomes, but such a focus should ideally not be at the expense of 
accurate disease management (Kinmonth et al, 1998). 
 
Pill et al (1998) similarly adopted an RCT approach at practice level with a before and after design 
for their three year study. In total 29 practices were recruited with 190 patients completing the first 
questionnaire (165 completed the second). Each practice was required to recruit 12 patients with 
established Type 2 diabetes over a six month period. The intervention practices received training for 
HCPs to encourage active patient participation including encouraging the patient to voice their 
concerns and to set targets; whilst the control practices delivered routine care. Patient data was 
collected by a blinded evaluation team at baseline and after 18 months to include physical measures, 
the SF 36 and validated diabetic specific measures to record well-being and satisfaction with 
treatment (Pill et al, 1998).  
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Results from Pill et al’s (1998) study demonstrated improved patient satisfaction with their recent 
consultations and the treatment they had received in the intervention arm of the study, although 
these outcomes also improved for the control arm over the period of the study. The study revealed 
that, despite enthusiasm from the HCPs involved in the study, after two years only 19% continued to 
apply the PCC approach systematically which is a concern since all practices involved already 
demonstrated an enhanced interest in diabetes care prior to recruitment to the study. 
 
Finally, Ogden and Hoppe (1997) undertook an RCT to investigate the impact of two styles of 
educational package on the management of obesity by PNs. The consented PNs were allocated 
randomly to three groups; the learner centred, who provided a leaflet but also underwent a learner 
centred seminar; the expert group, who provided a leaflet for the patient in addition to routine care 
and the control group who provided routine care. After a month, the PNs gave questionnaires to their 
five patients; this questionnaire related to the content and type of consultation that they had 
experienced. In addition, after 6 months, both the PN and the patients completed questionnaires 
about consultation style and weight loss respectively (Ogden & Hoppe, 1997).  
 
The study (Ogden & Hoppe, 1997) demonstrated that there was no change in PN beliefs about 
obesity, however the PNs allocated to the learner centred group provided longer consultations and 
were more PC; their patients rated themselves as more satisfied and reflected that they were simply 
offered calorie controlled diets less often. PNs in the expert group, providing a leaflet only, reported 
giving weight loss advice more often and being less PC in their consultation; their patients were 
confident about weight loss but felt that they were more likely to be offered traditional interventions. 
The study demonstrated no effects on weight overall. Ogden and Hoppe’s (1997) concluded that 
both PN and patient behaviour and the style of consultation could be altered by either training or 
access to educational resources. 
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6.7  Amalgamation of the study findings. 
All studies reflected some positive patient outcomes as a result of manipulation of the consultation. 
The improved outcomes tended to relate to the satisfaction of the patient participant with their 
consultation and the approach to their disease management, rather than any direct improvement in 
the actual management of their condition. Both Pill et al (1998) and Holmstrom et al (2004) reflected 
on the difficulties associated with changing the consultation behaviour of HCPs and, indeed, 
sustaining such change for the HCPs involved, despite their prior enthusiasm for that area of disease 
management (Pill et al, 1998). Results are summarised in table 31 below. 
 
Table 31: Summary of results from PCC studies. 
 
Author & year. Results  
Ogden & Hoppe (1997) - No change in PN beliefs about obesity.  
- Learner group spent longer on the consultation & 
were more PC, patients were more satisfied & were 
offered calorie controlled diets less often. 
- PNs in the expert group reported giving weight loss 
advice more often & being less PCC.  
Kinmonth et al (1998) - Patients in intervention group reported better 
communication with HCPs, greater treatment 
satisfaction & well-being.  
- First study to show training in PCC can significantly 
improve communication, wellbeing & satisfaction 
amongst newly diagnosed diabetics. 
Pill et al (1998) - More improvement in control group with satisfaction 
& physical functioning.  
- Failed to find significant clinical improvements in 
experimental group.  
- Compliance with intervention was minimal after 9 
months. 
 
Holmstrom et al (2004) - Overall PCC of consultations did not improve - 2 
better/2 worse. Staff reflected on improvements with 
involvement of the patient.  
- New patient understanding occurred only in reflective 
encounters.  
- Consultation skills of practitioner changed as early as 
the 2nd consultation. 
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6.8  Discussion. 
Despite a systematic search to evaluate nurse-led interventions that aimed to enhance the PC of 
consultations, a paucity of such studies was available, with only four studies retained for inclusion in 
the review. Three studies were relatively dated and were reported on between 1997-1998 and 
despite the final study being published in 2004, data was collected between 1997-1998. There were 
no more recent studies that fitted the criteria, which itself highlights a need for further and more up to 
date research in this area. All studies implemented a relatively robust randomised approach but 
some adopted extremely complex interventions that unduly lengthened the consultation beyond a 
sustainable level (Holmstrom et al, 2004); even to the point that HCP participants’ understanding of 
the study diminished over time (Pill et al, 1998). 
 
Enhanced satisfaction with the intervention consultation was revealed across all four studies, which 
demonstrates that a PCC approach improves patient experience. The ability to sustain such 
changes, even when the HCPs had a particular interest in the area of disease management, was 
demonstrated to be poor (Pill et al, 1998) but this could have reflected the complexity of the study 
design rather than the dedication of the HCPs. There was a comparable lack of change in physical 
outcomes across the studies as a result of the interventions described and an actual deterioration in 
knowledge and biomedical indices demonstrated by Kinmonth et al (2004), which may have been 
attributed to a shift of focus to PCC at the expense of disease management. 
 
6.9  Strengths and limitations. 
6.9.1  Strengths 
The strength of this review is the application of a replicable search strategy and the peer review 
process for study selection. As in chapter 3 (page 61), the application of the quality scoring tool 
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(Hawker et al, 2002) and the use of the CASP (CASP, 2010) approach to the critical appraisal of 
each article has enhanced the robustness of the review. 
 
6.9.2  Limitations.  
As with the review documented in chapter 3 (page 55), studies not available in English were 
excluded from the study, as there was no funding available for translation. Studies undertaken with 
participants under the age of 17 years were excluded which may have limited the breadth of the 
search, but since these generally demonstrated a family centred approach any relevancy with an 
adult population is uncertain. 
 
6.10  Conclusions and research implications. 
This chapter has presented a review of nurse-led interventions which aimed to enhance the PC of 
consultations in primary care, and to evaluate the effect on patient focused outcomes. Simplicity of 
the intervention appears to have been the key to its sustainability over the duration of the study and 
subsequent satisfaction of the patient with their consultation and treatment, the principal outcome 
measure to be improved by such interventions. These findings have directed and influenced the 
design of the consultation-based intervention, to enhance the patient focus in CVLU care. The 
simplicity of the tool, the duration of the study and the application of patient satisfaction as a primary 
outcome measure were all implemented as a result.  
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Chapter 7: Development of the consultation template. 
 
 
Chapter 7 presents provides detail of the underlying methodological decisions, the methods used, 
the procedure undertaken (7.1) and the template produced (results) (7.2), followed by a discussion of 
the process and output in the light of the research reviewed (7.3). 
  
7.1  The nominal group. 
The nominal group stage of this mixed methods study was designed to answer the following 
research question: 
 
Can expert and patient consensus create a model consultation template for patients with 
chronic venous leg ulceration? 
 
7.1.1  Nominal group design and methodology. 
Qualitative methods of enquiry were applied to facilitate the development of the new consultation 
template to focus wound care consultations on patient concern. Phase 1 (page 93 - 158) and 2 (page 
159 - 193) of the study established that CVLUs impact on every area of patient functioning however 
the participants appeared reluctant to disclose these issues during their subsequent consultations 
with their DN. Following consideration of other methods with which to effectively construct the 
planned consultation template, such as the Delphi technique or a traditional focus group, the nominal 
group technique (NGT) was selected.  
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The advantage of the NGT is the requirement for a single, face-to-face meeting of approximately two 
hours thus providing a cost effective and efficient method and minimal preparation by group 
participants (Carney et al, 1996; Vella et al, 2000; Potter et al, 2004). In addition, the NGT has the 
potential to facilitate both qualitative and quantitative data since items for inclusion in the meeting are 
prioritised during group discussion (Carney et al, 1996). The structured nature of the meeting 
minimises researcher bias as they take the role of facilitator rather than leader and ensures that 
members efficiently generate ideas (Potter et al, 2004). Immediate feedback is provided to group 
members by the researcher and, due to its democratic style, problems due to dominant group 
members, who may distort group functioning are minimised (Carney et al, 1996; Vella et al, 2000; 
Potter et al, 2004). Studies that have applied the technique have demonstrated that it effectively 
provides views representative of the wider community from which group members are drawn, despite 
the actual group itself being relatively small (Vella et al, 2000; Lancaster et al, 2002; Kadam et al, 
2006). The structured approach of the meeting comprises five clear stages (Carney et al, 1996) 
(figure16).  
 
Figure 16: Nominal Group stages (Carney et al, 1996). 
 
Introductory 
phase 
Generation of 
ideas 
Sharing of 
ideas 
Open 
discussion 
Prioritisation / 
voting 
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7.1.2.  Sampling framework for the nominal group. 
The acceptable range of participants for a NG ranges from five and nine participants to include a 
combination of nurse and patient participants (Potter et al, 2004). Participants were drawn from the 
two North Staffordshire PCTs, as with phase 1 and 2, and were purposively sampled to ensure the 
relevancy and validity of the subsequent template (Bowling & Ebrahim, 2005; Denscombe, 2007).  In 
order to ensure the quality of the template, it was felt that nurse participants should be experienced 
in the care of patients with leg ulceration or knowledgeable about the development of such 
consultation templates. Patient participants involved in phase 1 and 2 were approached to be 
involved. The following inclusion and exclusion criteria for nurse and patient participants were 
applied. 
 
7.1.2.1  Inclusion and exclusion criteria. 
Nurse participants: 
Inclusion criteria for nurse participants: 
 The nurse was registered with the Nursing and Midwifery Council. 
 The nurse was experienced in the care of patients with CVLU OR was experienced in the 
development of tools to enhance the PC of the consultation. 
 The nurse was willing to take part in the study. 
Exclusion criteria for nurse participants: 
 Unqualified staff. 
 Those who withhold consent. 
Patient participants: 
Inclusion criteria for patient participants: 
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 The patient had previously been involved in phase 1 and 2 of the study. 
 
7.1.3  Nominal group study procedure. 
As with phase 1 and 2 of the study, this phase was undertaken across the two local PCTs. Nurse 
managers were asked to nominate potential nurse participants for the NG based on their knowledge 
and experience in Tissue Viability. Once potential members were nominated, they were contacted 
directly to discuss the requirements of the NG, including a brief overview of the process and provided 
with written study information (appendix 15). Once participant consent forms were received, a venue, 
date and time for the NG was arranged in an easily accessible area with free parking; major 
considerations for the nurse participants who were allowed, by their managers, to attend within their 
scheduled working day. The patient participants consented to be part of the study but requested that 
their opportunity to comment on the template was after the ‘experts’ had developed the template 
during the NG. Despite this not being an ideal situation, in order to respect their views, this was 
arranged and further communication with group members was undertaken by email. 
 
7.1.4  Nominal group data collection. 
Prior to the meeting a small amount of pre-reading was circulated to prepare members for the topic 
and ensure prompt engagement in the meeting. The actual meeting started with an opening 
statement by the group facilitator, which summarised and described the task to be undertaken during 
the meeting and outlines the expected contribution from the group members and the NG process, 
summarising how the output or results will be utilised. The stages of the meeting were outlined and 
group ‘ground rules’ established and agreed (Carney et al, 1996); this ‘housekeeping’ section of the 
meeting settles group members and ensures all are aware of their role (Vella et al, 2000).  
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Following the introductory phase, ten minutes were allocated for the ‘silent generation of ideas’; 
providing group members with time to focus their thoughts on the task ahead. When members had 
collected their thoughts on the topic, each participant was provided with an opportunity to share their 
ideas in turn which were recorded by the scribe on a flipchart, providing a record of the ideas and 
comments generated (Vella et al, 2000). Each participant, individually and without interruption, has 
the opportunity to contribute their ideas to encourage participation, even from quieter group 
members. The systematic recording of ideas serves to de-personalise contributions, making ideas 
‘group’ rather than the individual ideas (Carney et al, 1996).  
 
Once all members had a chance to contribute, there was an opportunity for open discussion and for 
the recorded ideas to be clarified.  To conclude the NG meeting, group members have an 
opportunity to prioritise or rate the ideas that have been generated. Participants ‘voted’ for item 
inclusion in order to achieve this prioritisation, which provided some quantitative data (Carney et al, 
1996). The meeting concluded when no new ideas were generated, which indicates that data 
saturation was achieved (Basch, 1987; Krueger, 1994).  
 
7.1.5  Nominal group data analysis. 
The NGT represents a consensus technique, where all members discuss, debate, compromise but 
ultimately agree about the work undertaken within the timespan of the meeting (Vella et al, 2000). 
The output of the NG meeting, in this case, was the new consultation template, based on the phase 
1 and 2 findings. Both nurse and patient participants agreed items for inclusion in the template, using 
a voting technique. During the nominal group, the scribe made notes of the proceedings and the 
discussions that were undertaken (appendix 16) and, in addition, key concepts for inclusion were 
recorded on a flip chart. Notes were recorded on the prioritisation of factors for inclusion in the 
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template, thus ensuring the rigour of the process. Any further changes were communicated with all 
members via email for their agreement. Records of these emails were retained, again to ensure the 
integrity of the process. 
 
7.1.6  Ethical considerations for the nominal group. 
As discussed in chapter 4 (page 106), the ethical principles governing this research project were 
stringently adhered to and were informed by the guide to consent (DH, 2001b) and mental capacity 
guidance (DH, 2007). Ethical approval had been gained for phases 1 and 2 of the study (page 106). 
At the time of the original submission to LREC detail of the design of the study beyond the initial two 
phases was not finalised and the application merely stated that:  
'The model consultation template, once developed, will be verified by experts in the field of 
tissue viability to ensure content validity' (A13, p.18, Ethical approval: 10/H1203/13).  
As the study progressed and the NG phase was finalised, a minor amendment to the original LREC 
application was submitted detailing the formal NG design to develop the consultation template at the 
end of phase 2. After due consideration of the application and the accompanying documentation, 
LREC granted permission to proceed (LREC No: 10/H1203/13; AM01; appendix 14 & 15). 
 
Informed consent was sought from both nurse and patient participants for the NG and all potential 
participants were provided with a copy of their appropriate ‘study pack’ including the requirements of 
participant involvement in the study, arrangements for assuring the anonymity and confidentiality of 
information and withdrawal from the study, should this be necessary. For the nurse and patient 
participants completion of the consent forms evidenced their agreement to attend the NG for no 
more than 2 hours and undertake a small amount of pre-reading. Once consent was received, this 
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was reaffirmed at the start of the NG and in all correspondence or meetings; thus providing ample 
opportunity for consent to be withdrawn if any of the participants so desired. 
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7.2  Nominal group results. 
7.2.1  Introduction. 
Five nurse and three patient participants consented to take part in the NG. The patient participants 
were all previously involved in phase 1 and 2. Three specialist nurses, two representing Tissue 
Viability (TVNs), an academic nurse who was experienced in research surrounding the efficacy of 
nurse consultations and two experienced community nurses consented to be involved in the NG. The 
facilitator (the researcher) and a scribe made up the NG meeting membership (table 32 below). 
Three patients also provided review of the template during the development stages during one to 
one meetings with the researcher, details are provided in table 33 overleaf. 
 
Table 32: The nominal group nurse members. 
 
Background. Gender Experience 
1 Tissue Viability Specialist Nurse F 12 years 
2 Tissue Viability Specialist from industry. F 10 years 
3 Academic specialist in consultation design. F 20 years 
4 District Nursing Sister. F 25 years 
5 District Nursing Sister. F 20 years 
6 Scribe. F Student Nurse (Yr 3) 
7 Facilitator.  F 25 years  
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Table 33: Patient nominal group participants. 
Name          Gender Duration of ulceration 
1 Tom           M  10 years 
2 Mary                      F  30 years 
3 Sam           M  40 years 
 
7.2.2  General group discussion. 
On completion of the NG and once all members had made their suggestions and no new ideas were 
being generated, the charted ideas were discussed by the group as a whole, including individually 
with the patient participants, and were recorded in the meeting minutes (appendix 15). Some initial 
decisions regarding template layout were made at the start of the discussion period with all members 
agreeing that the template needed to be brief and should be printed back to back on a single A4 
sheet. It was felt that this length would facilitate speedy completion and avoid undue lengthening of 
the duration of the wound care visits. Group members also agreed on the inclusion of some brief 
explanatory guidance to ensure that the nurses completing the template would include appropriate 
topics in their discussions with their patients. This section would be constructed in question order for 
ease of use (figure 17). 
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Figure 17: Assessment guidance (excerpt from the template). 
 
 
 
 
In order to facilitate speedy completion of the template and to avoid lengthening consultation time, 
members suggested that ‘yes / no’ tick boxes in response to the questions posed and additional 
space for any relevant comments accompanied by a larger ‘comments and problem solving’ section, 
included at the end of the template (figure 18). 
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Figure 18: Comments and problem solving section (excerpt from the template). 
  
 
 
The wording for this section was carefully selected in order to encourage the consulting nurse to 
undertake a problem solving approach in preference to simply discussing the issues raised. This 
summary box would provide nurses on subsequent visits with a quick overview of any changes, 
topics raised and interventions implemented.  
 
Members agreed that a signature, where possible, from both the patient and the consulting nurse on 
completion of the form would potentially promote ‘ownership’ of the areas discussed and the actions 
agreed. It was accepted that for some patients this might not be possible. Self-completion prior to a 
DN visit by the patient and their carer was also discussed and felt to be something that could be 
encouraged by the DNs. 
 
Further discussion in the NG was organised under the four theme headings from phase 1 and 2; the 
ulcer, symptoms, wound management and effects on daily life, thus providing a link between the 
phases and template development. The decision for statements or questions to be included was 
made by members ‘voting’, using a simple show of hands.  
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7.2.2.1  The Ulcer. 
In order for the template to be concise and relatively quick to complete during time-limited wound 
care consultations, the theme of the ulcer was not included in the final template. It was felt by group 
members to represent an opportunity for patients to reflect on their ulcer history but not something 
that needed to be recorded or necessarily explored during every consultation. New detail or relevant 
comments would be recorded in the comments and problem solving section if necessary. 
 
7.2.2.2  Symptoms. 
As discussed (page 116-124), during the phase 1 interviews all participants reported a range of 
debilitating symptoms as a result of their ulceration. These included pain, exudate and odour and 
emotional effects of their ulceration.  
 
Pain was a priority for all patient participants in phase 1 and was deemed an essential inclusion in 
the new template by NG members. There was some debate on the need for the inclusion of a pain 
scale within the template, but it was agreed that this was not necessary since it was included within 
the current nurse assessment documentation. All members agreed that, rather than merely gaining a 
pain score, it was actually important to ascertain the trend of the patients’ pain, whether this was 
improving or deteriorating, in order for the nurse to take any necessary action.   
 
The use and effectiveness of analgesia was again felt to be important and an area that required 
specific assessment and action. It was agreed that this should include a note of current medication 
and an opportunity for the nurse to indicate the effectiveness of the current regime. The comments 
box was included to allow alternate suggestions to be recorded and a record made of any advice 
given (figure 19 overleaf). 
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Figure 19: Pain and analgesia (excerpt from the template). 
 
 
 
Group members unanimously agreed that the subthemes of exudate and odour should be included 
in the template. It was felt that by including a ‘yes / no’ tick box for whether the patient’s legs were 
wet and a comments section for whether odour was present would encourage the consulting nurse 
to apply their problem solving skills in this area. The exudate and odour section is demonstrated in 
Figure 20. 
 
Figure 20: Exudate and odour (excerpt from the template). 
 
 
 
Phase 1 of the study revealed that there were many emotional effects of leg ulceration that impacted 
on patients’ quality of life. All NG members agreed that psychological and social factors needed to be 
given a high priority within the template, especially since these issues were frequently overlooked 
during consultations. It was felt to be appropriate to ask whether the ulceration resulted in low mood 
and the following question was approved for inclusion: Do your ulcers get you down? Followed by 
the question: How are you feeling today? A ‘yes / no’ tick box and a comments section, aimed to 
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allow the nurse to record any discussions or recommendations made, followed these two questions 
(figure 21). 
 
Figure 21: The emotional impact (excerpt from the template). 
 
 
 
7.2.2.3   Wound management. 
All members of the NG group were keen to avoid duplication of information that was also required 
elsewhere, thus ensuring that the resulting template was not a burden to the consulting nurse. Since 
there is a requirement that the details of the physical care provided to patients be recorded in detail 
in the patient’s notes, with a carbon copy removed to place in the patients’ clinic notes; it was felt to 
be important that this information was not duplicated. In view of this, a brief wound management 
section was developed to include alongside the earlier mentioned exudate and odour question. This 
allowed the nurse to complete brief notes to document advice and treatment given, a record of the 
dressing applied and finally, a note that the patient has been made aware of their wound care and 
management plan (figure 22).  
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Figure 22: Wound management (excerpt from the template). 
 
 
 
 
7.2.2.4  Effects on daily life. 
Many of the phase 1 participants had reflected on their inability to get out and about as a result of 
their ulceration and reflected on the impact that this had on their lives. All NG members supported 
the inclusion of a question relating to this, along with a comparison to what the patient could achieve 
prior to their ulceration; thus providing the consulting nurse with an overall impression of any 
deterioration in function in this area (figure 23). 
 
Figure 23: Ability to get out and about (excerpt from the template). 
  
 
 
The group also decided that a question relating to the dietary intake, although this was not cited in 
the phase 1 findings, of the patient was important as this may reveal areas where the nurse could 
potentially organise additional support, advice or further interventions. The question: Are you eating 
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a normal diet? If not, why? was agreed for inclusion with a ‘yes / no’ tick box and a short comments 
section to detail what this may include (figure 24). 
  
Figure 24: Diet (excerpt from the template). 
  
 
 
Mobility and the limitations imposed both by the presence of ulcers and the dressings applied were 
felt to be important and were included at the start of the template. Mobility was seen by all NG 
members as a defining symptom and often an issue that limited the patient’s ability to engage with 
daily activities as they once did. As a result, the template started with the question: Are you able to 
mobilise as you did prior to having an ulcer? Again, a ‘yes / no’ tick box and a short comments 
section were included. This was then followed by the question relating to the patient’s ability to get 
out and socialise (figure 25).  
 
Figure 25: Mobility (excerpt from the template)- 
 
 
 
Maintenance of personal hygiene was agreed as being an important area to include in the template. 
For many of the study participants, hygiene posed complex problems, as many were unable to wash 
due to their ulcer, their bandages or both. It was recognised by NG members that a number of new 
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aids and adaptations were available to make bathing / showering achievable so a question was 
included: Are you managing to shower or bathe? With a ‘yes / no’ tick box and a comments section 
(figure 26).  
 
Figure 26: Hygiene (excerpt from the template). 
 
 
 
Participants reflected on their limited choices of both clothes and shoes during their interviews. It was 
felt by all NG members that this was an area to be addressed by the consulting nurse. Again, the 
group agreed that there was a need to establish whether this had become an issue since having an 
ulcer so the question: ‘Are you able to wear the clothes and shoes that you did prior to having an 
ulcer?’ was included along with a ‘yes / no’ tick box and a comments section. 
 
It was acknowledged that many patients modified previous clothing and shoes to fit over their 
bandages, etc. so all agreed to include a longer comments section and the questions:  If not, what 
are you wearing? Is this suitable? It was felt that nurses would then be able to record what was being 
used and any advice that had been given (figure 27). 
 
Figure 27: Clothes and shoes (excerpt from the template). 
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Sleep was an issue for many during the phase 1 interviews and was unanimously supported by the 
NG members for inclusion in the template. It was suggested that the location for sleeping was also 
an important issue. Two questions were included relating to sleeping. The first: ‘Where are you 
sleeping?’ with tick boxes for bed and chair and a short comments section; followed by: ‘Do you 
sleep well? If not, what stops you from sleeping?’ followed by a ‘yes / no’ tick box and a comments 
section (figure 28). 
 
Figure 28: Sleep (excerpt from the template). 
  
 
 
Relationships were seen to reflect the level of social support received by the patient and all NG 
members felt that it was important for the consulting nurse to explore this area. The following 
question was included in the template: ‘Do you have friends or family members who support you?’ 
followed by a comments box (figure 29).  
 
 
Figure 29: Relationships (excerpt from the template). 
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7.2.3  Final editorial considerations. 
For ease of application, NG members decided that themes and subthemes should be grouped 
together with similar items, thus allowing the nurse to explore similar areas at the same time. This 
led to the following groupings: (i) mobility, ability to get out and to socialise; (ii) sleep, diet and pain; 
(iii) personal hygiene and issues with clothes and shoes; (iv) emotional effects of ulceration, 
relationships and fears; (v) documentation of care provided, exudate and odour, type of dressings 
and information given to the patient. This arrangement reflects the activities of daily living expounded 
by Roper, Logan and Tierney (2000).  
 
At the end of the NG consensus had been reached about the themes and subthemes to be included 
in the template.  On completion of the meeting and a review of the meeting notes, a draft template 
was developed and circulated by email to the NG members. Brief comments were received from NG 
members regarding any typographical errors and the need for order changes. These were amended, 
version numbers changed and the template re-circulated for additional comments. 
 
7.2.4  Patient comments. 
Once there were no further comments from the nurse NG members, version 3 of the template was 
taken to three of the patient participants from phases 1 and 2 of the study (Tom, Mary and Sam). 
These pre-arranged visits, for which the patients had consented, provided an opportunity for them to 
individually comment on the new template.   
 
Tom suggested having a run through of the template with him as if it was being applied during a 
consultation. As a result of this process amendments were made to the wording of four of the 
questions to make them more easily understood. Also as a result of these comments, the 
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comments/problem solving section was increased in size. Mary also made some supportive 
suggestions for these alterations.  
 
Following the above amendments, a visit was made to Sam where it was confirmed that these 
simple wording adaptations were effective and made the template much easier to understand. Sam 
felt that the template did focus on relevant issues but made no further suggestions for further 
amendments. Finally, following the patient review, version 4 of the template was circulated to all NG 
members for final approval. Agreement was received from all members and the template was 
deemed ready for submission to the ethics committee in preparation to be piloted in phase 3 
(template in full in appendix 17). 
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7.3  The development of the consultation template: discussion. 
The NGT represents a novel research method which aims to achieve consensus between members, 
HCPs and patients in this case, and is often used to bring about change to policy or to develop 
educational interventions (Vella et al, 2000). Unfortunately all three patient participants, whilst 
wanting to be involved in the template development, refused to attend the formal NG group which 
would have provided an opportunity to integrate their comments and communicate with other group 
members. Patient participants revealed that they would be unlikely to contribute effectively at such a 
meeting due to the presence of ‘experts’ at the meeting; which further reflects that the HCP-patient 
relationship is not necessarily one of equals (Beck, 1997; Henderson, 2003; page 27). This lack of a 
cohesive NG limited the formation of the template.  
 
The new consultations template, with its focus on a range of issues that cross physical, social and 
psychological functioning, would encourage the adoption of a more holistic approach to wound care 
(Beresford, 2010), more effective communication (Ley, 1988; page 26) and aims to equalise power 
within the HCP-patient relationship (Hewison, 1995). Many of the personal characteristics presented 
in chapter 2 (page 39 - 48) attempt to explain why patients are willing to relinquish the control of their 
wound to their consulting nurse and do not appear to cope with the threat it poses (Rotter, 1954; 
Antonovsky, 1987); almost simply accepting their condition (Seligman, 1975). The intention for this 
template was to encourage the consulting nurse to activate the patient to engage in their care 
(Stewart et al, 2000), to make sense of their condition (Antonovsky, 1987; Lazarus, 1993) and to 
build a concordant relationship with their HCP (Rotter, 1954; Seligman, 1975; Morden et al, 2012). 
 
Research surrounding PCC, although scarce, purports positive benefits for the patient including 
optimised participation in care, enhanced satisfaction and improvements in QoL (Mead & Bower, 
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2000; Stewart et al, 2000; Stewart, 2001; de Haes, 2006). HCPs are shown to benefit from PCC as 
well (Thorne, 2005; Brown et al, 2006). The effectiveness of the new consultation template would 
therefore be evaluated in terms of its impact on patient satisfaction and QoL, since both of these 
patient outcomes are said to be responsive to PCC interventions (Mead & Bowers, 2000; Stewart et 
al, 2000).    
 
7.3.1  Strengths and weaknesses. 
7.3.1.1  Strengths. 
The NG meeting encompassed a range of experts, experienced in both CVLU care and the 
development of consultation aids which served to ensure that the resultant template was robust and 
suitable for this client group. Such expert knowledge underpinned the design which was then verified 
by patient participants as explained on page 215. 
 
7.3.1.2  Weaknesses. 
As explained, the patient participants declined to attend the actual group, preferring to provide 
individual comments with the researcher (page 215). The lack of patient involvement in the actual 
NG was a weakness to this phase since providing comment from outside of the meeting, although 
such comments were conveyed to other members via email, this was not as effective. 
 
In retrospect, if a future NG was planned, the need for the researcher to retain some editorial control 
would be a factor that would require consideration. Prior to the meeting, a few sketched templates 
had been considered but the output from the NG was very different from anything that had previously 
been considered. Had something been developed that was really not fit for purpose, introducing 
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editorial change after the meeting was held may have been extremely challenging. Dominant group 
members are a threat to any meeting structure which is minimised by the NGT structure since all 
members have an opportunity to contribute but, despite this, where grades of staff are mixed some 
appeared reluctant to comment (Paulhus & Reid, 1991). 
 
7.3.2 Contribution to new knowledge. 
 A range of physical assessment tools for patients with CVLU are readily available (SIGN, 
2010) but this new consultation template represents the first template to focus in detail on 
known QoL issues that impact on the day-to-day functioning for patients with CVLU.  
 
7.3.3 Further research.  
This consultation template aims to focus the consulting nurse on issues that are known to impact on 
the daily lives of patients with CVLU. Manipulating practitioner behaviour in order to facilitate PCC is 
a known approach (Kinnersley et al, 2007; EPOC, 2008; O’Connor, 2009); alternatively, activating 
the patient to become more involved in the consultation and to disclose their concerns could be 
used. Use of the consultation template for self-completion by the patient prior to their consultation 
may prove to be beneficial and serve to activate the patient. 
 
7.4  Conclusion. 
In conclusion, the NG process resulted in a concise, easy to complete template that promptly directs 
the consulting nurse to potential QoL issues for the patient as a result of their CVLU. The template 
developed was attractive and included a range of nurse responses from tick boxes, to additional 
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comments. The final box that encouraged ‘comments and problem solving’, it was anticipated, would 
encourage the nurse to detail goals, developed jointly with the patient, for consideration at the next 
consultation. Patient comment and recommendations confirmed the suitability of the template in 
preparation for the pilot which is detailed in chapter 8. 
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Chapter 8: Phase 3. 
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Chapter 8: Phase 3. 
 
This chapter presents the pilot of the consultation template and provides an outline of the 
methodology and the methods adopted (8.1), the results (8.2) and, finally, a discussion of these 
findings in the light of current research (8.3). 
 
8.1   Phase 3. 
This final phase of the study comprises a pilot designed to answer the following research question: 
 
Is a future full randomised controlled trial (RCT) of the new model consultation template 
feasible (Phase 3)?  
 
A future full RCT, if feasible, would investigate the following hypotheses however, since pilot studies 
do not support such hypothesis testing (Leon et al, 2011), these have simply been used to guide the 
design of the phase 3 pilot. 
 
H1 Patients with chronic venous leg ulceration will demonstrate improvements in satisfaction 
with their care as a result of a patient centred consultation when compared to their usual 
consultation. 
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H0 Patients with chronic venous leg ulceration will not demonstrate improvements in satisfaction 
with their care as a result of a patient centred consultation when compared to their usual 
consultation. 
H1 Patients with chronic venous leg ulceration will demonstrate improvements in their quality of 
life as a result of a patient centred consultation when compared to their usual consultation. 
H0 Patients with chronic venous leg ulceration will not demonstrate improvements in their 
quality of life as a result of a patient centred consultation when compared to their usual 
consultation. 
 
8.1.1  Phase 3 design and methodology. 
RCTs are a rigorous quantitative method which explore the relationship between a treatment or 
intervention and an outcome (Denscombe, 2007). Such quantitative methods involve the application 
of statistical formulae, testing of hypotheses and enumeration of data and are often accompanied by 
complex randomisation procedures underpinned by a pre-specified, deductive approach which is 
theory driven (Meadows, 2003; Denscombe, 2007). Such approaches, to date, have formed the 
cornerstone of health research (Meadows, 2003). Large quantitative studies can be extremely costly 
and time consuming so, prior to their commencement, their viability needs to be ensured; a process 
most often achieved by a pilot or feasibility study (Lancaster et al, 2004; Thabane et al, 2010).  
 
The terms pilot study or feasibility study, Morin (2013) highlights, have often been applied 
interchangeably (Arian et al, 2010) but more recent distinctions have been made between what 
constitutes a pilot study and what falls under the remit of a ‘feasibility’ study (Lancaster et al, 2010; 
Arain et al, 2010).  The preferred definition is provided by NETSCC (2014) 
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(www.netscc.ac.uk/glossary) and is agreed by the National Institute of Health Research 
(www.nihr.ac.uk), developed to reduce the any current confusion between the two terms (Arain et al, 
2010). The NETSCC (2014) glossary outlines that feasibility studies are undertaken prior to a main 
study in order to establish parameters required in the design of the full study and to answer the 
question “Can this study be done?” whereas a pilot study is a miniature of a full study and tests 
whether components of the full study can work together focusing on “recruitment, randomisation, 
treatment, and follow-up assessments” (Arain et al, 2010; NETSCC, 2014). These distinctions 
demonstrate that well designed feasibility or pilot studies provide differing but vital information in the 
planning, design and justification of the definitive study (Polit et al, 2001; Lancaster et al, 2004; 
Thabane et al, 2010; Leon et al, 2011). For both approaches, the samples are not based on formal 
power calculations so subsequent analysis of data should be descriptive and findings treated as 
preliminary rather than conclusive (van Teijlingen et al, 2001; Lancaster et al, 2004; Altman & 
Simera, 2010).   
 
In order to establish the viability of a full scale study, it is essential that a feasibility or pilot study has 
clearly defined and appropriate aims. There are five a priori aims for this phase of the study, which is 
described here as a pilot study, however taking into account the NETSCC definitions (2014), the first 
four most closely meet the feasibility remit and the final one that of a pilot study (Arain et al, 2010; 
NETSCC, 2014): 
 
 To test the recruitment procedure and to confirm the recruitment rates for nurse and patient 
participants to the study; 
 To test the utility or usefulness of the consultation template for the patient and the nurse;  
 To determine the most appropriate measures to assess the primary and secondary 
outcomes for a future full study; 
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 To determine the feasibility of a future randomised controlled trial; 
 To provide an initial indication of effect size in order to inform a power calculation. 
 
 
Of similar importance are the criteria adopted to establish the success of such a study for which 
there are four potential recommendations on completion: that a future study should not proceed; that 
modifications are required; that the study may proceed with close monitoring or that the study can 
proceed unchanged (Thabane et al, 2010). Any of these outcomes are acceptable and indicate that 
the pilot / feasibility study has been successful potentially preventing an expensive but ineffective 
study from proceeding (Thabane et al, 2010).  
 
A feasibility study can adopt a variety of designs which may or may not reflect the proposed design 
of the future full study, however a pilot study should ideally mirror the full study design (Meadows, 
2003; Arian et al, 2010; NETSCC, 2014). For phase 3, however, following consideration of other 
potential designs such as a RCT, a within-subjects design was selected as most appropriate 
(Seltman, 2010). The main advantage of this design is that the sample size requirements are 
minimised with participants acting as both control and subject to the intervention (Seltman, 2010) 
(table 34 below). This approach facilitates the evaluation of outcomes for all participants at a number 
of time intervals in order to evaluate change over time and, as a result, unsystematic variance is 
minimised since subjects act as their own control and thus the power of the experiment is increased 
(Hicks, 2004; Field, 2006; Seltman, 2010).  
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Table 34: Within subject outcome measure intervals. 
 
SUBJECT 1 PRETEST 
Measurement 
(M) 1   
CONTROL 
(6 weeks) 
TEST M 2 TEMPLATE 
APPLIED (6 
weeks) 
TEST M 3 TEMPLATE 
APPLIED (6 
weeks) 
POST 
TEST M 4 
 
 
8.1.2  Phase 3 outcome measures. 
Following a review the literature surrounding PCC (chapter 2; page 23-37) and nurse-led 
consultation interventions (chapter 6; page 194-210) the outcomes to be explored within the pilot 
were defined. Patient satisfaction, an important indicator of the quality of care and responsive to 
PCC interventions, was selected as the primary outcome measure (Donabedian, 1980; Mead & 
Bower, 2000; Bowling, 2005; Moore & Cowman, 2009). The QoL of participants, useful in evaluating 
the impact of chronic illness, was selected as the secondary outcome measure (Walters et al, 1999; 
Fayers & Machin, 2000; Franks & Moffatt, 2001; Asadi-Lari et al, 2004; Charles, 2004; van Korlaar et 
al, 2004; Bowling, 2005).  
 
Over the 18 week study these patient outcomes were assessed at four intervals utilising a total of 
four instruments. A number of other instruments were considered but dismissed for a variety of 
reasons: some instruments were condition specific and were therefore not relevant to CVLU 
(Vileikyte et al, 2003); others related to secondary or intermediate care (Wilson et al, 2006); others 
were excessively long and would thus increase the burden on patients (Ware & Sherbourne, 1992) 
and, finally, the validity of others was not, as yet, established (Asadi-Lari et al; 2004). The tools that 
were ultimately selected to assess the primary and secondary outcome measures were: Poulton’s 
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(1996) adapted Consultation Satisfaction Questionnaire (CSQ); the Medical Short Form 12 (SF-12) 
(Ware et al, 1996), the EuroQol 5D (EQ 5D) (EuroQol Group, 1990) and the Cardiff Wound Impact 
Scale (CWIS) (Price and Harding, 2004). These tools required patient participants to complete 67 
questions on each of the four occasions and, whilst it was accepted that this would pose a 
considerable burden to participants, their inclusion served to highlight their suitability for a future full 
study.  
 
8.1.2.1  Consultation Satisfaction Questionnaire (CSQ) (Baker, 1990, 1993; Poulton, 
1996). 
The CSQ (Poulton, 1996) (appendix 18) is a patient satisfaction tool used extensively within primary 
care, originally to measure patient satisfaction with recent GP consultations (Baker, 1990), but 
subsequently modified by Poulton (1996) to optimise utility for nurse consultations. It was the 
modified version which was utilised in phase 3. The CSQ has 18 questions over four scales: general 
satisfaction (CSQ-GS), professional care (CSQ-PC), depth of relationship (CSQ-DR) and length of 
consultation (CSQ-PT). Individual scores and an overall score for each scale are calculated (0-100), 
with high scores indicating a positive rating. Answers take the form of a 5-point scale from strongly 
agree to strongly disagree with statements varied with positive and negative framing, in order to 
increase the validity of the instrument (Baker, 1990).  Reliability and validity have been extensively 
evaluated (Cronbach’s alpha=0.81; Poulton, 1996), test-retest reliability was 0.92 over 3 weeks 
(Baker and Whitfield, 1992) and sensitivity to changes of care delivery have been demonstrated 
(Baker, 1990).   
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8.1.2.2  Short Form 12 v2 (SF-12) (Ware et al, 1996). 
The SF-12 (Ware et al, 1996) (appendix 19) is a multi-purpose, generic, short survey developed in 
1994 as an efficient and cost effective alternative to the then widely used SF-36 (Ware & 
Sherbourne, 1992). The 12 items ask the respondent to reflect on their experience over the last four 
weeks (a one week version is also available), with the updated version 2, used here, including 
improved wording. Each response assesses physical and mental functioning with scores 
amalgamated to provide two scales: physical health composite score (PCS) and mental health 
composite score (MCS). These are computed using the 12 question scores between 0-100, with 100 
indicating the highest level of health. Reliability of the SF-12 is represented by a Cronbach’s alpha of 
0.87 for PCS-12 and 0.84 for MCS-12 scales, both indicating a good level of internal consistency (de 
Smedt et al, 2012). The SF-12 has assured validity and is simple and quick to complete whilst 
providing reliable data (Ware et al, 1996). 
 
8.1.2.3  EuroQol 5D 5L (EQ-5D) (EuroQol, 1990). 
The EQ-5D (EuroQol, 1990) (appendix 20) is a brief, reliable, generic measure of health status for 
both clinical and economic evaluation. The EQ-5D consists of a descriptive system where the 
respondent indicates their health status in five dimensions: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression and, in addition, a EQ visual analogue score (VAS) allows 
the respondent to self-rate their health ‘today’ on a vertical scale from ‘worst imaginable health state’ 
to ‘best imaginable health state’; representing a quantitative measure of health. The EQ-5D-5 level 
(5L) version was introduced in 2005 to reduce ceiling effects reported from the 3L version, with 
responses for each of the 5 dimensions increased to include; no problems, slight problems, some 
problems, severe problems and extreme problems. Scoring provides a descriptive profile of the 
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respondents’ health status using the single digit score for each of the 5 dimensions, with a total of 
3125 possible health states (EuroQol, 1990). The 5 digit ‘score’, in the future, will be converted to a 
country specific single index value once full data is available but currently a ‘crosswalk’ score, a 
response mapping undertaken by EQ-5D with the established general population EQ-5D-3L scores 
is available, thus linking the 3L and 5L scores (Euroqol, 2012) (EQ5D Crosswalk). In addition, the 
EQ-5D provides a single index value from the VAS score (EQ5D VAS). Reliability of the EQ-5D is 
demonstrated with an overall Cronbach’s alpha of 0.73, indicating an acceptable level of internal 
consistency (de Smedt et al, 2012). The EQ-5D also facilitates economic costing of interventions 
(Euroqol, 2012). 
 
8.1.2.4  Cardiff Wound Impact Schedule (CWIS) (Price and Harding, 2004). 
The CWIS (Price & Harding, 2004) (appendix 21) is a validated questionnaire designed to measure 
the impact of chronic wounds on the QoL of the patient. The questionnaire contains 28-items over 
three scales: physical symptoms and everyday living (12 items) (CWIS PS), social life (7 items) 
(CWIS SL) and well-being (7 items) (CWIS WB). Each item is scored on a 5-point scale with patients 
reflecting on their experiences over the past week. Both physical symptoms and social life require 
the patient to also reflect on how stressful the experiences have been. All scales are transformed 
onto a 0-100 scale, with high scores indicating a positive rating. Finally, respondents are asked to 
rate their QoL (0-10) (CWIS QoL) and their satisfaction with their QoL (0-10) using a visual analogue 
scale (CWIS Satis). Questionnaire development was based on focus groups and semi-structured 
interviews for item generation and reliability and validity are acceptable with a Cronbach’s alpha of 
0.75 across the three scales; test-retest reliability 0.9 over 5-7 days and sensitivity to changes as a 
result of healing were demonstrated (Price and Harding, 2004).  
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8.1.3  Phase 3 sampling framework. 
Pilot study findings, via their calculated effect size, inform a sample size calculation for the full study. 
Thus the size of the sample recruited to the pilot is also an important consideration to minimise bias 
and optimise the accuracy of the calculation (Ross-McGill et al, 2000; Lancaster et al, 2004; Leon et 
al, 2011). Browne (1995) and Lancaster at al (2004) recommend a pilot sample of 30 or more 
patients in order to accurately estimate the parameter; however, more recently Sim and Lewis (2011) 
have recommended sample sizes of at least 55 for a pilot. In view of this, the recruitment procedure 
for this pilot aimed to recruit between 30-55 patient participants and to achieve this it aimed to recruit 
two DN teams and suitable patients. The following inclusion criteria were applied for nurse and 
patient participants selection. 
 
8.1.3.1  Inclusion and exclusion criteria. 
Nurse participants: 
Inclusion criteria for nurse participants: 
 The teams’ staff has experience in the care of patients with CVLU. 
 The team has sufficient suitable patients on their caseload. 
 Staff were willing to take part in the study and to apply the consultation template. 
 The teams had not been involved in earlier phases of this study. 
Exclusion criteria for nurse participants: 
 Where the team were undergoing widespread staff changes.  
 Staff were unwilling to take part. 
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Patient participants: 
Inclusion criteria for patient participants: 
 The patient has leg ulceration of either venous or mixed aetiology (as diagnosed by Doppler 
Ankle Brachial Pressure Index (ABPI) ratio of between 0.5 – 1.2 and detailed history taking) 
(Vowden & Vowden, 2001). 
 Ulceration has been present for in excess of 6 weeks. 
 The patient was able to understand English. 
 Visiting posed no risk to the patient or researcher. 
 The patient was willing to take part in the study. 
 The patient had not been involved in earlier phases of this study. 
Exclusion criteria for patient participants: 
 The patient does not fit the above inclusion criteria. 
 The patient’s leg ulceration, outlined under the first point of the inclusion criteria, is of arterial 
aetiology (as diagnosed by Doppler Ankle Brachial Pressure Index (ABPI) ratio of between 
0.5 – 1.2 and detailed history taking) (Vowden & Vowden, 2001). 
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8.1.4  Phase 3 study procedure. 
The final phase of the study was undertaken across the same two areas as earlier phases but this 
had now merged to form one large Primary Care Trust (PCT).  The phase 3 timeline is depicted in 
figure 30 below. 
 
Figure 30: Phase 3 timeline. 
 
 
 
 
 
         -6 weeks                           zero                                     week 6                                week 12     
 
 
 
Managers were requested to suggest appropriate DN teams who provided regular care for CVLU 
patients and where staffing appeared to be stable for the duration of the study. It was also a 
requirement that staff had not been involved in earlier phases of this study, in order to avoid any bias 
that this could potentially introduce with participants aware of earlier study phases (Hicks, 2004). 
Once managers had nominated teams, the researcher made contact with the respective team leader 
to discuss study requirements and to provide a brief overview of the study. Arrangements were then 
M1 - Outcome measures 
(Patient satisfaction, 
CWIS & SF12) recorded 
at minus six weeks. 
M4 – All outcome 
measures 
recorded & 
template 
completion 
assessed. 
M3 – All outcome 
measures recorded 
& template 
completion 
assessed. 
M2 – All 
outcome 
measures 
recorded 
at zero. 
Staff trained to apply 
the template after M2 
measurements 
recorded. 
Template applied at patient visits from zero to 12 weeks.                 
Postal questionnaire distributed 
to staff designed to assess the 
practicalities of using the 
template [sent at week 12].  
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made to post out study packs, including a letter of introduction, a detailed consent form and 
comprehensive written information describing the study (appendix 23). Informed consent from nurse 
participants would be established prior to the study commencing.  
 
Between January 2012 and June 2012, as a result of a frequent contact with managers and team 
staff, a total of four DN teams had been put forward and fully consented to take part in phase 3; but 
the first two withdrew their consent due to staffing changes prior to the start of their involvement. 
Once study packs had been dispatched and consent received, the two remaining teams were ready 
to start phase 3. Each team distributed study packs (appendix 23) to the patients on their caseload 
who met the inclusion criteria (page 246) and, once consent from patient participants had been 
received, the pilot study commenced. Throughout the 18 week study, patient participants continued 
to attend their routine, scheduled wound care consultations with the nurse participants (see figure 
30; page 245). During the first 6 weeks care was unchanged and during this time the outcome 
measurement tools (page 242-245) were completed with the patient participants at the start of the 
study (baseline: M1) and after 6 weeks (M2). This provided 2 sets of scores at the start and end of 
the control period (M1 and M2) for which a mean was calculated providing one data point. Since 
these results were derived from the same participant, it was assumed that these would remain 
roughly similar during this period (Field, 2006). After the control period, the experimental period of 
the study commenced with the two DN teams trained to apply the new consultation template, which 
the nurse participants applied weekly during their routine wound care consultations with each of the 
patient participants. During this 12 week period, the outcome measures were again recorded every 
six weeks (M3 and M4).  
 
 249 
8.1.5  Phase 3 data collection. 
For this 18 week study, a six week control period of ‘normal’ care was followed by a 12 week period 
when the nurse participant applied the consultation template during each patient visit, thus optimising 
the response rate and ensuring a consistent approach to data collection (Pallant, 2007). At six 
weekly intervals patient participants, supported by the researcher, undertook the four outcome 
measurement tools (page 242-245). This provided four data collection points in total but since the 
control period reflected unchanged care, the first two scores were averaged to providing three data 
points overall. In addition, at the end of the study, a brief, basic questionnaire developed by the 
researcher and approved by the ethics committee (LREC 10/H1203/13) (appendix 27) was circulated 
to the DN team members allowing them an opportunity to provide anonymous feedback and to 
evaluate the utility of the consultation template. 
 
8.1.6  Phase 3 data analysis. 
Data analysis for the pilot focused on the five a priori aims detailed on page 238 and, although 
analysis was mainly descriptive (Lancaster et al, 2004; Thabane et al, 2010; Leon et al, 2011), a 
limited amount of additional a posteriori exploratory analysis was undertaken on the data collected 
(appendix 26). Extreme caution has been applied to the interpretation of such ad hoc data analysis, 
the results of which have simply been used to provide suggestions for future research design.  
 
Studies adopting a within subject design provide the researcher with ‘paired data’ which, when 
statistically analysed, in this case using the Statistical Package for the Social Sciences v. 19 (SPSS) 
(IBM, 2010), can indicate change in outcome measures over time. Since preliminary analyses of the 
data using the Shapiro-Wilk Test of Normality demonstrated violation of normality and since outcome 
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scales were ordinal, non-parametric testing was deemed to be most appropriate for this pilot (Hicks, 
2004; Pallant, 2007) (appendix 23). In view of this the Wilcoxon Signed Rank Test, a test specifically 
designed for such paired data, was applied. The Wilcoxon Test converts the scores at each of the 
time interval to ranks (Z) and compares them. From this Z value it is then possible to calculate an 
effect size, an objective and standardised measure of the magnitude of an observed effect, which 
can then be used to estimate the required sample for a future full study (Lancaster et al, 2004; 
Thabane et al, 2010; Leon et al, 2011). Here effect size is represented by the notation r (Pallant, 
2007) and the scale, an adaptation of Cohen’s d (Cohen, 1988), of 0 to 1; r=0.1 (small effect), r=0.3 
(medium effect) and r=0.5 (large effect) has been applied (Pallant, 2007). 
 
8.1.7  Ethical considerations in phase 3. 
As with phases 1 and 2 of the study, to ensure that the rights, safety, dignity and well-being of all 
research participants were maintained (Dimond, 2005), the principles expounded in the guide to 
consent (DH, 2001b) and guidance related to mental capacity (DH, 2007) were followed. Ethical 
approval was applied for and granted by the Local Research Ethics Committee (LREC 10/H1203/13) 
(appendix 21) and agreement to proceed was confirmed by the National Health Service (NHS) 
Research and Development (R&D) Department in March 2012 (appendix 22).  
 
Specific ethical considerations relating to phase 3 included the location of meetings between the 
patient participant and the researcher and both the quantity and repeated nature of the recording of 
the outcome measures for the patient participants. Both of these were explained in the patient 
information leaflets to ensure that potential participants were fully aware of the level of commitment 
required (Appendix 23) and consent was reaffirmed at the start of every meeting; thus providing 
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opportunity for withdrawal from the study if necessary. Patients were reassured that their care would 
continue unchanged should this occur. 
 
8.2  Phase 3 results. 
As stated, two DN teams consented to be involved in phase 3 of the study. These were described as 
L4 (Location 4) and L5 (Location 5) and each had quite different characteristics. L4 was a busy, 
modern clinic in an inner city area serving a number of GP practices with patient referral made by 
DNs if the patients were mobile and willing to attend. A single nurse, trained in wound care, provided 
the care with clinics delivered every day. Each appointment provided a 20-minute slot, with double 
slots booked by the patient when clinically indicated. Whereas L5 was a busy DN team providing 
domiciliary visits to ‘housebound’ patients and, in addition, conducted clinics daily between 2-3pm for 
more mobile patients. The team consisted of six registered nurses and a Health Care Support 
Worker (HCSW). Patient visits were allocated to staff each day, with each lasting for varying periods 
of time, depending both on clinical need and the staff involved. Patients were informed of the day 
and approximate time period of their next visit by their nurse. For those able, clinic appointments 
were available at the surgery, at clinics staffed by any nurse from the team.  
 
Following distribution of study packs to potential patient participants, nine patients were recruited 
across the two teams: L4 provided 5 patients (L4, P1 – 5) all of whom were mobile and physically 
able to attend clinic and L5 provided four patients (L5, P1-4), three seen during domiciliary visits and 
one attending clinic. Seven participants were male and the median age was 68 years (range of 34 to 
87 years) (table 35 below). Demographic details were recorded during the first meeting with the 
participant to provide an additional insight into sample characteristics. 
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Table 35: Phase 3 patient participant details. 
Participant 
pseudonym.  Age. Gender. 
Marital 
status. Residential status. 
Total 
duration of 
ulceration. 
Number 
of 
episodes. 
Eric (L4) 85 Male Widower 
Lives alone in a ground floor 
flat 
10 years 2-3 
Dave (L4) 54 Male Divorced 
Lives with son in terraced 
house. 
30 years over 5 
Peter (L4) 72 Male Single Lives alone in a house 10 years over 3 
Paul (L4) 34 Male Single 
Lives alone in a ground floor 
flat 
8 years 1 
Stuart(L4) 52 Male Single Lives alone in a house 30 years 1 
Mick (L5) 68 Male Single Lives alone in a house 10 years 1 
Elsie (L5) 87 Female Widow Lives alone in a house 14 years over 3 
Ian (L5) 72 Male Married Lives with wife in a house 2 years 1 
Cath (L5) 45 Female Married Lives with family in a house 5 years 1 
 
 
8.2.1  The control period. 
Scores recorded at M1 and M2 (control period) were averaged to provide a mean baseline score to 
reflect the control period for each participant for each of the outcome measures (appendix 26); thus 
providing a baseline score and to enable further analysis to take place (table 36 below). 
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Table 36: Mean baseline scores for all outcomes. 
 Consultation Satisfaction 
Questionnaire 
SF-12 EuroQoL 
5D 
Cardiff Wound Impact Schedule 
CSQ 
GS 
CSQ 
PC 
CSQ 
DR 
CSQ 
PT 
PCS MCS EQ5
D 
EQ 
VAS 
CWIS 
QoL 
CWIS 
Satis 
CWIS 
WB 
CWIS 
PS 
CWIS 
SL 
L4P1 95.84 97.5 100 100 34.65 53.14 0.53 70 6.5 7.5 53.57 79.69 92.85 
L4P2 100 100 97.5 100 24.5 69.24 0.73 52.5 7 7 56.64 89.59 95.54 
L4P3 100 100 100 100 38.31 62.99 0.78 70 7 7 57.14 92.71 95.54 
L4P4 100 100 100 100 22.65 42.04 0.26 50 5 4.5 26.79 32.81 52.68 
L4P5 100 100 100 95.84 42.49 39.16 0.6 72.5 4.5 4.5 24.96 57.3 83.93 
L5P1 54.17 82.14 80 91.66 26.46 48.53 0.36 50 6 5 64.29 58.34 74.11 
L5P2 37.5 83.93 77.5 37.5 40.42 21.44 0.57 57.5 6.5 6.5 41.07 38.02 29.47 
L5P3 36.31 69.65 55 75 35.32 60.69 0.59 67.5 7 4 39.29 90.1 100 
L5P4 66.66 71.43 70 37.5 24.86 29.2 0.04 5 1.5 0 10.71 20.31 11.61 
 
 
8.2.2  Outcome data. 
8.2.2.1  The Wilcoxon Signed Rank Test.  
8.2.2.1.1 Time 1 (Mean M1 and M2) to Time 2 (M3). 
The difference between outcome scores between Time 1 and Time 2 was tested for significance 
using the Wilcoxon Signed Rank Test (table 37 below). This test provides a Z value and associated 
significance level (p value) along with a median score at Time 1 (Pre Md) and Time 2 (Post Md). 
From these results an effect size, r value, was calculated (Z value divided by the square root of N (N 
= total number of observations over the two time points) (Pallant, 2007). 
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Table 37: Wilcoxon Signed Rank Test between Time 1 (mean M1 and M2) and Time 2 (M3). 
 
 Outcome (median) Wilcoxon Effect size 
Time 1 (mean 
of M1 and M2) 
Time 2 (M3) Z value p value r 
Consultation 
Satisfaction 
Questionnaire 
CSQ GS 95.83 100 0.14 0.89 0.03 
CSQ PC 97.5 100 0.41 0.69 0.08 
CSQ DR 97.5 100 0.67 0.5 0.13 
CSQ PT 95.83 100 1.21 0.23 0.24 
SF-12 PCS 34.65 29.33 1.01 0.31 0.2 
MCS 48.53 55.27 0.42 0.68 0.08 
EuroQoL 5D EQ5D 0.57 0.64 0.3 0.77 0.06 
EQ VAS 57.5 70 0.28 0.79 0.06 
Cardiff 
Wound 
Impact 
Schedule 
CWIS QoL 6.5 7.0 1.02 0.31 0.2 
CWIS Satis 5.0 7.0 1.06 0.29 0.21 
CWIS WB 41.07 50 1.96 0.05 0.38 
CWIS PS 58.33 75 0.42 0.68 0.08 
CWIS SL 83.92 85.71 0.28 0.79 0.06 
 
As displayed above (table 37), all outcome scores, apart from the PCS, increased over the period 
Time 1 to Time 2, however, only one result was of significance (p<0.05), with an increase in the 
CWIS WB (well-being) score following the application of the consultation template over this six week 
period (z=1.96, p<0.05) demonstrating a medium effect size (r=0.38). Effect sizes for all outcomes 
were calculated (r) (table 37) however, as is usual, the effect size for the primary outcome measure 
(patient satisfaction) was used for the sample size calculation. For the primary outcome (CSQ 
scores) effect sizes were within the range of r = 0.03 to 0.24; thus demonstrating a small effect size.  
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8.2.2.1.2  Time 1 (Mean M1 and M2) to Time 3 (M4). 
The Wilcoxon Signed Rank Test from Time 1 (mean of M1 and M2) to Time 3 (M4) (table 38 below) 
was also calculated.  
 
Table 38: Wilcoxon Signed Rank Test between Time 1 (mean M1 and M2) and Time 3 (M4). 
 
 Outcome (median) Wilcoxon Effect size 
Time 1 (mean 
of M1 and M2) 
Time 3 (M4) Z value p value r 
Consultation 
Satisfaction 
Questionnaire 
CSQ GS 95.83 100 0.95 0.34 0.19 
CSQ PC 97.5 100 0.14 0.89 0.03 
CSQ DR 97.5 100 0.21 0.83 0.04 
CSQ PT 95.83 100 0.00 0.74 0.0 
SF-12 PCS 34.65 34.85 0.3 0.77 0.06 
MCS 48.53 45.07 1.36 0.17 0.27 
EuroQoL 5D EQ5D 0.57 0.57 1.36 0.17 0.27 
EQ VAS 57.5 60 0.28 0.78 0.06 
Cardiff 
Wound 
Impact 
Schedule 
CWIS QoL 6.5 7.0 0.94 0.35 0.18 
CWIS Satis 5.0 7.0 0.84 0.4 0.16 
CWIS WB 41.07 50 1.01 0.31 0.2 
CWIS PS 58.33 71.88 0.65 0.52 0.13 
CWIS SL 83.92 96.42 0.42 0.67 0.08 
 
 
Scores here revealed that while all outcome scores, other than the MCS and the EQ-5D Index score, 
may have increased following the control period, but that none of the changes were significant. Again 
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effect sizes (r) for all outcomes were calculated but only the effect sizes for the primary outcome 
measure (patient satisfaction) were used for the sample size calculation. CSQ outcomes were in the 
range r= 0.03 to 0.19 and again demonstrated a small effect size.  
 
 
8.2.3  Sample size calculation. 
In order to accurately calculate the sample that would be required for a future RCT based on the 
data from this pilot study the effect size of the Wilcoxon Signed Rank Tests for the primary outcome 
measures were used (Hicks, 2004; Pallant, 2007; Field, 2006; McCrum-Gardner, 2010; Leon et al, 
2011). The range of effects sizes (r) values (0.03 to 0.24) for the two data points Time 1-2  and Time 
1-3 demonstrate an overall small effect (Pallant, 2007). Using a reputable sample size calculation 
programme entitled ‘G*Power’ (Faul et al, 2009) the above effect size range was utilised to estimate 
the required sample size for a future full RCT: If the future RCT were to have the desired statistical 
power level of 0.8 and a probability level of less than or equal to 0.05; for a two tailed design, an 
overall sample of between 8716 (r = 0.03) and 131 (r = 0.24) patient participants would be required 
(Field, 2006; Pallant, 2007) (figure 31).  
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Figure 31: G*Power (Faul et al, 2007) output for the sample size calculation range 0.03 – 0.24. 
 
 
 
 
In view of the non-parametric nature of the data, accurate sample size calculation is known to be 
more difficult (Pallant, 2007), thus in such a case Lehmann (1998) recommends that, providing the 
intended sample is quite large and that distribution is not excessively unusual, an additional 15% 
should be added to the sample size, giving a total future RCT sample size of between 151 – 10, 024.  
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8.2.3  A posteriori findings. 
Although further statistical analysis was not planned at the start of the study due to the pilot study 
issues discussed (Field, 2006), a small amount of a posteriori exploratory analysis has been included 
in appendix 26. Such ad hoc analysis provided some additional information which, when cautiously 
considered, provides suggestions for a number areas for future research. The data for the nine 
participants indicated: 
 QoL scores were extremely variable during the control period which may indicate that, for 
this client group, QoL is not a suitable primary outcome measure (appendix 25).  
 The satisfaction scores (CSG) (Baker, 1990) indicated that patients in L4 who attended a 
clinic and saw the same nurse appeared to be more satisfied than both population scores 
(Shum et al, 2001) and the L5 participants who were seen at home by a variety of nurses.  
 Study patients reported lower QoL scores than the general population with the exception of 
the L4 patients who reported improved mental health functioning.  
 
 8.2.4  Nurse evaluation of the template. 
After phase 3 was completed, the nurses had the opportunity to comment on the utility of the 
template and its usefulness in their day-to-day care. A brief questionnaire, developed by the 
researcher and approved by the ethics committee (LREC 10/H1203/13) (appendix 27), was 
distributed to both teams, L4 and L5, but was completed by only one of the teams involved. L5 
returned a single, jointly completed questionnaire which included a comment that they felt that the 
template was simple and quick to apply but that patients did not feel that the full consultation 
template was required at each consultation. L5 felt that the impact of the template was positive 
overall stating that: 
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“Some patients did not appreciate more questions and tick boxes and the nurses completing 
more paper work than normal. Other patients enjoyed the opportunity to discuss their 
worries in depth.” 
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8.3  Phase 3 discussion. 
Discussion of the phase 3 results is initially presented in response to the five initial aims for the pilot / 
feasibility study presented on page 239. The first four aims reflect the feasibility aspects whilst the 
final aim the pilot study remit. 
 
8.3.1 To test the recruitment procedure and to confirm the recruitment rates for nurses and 
patients to the study. 
Arain et al (2010) asserts that feasibility studies provide important information in relation to the 
‘willingness of clinicians to recruit participants’ and the ability to recruit sufficient ‘number of eligible 
patients, carers or other appropriate participants.’ The procedure for phase 3 of the study aimed to 
recruit two DN teams across a now single PCT in order to access sufficient patient participants. 
Recruitment was problematic. Two teams, despite indicating that they would be keen to be involved, 
decided not to consent. Both appeared to be working under considerable pressure and had staffing 
shortages due to organisational changes and staff sickness. This process of engagement and 
withdrawal took in excess of three months of the study time. Once it was established that these initial 
teams were not proceeding, recruitment restarted and was successful with two new teams fully 
consented to take part in the study. 
 
Once these new DN teams were consented, they were requested to distribute study packs to their 
patients who met the study inclusion criteria (detailed on page 244). Twelve weeks were allocated for 
patient participant recruitment and eventually nine patient participants in total were recruited, many 
fewer than the target of 30-55 required for an effective pilot study (Browne, 1995; Lancaster et al, 
2004; Sim & Lewis, 2011). Despite encouragement, this could not be improved. Despite the 
inadequacy of the sample, it was decided to proceed with the pilot study but to treat any results with 
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caution. Positive elements of the recruitment process demonstrated that both the consented nurses 
and patients remained in the study and completed the required intervention or measurements 
throughout the 18 week duration. 
 
It was felt that the difficulties with recruitment were influenced by the extensive changes that local 
primary care delivery was undergoing during the period of the study. These changes appeared to 
severely limit potential recruitment and, despite a relatively straightforward process to recruit via the 
manager, then the DN and then the patient, this proved to be ineffective. Experiences with phase 3 
in relation to this feasibility aim indicate that the process of recruitment was not fit for purpose and 
the ability to recruit both the teams of nurses required and the patient participants for this type of 
community based study was extremely problematic, which indicates that a larger study of this design 
would not be possible. 
 
8.3.2  To test the utility or usefulness of the consultation template. 
Once the six week control period of the study had been undertaken, each DN team was trained in 
the application of the new consultation template. These training sessions lasted for between 10 - 20 
minutes and were designed to introduce the nursing staff in the application of the template. In terms 
of the initial utility of the template, the brevity of the required training indicated that training issues for 
this type of intervention were minimal. There were some concerns from nurses that they already had 
to complete considerable paper work but they were reassured when they reviewed the template, 
since having been developed with the input of local Tissue Viability experts, duplication of 
information had been minimised. Nurses appreciated the format of the template and reflected on the 
usefulness of tick boxes, with additional comment boxes if needed. 
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Evaluation by nurses at the end of phase 3 was minimal, with only one team completed 
questionnaire returned. This questionnaire indicated that some patients felt they had to repeat 
information when the template was completed during consecutive visits. This may indicate that less 
frequent completion would provide the required PC focus or that patient completion of the template 
prior to the DN consultation may well be as or more effective. This constitutes an area where further 
research might be beneficial. In terms of feasibility, this outcome may indicate the need to change 
the design of any future study to reflect less frequent application of the template. 
 
8.3.3 To determine the most appropriate measure to assess the primary outcome for a 
future full study. 
NETSCC (2014) criteria for a feasibility study describes the facility to explore the characteristics of 
the proposed outcome measure (Arain et al, 2010). It was acknowledged (page 240) that the 
application of the four measurement tools repeated at the four time intervals may potentially have 
presented a considerable burden to the patient participants of phase 3 of the study. However, it was 
felt that this was acceptable in order to establish the appropriate outcome measures for a future full 
study. 
 
Following the additional analysis of the data (appendix 26), although the sample size was small and 
the data was treated as exploratory, the considerable differences in scores for patient satisfaction 
between participants suggest that patient satisfaction would be the most suitable primary outcome 
measure for a future full study. This is in line with the outcome measures applied in the nurse based 
studies reviewed in chapter 6 (page 194 - 210) and an area where there is a need for more UK 
research.  
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8.3.4  To determine the feasibility of a future randomised controlled trial. 
As highlighted in the points above, the difficulties that the pilot study revealed in terms of recruitment 
combined with the need for such a large sample size, indicate that a full study with an RCT design of 
this intervention would not be feasible. This does not, however, preclude a further study that adopts 
an alternate design where the requirements of sample size are not as great.  
 
8.3.5 To provide an initial indication of effect sizes in order to inform a power           
calculation. 
The majority of outcome scores demonstrated a positive trend at each of the data collection points, 
which indicates that template application may be of some clinical benefit (page 253 - 255). These 
scores demonstrate that the intervention may have had a small effect on both the satisfaction and 
QoL of the patient participants.   
 
Sample size calculations for definitive trials from pilot data are imprecise (Leon et al, 2011). To 
improve the precision of such estimates, it is recommended that 30 plus participants are included in 
pilot studies (Sim and Lewis, 2011). Any sample size calculation based on these data (which were 
obtained from only nine participants) must therefore be treated cautiously. Furthermore, the effect 
sizes vary from 0.03 to 0.24 for satisfaction (the primary outcome measure) and thus a definitive trial 
would need 151 to 10, 024 participants, accounting for allowances for the non parametric nature of 
the data (Lehman, 1998).  
 
The clinical significance of the template, however, is based on the effectiveness, suitability and utility 
of the newly developed template in clinical practice. An improving trend of outcome scores during the 
experimental period of the pilot, although minimal, may indicate further exploration of template 
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acceptability and utility using an alternative method would be appropriate to determine its clinical 
significance. 
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8.4  Overview 
Currently the only available template in relation to CVLU for use by nurses during their consultations 
is a physical assessment tool and includes the minutiae of wound assessment (SIGN, 2010). Such 
templates present a very medicalised approach to CVLU care and almost direct the nurse away from 
seeing the patient holistically (Beresford, 2010; page 39). Since consultations between the nurse and 
patient in CVLU care are known to overlook these important QoL issues (Persoon et a, 2004; page 
2), this template was designed to re-dress this balance and to focus the nurse on issues and 
concerns that impact on the day-to-day lives of such patients.  
 
8.4.1  A posteriori findings. 
As said, the ad hoc, a posteriori analyses of the outcome measurement scores (appendix 26) 
provide some areas for future research.  
 The variability of QoL during the control period was unexpected and may indicate that QoL is 
a variable outcome measure for this client group (Franks & Moffatt, 1998, 2001; Franks et al, 
2006). Since many studies that seek to enumerate the impact of CVLU apply such QoL 
tools, this raises some doubts about the suitability of QoL as a primary outcome measure. 
Further study to explore the suitability of QoL for this client group would be informative. 
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 The overall reduced physical functioning represented by the SF-12 scores (Ware et al, 1996) 
echoes the findings of a number of other studies (Rich & McLachlan, 2003; Briggs & 
Flemming, 2007) and supports the severe physical impact of this condition on the life of the 
patient. Studies to implement and evaluate interventions that aim to improve physical 
functioning would be welcomed by patients and nurses alike and would constitute 
particularly useful research. 
 Whilst treating these results with caution (Leon et al, 2011), the differences identified 
between L4 and L5 may present interesting hypotheses for future research. L4 patients were 
unusual in that the same nurse provided their care, at each consultation, in a clinic location. 
Whether higher satisfaction with care is due to either the location of that care or continuity of 
the nurse delivering the care, a factor of importance alluded to by participants in phase 1 of 
the study (chapter 4; page 93 - 158) is worthy of further research. 
 Those patients in the L4 group who attended clinic, whilst being as physically compromised 
as their L5 counterparts (appendix 26), demonstrated a higher mental health (SF-12 MCS 
score; Ware et al, 1996) which indicates improved mental health functioning. This may be 
explained by the personal characteristic theories outlined in chapter 2 (page 23 - 49) and 
may reflect locus of control (Rotter, 1954; page 44), self efficacy (Bandura, 1977; page 45) 
or self management (Morden et al, 2012; page 45) theories. This would present an 
interesting area for future research. 
 Although CVLU predominantly affects those of increasing age (Posnett & Franks, 2007), the 
results suggest that those aged under 45 years may be more compromised using scores 
from both the SF-12 (Ware et al, 1996) and EQ-5D (EuroQol, 1990). Again, an important 
area for future research. 
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8.5  Strengths and weakness. 
8.5.1  Strengths. 
 The phase 3 pilot adopted a robust within-subjects design. This reduced the sample size 
required compared to a pilot that mirrored an RCT design (Seltman, 2010).  
 All outcome measures were recorded during face to face meetings between the researcher 
and the patient participants, thus ensuring consistency in the recording the responses and 
improving the response rate, often the case with more direct methods of contact with 
participants (Hicks, 2004). 
 
8.5.2  Weaknesses. 
 Despite every effort to optimise recruitment, the sample size for this pilot was much smaller 
than anticipated. The study was undertaken during an extended period of regional NHS 
reorganisation within both primary and secondary care and this appeared to have impacted 
greatly on the willingness of nurses to engage with the study.  Once the nurses had been 
consented to take part in the study, patient recruitment remained unsatisfactory: whether 
due to a lack of enthusiasm by nurses to recruit to the study, patients on their caseload 
being unsuitable or patients refusing to take part. This ultimately resulted in a sample of only 
nine patients. Despite poor recruitment proving to be a weakness, it served to inform the first 
aim of the study, that recruitment to such a full RCT would not be feasible and thus ruled out 
a future full RCT. 
 A lack of individual nurse response to the post study questionnaire was disappointing and 
limits understanding of the nurse perspective of the usefulness of the consultation template. 
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8.5.3  Contribution to new knowledge. 
 The consultation template itself represents new knowledge as it is the first template for use 
during a nurse-patient wound care consultation which addresses QoL issues which are 
known to impact on patients with CVLU.  
 The variability of QoL as an outcome measure in patients with CVLU may indicate its 
unsuitability for use as a primary outcome measure (caution as based on a posteriori 
analysis) and highlights the need for cautiousness when QoL outcome scores are reported. 
 Higher levels of satisfaction from patients receiving care from a single nurse in a clinic 
location (caution as based on an a posteriori analysis). 
 
8.5.4  Further research. 
The findings of this pilot study suggest a number of areas that are worthy of further research, 
including the evaluation of the efficacy of the consultation template using an alternative approach. 
Since the study did reveal small improvements in the patient outcomes across the duration of the 
pilot study (although the effect size was small r= 0.03 to 0.24), further exploration using a different 
approach such as observation as in phase 2 of the template application or using the template as a 
patient activation tool, may prove to be more successful. Since patients reflected on some repetition 
when the template was applied during every visit, further research into template efficacy with less 
frequent application or patient self-completion may prove beneficial. 
 
Some of the additional analysis included in appendix 26, indicated that there may have been higher 
satisfaction in clinic attendees and/or when care was delivered by the same nurse, although these 
results are treated with caution and may have been the result of a number of factors (Pallant, 2007). 
Phase 1 highlighted the importance of the continuity of the nurse to patients with CVLU (chapter 4; 
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page 93 - 156), thus further research to investigate the impact of the location of care and nurse 
consistency may prove worthwhile and serve to inform the design of future care delivery. 
 
Patient participants demonstrated variable psychological effects (MCS; Ware et al, 1996), with L4, 
the clinic attenders with a single nurse, functioning very well whereas L5, mainly receiving domiciliary 
visits, performed poorly in this area (appendix 26). These findings may reflect either patient 
participant personal characteristics (Rotter, 1954; Bandura, 1977; Morden et al, 2012) or their coping 
mechanisms (Antonovsky, 1987; Lazarus, 1993) or simply the effect of getting the patient out of the 
house. These would both provide interesting areas for future research. 
 
Younger patients with CVLU demonstrated more compromised SF-12 (Ware et al, 1996) and EQ-5D 
(EuroQol, 1990) scores (appendix 26). Although CVLU is not as prevalent in this age range, the 
impact on all areas of functioning appears greater and is an area that would also benefit from further 
study. 
 
8.6  Conclusion. 
This pilot has demonstrated that in the context of current nursing care delivery, recruitment of 
nursing teams for the necessary sample size for a future full RCT would not be possible. The small 
effect size demonstrated across the pilot study indicates that such a study would require an 
inordinately large sample, which further confounds the feasibility of such an undertaking.  Further 
research into template utility with a different design may provide an insight into potential usefulness 
and also would determine whether, despite this small effect, template application could be of clinical 
significance. The template was designed in response to a lack of disclosure of QoL issues that were 
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impacting on their lives by patients during their consultations, thus there remains a real area of need 
and further research is necessary. 
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Chapter 9: Overall discussion, conclusions and recommendations. 
 
9.1  Introduction.  
Research has demonstrated that wound care consultations are frequently of poor quality, with patient 
concerns about daily life often overlooked by nurses who specifically focus on the wound and its 
associated care (Callam et al, 1985; McGuckin et al, 2000; Persoon et al, 2004). In response to this 
lack of PCC, and as a result of personal experience, this study was designed to clarify the concerns 
of patients with CVLU (chapter 4; page 93 - 158) and to establish whether these were disclosed and 
addressed during their current wound care consultations (chapter 5; page 159 - 193). Phase 1 
effectively demonstrated the negative impact of CVLU on the participants’ QoL and phase 2 
indicated that, despite this compromised QoL, 38% of patients did not disclose their concerns to the 
consulting nurse and, even when concerns were disclosed, on 38% of occasions they were not fully 
addressed leaving only 24% of concerns partially or completely tackled by the nurse. In response to 
these findings and following a review of nurse-led primary care interventions to improve PCC 
(chapter 6; page 194 - 210), a consultation template with a focus on known QoL issues was 
developed using a consensus technique (chapter 7; page 211 - 234). Finally, a pilot study of the new 
template was undertaken to explore recruitment and effect size (chapter 8; page 236 - 269) which 
demonstrated that a future study using an RCT design would not be feasible.  
 
9.2  Synthesis of the research findings. 
The findings in phase 1 clarified the devastating consequences of CVLU for the patient; across 
physical, psychological and social functioning (Chase et al, 1997; Hyde et al, 1999; Douglas, 2001; 
Ebbeskog & Ekman, 2001; Rich & McLachlan, 2003; Hopkins, 2004). These findings were similarly 
corroborated by the low baseline QoL scores for patient participants in the phase 3 pilot study that 
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included SF-12 (Ware et al, 1996) and EQ-5D (EuroQol, 1990). When compared to population 
values (Gandek et al, 1998) these measures were significantly compromised (appendix 26). Indeed, 
Steve, the youngest participant, spoke at length about the devastating impact of his intractable ulcers 
and provided a very personal insight into the condition. 
‘It’s just the same pain, 24/7, (…) I just have to put up with it; it’s either that or kill myself...’ 
 
Phase 3 similarly demonstrated that younger participants (five under the age of 60 years) were more 
significantly compromised across all domains than their older counterparts; a finding not clearly 
alluded to previously but which could potentially be explained by the impact of CVLU on their body 
image (Price, 1999; page 42). 
 
A preference for seeing ‘their‘ nurse for consultations was a prevailing theme within the narratives of 
the phase 1 participants (chapter 4; page 125) however, participants acknowledged that this care 
probably did not differ in quality, but their relationship with ‘their’ nurse and the continuity were 
important to them. This finding may be supported by the pilot analysis which demonstrated that those 
whose care was provided by a single nurse (L4) may be more satisfied with their care (appendix 26); 
themes also evident in a number of earlier studies (Charles, 1995; Chase et al, 1997; Brown, 2005b; 
Byrne & Kelly, 2010). Key features of PCC include the patient focus, partnership and SDM, all 
elements which are reliant on the continuity of the relationship between the HCP and the patient 
(Stewart et al, 2000). 
 
Literature demonstrated that some patients with CVLU lacked a clear understanding of the 
underlying causes and treatment of their ulceration, which exacerbated their feelings of 
powerlessness and may have resulted in some compliance issues (Chase et al, 1997; Douglas, 
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2001).  In contrast to this evidence, phase 1 participants demonstrated an in-depth knowledge of the 
dressings used and the condition of their wound, they appeared to see themselves as partners with 
their consulting nurse, working together to heal the ulcer. Indeed, this was supported in phase 2 with 
the issues surrounding wound management being explored and addressed most effectively, with 
47% of concerns being fully dealt with by the nurses, effectively serving to maintain this level of 
patient insight. This sharing of information is essential to a PCC approach to care (Henderson, 2003) 
and serves to equalise the balance of power within the HCP-patient relationship (DH, 2001c). 
 
Despite the overwhelming psychological effects of CVLU (Bland, 1996; Hyde et al, 1999; Hopkins, 
2004), phase 1 similarly revealed that participants continued to have hope and an inner strength, 
which served to improve their ability to cope. Aspects potentially influenced by the personal 
characteristics reviewed in chapter 2 (page 39 - 48). Those able to draw on this ‘inner strength’ or 
internal locus of control (Rotter, 1954) or ‘sense of coherence’ (Antonovsky, 1987) seemed more 
able to cope with the daily impact of their CVLU. Interestingly, ad hoc analysis of phase 3 indicated 
that those patients who attended clinic (L4), despite being as physically compromised as their home 
visit counterparts, exhibited improved mental health functioning, as demonstrated by their SF-12 
MCS score (Ware et al, 1996), although if this is a generalisable finding is unknown. It would be 
interesting to explore whether their improved mental health functioning led these patients to engage 
with clinic attendance or whether clinic attendance actually led to their enhanced their mental health 
functioning. Similar considerations have led to a number of leg ulcer clinic developments (Lindsay, 
2000), although attendance at such clinics by those with such compromised physical functioning is 
not always possible. Research into this area may well inform future service design. 
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As outlined in Chapter 4 (page 116 - 119), pain dominated the interviews and often analgesia proved 
to be ineffective; a theme supported by the literature (Bland, 1996; Rich & McLachlan, 2003; Brown, 
2005b). Patient participants throughout the study were all severely physically compromised as a 
result of their CVLU but, nevertheless, pain was not raised during 42% of the observed 
consultations.  
 
During many of the consultations observed in phase 2 nurses exhibited a preference for discussion 
rather than adopting a problem solving approach, especially in the area of the effects of CVLU on 
daily life where 39% of concerns led to a discussion (page 174). Patients attend their consultation 
with many concerns, hopeful that they may be offered a solution and, if only a discussion with the 
nurse is provided the patient may well not raise these concerns during their future consultations. 
Nurses need to be trained to be more problem focused in their consultations, indeed the inclusion of 
a ‘comments and problem solving’ box within the new consultation template was designed in an 
attempt to encourage nurses to adopt this approach (page 222). Such a problem focused approach 
needs further exploration and evaluation to see if patient outcomes improve as a result. 
 
The lack of disclosure of established themes by patients during phase 2 was significant and provides 
an added insight into the findings of the study by Stewart et al (1979) where 45% of patient concerns 
were either not elicited or disclosed by the patient during GP-patient consultations. In this nurse-
patient study, 38% of concerns were not disclosed and, when raised, a further 38% were only either 
acknowledged or discussed; leaving the remaining 24% to be either partially or completely 
addressed (chapter 5; page 174). Data from this study serves to clarify earlier data from Stewart et al 
(1979) and provides worrying reading regarding the effectiveness of current consultation skills. 
Whilst this is unlikely to be sufficient on its own, patient activation may serve to increase the level of 
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disclosure and thus optimise the response of the HCP thereby enhancing PCC. All areas that require 
further investigation. 
 
9.3  Overall contribution to new knowledge. 
Across a number of areas this study has revealed new knowledge or extended previous knowledge. 
 Some findings suggest that consultations for those with CVLU lack of a PC focus. 
 Some participants reflected that their physical symptoms; pain, exudate and odour, were 
poorly managed and served to diminish their QoL.  
 For some, hope, despite the overwhelming impact of their CVLU, continued to be present. 
 Some participants reflected on the importance of having a consistent nursing team.  
 Observations of consultations suggested that nurses may prefer a discussion with their 
patient rather than a problem solving approach during consultations. 
 Some of the observations suggested that the disclosure of known concerns by patients was 
poor, most notably issues relating to pain.  
 The consultation template is the first template for use during a nurse-patient wound care 
consultation to address QoL issues which are known to impact on patients with CVLU.  
 The study suggests that both the location of and continuity of care has an impact on the 
patients’ satisfaction with their care.  
 Data suggests that QoL is a variable outcome measure for patients who suffer from CVLU 
and, for this feasibility study, patient satisfaction appeared to be more appropriate as a 
primary outcome for a future study. 
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9.4  Strengths and weaknesses. 
9.4.1  Strengths. 
This study demonstrated a number of overall strengths. The comprehensive systematic review of the 
impact of CVLU on the QoL of the patient was robustly conducted (chapter 3; page 50 - 92), using 
the most up to date guidelines (CRD, 2009; Higgins & Green, 2011) and served to corroborate our 
understanding of the effects of CVLU on all areas of functioning for the patient.  
 
This study demonstrates a novel approach across phases 1 and 2 to establishing the concerns of 
patients with CVLU and then tracking these into an observation phase, in order to establish whether 
they are appropriately explored. Such an approach has revealed a noteworthy insight into the nature 
of consultations and has exposed a lack of disclosure by patients and a deficiency of problem solving 
by nurses. Results have provided interesting data that provides a further dimension to key research 
by Stewart et al (1979). Similarly, the adoption of a consensus technique for the development of the 
consultation template ensured that a robust tool, validated by patient participants, was produced and 
subsequently piloted. 
 
This study has applied a wide-ranging mixed methods approach over a four year period which was 
robustly designed and conscientiously undertaken and, in its undertaking, has provided the 
opportunity for extensive and thorough research training for the researcher. This has also been 
accompanied by numerous opportunities to present findings to both national and international 
audiences (appendix 29) and the publication of a number of creditable articles (Green & Jester, 
2009; 2010; Green et al, 2013a & b) (appendix 30), which has further enhanced the value of this 
research training. 
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9.4.2  Weaknesses. 
For the duration of this study there have been major issues with recruitment. At a time when the NHS 
is undergoing considerable and relentless reorganisation (DH, 2013), undertaking research within 
primary care has proved to be extremely challenging. This, however, does not detract from the value 
of such research. Consultations in primary care (GP and nurse) in England are predicted to rise from 
300 million to 433 million between 2008 and 2035 (King’s Fund, 2013) and, if this is the case, 
research that endeavours to put the patient at the heart of the consultation may well improve the 
quality of the care delivered and the satisfaction of patients. 
 
9.5   Further research. 
This study has provided a novel insight into the experiences of patients with CVLU. In so doing it has 
highlighted a number of areas worthy of further research: 
 In this current climate of modernisation of community care (DH, 2013) priorities need to 
focus on the importance of the patient in the consultation and the delivery of holistic care. 
The importance of the nurse-patient relationship and the need for consistent care provision 
highlighted by this study is an area that is of central importance. Indeed, further research 
into the location of care and the consistency of the consulting nurse would be beneficial and 
would establish which of these factors had the greatest impact. Indeed, an exploration of 
whether engineering improved nurse-patient continuity would continue to enhance 
satisfaction may well serve to inform future service design. 
 An exploration of the reasons that result in the lack of patient disclosure would be 
informative and may well enhance developments to improve the patient centredness of 
future consultations.  
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 In addition, exploring why nurse participants demonstrated a reluctance to move to either 
partial or complete problem solving, preferring to simply discuss issues with the patient, may 
provide a basis to improve future training in relation to consultation skills. 
 The consultation template aims to focus the consulting nurse on issues that are known to 
impact on the daily lives of patients with CVLU. Manipulating practitioner behaviour in order 
to facilitate PCC is a known approach (Kinnersley et al, 2007; EPOC, 2008; O’Connor, 
2009); alternatively, activating the patient to become more involved in the consultation and 
to disclose their concerns could be used. Further research, using the consultation template, 
for patient self-completion prior to their consultation may prove to be beneficial and may 
serve to activate the patient.  
 The evidence surrounding the impact of personal characteristics on the patient’s ability to 
cope with their long term conditions appears to be relevant to patients with CVLU (page 38). 
Further research that explores this relationship, encompassing this knowledge to develop a 
‘personalised’ consultation may have the potential to enhance PCC.  
 Younger patients with CVLU seemed to be more compromised by the condition. Further 
research to determine this may inform approaches to care that are more effective for this 
client group. 
 The patients who attended a clinic for their wound care, reported a renewed positivity, an 
enhanced outlook and improved coping strategies, feeling that they were in control of their 
care, rather than controlled by it (page 122-124). Research that builds on that of Lindsay 
(2000) in relation to wound care clinics and aims to promote patient choice in the location of 
care delivery would be beneficial.  
 Reflection on personal narratives during the consultation is said to enhance patient 
understanding of their condition and enable them to develop effective coping strategies 
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(Lazarus, 1993) and a sense of coherence (Antonovsky, 1987). Consultation based research 
that facilitates a focus on such narratives may prove to be effective.  
 Triangulation of the phase 2 results would have enhanced the quality of this study. An 
opportunity to interview both patient and nurse participants following the consultation 
observations would provide detail regarding the underlying reasons for the deficits exposed. 
In retrospect, such a phase would have provided useful information and may be something 
that can be incorporated into a future study. 
 
9.6  Recommendations for practice. 
In addition to the contribution that this study has made to new knowledge and the recommendations 
made for future research, a number of simple recommendations for practice are highlighted. 
 Holistic assessment of patients and the delivery of care that addresses poorly managed 
symptoms such as pain, exudate, odour and depression.  
 The development and evaluation of interventions that improve the consulting skills of HCPs 
and activate the patient to express their concerns across a range of locations of care and 
conditions. 
 For a shift in focus in the delivery of chronic wound care from a blinkered approach with 
healing as the only goal to an approach that supports the patient and their carers, 
addresses the range of quality of life issues that such conditions inevitably bring and 
responds effectively to patient need.  
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9.7  Conclusion. 
This study was primarily designed to establish the impact of CVLU on QoL, to examine whether this 
was explored during current consultations and to design a tool to improve a patient focus.  The study 
was rigorously designed but demonstrated that a future full RCT would not be feasible. A number of 
factors contributed to this, including considerable change within the NHS and difficulties with 
recruitment. Demands on the DN service are increasing year on year, patients have a more acute 
profile and staff numbers are diminishing (QNI, 2013), both serving to increase the demands on the 
service. This study has demonstrated that patient centred care is not at the forefront of care delivery 
and, combined with these increasing pressures, may be an approach that becomes less achievable 
in the future unless action is taken now.   
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Appendix 1: Database search results (HDAS). 
Search Term MEDLINE  CINAHL  BNI  EMBASE  PsycINFO  AMED  Health 
Business 
Elite  
HMIC  Google 
Scholar 
Total 
1. venous ulcer* 4574 6393 507 6904 288 65 1092 54 0 19877 
2. chronic venous 
insufficiency 2096 253 21 3248 78 26 11 2 0 5735 
3. varicose ulcer* 2008 514 13 563 13 33 170 14 0 3328 
4. stasis ulcer* 435 893 7 677 30 10 239 1 0 2292 
5. leg ulcer* 5505 7389 1594 9438 354 116 2007 170 0 26573 
6. chronic wound* 9956 15437 501 12444 3876 175 4680 38 0 47107 
7. MeSH leg ulcer 10223 3244 1542 28951 0 0 0 71 0 44031 
8. OR all of above 17041 21619 1914 35095 4325 309 6860 212 0 87375 
9. quality of life 188718 160576 5862 296108 158722 10367 187888 6143 0 1014384 
10. “quality of life” 168082 97687 5855 263270 94581 9418 39318 4978 0 683189 
11. health related 
quality of life 33230 82317 779 46419 71995 2294 52900 771 0 290705 
12. “health related 
quality of life” 18222 12557 779 25048 22967 1675 1584 433 0 83265 
13. MeSH quality of life 103170 35861 4569 211195 22785 6478 3350 2303 0 389711 
14. OR 9-13 188594 160576 5862 296108 158722 10367 187888 6143 0 1014260 
15. combine 9 AND 14 741 7689 112 1713 1347 29 1890 17 0 13538 
Total for Review: 741 7689 112 1713 1347 29 1890 17 22 13560 
Studies retained 
following electronic 
screening stage.  105 143 50 108 14 9 3 10 11 453 
Studies retained 
following abstract 
screening stage. 6 35 37 21 0 6 0 0 9 114 
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Appendix 2: Quality appraisal of the literature (Hawker et al, 2002). 
 
Total Score:  <90 - Very Poor.  90-180 – Poor.   180-270 – Fair.   270-360 – Good.  
 
Author, year & 
location 
Abstract 
& title 
Introduction 
& aims 
Method & 
data 
Sampling Data 
analysis 
Ethics & 
bias 
Findings / 
results 
Transferability 
/generalisability 
Implications & 
usefulness 
Total Score  
(Range: 90-360) 
Bland, M. (1996) 10 
 
10 10 20 20 10 20 20 10 130 (P) 
Brown, A. (2005 a, b) 
  
20 30 30 40 30 40 40 30 30 290 (G) 
Byrne, O. & Kelly, M. 
(2010)  
10 20 
 
20 20 20 10 20 20 20 160 (P) 
Charles, H. (1995) 
  
20 20 20 20 20 20 20 20 10 170 (P) 
Charles, H. (2004)  40 
 
30 30 30 20 20 20 20 20 230 (F) 
Chase et al (1997) 
  
30 30 30 30 30 20 30 30 20 240 (F) 
Chase et al (2000)  
 
20 30 30 30 30 20 30 20 20 230 (F) 
Douglas, V. (2001)  
 
30 30 40 30 30 20 30 30 30 270 (G) 
Ebbeskog, B. & 
Ekman, S. (2001)  
30 30 40 40 40 30 40 40 30 320 (G) 
Faria, E. et al (2011)  30 20 
 
30 30 30 30 30 30 20 250 (F) 
Franks, P.J. & 
Moffatt, C. (1998) 
40 30 30 40 40 30 40 30 30 310 (G) 
Franks, P.J. & 
Moffatt, C. (2001) 
40 40 40 40 40 30 40 30 30 330 (G) 
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Franks,P, McCullagh, 
L. & Moffatt, C.(2003) 
40 40 40 40 40 20 40 30 20 310 (G) 
Franks et al (2006) 
 
40 40 40 40 40 40 40 30 40 350 (G) 
Furtado et al (2008)  40 40 
 
40 40 40 20 40 30 30 320 (G) 
Heinan et al (2006)  
 
40 40 40 40 40 40 40 30 30 340 (G) 
Hopkins, A. (2004)  20 30 
 
40 30 30 40 30 30 20 270 (G) 
Hyde et al (1999)  
 
30 30 40 30 40 20 40 30 20 280 (G) 
Jull et al (2004)  40 40 
 
40 40 40 40 30 30 30 330 (G) 
Lindholm et al (1993)  40 30 
 
40 10 30 30 10 30 30 240 (F) 
Rich, A. & 
McLachlan, L. (2003)  
40 40 
 
40 40 40 40 40 30 30 340 (G) 
Walshe, C. (1995)  30 40 
 
40 40 40 40 40 30 30 330 (G) 
Wissing et al (2002)  
 
30 10 20 20 30 30 30 30 30 230 (F) 
Yamada, B.& Santos, 
V. (2005)  
30 20 20 20 20 10 20 10 10 180 (P) 
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Appendix 3: CHRONIC VENOUS LEG ULCERATION – TOPIC GUIDE. 
 
AT THE START OF THE INTERVIEW: 
Explain the purpose of the study. 
Reassure the participant about confidentiality. 
Gain consent. 
 
HEALTH NARRATIVE: 
 
 Establish what health was like prior to leg ulceration. 
 Explore memories of the start of the leg ulceration. 
 Explore what life is like with leg ulceration? 
 Talk about interactions with the participants’ Doctor. 
 Talk about interactions with the participants’ Nurses. 
o What does your Nurse do? 
o What do you discuss? 
o What advice is given? 
o What arrangements do you make?  
o Is the information consistent? 
 Explore the impact of leg ulceration on family and friends? 
 Explore compliance with the advised treatment regimes. 
 Explore the impact on ulceration on ability to work. 
 
AT THE END OF THE INTERVIEW: 
Ask if there are any questions.                                                            
Reaffirm consent and confidentiality.  
Thank the participant for taking part and explain what will happen next. 
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South Staffordshire Local Research Ethics Committee 
Medical Institute 
Hartshill Road 
Hartshill 
Stoke-on-Trent 
Staffordshire 
ST4 7NY 
 
Telephone: 01782 714980  
Facsimile: 01782 714975 
11 March 2010 
 
Mrs Julie Green 
Lecturer in Nursing 
Keele University 
School of Nursing and Midwifery 
Clinical Education Centre,  
UHNS,  
Stoke-on-Trent 
ST4 6QG 
 
 
Dear Mrs Green 
 
Study Title: Does a patient focus to consultations in chronic venous 
leg ulcer care improve patient satisfaction and health 
related quality of life? (v2) 
REC reference number: 10/H1203/13 
Protocol number: 6 
 
The Research Ethics Committee reviewed the above application at the meeting held on 
03 March 2010. Thank you for attending to discuss the study.  The coordinator explained 
that the Committee did not need to see you. 
 
Ethical opinion 
 
The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation, subject to the conditions specified below. 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start 
of the study (see “Conditions of the favourable opinion” below). 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 
Management permission or approval must be obtained from each host organisation prior 
to the start of the study at the site concerned. 
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For NHS research sites only, management permission for research (“R&D approval”) 
should be obtained from the relevant care organisation(s) in accordance with NHS 
research governance arrangements.  Guidance on applying for NHS permission for 
research is available in the Integrated Research Application System or at 
http://www.rdforum.nhs.uk. Where the only involvement of the NHS organisation is as a 
Participant Identification Centre, management permission for research is not required but 
the R&D office should be notified of the study. Guidance should be sought from the R&D 
office where necessary. 
 
Sponsors are not required to notify the Committee of approvals from host organisations. 
 
Other conditions specified by the REC  
 
The Committee was content to give a favourable opinion of phases one and two of the 
application with the following condition/s:  
   
1. The reference to training in the information sheet for the district nurses should be 
removed as it relates to phase three  
   
2. In the information sheets participants are asked three times to “please complete 
the enclosed consent form and return in the prepaid envelope provided within 
seven days”.  The phrase is also included in the letters of invitation.  Such 
repetition is unnecessary and should be taken out.  
   
The Committee decided that phases one and two follow on naturally but phase three will 
require a separate application as, until phases one and two have been completed, there is 
insufficient detail relating to phase three to enable a decision to be made.  
 
It is responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 
Approved documents 
 
The documents reviewed and approved at the meeting were: 
  
Document    Version    Date      
Covering Letter    10 February 2010    
REC application    10 February 2010    
Protocol  6  25 January 2010    
Investigator CV    24 November 2009    
Participant Information Sheet: Phase 1 & 2  2  14 January 2010    
Participant Information Sheet: Phase 1 & 2 District Nurse  2  14 January 2010    
Participant Information Sheet: Phase 3  2  14 January 2010    
Participant Information Sheet: Phase 3 District Nurse  2  14 January 2010    
Participant Consent Form: Phase 1 & 2  3  14 January 2010    
Participant Consent Form: Phase 1 & 2 District Nurse  3  14 January 2010    
Participant Consent Form: Phase 3  3  14 January 2010    
Participant Consent Form: Phase 1 & 2 District Nurse  3  14 January 2010    
Evidence of insurance or indemnity    24 July 2009    
Letter from Sponsor    30 November 2009    
Referees or other scientific critique report    23 October 2009    
317 
 
Questionnaire: Community Nurse Satisfaction         
Questionnaire: Medical Outcome short form         
Questionnaire: Cardiff Wound Impact Schedule         
CV Professor Jester    18 November 2009    
Letter of Invitation Phase 1 & 2  3  14 January 2010    
Letter of Invitation Phase 1 & 2 District Nurse  3  14 January 2010    
Letter of Invitation Phase 3  3  14 January 2010    
Interview Schedules/Topic Guides  2  25 January 2010    
Letter of Invitation Phase 3 District Nurse  3  14 January 2010    
Full Study Flow Chart  5  10 February 2010    
Phase 1 Flow Chart  2  10 February 2010    
Phase 2 Flow Chart  2  10 February 2010    
Phase 3 Flow Chart  4  10 February 2010    
Unfavourable Opinion Letter    12 January 2010    
 
Membership of the Committee 
 
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet. 
 
Statement of compliance  
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
 
Now that you have completed the application process please visit the National Research 
Ethics Service website > After Review 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure. If you wish to make your views 
known please use the feedback form available on the website. 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Progress and safety reports 
 Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
We would also like to inform you that we consult regularly with stakeholders to improve 
our service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk. 
 
 
10/H1203/13 Please quote this number on all correspondence 
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With the Committee’s best wishes for the success of this project 
 
Yours sincerely 
 
 
Professor Tim Reynolds 
Chair 
 
Email: Janet.Clarke@uhns.nhs.uk 
 
Enclosures: List of names and professions of members who were present at the 
meeting and those who submitted written comments 
“After ethical review – guidance for researchers”  
 
Copy to: Nicola Leighton, Research and Enterprise Services, Keele University 
Nemonie Marriot, Research and Development, North Staffordshire and 
Stoke-on-Trent PCT 
Professor R Jester, School of Nursing, Keele University, Clinical 
Education Centre, UHNS, Stoke-on-Trent, ST4 6QG 
 
South Staffordshire Local Research Ethics Committee 
 
Attendance at Committee meeting on 03 March 2010 
  
Committee Members:  
 
Name   Profession   Present    Notes      
Mrs Sandra Chambers   Head Teacher (Retired)  Yes      
Mr  Robert Edgar  Engineer (Retired)  Yes      
Dr  Nitin Gupta  Consultant Psychiatrist  Yes      
Dr Brian Hynam  Retired Director of Pharmacy 
Services  
Yes      
Dr  Kathryn Kinmond  Senior Lecturer  Yes      
Dr Arabinda Kundu  Head of Contraceptive & Sexual 
Health Service  
Yes      
Dr Diarmuid Mulherin  Consultant Rheumatologist  Yes      
Dr Laofe Oladele Ogundipe  Consultant Psychiatrist  Yes      
Professor Tim Reynolds  Consultant Chemical 
Pathologist  
Yes      
Dr Sandie Sandbrook  Senior Lecturer  Yes      
Mr Victor Scofield  Legal Advisor, Banking 
(Retired)  
Yes      
  
Also in attendance:  
 
Name   Position (or reason for attending)     
Mrs Barbara Cannings  Coordinator    
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R&D approval. 
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Appendix 6 
Participant letters, consent & information leaflets: phase 1 & 2. 
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Version 3, Date: 14/01/2010. 
LREC Number: 10/H1203/13 
 
 
 
Keele University School of Nursing and Midwifery, 
Clinical Education Centre, 
University Hospital of North Staffordshire NHS Trust, 
City General Site, 
Newcastle Road, 
Stoke-on-Trent. 
ST4 6QG. 
Tel: 01782 556605. 
 
 
 
 
 
 
Dear Sir or Madam, 
 
I am currently studying for a PhD. The research I am undertaking explores chronic venous leg 
ulceration and the impact on the patients’ quality of life. I have enclosed an information leaflet for you 
to read which outlines the study in more depth and also what will be required of you if you agree to 
take part. 
If you have any queries about the study, please do not hesitate to contact me on the above 
telephone number. If you do agree to take part then I would be very grateful if you could complete 
the enclosed consent form and contact details and return, in the prepaid, addressed envelope within 
seven days. 
I am very grateful for your time and for the help that you can provide to this research project. 
Yours sincerely, 
 
 
Julie Green 
Lecturer in Nursing.  
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Version 3, Date: 14/01/2010. 
LREC Number: 10/H1203/13 
 
 
Keele University School of Nursing and Midwifery, 
Clinical Education Centre, 
University Hospital of North Staffordshire NHS Trust, 
City General Site, 
Newcastle Road, 
Stoke-on-Trent. 
ST4 6QG. 
Tel: 01782 556605. 
 
Dear District Nurse, 
 
I am currently studying for a PhD. The research I am undertaking explores chronic venous leg 
ulceration and the impact on the patients’ quality of life. Phase 1 of the study will involve interviewing 
some of your patients who suffer from leg ulceration. Once these interviews have been analysed, 
Phase 2 will involve observing your consultations with the same patients to explore the extent to 
which the factors they highlight as being important in Phase 1 are addressed. Your District Nursing 
team has been selected to take part in this research. 
I enclose an information leaflet to provide full details of the study and a consent form for each District 
Nurse who agrees to be involved in the study. Please complete these and return in the stamped 
addressed envelope provided, ideally within seven days. If you have any queries about the study, 
please do not hesitate to contact me on the above telephone number. 
I am very grateful for your time and for the help that you can provide to this research project. 
Yours sincerely, 
 
 
 
Julie Green 
Lecturer in Nursing.  
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Patient Information Leaflet. 
Version 2, Date: 14/01/10. 
LREC Number: 10/H1203/13. 
 
 
Study Title: 
Chronic venous leg ulceration and health related quality of life. 
You are invited to take part in a research study.  
Before you decide, it is important for you to understand why the research is being done and what it 
will involve.  
Please take time to read the following information carefully and discuss it with friends, relatives and 
your District Nurse if you wish.  
If there is anything that is not clear or if you would like more information, please feel free to contact 
Julie Green at the School of Nursing and Midwifery, Keele University on 01782 556605. 
 
What is the purpose of the study? 
Many people in the UK suffer from leg ulcers. This research will explore the day-to-day effects of 
having a leg ulcer.  
 
Why have I been chosen? 
You have been invited to take part because you are currently receiving care from a District Nurse for 
your leg ulcer.  
 
Do I have to take part? 
You are free to decide if you wish to take part or not.  
If you do decide to take part, please complete the enclosed consent form and return it in the prepaid 
envelope provided within seven days.  
If you do decide to take part, you can withdraw at any time and without having to give a reason. This 
will not affect your treatment or the care for your leg ulcer. 
If you do not wish to take part, please simply destroy the enclosed literature and be assured that 
your care will not be affected.  
 
What will happen if I take part? 
If you agree to take part in the study, I will contact you to arrange a convenient time to conduct an 
interview. When I visit, I will ask you to tell me about your experiences of having a leg ulcer. 
If you agree, I will record the interview on a small tape recorder. This will allow me to write down 
what is said after the interview, so that nothing is overlooked.  
The interview will take between 60 and 90 minutes. 
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Following your interview, I will arrange to accompany your District Nurse on a number of visits to 
provide care for your leg ulceration. During these visits, I will simply observe the visit and complete a 
brief checklist.  
 
What do I have to do? 
Simply complete and return the enclosed consent form and I will then contact you to arrange a visit 
to conduct the interview. 
 
What are the benefits of taking part? 
It is hoped that the information gathered during this study will provide an understanding of the day-
to-day lives of people with leg ulceration and may help to shape the care that is delivered in the 
future.   
 
What are the possible disadvantages or risks of taking part? 
There are no expected disadvantages or risks associated with taking part in this study. 
 
What if something goes wrong? 
I do not expect any problems to arise during this study.  
If you have a concern about any aspect of the study, you should speak to me, Julie Green, and I will 
do my best to answer your questions. I can be contacted on 01782 556605.   
If you remain unhappy about the research and/or wish to raise a complaint about any aspect of the 
way that you have been approached or treated during the course of the study please write to Nicola 
Leighton who is the University’s contact for complaints regarding research at the following address:- 
Nicola Leighton, Research Governance Officer, Research & Enterprise Services, Dorothy Hodgkin 
Building, Keele University, ST5 5BG. 
 
Will my taking part be kept confidential? 
All of the information collected during this study will be kept strictly confidential.  
Your name and address will be removed from all documents and any other identifying information, 
including the consent form, will be kept in a locked drawer in a lockable office. Some information 
may be stored on a computer, but this will be protected by a password known only to myself.   
 
What will happen to the results of the research study? 
This research will form part of a PhD study. No one will be identifiable in the completed thesis. 
 
Who is organising and funding this research? 
This research is a student project for a PhD. It has no funding available from any organisations or 
drug companies. Most of the work will be done in my own time. 
 
Thank you for your time in reading this information sheet.  
If you agree to take part in this study, please complete the enclosed consent form. 
 
Many thanks, 
 
Julie Green 
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District Nurse Information Leaflet. 
Version 2, Date: 14/01/2010. 
LREC Number: 10/H1203/13 
Study Title: 
Chronic venous leg ulceration and health related quality of life. 
You are being invited to take part in a research study.  
Before you decide, it is important for you to understand why the research is being done and what it 
will involve.  
Please take time to read the following information carefully and discuss it with your colleagues.  
If there is anything that is not clear or if you would like more information, please feel free to contact 
Julie Green at the School of Nursing and Midwifery, Keele University on 01782 556605. 
 
What is the purpose of the study? 
Leg ulceration affects many thousands of people in the UK. Dressing products and techniques are 
frequently reviewed but the impact of the ulceration on the day-to-day life of the sufferer is often 
overlooked. This research aims to explore the lived experience of a number of patients who suffer 
from leg ulcers. 
 
Why has my team been chosen? 
The research involves interviewing a number of patients from your caseload, with their consent, who 
suffer from chronic leg ulceration. Following the interview, again with their consent, these patients 
will have their visits from the nurse observed over a four week period. This will involve me 
accompanying the District Nurses as they provide leg ulcer care during their domiciliary visits. Your 
team has been selected due to the suitability of the patients that you see. 
 
Do I have to take part? 
You are free to decide if you wish to take part.  
If you do decide to take part, please complete the enclosed consent form and return it in the prepaid 
envelope provided within seven days.  
If you do not wish to take part, please simply destroy the enclosed literature.  
 
What will happen if I take part? 
If you do decide to take part in the study, I will ask that you distribute a pack containing a letter of 
invitation, an information leaflet, a consent form and a stamped addressed envelope to all of the 
patients registered on your caseload who meet the study inclusion criteria.  
Once patient consent has been received, I will arrange to conduct interviews on a one to one basis 
in the patient’s home, at a time convenient to them. These interviews will be unstructured and will 
explore the lived experience of patients with chronic venous leg ulceration. If the patient agrees, the 
interview will be recorded on a small tape recorder to enable the researcher to write down what was 
said, so that nothing is overlooked. These interviews will then be analysed to identify key factors that 
the patients’ feel affect their quality of life. These factors will be used to construct an observation 
checklist.   
327 
 
Once this is completed, I will arrange the period of observation. I will accompany you on a number of 
occasions and observe your consultations with the same patient participants. During these visits I 
will be as unobtrusive as possible. I will complete the brief checklist based on the factors elicited 
from the interview phase of the study. These accompanied visits will take place over a period of 
approximately four weeks.  
In the unlikely event of me observing poor practice, in accordance with the requirements of the Code 
of Conduct (NMC, 2009), I will be duty bound to report this. 
 
What do I have to do? 
If you decide to take part in the study, please complete and return the enclosed consent form in the 
prepaid envelope provided within seven days.  
I will then contact you to arrange to visit to provide an overview of the study. 
 
What are the benefits of taking part? 
It is the aim that the information gathered from this study will give an insight into the day-to-day lives 
of people suffering from venous leg ulceration and, as a result, may be used to make 
recommendations about future care that is delivered. This, however, is not a guaranteed outcome.   
 
What are the possible disadvantages or risks of taking part? 
There are no expected disadvantages or risks associated with taking part in this study. 
 
What if something goes wrong? 
I do not expect any problems to arise during this study.  
If you have a concern about any aspect of the study, you should speak to me, Julie Green, and I will 
do my best to answer your questions. I can be contacted on 01782 556605.   
If you remain unhappy about the research and/or wish to raise a complaint about any aspect of the 
way that you have been approached or treated during the course of the study please write to Nicola 
Leighton who is the University’s contact for complaints regarding research at the following address:- 
Nicola Leighton, Research Governance Officer, Research & Enterprise Services, Dorothy Hodgkin 
Building, Keele University, ST5 5BG. 
 
Will my taking part be kept confidential? 
All of the information collected during this study will be kept strictly confidential.  
Your name and address will be removed from all documents and any other identifying information, 
including the consent form, will be kept in a locked drawer in a lockable office. Some information 
may be stored on a computer, but this will be protected by a password known only to myself.   
 
What will happen to the results of the research study? 
This research will form part of a PhD study. No one will be identifiable in this piece of work. 
 
Who is organising and funding this research? 
This research is a student project for a PhD. It has no funding available from any organisations or 
drug companies. Most of the work will be done in my own time. 
 
Thank you for your time in reading this information sheet.  
If you agree to take part in this study, please complete the enclosed consent form and return in the 
prepaid envelope provided within seven days. 
Many thanks,  
Julie Green 
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Patient Consent Form. 
Version 3, Date: 14/01/2010. 
LREC Number:  10/H1203/13 
 
Title of Project: Does a patient focus to consultations in chronic venous leg ulcer care 
improve patient satisfaction and health related quality of life? 
Name of Researcher: Julie Green. 
          Please Tick. 
 
1. I confirm that I have read and understood the information leaflet and have  
had the opportunity to ask questions...................................................................... 
 
2. I understand that my participation is voluntary, that I can refuse to answer 
a question, or withdraw at any time, without giving a reason, and without my  
medical care or legal rights being affected.............................................................. 
 
3. I understand that the interview will be taped and transcribed, and that tapes will 
be stored in a secure location, but will bear no personal identifying information. I  
understand that the tapes and transcripts will be kept for up to 10 years and after  
this time they will be destroyed.................................................................................. 
 
4. I understand that quotations from the interview may be included in reports 
or publications from this study, but that these will be anonymous and I will not  
be identifiable............................................................................................................  
 
I want to see all quotations obtained during my interview before 
publication.................................................................................................... 
 
5. I agree to take part in the above study................................................................... 
 
6. I understand that data collected during the study may be looked at by                                                                         
individuals from regulatory authorities or from the NHS Trust, where it is                                                                                              
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relevant to my taking part in this research. I give permission to these                                               
individuals to have access to my records................................................................. 
Please sign and date on the line below: 
 
-----------------------------------------   ---------------------------  ------------------------ 
Name of Patient     Date    Signature 
 
-----------------------------------------   ---------------------------  ------------------------ 
Name of Researcher    Date    Signature 
 
 
Please provide me with your contact details below: 
Your full name, address and telephone number. 
 
Name:.............................................................................................................. 
Address:......................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
Telephone number:....................................................................................... 
 
 
 
Thank you for your help with this research study. 
If you have any further questions about this study 
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District Nurse Consent Form. 
Version 3, Date: 14/01/2010. 
LREC Number: 10/H1203/13 
    
 
Title of Project: Does a patient focus to consultations in chronic venous leg ulcer care 
improve patient satisfaction and health related quality of life? 
Name of Researcher: Julie Green. 
          Please Tick. 
1. I confirm that I have read and understood the information leaflet and have  
had the opportunity to ask questions...................................................................... 
 
2. I understand that my participation is voluntary, that I can refuse to answer 
a question, or withdraw at any time, without giving a reason.................................. 
 
3. I agree to take part in the study and to have my patient consultations 
observed................................................................................................................. 
 
4. I understand that data collected during the study may be looked at by                                                                         
individuals from regulatory authorities or from the NHS Trust, where it is                                                                                              
relevant to my taking part in this research. I give permission to these                                               
individuals to have access to my records................................................................. 
 
 
-----------------------------------------   ---------------------------  ------------------------ 
Name of District Nurse    Date    Signature 
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-----------------------------------------   ---------------------------  ------------------------ 
Name of Researcher    Date    Signature 
 
 
Please provide me with your work contact details below: 
 
Your full name, work address and telephone number. 
Name:.............................................................................................................. 
Work Address:......................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
Work Telephone number:....................................................................................... 
 
 
 
Thank you for your help with this research study. 
If you have any further questions about this study, you can telephone me, Julie Green, on 01782 
556605. 
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Appendix 7 
Thematic map phase 1. 
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Appendix 7: Thematic map phase 1. 
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Appendix 8 
Checklist items linked to thematic map. 
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Appendix 8: Checklist items linked to thematic map. 
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Appendix 9 
Observation checklist from phase 2. 
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Observation checklist from phase 2: 
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Appendix 10 
Example field notes from phase 2 
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Example field notes from phase 2: 
 
L1, P1 – Consultation Observations. 
O1 – Wednesday 12th January 2011. 
Over to Moorland Medical centre at Leek for 8.50am to accompany Sr. (S2) to visit 3 of the 6 
patients interviewed. (P4 in hospital with fractured femur, P3 healed and P5 attending clinic – need 
to liaise directly with her). 
S2 rang P2 to take P1’s dressing down in preparation for our visit in 15 minutes time. Travelled over. 
P1 sat in wheelchair in bedroom. Left trouser leg up to knee, dressing off and leg resting on sterile 
field. P2 noted that leg less wet but S2 and P1 discussed P1’s longstanding sweating problem. Felt 
legs were more of a deteriorating issue than simple leg ulceration. P1 had been on Myocrisin and 
Methotrexate for many years. Leg reddened and skin thickened to knee and toes raw and 
discharging, break to inner and outer malleolus. Redressed by S2. 
P1 discussed his pain – constant but tolerable. Takes too many tablets for other conditions and felt 
that the pain is not the type that analgesia is effective on. Is now less severe than previously – worse 
after the dressing and when in bed resulting in disturbed sleep. Not able to elevate legs due to knee 
difficulties and has to side lie whilst in bed, which results in some sleep issues. S2 did discuss timing 
and effectiveness of analgesia. Commented and discussed the improvement in exudate and 
currently no odour present. Legs padded well until next visit. Due to rural nature of visit, S2 felt this 
was a contingency plan in case visits need to be cancelled due to snow.  
S2 discussed P1’s lack of bathing / showering – P1 seemed very resistant to any suggestions. 
Transfers on a board so felt bath would not work and reluctant to have any adaptations made to 
shower – S2 encouraged stating she felt it would be helpful to his legs. P1 said he would think about 
this. Not able to elevate his legs at all due to knee issues. Immobile and non-weight bearing – only 
able to transfer. 
Soft boots only worn due to the size of the dressings, etc. – not able to wear ‘normal’ shoes. 
Complained of discomfort initially after the dressing change and during the procedure. P1 given an 
update on the condition of his wounds but no measurements taken. Legs not washed today but 
arrangements made for the next visit – too time consuming to wash at every visit. 
P1 positive, cheerful and accepting – feels legs will never get better but are improving – currently 
redressed three times a week. Isolation mentioned – not been out for three months due to the 
weather, etc. so quite isolated due to co-morbidities. Joking with the nurses – lots of banter and 
sarcasm but a nice supportive relationship. P1 had commented in his interview that he values this 
relationship. S2 gave some advice regarding analgesia, personal hygiene, etc. but P1 quite resistive 
to change. P1 dictated level of compression – not tolerating at correct tightness. Fully aware of 
application and process. 
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O2 – Wednesday 26th January 2011. 
Over to Leek for 8.45. S2 out seeing diabetic patients. Student on placement today. Out with S2 and 
student. Travelled over to Rudyard following a phone call to request P2 to soak P1s legs. 
P1 had dressings removed and had soaked legs prior to timed visit. Very jovial and jokey on arrival. 
Student undertook the dressing procedure with teaching from S2. P1 complained of discomfort in 
legs which is worse overnight once legs are elevated, in addition to pain due to arthritis. Difficulties 
positioning comfortably in bed. Unable to tolerate correct level of compression so quite anxious 
whilst lymphoedema (Actico) bandages were applied. Analgesia not discussed ? because P1 is on 
such a range of other medication. Long term Gold patient, now on Methotrexate for over 10 years. 
Night time highlighted as a time with problems due to discomfort.  
No odour or exudate evident. Personal hygiene managed by P2 and a carer, legs soaked but 
solutions to bathing / showering refused. Wheelchair user – had been to GPs for bloods on Monday 
and had had to transfer 12 times which had made him really uncomfortable. S2 offered that in the 
future bloods could be done at home. Difficulties with the procedure due to tightness of trousers at 
the knee – S2 requested that he remove his trousers prior to the next visit. Soft orthopaedic shoes 
worn but modified by P1 as uncomfortable. Patient manages level of compression – adhered to by 
nurses.  
Wounds progressing well and nurse provided this feedback but no objective measurements taken. 
Itching recognised as problematic. Betnovate prescribed and applied, especially around dressing 
margin. P1 appeared to be brighter although tired due to trip to GP. Felt weather improving with 
increased possibilities to get out – had been for a ride to the Roaches on Monday and visitors 
yesterday. Reflected on feeling tired.  
Very jovial and cheerful with the student but very much the ‘expert’ patient who dictated dressing 
procedure.    
03 – Wednesday 2nd February 2011. 
Over to Leek and out with S2 again. Over to P1 following a phone call to prepare legs. P1 was quite 
cheerful, sat on the side of his bed without his trousers on, as requested by S2. As she had 
commented how difficult it was to get his dressing and cream high enough up with trousers on. Legs 
not washed. S2 commented that the left leg seemed to not be as wet which was confirmed by P1. P1 
requested right leg to be redressed as well and for Betnovate rather than Betnovate RD to be 
applied (Betnovate RD had been recommended by the Dermatology Specialist nurse) as he felt that 
this was ineffective.  
Leg redressed, creamed with Trimovate, non-adherent between toes following cleaning, 50/50 to 
legs, N/A and padding, K soft & Actico Lymphoedema bandaging. Again commented and requested 
that these were not applied too tightly. No comments about pain, etc., continuing to take a wide 
range of medication for Rheumatoid Arthritis. Had been out for a ride in the car yesterday and 
seemed tired and less talkative. Itching to legs less of a problem so Benovate omitted. 
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04 – Wednesday 9th February 2011. 
Over to Moorland Medical Centre. Out with S2 and a student. S2 rang ahead to P2 to ask her to 
soak P1’s legs in Potassium Permanganate. Arrived after they had been soaked for 20 minutes. 
Both in the bedroom. P1 sat on the side of the bed with left leg soaking. Right not due to be 
redressed today. Both appeared to be cheerful and welcoming. 
John complained of some redness to left knee where stoma bag insitu – S2 will arrange for ? new 
stoma bags. Complained of the same areas of itching around the margin of the bandaging and new 
wet area to lateral malleolus. Leg dried and redressed. P1 advised student on the dressing 
procedure throughout: which creams were to be applied where, how much padding and in what 
order and the tightness of application of the bandage. Continuing on 3 times weekly visits each 
lasting 60 minutes. 
P1 chatted light heartedly throughout the procedure. Commented on having been out yesterday and 
of looking forward to spring coming. Had had different nurses on Monday due his usual nurses being 
busy but reflected that it had been OK. Happy with the leg dressing. 
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Appendix 11 
Phase 2 pie chart subtheme results 
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Appendix 11 – Phase 2 pie chart subtheme results. 
 
11.1 The presence of pain. 
 
The checklist item entitled the ‘presence of pain’ was emphasised as being of importance by all 
observation participants. Results are summarised in the pie chart below (Chart 1).  
 
Chart 1: The presence of pain. 
 
 
 
Scoring for the presence of pain indicated that, although it was a subtheme of known importance to 
all participants, a discussion was the dominant result within the consultation. The nurse only moved 
to a partial or complete solution on 25% of occasions possible. 
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15% 
Presence of pain scores 
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11.2 The cause of pain. 
All phase 2 participants again raised the cause of pain as significant. Results are summarised in the 
pie chart below (Chart 2).  
 
Chart 2: The cause of pain. 
 
 
 
Scoring for the cause of the participants’ pain, again a subtheme of known importance to all 
participants, indicated that the theme was most often not raised during the consultation. Where it 
was raised, the consulting nurse offered a solution on 30% of opportunities 
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Cause of pain. 
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11.3 Type of pain. 
 
Four of the five phase 2 participants raised their type of pain during their phase 1 interview. Results 
are summarised in the pie chart below (Chart 3).  
 
Chart 3: Type of pain. 
 
 
 
Scoring for the type of pain described by the participant indicated that the theme was most often not 
raised during the consultation. When the theme was raised a discussion ensued on 25% of 
occasions and a solution, whether partial of complete on only 12% of the possible opportunities.  
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11.4 Timing and duration of pain. 
 
All phase 2 participants again raised the timing and duration of their pain as significant during the 
phase 1 interviews. The results are summarised in the pie chart below (Chart 4).  
 
Chart 4: Timing and duration of pain. 
 
 
 
Scoring for the timing and duration of pain, again a subtheme of known importance to all 
participants, indicated that the theme was most often not raised during the consultation. Where it 
was raised, the consulting nurse offered a solution of some form on 15% of opportunities. 
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11.5 Use and effectiveness of analgesia. 
 
All phase 2 participants raised the use and effectiveness of analgesia as significant during the phase 
1 interviews. The results are summarised in the pie chart below (Chart 5).  
 
Chart 5: Use and effectiveness of analgesia. 
 
 
 
Scoring for the use and effectiveness of analgesia, again a subtheme of known importance to all 
participants indicated that the theme was most often not raised during the consultation. Where it was 
raised, the consulting nurse offered a solution of some form on 15% of opportunities. 
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11.6 Advice on pain management. 
 
Three of the five phase 2 participants raised advice on pain management during their phase 1 
interview. The results are summarised in the pie chart below (Chart 6).  
 
Chart 6: Advice on pain management. 
 
 
 
Scoring for advice on pain management during the consultation, of known importance to three of the 
participants, indicated that the theme was frequently not raised during the consultation. Where it was 
raised, the consulting nurse offered a complete solution on 42% of opportunities. 
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11.7 Comfort of the dressing. 
 
Again, three of the five phase 2 participants stressed the importance of their dressing being 
comfortable during their phase 1 interview. The results are summarised in the pie chart below (Chart 
7).  
 
Chart 7: Comfort of the dressing. 
 
 
 
Scoring for the comfort of the dressing indicated that the theme was most often discussed during the 
consultation. Where it was raised, the consulting nurse offered a solution of some form on 33% of 
opportunities. 
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11.8  Discomfort during the procedure. 
 
The final subtheme of pain referred to discomfort during the dressing procedure and was stressed as 
important by three participants during their phase 1 interview. The results are summarised in the pie 
chart below (Chart 8).  
 
Chart 8: Discomfort during the procedure. 
 
 
 
Scoring for discomfort during the dressing procedure indicated that the theme was most often not 
raised during the consultation. Where it was raised, the consulting nurse offered a solution of some 
form on 25% of opportunities. 
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11.9 Exudate.  
 
Four of the five phase 2 participants raised exudate during their phase 1 interview. Results are 
summarised in the pie chart below (Chart 9).  
 
Chart 9: Exudate. 
 
 
 
Scoring for the subtheme of exudate, of importance to four of the five participants, indicated that the 
theme was most often fully addressed and was rarely not raised.  
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11.91 Odour. 
 
Three of the five phase 2 participants raised odour during their phase 1 interview. Results are 
summarised in the pie chart below (Chart 10).  
 
Chart 10: Odour. 
 
 
 
Scoring for odour indicated that the theme was most often not raised during the consultation. Where 
it was raised, the consulting nurse offered a partial solution on 8% of opportunities. A complete 
solution was not offered. 
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11.92  Depression. 
 
Two of the five phase 2 participants raised depression during their phase 1 interview. The results are 
summarised in the pie chart below (Chart 11).  
 
Chart 11: Depression. 
 
 
 
Scoring for depression, a subtheme of known importance to two of the participants, indicated that the 
theme was most often not raised during the consultation. Where it was raised, the consulting nurse 
most often discussed the issues rather than offering a solution.  
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11.93 Self-image. 
 
One of the five phase 2 participants raised self-image issues during their phase 1 interview. Results 
are summarised in the pie chart below. 
 
11.94 Fears and concerns. 
 
Three patients in raised fears during their phase 1 interview.  Fears included the fears and concerns, 
fear of recurrence and fears of people’s reactions. Results are summarised in the pie chart below 
(Chart 12).  
 
Chart 12: Fears and concerns. 
 
 
 
Scoring for fears and concerns that the theme was often not raised during the consultation. Where it 
was raised, the consulting nurse discussed the issues on 42% of occasions. A solution, whether 
partial or complete, was never offered. 
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11.95 Update on the wound. 
 
One of the five phase 2 participants raised having an update on the progress of their wound during 
their phase 1 interview. Results are summarised in the pie chart below (Chart 13). 
 
Chart 13: Update on the wound. 
  
 
 
Scoring for a wound update indicated that a full solution was offered on 75% of the opportunities 
presented.   
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11.97 Nurse advice. 
 
All five of the phase 2 participants emphasised the need for advice from the nurse during their phase 
1 interview. Results are summarised in the pie chart below (Chart 144).  
 
Chart 14: Nurse advice. 
 
 
 
Scoring for nurse advice, again a subtheme of known importance to all participants, indicated that 
the theme was always raised and a solution was offered on 65% of occasions.  
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11.98 Patient knowledge and understanding. 
 
Two of the phase 2 participants emphasised the importance of understanding their treatment during 
their phase 1 interviews. These results are summarised in the pie chart below (Chart 15).  
 
Chart 15: Patient knowledge and understanding. 
 
 
 
Scoring for patient knowledge and understanding indicated that the theme was discussed most often 
during the consultation. Where it was raised, the consulting nurse offered a solution of some form on 
38% of opportunities. 
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11.99 Opportunities for work and leisure. 
 
Two of the phase 2 participants emphasised the importance of work and leisure during their phase 1 
interview). These results are summarised in the pie chart below (Chart 16).  
 
Chart 16: Opportunities for work and leisure. 
 
 
 
Scoring for issues surrounding work and leisure indicated that the theme was most often discussed 
during the consultation. Solutions to the issues raised were not offered. A cue was overlooked by the 
nurse during a quarter of consultations. 
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11.991 Mobility. 
 
Three of the phase 2 participants emphasised the importance of their mobility during their phase 1 
interview. These results are summarised in the pie chart below (Chart 17).  
 
Chart 17: Mobility. 
 
 
 
Scoring for issues relating to mobility indicated that the theme was most discussed with a solution 
only offered on 8% of occasions.  Again, a cue was overlooked during 25% of consultations. 
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11.992 Hygiene. 
 
Three of the phase 2 participants emphasised the importance of personal hygiene during their phase 
1 interview. These results are summarised in the pie chart below (Chart 18).  
 
Chart 18: Hygiene. 
 
 
 
Scoring for hygiene subtheme indicated a full solution to the issues raised was provided on 42% of 
opportunities. The theme was overlooked or not explored on 16% of occasions.  
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11.993 Clothes and shoes. 
 
Four of the phase 2 participants emphasised the importance of their choices with clothes and shoes 
during their phase 1 interview. These results are summarised in the pie chart below (Chart 19).  
 
Chart 19: Clothes and shoes. 
 
 
 
Scoring for problems with clothes and shoes indicated that the theme was most often discussed 
during the consultation.  
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11.994 Sleep. 
 
Four of the phase 2 participants emphasised the importance of sleep during their phase 1 interview. 
These results are summarised in the pie chart below (Chart 20).  
 
Chart 20: Sleep. 
 
 
 
Scoring sleep issues, a subtheme of known importance to four of the participants, indicated that the 
theme was most often not raised during the consultation. Where it was raised, the consulting nurse 
discussed or offered a partial solution during 12% of opportunities. 
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11.995 Relationships. 
 
Three of the phase 2 participants emphasised the importance of relationships during their phase 1 
interview. These results are summarised in the pie chart below (Chart 21).  
 
Chart 21: Relationships. 
 
 
 
Scoring for the subtheme of relationships indicated that it was most often discussed during the 
consultation.  
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Search results: Patient intervention literature review. 
 
Search Term AMED 
(NHS) 
BNI 
(NHS) 
CINAHL 
(NHS) 
EMBASE 
(NHS) 
Health 
Business 
Elite 
(NHS) 
HMIC 
(NHS) 
MEDLINE 
(NHS) 
Psyc 
INFO 
(NHS) 
All 
Health 
(Keele) 
RCN 
search 
Google 
Scholar 
Total 
1. consult* 2048 2048 21040 95893 44385 14101 71477 33888 240590 - - - 
2. intervent* 18560 6802 128587 582959 12183 14312 465556 19284
4 
878921 - - - 
3. 1 AND 2 339 68 2330 9854 211 763 7033 5187 24466 - - - 
4. patient 
centre* 
666 621 4055 31913 889 2881 19800 2101 7504 - - - 
5. 3 AND 4 6 3 50 287 1 45 177 0 91 - - - 
6. nurs* 7394 61049 307810 331739 29832 35589 309851 60639 1326623 - - - 
7. 5 AND 6 0 0 18 71 0 0 0 0 30 15 45 - 
Items selected: 1 2 10 13 0 9 20 0 18 5 30 108 
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Appendix 13: Quality appraisal of the literature (Hawker et al, 2002). 
 
Total Score:  <90 - Very Poor.  90-180 – Poor.   180-270 – Fair.   270-360 – Good.  
 
Author, year & 
location 
Abstract & 
title 
Introduction 
& aims 
Method & 
data 
Sampling Data analysis Ethics & bias Findings / 
results 
Transferability 
/generalisability 
Implications 
& usefulness 
Total Score  
(Range: 90-
360) 
Holmstrom, Larsson, 
Lindberg & 
Rosenqvist (2004)  
 
30 
 
 
20 
 
30 
 
20 
 
20 
 
 
20 
 
30 
 
20 
 
30 
 
220 (F) 
Ogden & Hoppe 
(1997)  
 
 
40 
 
30 
 
30 
 
30 
 
20 
 
20 
 
30 
 
30 
 
20 
 
250 (F) 
Pill, Stott, Rollnick & 
Rees (1998) 
  
 
40 
 
20 
 
20 
 
40 
 
30 
 
20 
 
30 
 
30 
 
20 
 
250 (F) 
Kinmonth, 
Woodcock, Griffin, 
Spiegal, Campbell 
(1998)  
 
40 
 
30 
 
40 
 
30 
 
40 
 
30 
 
30 
 
30 
 
30 
 
300 (G) 
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Appendix 15 
Patient letters, information leaflets & consent: nominal group meeting. 
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LREC Number: 10/H1203/13 Amendment number one 
 
 
Keele University School of Nursing and Midwifery, 
Clinical Education Centre, 
University Hospital of North Staffordshire NHS Trust, 
City General Site, 
Newcastle Road, 
Stoke-on-Trent. 
ST4 6QG. 
Tel: 01782 556605. 
 
 
 
 
Dear Sir or Madam, 
 
I am currently studying for a PhD and you have kindly taken part in my research that explores 
chronic venous leg ulceration and the impact that this condition has on quality of life. I now wish to 
invite you to comment on the completed consultation template. I have enclosed an information leaflet 
for you to read which outlines the study in more depth and also what will be required of you if you 
agree to take part. 
If you have any queries about the study, please do not hesitate to contact me on the above 
telephone number. If you do agree to take part then I would be very grateful if you could complete 
the enclosed consent form and return in the prepaid, addressed envelope within seven days. 
I am very grateful for your time and for the help that you can provide to this research project. 
Yours sincerely, 
 
 
 
Julie Green 
Lecturer in Nursing.  
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Version , Date: 14/03/20110. 
LREC Number: 10/H1203/13 Amendment number one 
 
 
Keele University School of Nursing and Midwifery, 
Clinical Education Centre, 
University Hospital of North Staffordshire NHS Trust, 
City General Site, 
Newcastle Road, 
Stoke-on-Trent. 
ST4 6QG. 
Tel: 01782 556605. 
 
 
Dear Sir or Madam,  
 
I am currently studying for a PhD. The research I am undertaking explores chronic venous leg 
ulceration and the impact on the patients’ quality of life. I have complete two phases of my research 
so far which has included interviewing patients who suffer from leg ulceration and observation of 
their consultations to explore the extent to which the factors they highlight as being important are 
addressed.  
I now wish to use the information gained, along with the literature available in this area, to formulate 
a new consultation template. I wish to invite you to be part of such a focus group, known as a 
nominal group. I enclose an information leaflet to provide full details of the study and a consent form 
for you to return if you wish to take part. Please complete these and return in the stamped addressed 
envelope provided, ideally within seven days. If you have any queries about the study, please do not 
hesitate to contact me on the above telephone number. 
I am very grateful for your time and for the help that you can provide to this research project. 
Yours sincerely, 
 
 
 
Julie Green 
Lecturer in Nursing.  
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Patient Information Leaflet. 
LREC Number: 10/H1203/13 Amendment number one 
 
 
Study Title: 
Chronic venous leg ulceration and health related quality of life. 
You are invited to take part in a research study.  
Before you decide, it is important for you to understand why the research is being done and what it 
will involve.  
Please take time to read the following information carefully and discuss it with friends, relatives and 
your District Nurse if you wish.  
If there is anything that is not clear or if you would like more information, please feel free to contact 
Julie Green at the School of Nursing and Midwifery, Keele University on 01782 556605. 
 
What is the purpose of the study? 
Many people in the UK suffer from leg ulcers. This research will explore the day-to-day effects of 
having a leg ulcer.  
 
Why have I been chosen? 
You have been invited to take part because you are currently receiving care from a District Nurse for 
your leg ulcer.  
 
Do I have to take part? 
You are free to decide if you wish to take part or not.  
If you do decide to take part, please complete the enclosed consent form and return it in the prepaid 
envelope provided within seven days.  
If you do decide to take part, you can withdraw at any time and without having to give a reason. This 
will not affect your treatment or the care for your leg ulcer. 
If you do not wish to take part, please simply destroy the enclosed literature and be assured that 
your care will not be affected.  
 
What will happen if I take part? 
If you agree to take part in the study, I will contact you to arrange a convenient time to meet with you 
to discuss the newly developed consultation template. This has been developed based on the 
patient interviews and observations that you were part of. By giving your input you will help to 
confirm that the new template accurately reflects the issues that are important to the patients with 
chronic venous leg ulcers.  
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What do I have to do? 
Simply complete and return the enclosed consent form and I will then contact you to arrange a visit 
to conduct the interview. 
 
What are the benefits of taking part? 
It is hoped that the information gathered during this study will provide an understanding of the day-
to-day lives of people with leg ulceration and may help to shape the care that is delivered in the 
future.   
 
What are the possible disadvantages or risks of taking part? 
There are no expected disadvantages or risks associated with taking part in this study. 
 
What if something goes wrong? 
I do not expect any problems to arise during this study.  
If you have a concern about any aspect of the study, you should speak to me, Julie Green, and I will 
do my best to answer your questions. I can be contacted on 01782 556605.   
If you remain unhappy about the research and/or wish to raise a complaint about any aspect of the 
way that you have been approached or treated during the course of the study please write to Nicola 
Leighton who is the University’s contact for complaints regarding research at the following address:- 
Nicola Leighton, Research Governance Officer, Research & Enterprise Services, Dorothy Hodgkin 
Building, Keele University, ST5 5BG. 
 
Will my taking part be kept confidential? 
All of the information collected during this study will be kept strictly confidential.  
Your name and address will be removed from all documents and any other identifying information, 
including the consent form, will be kept in a locked drawer in a lockable office. Some information 
may be stored on a computer, but this will be protected by a password known only to myself.   
 
What will happen to the results of the research study? 
This research will form part of a PhD study. No one will be identifiable in the completed thesis. 
 
Who is organising and funding this research? 
This research is a student project for a PhD. It has no funding available from any organisations or 
drug companies. Most of the work will be done in my own time. 
 
Thank you for your time in reading this information sheet.  
If you agree to take part in this study, please complete the enclosed consent form. 
 
Many thanks, 
 
Julie Green 
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Nominal Group Information Leaflet. 
Version 1, Date: 14/03/2011. 
LREC Number: 10/H1203/13 Amendment number one 
Study Title: 
Chronic venous leg ulceration and health related quality of life. 
You are being invited to take part in a research study.  
Before you decide, it is important for you to understand why the research is being done and what it 
will involve.  
Please take time to read the following information carefully and discuss it with your colleagues.  
If there is anything that is not clear or if you would like more information, please feel free to contact 
Julie Green at the School of Nursing and Midwifery, Keele University on 01782 556605. 
 
What is the purpose of the study? 
Leg ulceration affects many thousands of people in the UK. Dressing products and techniques are 
frequently reviewed but the impact of the ulceration on the day-to-day life of the sufferer is often 
overlooked. This research aims to explore the lived experience of a number of patients who suffer 
from leg ulcers. 
 
Why have I been chosen? 
The research has involved interviewing a number of patients who have chronic venous leg ulcers 
and observing their care over a four week period. This information, along with themes from the 
literature, will now be developed into a new consultation template. You have been asked to take part 
in a short focus group, known as a nominal group, to aid in the development of this template.  
 
Do I have to take part? 
You are free to decide if you wish to take part.  
If you do decide to take part, please complete the enclosed consent form and return it in the prepaid 
envelope provided within seven days.  
If you do not wish to take part, please simply destroy the enclosed literature.  
 
What will happen if I take part? 
If you do decide to take part in the study, I will ask that you to attend a short nominal group lasting 
approximately 90 minutes at the School of Nursing and Midwifery at Keele University, where I will 
present the findings from the project to date, both interviews and observations, along with themes 
from the literature.  
During this group, a number of nurses with experience in this area of wound care, will discuss and 
come to some consensus as to the content of a new consultation template for chronic venous leg 
ulceration. Following this meeting, two patients who have been involved in the study will have the 
opportunity to review the template. Should this result in any recommendations for the template to be 
amended, this will be communicated to you via email for further comment. The finalised template will 
then be piloted in the next phase of my project. 
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What do I have to do? 
If you decide to take part in the study, please complete and return the enclosed consent form in the 
prepaid envelope provided within seven days.  
I will then contact you to arrange to visit to provide an overview of the study. 
 
What are the benefits of taking part? 
It is the aim that the information gathered from this study will give an insight into the day-to-day lives 
of people suffering from venous leg ulceration and, as a result, may be used to make 
recommendations about future care that is delivered. This, however, is not a guaranteed outcome.   
 
What are the possible disadvantages or risks of taking part? 
There are no expected disadvantages or risks associated with taking part in this study. 
 
What if something goes wrong? 
I do not expect any problems to arise during this study.  
If you have a concern about any aspect of the study, you should speak to me, Julie Green, and I will 
do my best to answer your questions. I can be contacted on 01782 556605.   
If you remain unhappy about the research and/or wish to raise a complaint about any aspect of the 
way that you have been approached or treated during the course of the study please write to Nicola 
Leighton who is the University’s contact for complaints regarding research at the following address:- 
Nicola Leighton, Research Governance Officer, Research & Enterprise Services, Dorothy Hodgkin 
Building, Keele University, ST5 5BG. 
 
Will my taking part be kept confidential? 
All of the information collected during this study will be kept strictly confidential.  
Your name and address will be removed from all documents and any other identifying information, 
including the consent form, will be kept in a locked drawer in a lockable office. Some information 
may be stored on a computer, but this will be protected by a password known only to myself.   
 
What will happen to the results of the research study? 
This research will form part of a PhD study. No one will be identifiable in this piece of work. 
 
Who is organising and funding this research? 
This research is a student project for a PhD. It has no funding available from any organisations or 
drug companies. Most of the work will be done in my own time. 
 
Thank you for your time in reading this information sheet.  
If you agree to take part in this study, please complete the enclosed consent form and return in the 
prepaid envelope provided within seven days. 
Many thanks,  
Julie Green 
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Patient Consent Form. 
Version 1, Date: 14/01/2010. 
LREC Number:  10/H1203/13 Amendment one. 
 
Title of Project: Does a patient focus to consultations in chronic venous leg ulcer care 
improve patient satisfaction and health related quality of life? 
Name of Researcher: Julie Green. 
          Please Tick. 
 
1. I confirm that I have read and understood the information leaflet and have  
had the opportunity to ask questions...................................................................... 
 
2. I understand that my participation is voluntary, that I can refuse to answer 
a question, or withdraw at any time, without giving a reason, and without my  
medical care or legal rights being affected.............................................................. 
 
3. I agree to review and comment on the newly developed consultation template 
................................................................................................................................ 
 
4. I understand that data collected during the study may be looked at by                                                                         
individuals from regulatory authorities or from the NHS Trust, where it is                                                                                              
relevant to my taking part in this research. I give permission to these                                               
individuals to have access to my records................................................................. 
 
Please sign and date on the line below: 
 
------------------------------   ---------------------------  --------------------------- 
Name of Patient     Date    Signature 
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-----------------------------------------   ---------------------------  ------------------------ 
Name of Researcher    Date    Signature 
 
 
Please provide me with your contact details below: 
Your full name, address and telephone number. 
 
Name:.............................................................................................................. 
Address:......................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
Telephone number:....................................................................................... 
 
 
 
Thank you for your help with this research study. 
If you have any further questions about this study, you can me, Julie Green, on 01782 556605. 
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District Nurse Consent Form. 
Version 1, Date: 14/03/2011. 
LREC Number: 10/H1203/13 : Amendment One.  
    
 
Title of Project: Does a patient focus to consultations in chronic venous leg ulcer care 
improve patient satisfaction and health related quality of life? 
Name of Researcher: Julie Green. 
          Please Tick. 
1. I confirm that I have read and understood the information leaflet and have  
had the opportunity to ask questions...................................................................... 
 
2. I understand that my participation is voluntary, that I can refuse to answer 
a question, or withdraw at any time, without giving a reason.................................. 
 
3. I agree to take part in the nominal group to develop the new consultation                                        
template...............................................................  
 
4. I am aware that notes will be taken during this meeting……………………… 
 
5. I agree to being contacted by email should any recommendations be made                                                                      
following patient review of the new template...................................................... 
 
6. I understand that data collected during the study may be looked at by                                                                         
individuals from regulatory authorities or from the NHS Trust, where it is                                                                                              
relevant to my taking part in this research. I give permission to these                                               
individuals to have access to my records................................................................. 
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-------------------------------   ---------------------------  --------------------------- 
Name of District Nurse    Date    Signature 
 
 
 
---------------------------------  ---------------------------  --------------------------- 
Name of Researcher    Date    Signature 
 
 
Please provide me with your work contact details below: 
 
Your full name, work address and telephone number. 
Name:.............................................................................................................. 
Work Address:......................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
Work Telephone number:....................................................................................... 
 
 
 
Thank you for your help with this research study. 
If you have any further questions about this study, you can telephone me, Julie Green, on 01782 
556605. 
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Appendix 16: Nominal group minutes. 
 
What are the factors that impact on the day-to-day lives of people with  
leg ulcers and do we address these during patient consultations? 
 
Nominal Group – 8th July 2011, Keele Management Centre. 
 
 
Meeting minutes recorded by DM. 
 
1. Meeting began with introductions and a brief explanation of the purpose of the meeting. 
 
2. JG gave a short presentation of the findings of the study to date. She outlined the themes 
from the patient interviews and the findings from the period of observation of the 
participant’s current consultations. She stated that on 52% of occasions patient’s failed to 
raise the issues that impacted on their quality of life. Nurses performed better when the 
needs of the patient were related to physical issues rather than when these were of a 
psychological or social nature. JG had provided attendees with laminated copies of the 
themes in order to discuss which should be included in the final template and circulated 3 
draft copies of template designs as a starting point. 
 
3. MW suggested the inclusion of nutritional needs/assessment, which had not currently been 
included. All members agreed that this would be an important additional area which is often 
overlooked. Issues with nutrition could arise due to pain, lack of sleep, etc. and as a result 
would lead to further exploration of potential issues that were impacting on quality of life. 
MUST tool was mentioned and the use of PROCAL shots to enhance patient nutritional 
intake. 
 
4. JG mentioned that the theme of itching was prevalent in the literature but had not come out 
as a theme from the interviews/observations. JG asked whether reference to itching should 
be included. SM urged that this not be included directly as where a patient was not 
experiencing this symptom, just mentioning it may make encourage them focus on itching in 
the future. It was agreed that this, if it was an issue, would arise in some of the patient’s 
responses in other areas and then could be explored further. 
 
5. JG asked whether it was necessary to include a pain scale and if so, which one (copies of a 
number of scales were made available). All agreed that the inclusion of a scale was not 
necessary as a pain score is used within the general patient notes. All felt it was important to 
ascertain whether pain was deteriorating or improving. 
 
6. SM commented that sections to be completed appeared too long in the draft templates and 
suggested that tick boxes would be better and more likely to be completed accurately. 
 
7. SR recommended the inclusion of the term assessment within the tool, emphasising that 
explicit words would encourage actual assessments to be undertaken by the consulting 
nurses. 
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8. DG and HS both commented that the DN service is very restricted at the moment with visits 
limited to 10 minutes for a patient with bilateral 4 layer bandaging and suggested that for this 
template to be applied, it needs to be quick and easy to complete.  
 
9. SM and HS commented that commissioners simply wanted the physical needs of the patient 
addressing, rather than using additional time looking at other needs of the patient. SR 
commented that there appeared to be a huge gap between this model of delivery and the 
need for prevention and education to heal and prevent recurrence of ulcers.  
 
10. SR and DM urged that the tool needed to be holistic, not just clinical to avoid the 
psychological aspects of care from being overlooked. These factors would all lead into 
prevention and influence the cost implications of care delivery. From discussions it appears 
that commissioners are driving quantity and not quality, which this study may inform. The 
costing of such improvements need to be addressed. SM mentioned both QUIPP and 
CQUIN targets which next year will focus on leg ulceration. 
 
11. SM asked where the patient voice fitted in with the template development. JG explained that 
she was planning to return to patients once the template had been agreed at this meeting to 
get their comments and suggestions. 
 
12. SR again stressed the importance of having assessment in the template. SR also suggested 
a problem solving area as not all of the issues identified would be addressed or ‘solved’ 
during every consultation. These would serve to raise awareness for the nurse and alert 
them to particular areas that required attention. 
 
13. DJ stressed the need for the template to be simple as time is of the essence due to the 
restrictions on the service. 
 
14. SM suggested to remove the section entitled ‘record your advice’ into an overall nurse 
advice section at the end of the template.  
 
15. In terms of Wound Management, SM argued that these areas should all be addressed 
anyway and included in the patient notes so she suggested replacing with a simple Yes/No 
tick box. HS agreed with this.  
 
16. SM also suggested that pain could be a tick box and a question asked of whether analgesia 
offered or an alternative suggested. Sleeping – suggested a question of ‘Where are you 
sleeping? Are you sleeping well?’ What stops you sleeping?’. Direct, simple questions to the 
patient that many DNs ask anyway but maybe do not clearly address currently. 
 
17. SM suggested to start with the wound management whereas SR disagreed and felt that it 
should start with the psychological in order to enhance the importance of this area. After 
some discussion everyone agreed that wound management could come towards the end. 
 
18. All agreed that one sheet for the template was a maximum. 
 
19. SM suggested linking questions: mobility – are you able to get out and about? SM felt that 
such leading questions would be quick but also would reveal where problems lay, eg. What 
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did you do prior to the ulcer? Are you able to do what you did before? What stops you doing 
the things that you like?  Almost trigger questions. 
 
20. SM suggested of using a scribe to assist nurses to complete the form – JG said that this was 
unlikely as no funding but she would look into it. 
 
21. SM suggested linking pain to nutrition and sleep as they are all factors that influence each 
other, eg. Are you sleeping well? If not, why? Are you eating a normal diet? Why not? Pain, 
has this improved since your last visit? Do you take analgesia regularly? 
 
22. Also suggested and agreed to link personal hygiene (are you managing to shower or 
bathe?), to clothes (can you dress and wear the same shoes as before you had your ulcer?) 
and to tie fears into emotional issues – how are you feeling today? 
 
23. It was agreed to put exudate and odour into the wound management section as this would 
be covered and documented along with the wound assessment. MW suggested responses 
to exudate and odour may prompt the nurse to reassess the need for change in dressing 
and frequency of visits. To include a tick box for this. 
 
24. To include an additional information box at the end of the template (or ?problem solving) and 
a small comments box for each of the questions, following the tick box. 
 
25. SM suggested including a question about would it be beneficial to have a leaflet explaining 
how to manage with ulcers? 
 
26. All agreed with the need for completion guidance notes to prompt the nurse on the back of 
the template. 
 
27. SM suggested gaining the signature of the patient and the nurse at the end of the form. Also 
a suggestion of the patient and/or carer completing the ADLs section together maybe prior 
to the nurse visit. 
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Appendix 17 
Consultation template. 
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Appendix 18 
Copy of Consultation Satisfaction Questionnaire (CSQ). 
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Appendix 18: Copy of CSQ 
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Appendix 19 
Copy of SF-12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
393 
 
 
Appendix 19: Copy of the SF-12 
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Appendix 20 
Copy of EuroQoL-5D. 
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Appendix 20: Copy of the EuroQol 5D 
 
Under each heading, please tick the ONE box that best describes your health TODAY  
 
MOBILITY 
I have no problems in walking about      
I have slight problems in walking about     
I have moderate problems in walking about     
I have severe problems in walking about      
I am unable to walk about        
 
SELF-CARE 
I have no problems washing or dressing myself    
I have slight problems washing or dressing myself    
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself     
I am unable to wash or dress myself      
 
USUAL ACTIVITIES (e.g. work, study, housework,  
family or leisure activities) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities    
I have moderate problems doing my usual activities     
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I have severe problems doing my usual activities     
I am unable to do my usual activities       
 
PAIN / DISCOMFORT 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
 
ANXIETY / DEPRESSION 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed     
I am severely anxious or depressed       
I am extremely anxious or depressed       
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 We would like to know how good or bad your health is  
TODAY. 
 This scale is numbered from 0 to 100. 
 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
 Mark an X on the scale to indicate how your health is 
TODAY.  
 Now, please write the number you marked on the scale 
in the box below.  
                     
 
 
 
YOUR HEALTH TODAY  = 
 
 
 
 
 
 
 
 
 
 
 
 
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
The best health        
 you can imagine 
 
The worst health        
 you can imagine 
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Appendix 21 
Copy of the Cardiff Wound Impact Schedule (CWIS). 
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Appendix 21: Copy of the Cardiff Wound Impact Schedule 
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Appendix 22 
Ethical approval phase 3. 
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South Staffordshire Local Research Ethics Committee 
Medical Institute 
Hartshill Road 
Hartshill 
Stoke-on-Trent 
Staffordshire 
ST4 7NY 
 
Telephone: 01782 714980  
Facsimile: 01782 714975 
11 March 2010 
 
Mrs Julie Green 
Lecturer in Nursing 
Keele University 
School of Nursing and Midwifery 
Clinical Education Centre,  
UHNS,  
Stoke-on-Trent 
ST4 6QG 
 
 
Dear Mrs Green 
 
Study Title: Does a patient focus to consultations in chronic venous 
leg ulcer care improve patient satisfaction and health 
related quality of life? (v2) 
REC reference number: 10/H1203/13 
Protocol number: 6 
 
The Research Ethics Committee reviewed the above application at the meeting held on 
03 March 2010. Thank you for attending to discuss the study.  The coordinator explained 
that the Committee did not need to see you. 
 
Ethical opinion 
 
The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation, subject to the conditions specified below. 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start 
of the study (see “Conditions of the favourable opinion” below). 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 
Management permission or approval must be obtained from each host organisation prior 
to the start of the study at the site concerned. 
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For NHS research sites only, management permission for research (“R&D approval”) 
should be obtained from the relevant care organisation(s) in accordance with NHS 
research governance arrangements.  Guidance on applying for NHS permission for 
research is available in the Integrated Research Application System or at 
http://www.rdforum.nhs.uk. Where the only involvement of the NHS organisation is as a 
Participant Identification Centre, management permission for research is not required but 
the R&D office should be notified of the study. Guidance should be sought from the R&D 
office where necessary. 
 
Sponsors are not required to notify the Committee of approvals from host organisations. 
 
Other conditions specified by the REC  
 
The Committee was content to give a favourable opinion of phases one and two of the 
application with the following condition/s:  
   
1. The reference to training in the information sheet for the district nurses should be 
removed as it relates to phase three  
   
2. In the information sheets participants are asked three times to “please complete 
the enclosed consent form and return in the prepaid envelope provided within 
seven days”.  The phrase is also included in the letters of invitation.  Such 
repetition is unnecessary and should be taken out.  
   
The Committee decided that phases one and two follow on naturally but phase three will 
require a separate application as, until phases one and two have been completed, there is 
insufficient detail relating to phase three to enable a decision to be made.  
 
It is responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 
Approved documents 
 
The documents reviewed and approved at the meeting were: 
  
Document    Version    Date      
Covering Letter    10 February 2010    
REC application    10 February 2010    
Protocol  6  25 January 2010    
Investigator CV    24 November 2009    
Participant Information Sheet: Phase 1 & 2  2  14 January 2010    
Participant Information Sheet: Phase 1 & 2 District Nurse  2  14 January 2010    
Participant Information Sheet: Phase 3  2  14 January 2010    
Participant Information Sheet: Phase 3 District Nurse  2  14 January 2010    
Participant Consent Form: Phase 1 & 2  3  14 January 2010    
Participant Consent Form: Phase 1 & 2 District Nurse  3  14 January 2010    
Participant Consent Form: Phase 3  3  14 January 2010    
Participant Consent Form: Phase 1 & 2 District Nurse  3  14 January 2010    
Evidence of insurance or indemnity    24 July 2009    
Letter from Sponsor    30 November 2009    
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Referees or other scientific critique report    23 October 2009    
Questionnaire: Community Nurse Satisfaction         
Questionnaire: Medical Outcome short form         
Questionnaire: Cardiff Wound Impact Schedule         
CV Professor Jester    18 November 2009    
Letter of Invitation Phase 1 & 2  3  14 January 2010    
Letter of Invitation Phase 1 & 2 District Nurse  3  14 January 2010    
Letter of Invitation Phase 3  3  14 January 2010    
Interview Schedules/Topic Guides  2  25 January 2010    
Letter of Invitation Phase 3 District Nurse  3  14 January 2010    
Full Study Flow Chart  5  10 February 2010    
Phase 1 Flow Chart  2  10 February 2010    
Phase 2 Flow Chart  2  10 February 2010    
Phase 3 Flow Chart  4  10 February 2010    
Unfavourable Opinion Letter    12 January 2010    
 
Membership of the Committee 
 
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet. 
 
Statement of compliance  
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
 
Now that you have completed the application process please visit the National Research 
Ethics Service website > After Review 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure. If you wish to make your views 
known please use the feedback form available on the website. 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Progress and safety reports 
 Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
We would also like to inform you that we consult regularly with stakeholders to improve 
our service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk. 
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10/H1203/13 Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project 
 
Yours sincerely 
 
Professor Tim Reynolds 
Chair 
 
Email: Janet.Clarke@uhns.nhs.uk 
 
Enclosures: List of names and professions of members who were present at the 
meeting and those who submitted written comments 
“After ethical review – guidance for researchers”  
 
Copy to: Nicola Leighton, Research and Enterprise Services, Keele University 
Nemonie Marriot, Research and Development, North Staffordshire and 
Stoke-on-Trent PCT 
Professor R Jester, School of Nursing, Keele University, Clinical 
Education Centre, UHNS, Stoke-on-Trent, ST4 6QG 
 
South Staffordshire Local Research Ethics Committee 
 
Attendance at Committee meeting on 03 March 2010 
  
Committee Members:  
 
Name   Profession   Present    Notes      
Mrs Sandra Chambers   Head Teacher (Retired)  Yes      
Mr  Robert Edgar  Engineer (Retired)  Yes      
Dr  Nitin Gupta  Consultant Psychiatrist  Yes      
Dr Brian Hynam  Retired Director of Pharmacy 
Services  
Yes      
Dr  Kathryn Kinmond  Senior Lecturer  Yes      
Dr Arabinda Kundu  Head of Contraceptive & Sexual 
Health Service  
Yes      
Dr Diarmuid Mulherin  Consultant Rheumatologist  Yes      
Dr Laofe Oladele Ogundipe  Consultant Psychiatrist  Yes      
Professor Tim Reynolds  Consultant Chemical 
Pathologist  
Yes      
Dr Sandie Sandbrook  Senior Lecturer  Yes      
Mr Victor Scofield  Legal Advisor, Banking 
(Retired)  
Yes      
  
Also in attendance:  
 
Name   Position (or reason for attending)     
Mrs Barbara Cannings  Coordinator    
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Appendix 23 
Phase 3 R&D approval. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
411 
 
 
 
 
 
 
412 
 
 
 
 
 
413 
 
 
 
 
 
Appendix 24 
Participant letters, information leaflet and consent: phase 3. 
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Version 4, Date: 04/10/11. 
LREC Number: 11/WM/0264. 
 
 
 
Keele University School of Nursing and Midwifery, 
Clinical Education Centre, 
University Hospital of North Staffordshire NHS Trust, 
City General Site, 
Newcastle Road, 
Stoke-on-Trent. 
ST4 6QG. 
Tel: 01782 679605. 
 
 
 
 
 
 
Dear Sir or Madam, 
 
I am currently studying for a PhD. The research I am undertaking explores chronic venous leg 
ulceration and the impact on the patients’ quality of life. I have enclosed an information leaflet for you 
to read which outlines the pilot study in more depth and also what will be required of you if you agree 
to take part. 
If you have any queries about the study, please do not hesitate to contact me on the above 
telephone number. If you do agree to take part then I would be very grateful if you could complete 
the enclosed consent form and contact details and return, in the prepaid, addressed envelope within 
seven days. 
I am very grateful for your time and for the help that you can provide to this research project. 
Yours sincerely, 
 
 
Julie Green 
Lecturer in Nursing.  
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Version 5, Date: 04/10/11. 
LREC Number: 11/WM/0264. 
 
Keele University School of Nursing and Midwifery, 
Clinical Education Centre, 
University Hospital of North Staffordshire NHS Trust, 
City General Site, 
Newcastle Road, 
Stoke-on-Trent. 
ST4 6QG. 
Tel: 01782 679605. 
 
 
 
 
Dear District Nurse, 
 
I am currently studying for a PhD. The research I am undertaking is a pilot study and explores 
chronic venous leg ulceration and the impact this has on the patients’ quality of life. You have been 
selected to take part in this pilot study.  
I enclose an information leaflet to provide you with the full details of the study and have also 
attached a consent form for you. Before you decide, it is important that you understand why the 
research is being done and what it will involve. Please take time to read the information carefully and 
discuss it with your colleagues. If you do decide to take part, please complete the enclosed consent 
form and return it in the prepaid envelope provided within seven days. If you do not wish to take part, 
please simply destroy the enclosed literature.  
 
If you have any queries about the study, please do not hesitate to contact me on the above 
telephone number. I am very grateful for your time and for the help that you can provide to this 
research project. 
Yours sincerely, 
 
 
Julie Green    
Lecturer in Nursing.  
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Patient Information Leaflet. 
Version 5, Date: 04/10/11. 
LREC Number: 11/WM/0264. 
 
 
Study Title: 
Chronic venous leg ulceration and health related quality of life – pilot study. 
You are invited to take part in a research study.  
Before you decide, it is important for you to understand why the research is being done and what it 
will involve.  
Please take time to read the following information carefully and discuss it with friends, relatives and 
your District Nurse if you wish.  
If there is anything that is not clear or if you would like more information, please feel free to contact 
Julie Green at the School of Nursing and Midwifery, Keele University on 01782 679605. 
 
What is the purpose of the study? 
Many people in the UK suffer from leg ulcers. This research will explore the day-to-day effects of 
having a leg ulcer.  
 
Why have I been chosen? 
Your District Nurse has been selected to take part in this study. The study will look at the patients 
they see who have leg ulcers. You have been selected as one of the patients currently receiving 
care for your leg ulcer. 
 
Do I have to take part? 
You are free to decide if you wish to take part or not.  
If you do decide to take part, please complete the enclosed consent form and return it in the prepaid 
envelope provided, ideally within seven days.  
If you do decide to take part, you can withdraw at any time and without having to give a reason. This 
will not affect your treatment or care for your leg ulceration. 
If you do not wish to take part, please simply destroy the enclosed literature and be assured that 
your care will not be affected.  
 
What will happen if I take part? 
If you agree to take part in the study, I will contact you to arrange a convenient time to visit to 
complete four simple questionnaires about your condition. This visit will take around 15 minutes.  
I will repeat this visit and the same questionnaires on another 3 occasions at 6 week intervals. All of 
these visits will be arranged at a time convenient to yourself.  
During these visits, in the unlikely event of distress about nursing care or poor practice being 
disclosed I will be duty bound to report this, in accordance with the requirements of the Code of 
Conduct (NMC, 2008). 
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What do I have to do? 
If you decide to take part you, please complete the enclosed consent form and return it in the 
prepaid envelope provided within seven days.  
I will then contact you to arrange the first visit to complete the questionnaires. 
 
What are the benefits of taking part? 
It is hoped that the information gathered during this study will provide an understanding of the day-
to-day lives of people with leg ulceration and may help to shape the care that is delivered in the 
future.   
 
What are the possible disadvantages or risks of taking part? 
There are no expected disadvantages or risks associated with taking part in this study. 
 
What if something goes wrong? 
I do not expect any problems to arise during this study.  
If you have a concern about any aspect of this study, you should speak to me, Julie Green, and I will 
do my best to answer your questions. I can be contacted on 01782 679605.   
If you remain unhappy about the research and/or wish to raise a complaint about any aspect of the 
way that you have been approached or treated during the course of the study please write to Nicola 
Leighton who is the University’s contact for complaints regarding research at the following address:- 
Nicola Leighton, Research Governance Officer, Research & Enterprise Services, Dorothy Hodgkin 
Building, Keele University, ST5 5BG. 
 
Will my taking part be kept confidential? 
All of the information collected during this study will be kept strictly confidential.  
Your name and address will be removed from all documents and any other identifying information, 
including the consent form, will be kept in a locked drawer in a lockable office. Some information 
may be stored on a computer, but this will be protected by a password known only to myself.   
 
What will happen to the results of the research study? 
This research will form part of a PhD study. No one will be identifiable in this piece of work. 
 
Who is organising and funding this research? 
This research is a student project for a PhD. It has no funding available from any organisations or 
drug companies. Most of the work will be done in the researchers own time. 
 
Thank you for your time in reading this information sheet.  
If you agree to take part in this study then please complete the enclosed consent form and return in 
the prepaid envelope provided within seven days. 
 
  
Many thanks, 
Julie Green 
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District Nurse Information Leaflet. 
Version 5, Date: 04/10/11. 
LREC Number: 11/WM/0264. 
 
 
Study Title: 
Chronic venous leg ulceration and health related quality of life – pilot study. 
You are invited to take part in a research study.  
Before you decide, it is important for you to understand why the research is being done and what it 
will involve.  
Please take time to read the following information carefully and discuss it with your colleagues.  
If there is anything that is not clear or if you would like more information, please feel free to contact 
Julie Green at the School of Nursing and Midwifery, Keele University on 01782 679605. 
 
What is the purpose of the study? 
Leg ulceration affects many thousands of people in the UK. Dressing products and techniques are 
regularly reviewed but the impact of the ulceration on the day-to-day life of the sufferer is often 
overlooked. This research aims to explore the lived experience of a number of patients who suffer 
from leg ulcers. 
 
Why have I been chosen? 
You have been selected to take part in the study because you regularly see patients with leg 
ulceration. This selection has included all of the District Nursing Teams within your Primary Care 
Trust.  
 
Do we have to take part? 
You are free to decide if you wish to take part or not. 
If you do decide to take part, please complete the enclosed consent form and return it in the prepaid 
envelope provided, ideally within seven days.  
If you do not wish to take part, please simply destroy the enclosed literature.  
 
What will happen if we take part? 
If you decide to take part, I will arrange a short visit to explain your involvement in the study, at a 
time convenient to you.  
I will then ask you to distribute a study pack to all of patients on your caseload who suffer from 
chronic venous leg ulceration. I will visit the patients who consent at the start of the study and after 6 
weeks, to undertake baseline scores of patient satisfaction and quality of life.  
I will then arrange to visit and train you and other consenting team members to implement a newly 
developed patient consultation template, developed as a result of earlier research that explored the 
day-to-day experiences of leg ulcer patients.  
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This training will take between 90-120minutes and will be delivered at a time convenient to you. 
Following this training and during the next 12 weeks of the study, members of staff from your team, 
who have agreed to take part, will implement the consultation template during each visit to the 
consented patients.  
Again all of the patients selected, with their consent, will complete patient satisfaction and quality of 
life questionnaires during a short visit from me after 6 weeks and finally after the 12 weeks.  
During these visits, in the unlikely event of distress about nursing care or poor practice being 
disclosed I will be duty bound to report this, in accordance with the requirements of the Code of 
Conduct (NMC, 2008). 
 
What do we have to do? 
If you decide to take part in the study, please complete and return the enclosed consent form in the 
prepaid envelope provided within seven days. I will then contact you to make arrangements to meet 
with you.  
 
What are the benefits of taking part? 
It is the aim that the information gathered from this study will determine whether focussing 
consultations for people with chronic ulceration on factors they deem to be important improves their 
health related quality of life and satisfaction. This, however, is not a guaranteed outcome.   
 
What are the possible disadvantages or risks of taking part? 
There are no expected disadvantages or risks associated with taking part in this study. 
 
What if something goes wrong? 
I do not expect any problems to arise during this study.  
If you have a concern about any aspect of the study, you should speak to me, Julie Green, and I will 
do my best to answer your questions. I can be contacted on 01782 670605.   
If you remain unhappy about the research and/or wish to raise a complaint about any aspect of the 
way that you have been approached or treated during the course of the study please write to Nicola 
Leighton who is the University’s contact for complaints regarding research at the following address:- 
Nicola Leighton, Research Governance Officer, Research & Enterprise Services, Dorothy Hodgkin 
Building, Keele University, ST5 5BG. 
 
Will my taking part be kept confidential? 
All of the information collected during this study will be kept strictly confidential.  
Your name and address will be removed from all documents and any other identifying information, 
including the consent form, will be kept in a locked drawer in a lockable office. Some information 
may be stored on a computer, but this will be protected by a password known only to myself.   
 
What will happen to the results of the research study? 
This research will form part of a PhD study. No one will be identifiable in this piece of work. 
 
Who is organising and funding this research? 
This research is a student project for a PhD and has been funded by a West Midlands Strategic 
Health Authority Award. 
Thank you for your time in reading this information sheet.  
If you agree to take part in this study, please complete the enclosed consent form and return in the 
prepaid envelope provided within seven days. 
Many thanks, 
Julie Green. 
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Patient Consent Form. 
Version 5, Date: 04/10/11. 
LREC Number: 11/WM/0264. 
  
 
Title of Project: Does a patient focus to consultations in chronic venous leg ulcer care 
improve patient satisfaction and health related quality of life – pilot study? 
Name of Researcher: Julie Green. 
          Please Tick. 
 
1. I confirm that I have read and understood the information leaflet and have  
had the opportunity to ask questions...................................................................... 
 
2. I understand that my participation is voluntary, that I can refuse to answer 
a question, or withdraw at any time, without giving a reason, and without my  
medical care or legal rights being affected.............................................................. 
 
3. I am happy for the researcher to visit me, at a time convenient to me, in order 
to complete some brief questionnaires..................................................................... 
 
4. I agree to take part in the above study................................................................... 
5. I understand that data collected during the study may be looked at by                                                                         
individuals from regulatory authorities or from the NHS Trust, where it is                                                                                              
relevant to my taking part in this research. I give permission to these                                               
individuals to have access to my records................................................................. 
 
 
Please sign and date on the line below: 
 
-----------------------------------------   ---------------------------  ------------------------ 
Name of Patient     Date    Signature 
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-----------------------------------------   ---------------------------  ------------------------ 
Name of Researcher    Date    Signature 
 
 
Please provide me with your contact details below: 
Your full name, address and telephone number. 
 
Name:.............................................................................................................. 
Address:......................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
Telephone number:....................................................................................... 
 
 
 
Thank you for your help with this research study. 
If you have any further questions about this study, you can telephone me, Julie Green, on 01782 
679605. 
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District Nurse Consent Form. 
Version 6, Date: 04/10/11. 
LREC Number: 11/WM/0264. 
  
 
Title of Project: Does a patient focus to consultations in chronic venous leg ulcer care 
improve patient satisfaction and health related quality of life – pilot study? 
Name of Researcher: Julie Green. 
          Please Tick. 
1. I confirm that I have read and understood the information leaflet and I have  
had the opportunity to ask questions...................................................................... 
 
2. I understand that my participation is voluntary, that I can refuse to answer 
a question or withdraw at any time, without giving a reason.................................. 
 
3. During the study, venous leg ulcer patients identified within my District  
Nursing caseload will be contacted to complete a number of questionnaires  
at 6 weekly intervals over 18 weeks. I agree to distribute study packs to patients  
with venous leg ulceration on the caseload........................................................... 
 
4. I understand that I will be trained to implement the new consultation template  
which will then be used on a weekly basis with the patient participants,  
over a 12 week period............................................................................................ 
 
 
5. I understand that data collected during the study may be looked at by                                                                         
individuals from regulatory authorities or from the NHS Trust, where it is                                                                                              
relevant to my taking part in this research. I give permission to these                                               
individuals to have access to my records................................................................. 
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-----------------------------------------   ---------------------------  ------------------------ 
Name of District Nurse      Date    Signature 
 
 
-----------------------------------------   ---------------------------  ------------------------ 
Name of Researcher    Date    Signature 
 
 
Please provide me with your work contact details below: 
Your full name, work address and telephone number. 
 
Name:.............................................................................................................. 
Work Address:......................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
......................................................................................................................... 
Work Telephone number:....................................................................................... 
 
 
 
Thank you for your help with this research study. 
If you have any further questions about this study, you can telephone me, Julie Green, on 01782 
679605. 
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Appendix 25 
Phase 3 Tests for Normality. 
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Appendix 25: Tests for normality. 
 
In order to decide the appropriate statistical analysis to apply to the study data it was necessary to 
assess the distribution of scores for their normality. If normality is demonstrated, parametric testing 
can be undertaken as opposed to the non-parametric equivalents, which are deemed to be less 
powerful. SPSS (IBM, xxxx) allows such exploration via the Explore command and the chart below is 
generated (Pallant, 200x). 
 
The Shapiro-Wilk Test of Normality is deemed to provide the more accurate assessment of normality 
where sample sizes are small, as is the case with this pilot study (n=9). Normality is assessed via its 
significance value. Where the Sig. value for this test is greater than 0.05, thus non-significant, the 
data are said to demonstrate normal distribution. If the significance is below 0.05, the data deviate 
significantly from normal distribution.  
 
When reviewing the results for the first data collection point (M1) for phase 3 using the Shapiro-Wilk 
Test of Normality; of the 13 scores generated, seven scores demonstrate normality and 6 deviate 
from normality. Although the parametric tests are more powerful than their non-parametric 
alternative, in such situations where results are variable in terms of their normality, it is always 
deemed acceptable to apply the non-parametric tests.  
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Table 1: Tests for Normality. 
 
 
 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
CONSULTATION 
SATISFACTION 
QUESTIONNAIRE - 
GENERAL SATISFACTION 
.242 9 .136 .819 9 .033 
CONSULTATION 
SATISFACTION 
QUESTIONNAIRE - 
PROFESSIONAL CARE 
.312 9 .012 .724 9 .003 
CONSULTATION 
SATISFACTION 
QUESTIONNAIRE - DEPTH 
OF RELATIONSHIP 
.308 9 .014 .748 9 .005 
CONSULTATION 
SATISFACTION 
QUESTIONNAIRE - 
PERCEIVED TIME 
.300 9 .019 .729 9 .003 
PHYSICAL COMPONENT 
SUMMARY 
.163 9 .200* .946 9 .643 
MENTAL COMPONENT 
SUMMARY 
.183 9 .200* .972 9 .908 
EQ 5D 5L CROSSWALK 
SCORE 
.144 9 .200* .948 9 .666 
EQ 5D 5L VAS SCORE .257 9 .088 .805 9 .023 
CWIS QOL SCORE .227 9 .199 .926 9 .447 
CWIS QOL SATISFACTION 
SCORE 
.150 9 .200* .943 9 .614 
CWIS WELL-BEING SCORE .190 9 .200* .946 9 .649 
CWIS PHYSICAL 
SYMPTOMS & DAILY LIVING 
SCORE 
.159 9 .200* .930 9 .485 
CWIS SOCIAL LIFE SCORE .300 9 .019 .815 9 .030 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 26 
Paired difference over the control period. 
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Appendix 26: Paired difference over the control period, % and actual change during Phase 3. 
 
 
 
 CSQGS CSQPC CSQDR CSQPT PCS MCS EQ5D EQVAS 
CWIS 
QoL 
CWIS 
sat 
CWIS 
WB 
CWIS 
PS 
CWIS 
SL 
L4P1 
+ 9% 
(8.33) 
-5% 
(-5) 
0% 
(0) 
0% 
(0) 
+11.68% 
(+4.3) 
+10.16% 
(+5.14) 
-10.97% 
(-0.062) 
+15.38% 
(+10) 
+16.67% 
(+1) 
+12.5% 
(-1) 
-12.49% 
(-7.14) 
+31.82% 
(+21.88) 
+16.67% 
(14.29) 
L4P2 
0% 
(0) 
0% 
(0) 
+5.27% 
(+5) 
0% 
(0) 
+54.94% 
(+10.56) 
-17.85% 
(-13.57) 
-19.58% 
(-0.159) 
+65.5% 
(+25) 
-25% 
(-2) 
-44.45% 
(-4) 
+26.58% 
(+13.29) 
+7.23% 
(+6.25) 
+9.8% 
(+8.93) 
L4P3 
0% 
(0) 
0% 
(0) 
0% 
(0) 
0% 
(0) 
+60.22% 
(+17.73) 
+0.08% 
(+0.05) 
-7.5% 
(-0.061) 
0% 
(0) 
0% 
(0) 
0% 
(0) 
+155.6% 
(+50) 
0% 
(0) 
+9.8% 
(+8.93) 
L4P5 
0% 
(0) 
0% 
(0) 
0% 
(0) 
+9.08% 
(+8.33) 
+2.33% 
(+0.98) 
-12.25% 
(-5.11) 
-12.6% 
(-0.08) 
+7.14% 
(+5) 
-20% 
(-1) 
-87.5% 
(-7) 
+151.5% 
(+21.51) 
+34.05% 
(+16.67) 
+4.35% 
(+3.57) 
L5P1 
-37.5% 
(-25) 
0% 
(0) 
0% 
(0) 
-16.67% 
(-16.67) 
-43.14% 
(-14.55) 
+63.25% 
(+23.32) 
-42.55% 
(-0.197) 
0% 
(0) 
+40% 
(+2) 
+133.3% 
(+4) 
-26.17% 
(-19.63) 
-44.44% 
(-33.33) 
-51.79% 
(-51.79) 
L5P2 
-50% 
(-25) 
+4.35% 
(+3.57) 
-6.25% 
(-5) 
+25% 
(+8.34) 
-22.45% 
(-10.22) 
+122.6% 
(+16.29) 
-7.12% 
(-0.042) 
+9.1% 
(+5) 
+60% 
(+3) 
+37.5% 
(+3) 
+30.02% 
(+10.72) 
-21.94% 
(-9.37) 
+6.27% 
(+1.79) 
L5P3 
+14.3% 
(8.34) 
+16.66% 
(+10.71) 
0% 
(0) 
0% 
(0) 
-15.64% 
(-5.99) 
+8.71% 
(+5.07) 
+130% 
(+0.464) 
+25% 
(+15) 
0% 
(0) 
-33.34% 
(-2) 
+75.01% 
(+21.43) 
+16.25% 
(+13.54) 
0% 
(0) 
L5P4 
-40% 
(-33.33) 
-51.17% 
(-48.57) 
-52.63% 
(-50) 
-50% 
(-25) 
+37.17 
(+7.79) 
-45.9% 
(-17.39) 
0% 
(0) 
+1000% 
(+10) 
-300% 
(-3) 
0% 
(0) 
0% 
(0) 
-37.52% 
(-9.38) 
-81.82% 
(-16.07) 
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Appendix 27 
Additional and subgroup analysis of phase 3 data. 
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Appendix 27: Additional and subgroup analysis of phase 3 data. 
Although more detailed statistical analysis was not planned at the start of the study and caution 
needs to be applied to any results due to both the small sample size and nature of a pilot study, this 
additional exploration provides interesting information and may serve to indicate suitable designs for 
future study. 
 
27.1  Baseline data from the outcome measures. 
 
This section presents the baseline data for the participants derived from data collected at the first time point 
(M1) (Phase 3 timeline; figure 20, page 244). Where it was felt to be useful, the study population was also 
reviewed as two separate groups (L4 and L5) but any inferences have been treated with caution in view of the 
nature of the study and the small sample size (Sim and Lewis, 2011). Where the sample has been explored 
as two groups, the Mann Whitney U Test has been applied, the non-parametric test for differences between 
two groups (Pallant, 2007). 
 
27.2  Baseline CSQ data. 
 
Table 1 below provides the mean score and standard deviation for the four categories of the CSQ - general 
satisfaction, professional care, depth of relationship and length of consultation - for the participants in L4, L5. 
In addition, established scores from a large primary care study were used for comparison (Shum et al, 2001).  
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Table 1: Mean and SD scores for baseline CSQ Phase 3 and Shum et al (2001). 
 L4 Scores 
(n=5) 
SD  L5 Scores 
(n=4) 
SD Nurse study 
(n) (Shum et 
al, 2001) 
SD 
General satisfaction 
(mean) 
98.3  3.72  64.58  14.23  78.6 (635) 16.0  
Professional care     
(mean) 
98.3  3.72  81.25  13.61  79.2 (662) 13.4  
Depth of relationship 
(mean) 
99.0  2.23  77.5  16.58  64.3 (618) 15.7  
Length of consultation 
(mean) 
98.3  3.73  64.58 29.17  73.3 (645) 16.9  
 
The standard deviation of these scores represents the variation of distribution (Pallant, 2007). Here it reveals 
that the L4 study population, the clinic attenders with a single nurse, demonstrated far greater homogeneity 
(SD range 2.23 - 3.73) when compared to the L5 sample, the traditional home care group (SD range 13.61 - 
29.17).  
 
When the raw data was appraised, of the possible 20 scores for this subset of patients, 100% satisfaction was 
achieved on 17 of these occasions for the L4 participants whereas, for L5, a score of 100% was achieved on 
only one occasion of the total 16 available. Thus, mean baseline scores for L4 indicate higher levels of 
satisfaction overall than the L5 group and when compared to the nurse study (Shum et al, 2001). All four 
subscales reveal lower scores for the L5 patients when compared to L4 baseline scores, although scores for 
professional care and the depth of relationship were both above the means cited in Shum et al (2001). Mann-
Whitney U tests were undertaken in order to establish whether the difference in scores between L4 and L5 
were of significance. The test revealed significant differences in: 
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 General satisfaction outcome of L4 (Md=100, n=5) and L5 (Md=62.5, n=4), U=0.000, z=-2.56, 
p=0.011, r=0.85.  
 Professional care outcome of L4 (Md=100, n=5) and L5 (Md=82.14, n=4), U=0.000, z=-2.3, p=0.007, 
r=0.65.  
 Depth of relationship outcome of L4 (Md=100, n=5) and L5 (Md=80, n=4), U=0.500, z=-2.45, 
p=0.014, r=0.67.  
 The test also revealed a difference in the perceived time outcome, but this was not deemed to be of 
statistical significance. L4 (Md=100, n=5) and L5 (Md=62.5, n=4), U=3.0, z=-1.88, p=0.060, r=0.62.  
  
Baseline CSQ scores demonstrate that L4 were consistently more satisfied with their care than both L5 and 
Shum et al (2001). 
 
27.3  Baseline SF-12 data. 
 
The SF12 results provide the physical and mental health composite scores (PCS and MCS) that have 
established UK norms (Gandek et al, 1998). When the participants were treated as a single group (n=9) and 
means compared to the UK norm (Gandek et al, 1998), a comparison of PCS and MCS outcomes was again 
undertaken using the Mann-Whitney U test in order to detect whether differences were of significance (table 2 
below). The test revealed: 
 No significant difference in the PCS of the overall sample (Md=32.05, n=9) and the UK norm 
(Md=50.9, n=1751), U=0.000, z=-1.00, p=0.317, r=-0.706.  
 No significant difference in the MCS of the overall sample (Md=46.92, n=9) and the UK norm 
(Md=52.1, n=1751), U=0.000, z=-1.00, p=0.317, r=-0.18. 
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Table 2: Mean and SD scores for baseline SF-12 Phase 3 and Gandek et al (1998). 
 
 All Scores 
(n=9) 
SD  Gandek et al 
(1998) (n=1751) 
UK norm scores. 
SD  
PCS-12 (mean) 32.05 9.5 50.9 9.4 
MCS-12 
(mean) 
46.92 17.99 52.1 8.7 
 
Baseline scores are displayed in table 3 below and reveal both L4 and L5 to have substantially lower PCS-12 
scores at 29.99 and 34.6 respectively, when compared to the UK norm score (Gandek et al, 1998) of 50.9.  In 
contrast, the L4 MCS-12 value (55.21) was higher than both the UK norm (Gandek et al, 1998) (52.1) and the 
L5 score, which at 36.55 was significantly below the norm.  
 
Table 3: Mean and SD scores for baseline SF-12 Phase 3 and Gandek et al (1998). 
 L4 Scores 
(n=5) 
SD  L5 Scores 
(n=4) 
SD Gandek et al 
(1998) (n=1751) 
UK norm scores. 
SD  
PCS-12 
(mean) 
29.99 9.53 34.63 10.33 50.9 9.4 
MCS-12 
(mean) 
55.21 14.18 36.55 18.35 52.1 8.7 
 
These results demonstrate poorer physical functioning than the UK norm for both groups. Also, reduced 
mental functioning for the L5 group. In contrast, mental functioning above that of the UK norm was 
demonstrated at baseline for the L4 participants. 
 
434 
 
When the participants were treated as two independent groups, a comparison of PCS and MCS outcomes 
was undertaken, again using the Mann-Whitney U test, in order to detect whether any of these differences 
were of significance. The test revealed: 
 
 No significant difference in the PCS of L4 (Md=100, n=5) and L5 (Md=62.5, n=4), U=7.0,  z=-0.735, 
p=0.462, r=-0.23.  
 A difference in MCS, but did not deem this to be of statistical significance, between L4 (Md=100, 
n=5) and L5 (Md=82.14, n=4), U=3.0, z=-1.715, p=0.086, r=0.49.  
 
Table 4 below displays age-matched PCS and MCS scores for the sample as a whole (n=9) and 
demonstrates that the lowest overall scores for both of these outcomes was in the under 45 years age range, 
demonstrating severely compromised PCS (21.72) and compromised MCS (41.35) when compared to other 
age ranges and the UK norm (Gandek et al, 1998).   
 
Table 4: Comparison of SF-12 PCS & MCS scores with age-matched general population. 
Age 
(banded) 
N SF-12 PCS & MCS Mean 
Values. 
Population Value. 
(Gandek et al, 1998) 
PCS Mean MCS Mean PCS Mean MCS Mean  
Under 45 2 21.72 41.35 53.4 52.2 
46 - 64 1 42.0 41.71 48.7 51.4 
65 – 74 4 34.57 52.14 44.8 53.2 
Over 75 2 32.38 44.66 Not available. 
 
Baseline SF-12 data demonstrates that L4 participants were the most physically compromised, but both 
groups fall below the UK norm. In contrast L4 displayed greater mental functioning than both L5 and UK 
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values. The younger patients were, overall, more compromised in physical and mental health than other age 
ranges and the UK values (Gandek et al, 1998). 
 
27.4  Baseline EQ-5D data. 
 
The scores from the EG-5D provide a Crosswalk score for the EQ Index value and a visual assessment scale 
score (VAS) are recorded in table 5 below. This instrument is again well used with established UK norms. 
Baseline scores for both L4 and L5 are below the EuroQol (1990) published data (0.76) (table 5 below). L5 is 
particularly compromised at 0.362. Again, both L4 and L5 demonstrated compromised EQ VAS scores at 59 
and 41.25 respectively compared to a population norm of 84 (EuroQol, 1990). 
 
Table 5: Mean and SD scores for baseline EQ-5D Phase 3 and EuroQol Group (1990). 
 L4 Scores 
(n=5) 
SD  L5 Scores 
(n=4) 
SD EuroQol (1990) 
(n=110) 
SD  
EQ Index Value 
(mean) 
0.63 0.21 0.362 0.24 0.76 0.015 
(Standard 
error) 
EQ VAS 
(mean) 
59.0 13.416 41.25 27.8 84.0 12.6 SD 
 
Applying the Mann-Whitney U test in order to detect the significance of these differences revealed: 
 No significant difference in the EQ Index Value between L4 (Md=.635, n=5) and L5 (Md=.41, n=4), 
U=4.0, z=-1.476, p=0.140, r=0.51.  
 No significant difference in EQ VAS score between L4 (Md=65.0, n=5) and L5 (Md=52.5, n=4), 
U=5.500, z=-1.112, p=0.266, r=0.377. 
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As with the SF-12, when the results were reviewed in terms of age range (table 6), the under 45 years were 
most severely compromised at 0.173 compared to a population value for that age range of 0.9 (Dolan, 1997). 
 
Table 6: Comparison of EQ-5D scores with age-matched general population. 
Age (banded) N EQ-5D Crosswalk Utility 
Mean Value 
Population Value (Dolan, 
1997) 
  
Under 45 2 0.173 0.90 
46 - 64 1 0.635 0.82 
65 – 74 4 0.55 0.78 
Over 75 2 0.702 0.73 
 
A review of baseline data for EQ-5D scores demonstrated compromised scores for both L4 and L5, with the 
L5 participants being the most severely compromised. Again, those under 45 demonstrated the greatest 
deficits.  
 
 
27.5  Baseline CWIS data. 
 
The CWIS provides five areas of scoring: physical symptoms, social life, well-being along with two HRQoL 
measures, global HRQoL and participant satisfaction with their HRQoL. Table 7 below provides a comparison 
of means for L4, L5 and established scores derived from Price and Harding’s (2004) data.  
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Table 7: Mean and SD scores for baseline CWIS Phase 3 and Price and Harding (2004). 
 L4 Scores 
(n=5) 
SD  L5 Scores 
(n=4) 
SD Non-healed 
(n=89) (Price& 
Harding, 2004) 
Physical symptoms 
(mean) 
70.68 24.99  56.51 27.35  71.7 
 
 
Social life (mean) 78.93 19.54  62.05 43.97  76.1 
 
Well-being (mean) 36.41 17.23  37.5 27.12  38.7 
 
Global HRQoL 
(mean) 
6.2 1.30  5.0 1.63  6.9 
Satisfaction with 
HRQoL (mean) 
7.2 1.92  3.25 2.36 6.7 
 
Baseline scores for L4 indicate higher levels of functioning in the areas of physical symptoms and everyday 
living, when compared to both L5 patients and for the Price and Harding (2004) study. L5 scores for all three 
subscales, physical functioning, social life and well-being, are all lower when compared to Price and Harding’s 
(2004) data. Global HRQoL has the highest values in Price and Harding (2004) study at 6.9. L4 participants 
generated a mean of 6.2 for their global HRQoL whereas L5 was more compromised in this area with a score 
of 5.0. The L4 participants were most satisfied with their HRQoL (7.2), followed by Price and Harding (2004) 
at 6.7. L5 patients were much less satisfied with their HRQoL at baseline with a score of only 3.25. 
 
Where the participants were treated as two independent groups and the five outcomes compared using the 
Mann-Whitney U test in order to detect the significance of any differences, the test revealed: 
 No significant difference in the physical symptoms outcome of L4 (Md=68.75, n=5) and L5 
(Md=58.85, n=4), U=7.000, z=-0.735, p=0.462, r=0.261. 
 No significant difference in the social life outcome of L4 (Md=85.71, n=5) and L5 (Md=64.29, n=4), 
U=10.000, z=0.000, p=1.0, r=0.24. 
438 
 
 No significant difference in the well-being outcome of L4 (Md=32.14, n=5) and L5 (Md=32.14, n=4), 
U=9.50, z=-0.123, p=0.902, r=-0.024. 
 No significant difference in the global HRQoL outcome between L4 (Md=6, n=5) and L5 (Md=5, n=4), 
U=5.50, z=-1.157, p=0.247, r=0.38.  
 The test did however reveal a significant difference in satisfaction with the HRQoL outcome between 
L4 (Md=8, n=5) and L5 (Md=4, n=4), U=2.0, z=-1.976 p=0.048, r=0.68, demonstrating that the L4 
participants were more satisfied with their HRQoL. 
 
A review of CWIS data revealed that L4 had improved functioning in physical symptoms and social life when 
compared to the L5 participants, but reduced well-being. Global HRQoL and participant satisfaction with their 
HRQoL was compromised for the L5 participants. 
 
When reviewing CWIS, QoL and satisfaction with QoL were noticeably diminished for the younger 
participants. Paul (34), who lived alone, in L4 revealed a QoL score of 5 and a satisfaction of 4 and Cath (45), 
who lived with her supportive family, in L5 a QoL score of 3 and a satisfaction score of 0 at the first data 
collection point.  
 
27.6  Summary of baseline data. 
 
This section has provided a review of the baseline scores for all outcome measures for phase 3 participants 
and compared these to established UK norm scores, where available. This data has provided an insight into 
the characteristics of the study population at the start of this quantitative phase. Mann Whitney U Tests were 
applied in order to establish whether L4 and L5 data differ significantly at baseline. 
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27.7  Mann Whitney U Test. 
 
Where the participants were treated as two independent groups, L4 and L5, a comparison of all scores at 
each time point was undertaken using the Mann-Whitney U test in order to detect whether the L4 participants 
differed from those in the L5 group. 
 
Mann Whitney U Test M1. 
 
Table 8: Mann Whitney U Test of all scores between L4 and L5 at M1. 
 U Z p r Md Grp 1 Md Grp 2 
CSQ – GS  0.00 -2.558 0.01 0.85 100 62.5 
CSQ – PC  0.00 -2.697 0.01 0.9 100 82.14 
CSQ – DR  0.5 -2.453 0.01 0.82 100 80.0 
CSQ – PT 3.0 -1.878 0.06 0.62 100 62.5 
PCS 7.0 -0.735 0.46 0.25 29.44 36.02 
MCS 3.0 -1.715 0.09 0.57 50.57 37.38 
EQ5D Cross 4.0 -1.476 0.14 0.49 0.635 0.41 
EQ5D VAS 5.5 -1.112 0.27 0.37 65.0 52.50 
CWIS QoL 5.5 -1.157 0.25 0.39 6.0 5.0 
CWIS Satis 2.0 -1.976 0.05 0.66 8.0 4.0 
CWIS WB 9.5 -0.123 0.9 0.04 32.14 32.14 
CWIS PS 7.0 -0.735 0.46 0.25 68.75 58.85 
CWIS SL 10.0 0.000 1.0 0 85.71 64.28 
 
Table 8 above demonstrates that three of the four composite scores (general satisfaction, professional care, 
depth of relationship) of the CSQ demonstrated a statistically significant difference between the L4 
participants and those in the L5 group, with L4 demonstrating higher levels of satisfaction when compared to 
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L5. In addition the CWIS satisfaction with QoL also demonstrated a statistically significant difference between 
the L4 and L5 participants, with the L4 participants being more satisfied with their QoL score than L5. 
 
27.8  Mann Whitney U Test M2. 
 
Table 9: Mann Whitney U Test of all scores between L4 and L5 at M2. 
 U Z p r Md Grp 1 Md Grp 2 
CSQ – GS  0.000 -2.588 0.01 0.86 100.0 45.84 
CSQ – PC  0.000 -2.588 0.01 0.86 100.0 78.57 
CSQ – DR  0.000 -2.588 0.01 0.86 100.0 65.0 
CSQ – PT 0.000 -2.57 0.01 0.86 100.0 58.34 
PCS 6.0 -0.98 0.33 0.33 32.5 30.5 
MCS 8.0 -0.49 0.62 0.16 55.71 44.885 
EQ5D Cross 8.0 -0.49 0.62 0.16 0.555 0.407 
EQ5D VAS 5.5 -1.126 0.26 0.38 70.0 55.0 
CWIS QoL 7.0 -1.126 0.44 0.38 6.0 7.0 
CWIS Satis 10.0 0.000 1.0 0 5.0 5.0 
CWIS WB 7.5 -0.615 0.54 0.21 50.00 48.2 
CWIS PS 7.0 -0.738 0.46 0,25 90.63 37.5 
CWIS SL 3.5 -1.663 0.1 0.54 100.0 39.285 
 
Table 9 demonstrates that when the Mann Whitney U Test was repeated at M2, all four composite scores of 
the CSQ (general satisfaction, professional care, depth of relationship and perceived time) demonstrated a 
statistically significant difference between L4 and L5, with L4 being more satisfied at each time point 
compared to L5. 
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27.9  Mann Whitney U Test M3. 
 
At M3 just two of the composite scores (depth of relationship and perceived time) of the CSQ and the PCS 
scores demonstrated a statistically significant difference between L4 and L5, with L4 again being more 
satisfied at each time point when compared to L5 and also having a higher physical functioning composite 
score (table 10 below). 
 
Table 10: Mann Whitney U Test between groups at M3. 
 U Z p R Md Grp 1 Md Grp 2 
CSQ – GS  0.000 -2.697 0.07 0.9 100.0 54.17 
CSQ – PC  5.00 -1.677 0.09 0.6 100.0 82.15 
CSQ – DR  0.000 -2.683 0.01 0.89 100.0 57.5 
CSQ – PT 2.500 -2.196 0.03 0.73 100.0 4.165 
PCS 2.00 -1.96 0.05 0.653 40.48 27.445 
MCS 4.00 -1.47 0.14 0.49 57.47 40.655 
EQ5D Cross 7.00 -0.738 0.46 0.25 0.654 0.464 
EQ5D VAS 6.500 -0.878 0.38 0.29 70.0 45.0 
CWIS QoL 9.500 -0.135 0.89 0.05 7.0 6.0 
CWIS Satis 4.00 -1.535 0.13 0.51 7.0 5.0 
CWIS WB 10.00 0.0 1.0 0 60.71 44.645 
CWIS PS 7.00 -0.735 0.46 0.25 80.36 44.275 
CWIS SL 6.00 -0.997 0.32 0.33 94.64 54.46 
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27.91  Mann Whitney U Test M4. 
 
Finally, at M4 two of the composite scores (general satisfaction and perceived time) of the CSQ continued to 
demonstrate a statistically significant difference between L4 and L5, with L4 being more satisfied at this time 
point compared to L5 (table 11 below). 
 
Table 11: Mann Whitney U Test between groups at M4. 
 U Z p r Md Grp 1 Md Grp 2 
CSQ – GS  0.000 -2.697 0.01 0.9 100.0 70.84 
CSQ – PC  3.00 -1.878 0.06 0.63 100.0 83.93 
CSQ – DR  3.00 -1.878 0.06 0.63 100.0 70.0 
CSQ – PT 0.000 -2,683 0.01 0.9 100.0 50.0 
PCS 8.00 -0.49 0.62 0.16 35.64 30.01 
MCS 9.00 -0.2545 0.81 0.08 45.07 47.255 
EQ5D Cross 7.00 -0.735 0.46 0.25 0.65 0.48 
EQ5D VAS 10.00 0.00 1.0 0 60.0 60.0 
CWIS QoL 6.50 -0.876 0.38 0.29 7.0 5.5 
CWIS Satis 9.00 -0.254 0.8 0.08 7.0 5.0 
CWIS WB 8.00 -0.49 0.62 0.16 50.00 50.00 
CWIS PS 7.50 -0.615 0.54 0.21 91.66 54.17 
CWIS SL 4.50 -1.407 0.16 0.47 100.00 66.08 
 
These Mann Whitney U scores demonstrate overall differences between L4 and L5 in relation to the 
composite scores of the CSQ at all four time points, with a large effect size, demonstrating increased 
satisfaction with all areas of care for the L4 participants at each time point.  
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Appendix 28 
Phase 3 Staff Questionnaire. 
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Appendix 29 
Conference Presentations. 
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Conference Presentations. 
Regional Conference Presentations: 
 
Green, J. (2010). “My leg ulcers are ruining my life…” Poster presented at the Keele University 
Research Symposium, 5th May 2010.  
 
Green, J. (2012). Do patient centred consultations improve quality of life for people with chronic 
venous ulcers? Institute of Primary Care and Health Sciences Symposium, Keele University 28th 
May 2012. 
 
National Conference Presentations: 
 
Green, J. (2012). Patient centred consultations in chronic venous leg ulcer care. ‘Living and 
Researching Later Life’, Emerging Researchers in Ageing Conference, Keele University 10th July 
2012. 
 
Green, J. (2012). Nurse-patient leg ulcer consultations in primary care – do patients disclose their 
concerns? Society of Academic Primary Care (North) Conference, Kendal, 22nd November 2012. 
Winner of Best in Research Award. 
 
Green, J. (2013). Nurse-patient leg ulcer consultations in primary care – do patients disclose their 
concerns? Ageing Conference, Aston University, Birmingham, 25th April 2013. 
 
International Conference Presentations: 
 
Green, J. (2010). 'Chronic venous leg ulcers and quality of life'. Poster presented at Wounds UK 
Conference, Harrogate, 15 - 17th November 2010. 
 
Green, J. (2011). What are the factors that impact on the day-to-day lives of people with leg ulcers? 
Concurrent session presented at the Royal College of Nursing International Research Conference, 
Harrogate 17th May 2011. 
 
Green, J. (2011). Are we missing the point? What factors impact on the daily lives of people with leg 
ulcers and do we currently address these during their consultations? Free Paper presented at 
Wounds UK Harrogate, 15th November 2011. 
 
Green, J. (2012). The application of the nominal group technique in the design of a consultation 
template for use with patients with leg ulceration. Concurrent session presented at the Royal College 
of Nursing International Research Conference, London 24th April 2012. 
 
Green, J. (2012). Nurse-patient leg ulcer consultations in primary care – do patients disclose their 
concerns? Wounds UK Patient Wellbeing winning presentation, 13th November 2012. 
 
Green, J. (2013). Nurse-patient consultations in primary care. Transforming Community Health 
International Conference, Edinburgh, 13-14th March 2013. 
 
Green, J. (2013). Nurse-patient leg ulcer consultations in primary care – do patients disclose their 
concerns? European Wound Management Association Conference, Copenhagen, 15th May 2013. 
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Appendix 30 
Publications from the study. 
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